Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Less pain. Less opioids. From the start. OFIRMEV® provides significant pain relief*1 • OFIRMEV 1 g (Q6h) + patient-controlled analgesia (PCA) morphine demonstrated significant pain relief vs placebo + PCA morphine (P<0.05 over 6 h)1 • OFIRMEV 1 g (Q6h) + PCA morphine showed greater reduction in pain intensity over 24 h (SPID24)† compared to placebo + PCA morphine (P<0.001)2 OFIRMEV reduces opioid consumption*1 • OFIRMEV 1 g (Q6h) + PCA morphine significantly reduced morphine consumption vs placebo + PCA morphine (–46% over 6 h, P<0.01; –33% over 24 h, P<0.01)1 • The clinical benefit of reduced opioid consumption was not demonstrated OFIRMEV from the start • Consider administering the first dose of OFIRMEV PreOp or post-induction • Schedule OFIRMEV Q6h for first 24 h and continue as clinically warranted INDICATIONS AND USAGE OFIRMEV® (acetaminophen) injection is indicated for the management of mild to moderate pain, management of moderate to severe pain with adjunctive opioid analgesics, and reduction of fever. IMPORTANT RISK INFORMATION WARNING: RISK OF MEDICATION ERRORS AND HEPATOTOXICITY Take care when prescribing, preparing, and administering OFIRMEV Injection to avoid dosing errors which could result in accidental overdose and death. In particular, be careful to ensure that: • the dose in milligrams (mg) and milliliters (mL) is not confused; • the dosing is based on weight for patients under 50 kg; • infusion pumps are properly programmed; and • the total daily dose of acetaminophen from all sources does not exceed maximum daily limits. OFIRMEV contains acetaminophen. Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed the recommended maximum daily limits, and often involve more than one acetaminophen-containing product. CONTRAINDICATIONS • Acetaminophen is contraindicated in patients with: − known hypersensitivity to acetaminophen or to any of the excipients in the intravenous (IV) formulation. − severe hepatic impairment or severe active liver disease. WARNINGS AND PRECAUTIONS • Administration of acetaminophen in doses higher than recommended may result in hepatic injury, including the risk of liver failure and death. Do not exceed the maximum recommended daily dose of acetaminophen. The maximum recommended daily dose of acetaminophen includes all routes of acetaminophen administration and all acetaminophen-containing products administered, including combination products. Dosing errors could result in accidental overdose and death. Please see Brief Summary of Full Prescribing Information, including complete boxed warning, on the following page. Mallinckrodt, the “M” brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2014 Mallinckrodt. OFV1513 10/14 | OFIRMEV.com • Use caution when administering acetaminophen in patients with the following conditions: hepatic impairment or active hepatic disease, alcoholism, chronic malnutrition, severe hypovolemia (e.g., due to dehydration or blood loss), or severe renal impairment (creatinine clearance ≤ 30 mL/min). • Rarely, acetaminophen may cause serious skin reactions such as acute generalized exanthematous pustulosis (AGEP), Stevens-Johnson Syndrome (SJS), and toxic epidermal necrolysis (TEN), which can be fatal. • Hypersensitivity and anaphylaxis associated with the use of acetaminophen have been reported. Clinical signs included swelling of the face, mouth, and throat, respiratory distress, urticaria, rash, and pruritus. • The antipyretic effects of OFIRMEV may mask fever. ADVERSE REACTIONS • Serious adverse reactions may include hepatic injury, serious skin reactions, hypersensitivity, and anaphylaxis. • Common adverse reactions in adults include nausea, vomiting, headache, and insomnia. Common adverse reactions in pediatric patients include nausea, vomiting, constipation, pruritus, agitation, and atelectasis. USE IN SPECIFIC POPULATIONS • Pregnancy: Pregnancy Category C. OFIRMEV should be given to a pregnant woman only if clearly needed. • Breast Feeding: While studies with OFIRMEV have not been conducted, acetaminophen is secreted in human milk in small quantities after oral administration. • Pediatrics: The effectiveness of OFIRMEV for the treatment of acute pain and fever has not been studied in pediatric patients < 2 years of age. To report SUSPECTED ADVERSE REACTIONS, contact Mallinckrodt Pharmaceuticals, at 1.800.778.7898 or FDA at 1.800.FDA.1088 or www.fda.gov/medwatch. *Randomized, double-blind, placebo-controlled, single- and repeated-dose 24-h study (n=101). Patients received OFIRMEV 1 g + PCA morphine or placebo + PCA morphine the morning following total hip or knee replacement surgery. Primary endpoint: pain relief measured on a 5-point verbal scale over 6 h. Morphine rescue was administered as needed. †SPID24=sum of pain intensity differences, based on VAS score, from baseline, at 0 to 24 h. References: 1. Sinatra RS, Jahr JS, Reynolds LW, et al. Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology. 2005;102:822-831. 2. Sinatra RS, Jahr JS, Reynolds L, et al. Intravenous acetaminophen for pain after major orthopedic surgery: an expanded analysis. Pain Pract. 2012;12:357-365. 2.4 Instructions for Intravenous Administration For adult and adolescent patients weighing ≥ 50 kg requiring 1000 mg doses of OFIRMEV, administer the dose by inserting a vented intravenous set through the septum of the 100 mL vial. OFIRMEV may be administered without further dilution. Examine the vial contents before dose preparation or administering. DO NOT USE if particulate matter or discoloration is observed. Administer the contents of the vial intravenously over 15-minutes. Use aseptic technique when preparing OFIRMEV for intravenous infusion. Do not add other medications to the OFIRMEV vial or infusion device. For doses less than 1000 mg, the appropriate dose must be withdrawn from the vial and placed into a separate container prior to administration. Using aseptic technique, withdraw the appropriate dose (650 mg or weight-based) from an intact sealed OFIRMEV vial and place the measured dose in a separate empty, sterile container (e.g. glass bottle, plastic intravenous container, or syringe) for intravenous infusion to avoid the inadvertent delivery and administration of the total volume of the commercially available container. The entire 100 mL vial of OFIRMEV is not intended for use in patients weighing less than 50 kg. OFIRMEV is a single-use vial and the unused portion must be discarded. Place small volume pediatric doses up to 60 mL in volume in a syringe and administer over 15 minutes using a syringe pump. Monitor the end of the infusion in order to prevent the possibility of an air embolism, especially in cases where the OFIRMEV infusion is the primary infusion. Once the vacuum seal of the glass vial has been penetrated, or the contents transferred to another container, administer the dose of OFIRMEV within 6 hours. Do not add other medications to the OFIRMEV solution. Diazepam and chlorpromazine hydrochloride are physically incompatible with OFIRMEV, therefore do not administer simultaneously. 3 DOSAGE FORMS AND STRENGTHS OFIRMEV is a sterile, clear, colorless, non pyrogenic, preservative free, isotonic formulation of acetaminophen intended for intravenous infusion. Each 100 mL glass vial contains 1000 mg acetaminophen (10 mg/mL). 4 CONTRAINDICATIONS Acetaminophen is contraindicated: t in patients with known hypersensitivity to acetaminophen or to any of the excipients in the intravenous formulation. t in patients with severe hepatic impairment or severe active liver disease. 5 WARNINGS AND PRECAUTIONS 5.1 Hepatic Injury Administration of acetaminophen in doses higher than recommended may result in hepatic injury, including the risk of liver failure and death. Do not exceed the maximum recommended daily dose of acetaminophen. The maximum recommended daily dose of acetaminophen includes all routes of acetaminophen administration and all acetaminophen-containing products administered, including combination products. Use caution when administering acetaminophen in patients with Table 1: Dosing for Adults and Adolescents the following conditions: hepatic impairment or active hepatic Dose given Dose given Maximum single Maximum total Age group every 4 hours every 6 hours dose daily dose of disease, alcoholism, chronic malnutrition, severe hypovolemia acetaminophen (e.g., due to dehydration or blood loss), or severe renal impairment (by all routes) (creatinine clearance ≤ 30 mL/min). 650 mg 1000 mg 1000 mg 4000 mg in Adults and 5.2 Serious Skin Reactions 24 hours adolescents (13 years and older) Rarely, acetaminophen may cause serious skin reactions such weighing ≥ 50 kg as acute generalized exanthematous pustulosis (AGEP), StevensJohnson Syndrome (SJS), and toxic epidermal necrolysis (TEN), which Adults and 12.5 mg/kg 15 mg/kg 15 mg/kg 75 mg/kg in adolescents (13 (up to 750 mg) 24 hours can be fatal. Patients should be informed about the signs of serious years and older) (up to 3750 mg) skin reactions, and use of the drug should be discontinued at the first weighing < 50 kg appearance of skin rash or any other sign of hypersensitivity. 5.3 Risk of Medication Errors 2.3 Recommended Dosage: Children Take care when prescribing, preparing, and administering OFIRMEV Children 2 to 12 years of age: the recommended dosage of OFIRMEV (acetaminophen) Injection in order to avoid dosing errors which could is 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours, with a result in accidental overdose and death. In particular, be careful to maximum single dose of OFIRMEV of 15 mg/kg, a minimum dosing ensure that: interval of 4 hours, and a maximum daily dose of acetaminophen of t the dose in milligrams (mg) and milliliters (mL) is not confused; 75 mg/kg per day. t the dosing is based on weight for patients under 50 kg; t infusion pumps are properly programmed; and Table 2: Dosing for Children t the total daily dose of acetaminophen from all sources does not Dose given Dose given Maximum single Maximum total Age group exceed maximum daily limits. every 4 hours every 6 hours dose daily dose of Brief Summary (For full Prescribing Information refer to package insert.) WARNING: Risk of Medication Errors and Hepatotoxicity Take care when prescribing, preparing, and administering OFIRMEV® Injection to avoid dosing errors which could result in accidental overdose and death. In particular, be careful to ensure that: t the dose in milligrams (mg) and milliliters (mL) is not confused; t the dosing is based on weight for patients under 50 kg; t infusion pumps are properly programmed; and t the total daily dose of acetaminophen from all sources does not exceed maximum daily limits. OFIRMEV contains acetaminophen. Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed the maximum daily limits, and often involve more than one acetaminophencontaining product (see WARNINGS). 1 INDICATIONS AND USAGE OFIRMEV® (acetaminophen) injection is indicated for t the management of mild to moderate pain t the management of moderate to severe pain with adjunctive opioid analgesics t the reduction of fever. 2 DOSAGE AND ADMINISTRATION 2.1 General Dosing Information OFIRMEV may be given as a single or repeated dose for the treatment of acute pain or fever. No dose adjustment is required when converting between oral acetaminophen and OFIRMEV dosing in adults and adolescents who weigh 50 kg and above. Calculated maximum daily dose of acetaminophen is based on all routes of administration (i.e., intravenous, oral, and rectal) and all products containing acetaminophen. Exceeding the maximum mg/kg daily dose of acetaminophen as described in Tables 1 and 2 may result in hepatic injury, including the risk of liver failure and death. To avoid the risk of overdose, ensure that the total amount of acetaminophen from all routes and from all sources does not exceed the maximum recommended dose. 2.2 Recommended Dosage: Adults and Adolescents Adults and adolescents weighing 50 kg and over: the recommended dosage of OFIRMEV is 1000 mg every 6 hours or 650 mg every 4 hours, with a maximum single dose of OFIRMEV of 1000 mg, a minimum dosing interval of 4 hours, and a maximum daily dose of acetaminophen of 4000 mg per day (includes all routes of administration and all acetaminophen-containing products including combination products). Adults and adolescents weighing under 50 kg: the recommended dosage of OFIRMEV is 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours, with a maximum single dose of OFIRMEV of 15 mg/kg, a minimum dosing interval of 4 hours, and a maximum daily dose of acetaminophen of 75 mg/kg per day (includes all routes of administration and all acetaminophen-containing products including combination products). acetaminophen (by all routes) Children 2 to 12 years of age 12.5 mg/kg 15 mg/kg 15 mg/kg (up to 750 mg) 75 mg/kg in 24 hours (up to 3750 mg) 5.4 Allergy and Hypersensitivity There have been post-marketing reports of hypersensitivity and anaphylaxis associated with the use of acetaminophen. Clinical signs included swelling of the face, mouth, and throat, respiratory distress, urticaria, rash, and pruritus. There were infrequent reports of life-threatening anaphylaxis requiring emergent medical attention. Discontinue OFIRMEV immediately if symptoms associated with allergy or hypersensitivity occur. Do not use OFIRMEV in patients with acetaminophen allergy. 6 ADVERSE REACTIONS The most common adverse reactions in patients treated with OFIRMEV were nausea, vomiting, headache, and insomnia in adult patients and nausea, vomiting, constipation, pruritus, agitation, and atelectasis in pediatric patients. To report SUSPECTED ADVERSE REACTIONS, contact Cadence Pharmaceuticals Inc. at 1-877-647-2239 or FDA at 1-800-FDA1088 or www.fda.gov/medwatch. 7 DRUG INTERACTIONS 7.1 Effects of other Substances on Acetaminophen Substances that induce or regulate hepatic cytochrome enzyme CYP2E1 may alter the metabolism of acetaminophen and increase its hepatotoxic potential. The clinical consequences of these effects have not been established. Effects of ethanol are complex, because excessive alcohol usage can induce hepatic cytochromes, but ethanol also acts as a competitive inhibitor of the metabolism of acetaminophen. 7.2 Anticoagulants Chronic oral acetaminophen use at a dose of 4000 mg/day has been shown to cause an increase in international normalized ratio (INR) in some patients who have been stabilized on sodium warfarin as an anticoagulant. As no studies have been performed evaluating the short-term use of OFIRMEV in patients on oral anticoagulants, more frequent assessment of INR may be appropriate in such circumstances. 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy Pregnancy Category C. There are no studies of intravenous acetaminophen in pregnant women. OFIRMEV should be given to a pregnant woman only if clearly needed. 8.3 Nursing Mothers Caution should be exercised when OFIRMEV is administered to a nursing woman. 8.4 Pediatric Use Pediatric Use: The effectiveness of OFIRMEV for the treatment of acute pain and fever has not been studied in pediatric patients less than 2 years of age. The safety and effectiveness of OFIRMEV in pediatric patients older than 2 years is supported by evidence from adequate and well controlled studies in adults with additional safety and pharmacokinetic data for this age group. 8.5 Geriatric Use No overall differences in safety or effectiveness were observed between geriatric subjects and younger subjects. 8.6 Patients with Hepatic Impairment OFIRMEV is contraindicated in patients with severe hepatic impairment or severe active liver disease and should be used with caution in patients with hepatic impairment or active liver disease. A reduced total daily dose of acetaminophen may be warranted. 8.7 Patients with Renal Impairment In cases of severe renal impairment (creatinine clearance ≤ 30 mL/min), longer dosing intervals and a reduced total daily dose of acetaminophen may be warranted. Manufactured for: Cadence Pharmaceuticals, Inc. San Diego, CA 92130 Revised 1/2014 U.S. PATENT NUMBERS: 6,028,222; 6,992,218 OFIRMEV ® and CADENCE ® are trademarks of Cadence Pharmaceuticals, Inc. © 2014 Cadence Pharmaceuticals, Inc. All rights reserved. OFV12821013BS ASCRS Premier Partners The American Society of Colon & Rectal Surgeons appreciates the role that health care companies play in helping the Society maintain its focus on colorectal surgery and enhance the care its members provide to patients. ASCRS thanks the following companies for their generous support of this year’s Annual Scientific Meeting. PLATINUM $100,000 + Applied Medical Ethicon Intuitive Surgical, Inc. Medtronic, plc GOLD $50,000 – $99,999 Mallinckrodt Pharmaceuticals Medtronic & Covidien SILVER $25,000 – $49,999 American Medical Systems Edwards Lifesciences KARL STORZ Endoscopy-America, Inc. Olympus Corporation of the Americas Richard Wolf Medical Instruments Corporation BRONZE $5,000 – $24,999 BK Ultrasound ConvaTec, Inc. Merck & Co., Inc. Salix Pharmaceuticals, Inc. OTHER CONTRIBUTORS ACell, Inc. Carl Zeiss Meditec CONMED CooperSurgical LABORIE LifeCell, an Acelity Company Novadaq Technologies, Inc. Pacira Pharmaceuticals, Inc. Redfield Corporation Seiler Instrument & Manufacturing Co, Inc. Stryker Endoscopy THD America The Prometheus Group Torax Medical, Inc. Zinnanti Surgical Design Group Inc. 2 Welcome to the ASCRS Annual Meeting May 30 – June 3, 2015 Hynes Convention Center & Sheraton Boston Hotel Boston, Massachusetts 3 Echelon Flex™ A better grip on movement Now experience the least tissue slippage during firing† The ECHELON FLEX™ GST System* is uniquely designed for better grip to provide you the least tissue slippage during firing.† Its enhanced end effector and proprietary reloads with Gripping Surface Technology now deliver 4X less tissue slippage‡ and reliable staple formation across a range of tissue thicknesses.§ A better way to staple— visit ethicon.com/gst or contact your local sales representative ECHELON FLEX™ GST System with Gripping Surface Technology * System components include ECHELON FLEX™ Powered Plus Stapler and ENDOPATH ECHELON™ Reloads with Gripping Surface Technology † Benchtop testing in porcine stomach tissue. Mean tissue movement from after clamping on tissue to after firing ECHELON FLEX Powered Plus Stapler (PSEE60A) and ECHELON Reload with GST vs ENDO GIA™ ULTRA Handle (EGIAUSTND) and Endo GIA™ Reload with Tri-Staple™ Technology at 1.5, 2.5, 3.3 and 4.0mm tissue thicknesses (1.5mm; GST60B 1.067mm vs EGIA60AMT 2.452mm p<0.001; 2.5mm: GST60G 1.148mm vs EGIA60AMT 3.261mm p<0.001; 3.3mm: GST60T 0.642mm vs EGIA60AMT 4.806mm p<0.001; 4.0mm: GST60T 0.654mm vs EGIA60AXT 5.116mm p<0.001). ‡ Benchtop testing in porcine stomach tissue. Mean tissue movement from after clamping on tissue to after firing ECHELON FLEX™ Powered Plus Stapler (PSEE60A) and ECHELON Reload with GST vs ENDO GIA™ ULTRA Handle (EGIAUSTND) and Endo GIA™ Reload with Tri-Staple™ Technology at 3.3 and 4.0mm tissue thicknesses (3.3mm: GST60T 0.642mm vs EGIA60AMT 4.806mm p<0.001; 4.0mm: GST60T 0.654mm vs EGIA60AXT 5.116mm p<0.001). The third-party trademarks used herein are trademarks of their respective owners. ©2015 Ethicon, Inc. All rights reserved. 028739-150129 § Porcine tissue thickness ranging from 1.0mm to 4.0mm measured at 8g/mm2 prior to firing. Tissue comfortably compressed to closed staple height per IFU. Page ASCRS Executive Council . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8 Program Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8 Education Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9 Online Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10 Maintenance of Certification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11 General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .12 Annual Named Lectures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .15 Masters in Colorectal Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .16 Awards . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .17 Non-CME Corporate Forums . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18 Thanks to our Corporate Supporters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .19 On-Going Video Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21 Daily Schedule . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .22 Schedule-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28 Committee Meetings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31 Past Presidents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32 Saturday Program Transanal Endoscopic Surgery Workshop . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33 AIN and HRA: What the Colorectal Surgeon Needs to Know Workshop . . . . . . . . . . . . . . . . . . . . . . . . . . . . .36 Laparoscopic Colectomy Symposium and Workshop . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .39 Optimal Management of Fecal Incontinence Symposium and Workshop . . . . . . . . . . . . . . . . . . . . . . . . . . .42 Robotic Colon and Rectal Surgery: Tips, Tricks, and Simulation Symposium and Workshop . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46 Symposium: Advanced Endoscopy and Endoluminal Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48 Question Writing Workshop: How to Write Exam Questions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50 Symposium: Improving Outcomes-Identifying and Managing the Complex Surgical Patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51 Sunday Program Core Subject Update . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52 Symposium: Healthcare Economics in the ACA Era . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53 Symposium: Quality Initiatives in Clinical Practice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54 Symposium: Laparoscopic Nuts & Bolts and Robotic Rivets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55 Symposium: Complications: Prevention and Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57 Luncheon Symposium: Current Advances in the Management of Fecal Incontinence . . . . . . . . . . . . . . . .58 Luncheon Symposium: The Genetics of Colorectal Cancer and Cancer Related Syndromes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59 Welcome and Opening Announcements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60 Symposium: Technical Pearls – How it’s Really Done . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61 Abstract Session: Neoplasia I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62 5 G E N E R A L I N F O R M AT I O N Table of Contents Table of Contents Norman D. Nigro, MD, Research Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .63 After Hours Debate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64 Welcome Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64 Monday Program Meet the Professor Breakfasts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65 Residents’ Breakfast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65 Symposium: Robotic Colorectal Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66 Symposium: Rectal Cancer: Optimizing Outcomes through Techniques . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67 Memorial Lectureship Honoring John M. MacKeigan, MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68 Presidential Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68 Symposium: Navigating a Career Path in Colon and Rectal Surgery – Orchestrating and Optimizing Career Transitions at All Levels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69 Abstract Session: Benign Colonic Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70 Symposium: Past Presidents’ Panel: Controversies and Cases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72 Abstract Session: Pelvic Floor/Anorectal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73 Harry E. Bacon, MD, Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75 Parviz Kamangar Humanities in Surgery Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75 Special Lecture: Trials and Tribulations of Clinical Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .76 What Receiving the Scholarship Means to Me . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .76 New Technologies Symposium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77 Tuesday Program Meet the Professor Breakfasts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78 Symposium: Anorectal Disorders: Balancing Innovation with Conventional Wisdom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79 Symposium: Update on Inflammatory Bowel Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .80 Ernestine Hambrick, MD, Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .81 Symposium: Controversies in Rectal Cancer Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82 Symposium: Ostomies: Location, Creation and Complications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .83 Abstract Session: General Surgery Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84 Masters in Colorectal Surgery Lectureship Honoring David J. Schoetz, Jr., MD . . . . . . . . . . . . . . . . . . . . . . .86 Women in Colorectal Surgery Luncheon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .86 Symposium: Anal Cancer: Prevention, Diagnosis and Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87 Abstract Session: Inflammatory Bowel Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88 Abstract Session: Research Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89 Symposium: Medical Legal Symposium: How to Protect Yourself . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .91 Symposium: Anal Fistulas: Diagnosis, Imaging and Therapy – Rational Approaches . . . . . . . . . . . . . . . . .93 After Hours Debate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .94 Residents’ Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .94 6 Wednesday Program Meet the Professor Breakfasts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95 Symposium: Colon Cancer: Staging, Techniques and the Role of Adjuvant Therapy . . . . . . . . . . . . . . . . .96 Abstract Session: Outcomes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97 ASCRS/SSAT Symposium: Challenges and Controversies: Surgical Management of Advanced Disease and Recurrent Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99 Abstract Session: Video Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100 Symposium: Optimizing Treatment for Rectal Prolapse, Constipation and Obstructed Defecation Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102 Abstract Session: Neoplasia II . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103 Symposium: Enhanced Perioperative Care Pathways and Postoperative Pain Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105 Symposium: Is there a Paradigm Shift in the Management of Diverticular Disease? . . . . . . . . . . . . . . . .106 ASCRS Annual Business Meeting and State of the Society Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .107 ASCRS Annual Reception and Dinner Dance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .107 Exhibits, Posters, Faculty, Disclosures ePosters of Distinction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .109 ePosters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .112 Featured Lecturers and Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .142 Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .149 Program Participant Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .154 Product Theaters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .156 Exhibits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .157 Maps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .172 The presentations, slides, and handouts provided in this program are the property of The American Society of Colon and Rectal Surgeons. Attendees may not photograph, videotape, audiotape or otherwise record or reproduce any of the presentations without express written permission from ASCRS. Any attendee believed to be violating this restriction will be removed from the session and may be prohibited from participating in further ASCRS events. ASCRS Administrative Office Diseases of the Colon & Rectum 85 West Algonquin Road, Suite 550 Arlington Heights, IL 60005 (847) 290-9184 • Fax: (847) 290-9203 www.fascrs.org Pat Oldenburg Managing Editor Phone: (218) 769-4464 7 G E N E R A L I N F O R M AT I O N Table of Contents ASCRS Executive Council Terry C. Hicks, MD President New Orleans, LA Charles E. Littlejohn, MD President Elect Stamford, CT Michael J. Stamos, MD Past President Orange, CA Gerald A. Isenberg, MD Vice President Philadelphia, PA Tracy L. Hull, MD Secretary Cleveland, OH Patricia L. Roberts, MD Treasurer Burlington, MA Steven D. Wexner, MD, PhD (Hon) Research Foundation President Weston, FL Elisa H. Birnbaum, MD Council Member (2013-2016) St. Louis, MO John E. Garry, MD Member-at-Large (2012-2015) Fresno, CA David A. Margolin, MD Member-at-Large (2013-2016) New Orleans, LA John R. T. Monson, MD Council Member (2014-2017) Rochester, NY Deborah A. Nagle, MD Member-at-Large (2012-2015) Boston, MA Heidi Nelson, MD Council Member (2014-2017) Rochester, MN Bruce A. Orkin, MD Council Member (2014-2017) Chicago, IL Harry T. Papaconstantinou, MD Member-at-Large (2012-2015) Temple, TX Thomas E. Read, MD Member-at-Large (2013-2016) Burlington, MA Program Committee David Margolin, MD Program Chair Maher Abbas, MD Karim Alavi, MD Suraj Alva, MD Louis Barfield, MD Mariana Berho, MD Joshua Bleier, MD Joseph Carmichael, MD Gentry Caton, MD Bradley Champagne, MD Hueylan Chern, MD Philip Cole, MD David Dietz, MD Gary Dunn, MD Sandy Fang, MD Jeffrey Farma, MD Emily Finlayson, MD Joseph Frenkel, MD Askash Gajjar, MD Virgilio George, MD Stephen Goldstone, MD Lori Gordon, MD Kerry Hammond, MD Imran Hassan, MD Alan Herline, MD Daniel Herzig, MD Terry Hicks, MD Stefan Holubar, MD Atif Iqbal, MD Barry Jenkins, MD Christine Jensen, MD H. David Vargas, MD Program Vice-Chair Thomas Read, MD Council Representative Shane McNevin, MD Genevieve Melton-Meaux, MD John Migaly, MD Nitin Mishra, MD Husein Moloo, MD R. Scott Nelson, DO Jitesh Patel, MD Walter Peters, Jr., MD Janice Rafferty, MD Jan Rakinic, MD Jennifer Rea, MD Craig Reickert, MD Rocco Ricciardi, MD Timothy Ridolfi, MD Bruce Robb, MD Brian Kann, MD Joshua Katz, MD Kevork Kazanjian, MD Gregory Kennedy, MD Pokala Kiran, MD Walter Koltun, MD Mukta Krane, MD Alex Ky, MD Anne Lin, MD Charles Littlejohn, MD Kim Lu, MD Mari Madsen, MD Mark Manwaring, MD David Maron, MD Elisabeth McLemore, MD Disclosures of Executive Council and Program Committee are listed on pages 149-153. 8 Bashar Safar, MD Chitra Sambasivan, MD Dana Sands, MD Tereza Sardinha, MD Stephen Sentovich, MD Josef Shehebar, MD Matthew Sherman, MD David Shibata, MD Marc Singer, MD Bradford Sklow, MD Michael Stamos, MD Scott Steele, MD David Stewart, MD Scott Strong, MD Sanda Tan, MD Alan Thorson, MD Judith Trudel, MD Kelly Tyler, MD Mark Welton, MD Steven Wexner, MD Mark Whiteford, MD Charles Whitlow, MD Kirsten Wilkins, MD Laurence Yee, MD D. Mark Zebley, MD Massarat Zutshi, MD Annual Scientific Meeting Mission, Goal, Purpose and Learning Objectives Continuing Medical Education Credit The American Society of Colon and Rectal Surgeons (ASCRS) designates this live activity for a maximum of 45.75 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity. Attendees can earn 1 CME Credit hour for every 60 minutes of educational time. The goal of the American Society of Colon and Rectal Surgeons’ Annual Scientific Meeting is to improve the quality of patient care by maintaining, developing and enhancing the knowledge, skills, professional performance and multidisciplinary relationships necessary for the prevention, diagnosis and treatment of patients with diseases and disorders affecting the colon, rectum and anus. The Annual Program Committee is dedicated to meeting these goals. Method of Participation Participants must be registered for the conference and attend the session(s). Each participant will enter a username and password for completion of the evaluations for the ASCRS 2015 Annual Scientific Meeting; participants must complete an online evaluation form for each session they attend to receive credit hours. There are no prerequisites unless otherwise indicated. This scientific program is designed to provide surgeons with in-depth and up-to-date knowledge relative to surgery for diseases of the colon, rectum and anus with emphasis on patient care, teaching and research. Presentation formats include podium presentations followed by audience questions and critiques, panel discussions, e-poster presentations, video presentations and symposia focusing on specific state-of-the-art diagnostic and treatment modalities. Self-Assessment Credit Many of the sessions offered will be designated as selfassessment MOC credit, applicable to Part 2 of the ABCRS MOC program. In order to claim self- assessment credit, attendees must take a post-test. Information/ instructions will be given to all meeting registrants. The purpose of all sessions is to improve the quality of care of patients with diseases of the colon and rectum. At the conclusion of this meeting, participants should be able to: Recognize new information in colon and rectal benign and malignant treatments, including the latest in basic and clinical research. Describe current concepts in the diagnosis and treatment of diseases of the colon, rectum and anus. Apply knowledge gained in all areas of colon and rectal surgery. Recognize the need for multidisciplinary treatment in patients with diseases of the colon, rectum and anus. ASCRS Mission The American Society of Colon and Rectal Surgeons is an association of surgeons and other professionals dedicated to assuring high quality patient care by advancing the science through research and education for prevention and management of disorders of the colon, rectum and anus. Disclaimer The primary purpose of the ASCRS Annual Meeting is educational. Information, as well as technologies, products and/or services discussed, are intended to inform participants about the knowledge, techniques and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exist in the specialty and the views of the American Society of Colon and Rectal Surgeons disclaims any and all liability for damages to any individual attending this conference and for all claims which may result from the use of information, technologies, products and/or services discussed at the conference. This activity is supported by educational grants from commercial interests. Complete information will be provided to participants prior to the activity. Target Audience The program is intended for the education of colon and rectal surgeons as well as general surgeons and others involved in the treatment of diseases affecting the colon, rectum and anus. Accreditation The American Society of Colon and Rectal Surgeons (ASCRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Continued next page 9 G E N E R A L I N F O R M AT I O N Education Information Education Information This activity is also supported by the following companies through an independent educational grant consisting of loaned durable equipment and disposable supplies. • American Medical Systems • Applied Medical • BK Ultrasound • Carl Zeiss Meditec • CONMED • CooperSurgical • Ethicon • Intuitive Surgical, Inc. • KARL STORZ Endoscopy-America, Inc. • LABORIE • Medtronic & Covidien • Medtronic, plc • Olympus Corporation of the Americas • Redfield Corporation • Richard Wolf Medical Instruments Corporation • Salix Pharmaceuticals, Inc. • Seiler Instrument & Manufacturing Co, Inc • Stryker Endoscopy • The Prometheus Group • Zinnanti Surgical Design Group Inc. Disclosures and Conflict of Interest In compliance with the standards of the Accreditation Council for Continuing Medical Education and the ASCRS, faculty has been requested to complete a Disclosure of Financial Relationships. Disclosures will be made at the time of presentation, as well as included in the Program Book and mobile app. All perceived conflicts of interest will be resolved prior to presentation; and, if not resolved, the presentation will be denied. Educational Grant Commercial Supporters This activity is supported by independent educational grants from: • American Medical Systems • Applied Medical • BK Ultrasound • Edwards Lifesciences • Ethicon • Intuitive Surgical, Inc. • KARL STORZ Endoscopy-America, Inc. • LABORIE • LifeCell, an Acelity Company • Mallinckrodt Pharmaceuticals • Medtronic & Covidien • Medtronic, plc • Merck & Co., Inc. • Olympus Corporation of the Americas • Richard Wolf Medical Instruments Corporation • Salix Pharmaceuticals, Inc. • The Prometheus Group • Torax Medical, Inc. SELF ASSESSMENT (MOC) CREDIT Online Evaluation ASCRS will again use a convenient online evaluation for the 2015 Annual Meeting. This system will allow you to complete evaluations online for all the certified CME sessions you attend. This year, WiFi will be available in the meeting rooms and you can access the evaluation forms from your mobile device. You can also access the forms from the kiosks located on the 2nd Floor outside the Auditorium, or from your home or office computer (recommended). Online access: http://www.pswebsurvey.com/ASCRS You will be asked to enter your Last Name and ID Number in order to complete the evaluations. Your ID Number is located on your Registration Card and Badge. Scan the QR Code with your smartphone to access the evaluation site. Maintenance of Certification (MOC) Self-Assessment This year, portions of the Annual Meeting will be given for MOC/Self-Assessment Credit. These selected sessions for self-assessment are identified in this Program as MOC Credit. Following the session, attendees will be able to take an online post-session test that must be completed and passed with a minimum score of 75% in order to receive Self-Assessment (MOC) Credit. If for some reason you do not pass the test, you will receive the regular CME credit for the sessions you attend. Tests must be taken by July 31, 2015. Online evaluations must be completed by July 31. 10 The 2015 scientific offerings assist the physician with the six core competencies first adopted by the Accreditation Council for Graduate Medical Education (ACGME) and the American Board of Medical Specialties. Attendees are encouraged to select areas of interest from the program which will enhance their knowledge and improve the quality of patient care. 1 Patient Care and Procedural Skills – Provide care that is compassionate, appropriate and effective treatment for health problems and to promote health. 2 Medical Knowledge – Demonstrate knowledge about established and evolving biomedical, clinical and cognate sciences and their application in patient care. 3 4 Professionalism – Demonstrate a commitment to carrying out professional responsibilities, adherence to ethical principles and sensitivity to diverse patient populations. 5 Systems-based Practice – Demonstrate awareness of and responsibility to larger context and systems of healthcare. Be able to call on system resources to provide optimal care (e.g. coordinating care across sites or serving as the primary case manager when care involves multiple specialties, professions or sites). 6 Practice-based Learning and Improvement – Able to investigate and evaluate their patient care practices, appraise and assimilate scientific evidence and improve their practice of medicine. Interpersonal and Communication Skills – Demonstrate skills that result in effective information exchange and teaming with patients, their families and professional associates (e.g. fostering a therapeutic relationship that is ethically sound, uses effective listening skills with non-verbal and verbal communication; working as both a team member and at times as a leader). The ASCRS assists the American Board of Colon and Rectal Surgery with a 4-part process for continuous learning: Part I – Professional Standing (Every 3 years) Part III – Cognitive Expertise (Every 10 years) • A valid, full and unrestricted medical license. • Hospital privileges in the specialty, if clinically active. • Chief of Staff Evaluation – contact information for the chief of surgery and chair of credentials at the institution where most work is performed. • Successful completion of a secure recertification examination, which may be taken three years prior to certificate expiration. A full exam application is required. All MOC requirements must be fulfilled up to this point to apply. Part II – Lifelong Learning and Self-Assessment (Every 3 years) • Continuing medical education (CME)—completion of at least 90 hours of Category I CME relevant to the physician’s practice over a three-year cycle. • Completion of Self-assessment: Over a 3-year cycle, 50 of the 90 Category I CME must include a self-assessment activity – a written or electronic question-and-answer exercise that assesses the physician’s understanding of the material presented in the CME program. • CARSEP or SESAP are suggested; however, any approved CME credit that provides self-assessment greater that 75% or passing score (including CME components for MOC) will be accepted for Part II. Part IV – Evaluation of Performance in Practice (Every 3 years) • Communications and interpersonal skills • Ongoing participation in a national, regional or local outcomes registry or quality assessment program (such as SCIP, ACS NSQIP®, SQIP or the ACS case log system). 11 G E N E R A L I N F O R M AT I O N Maintenance of Certification General Information Abstracts Capturing of NPI Numbers All abstract presentations are numbered and available on the ASCRS website. To view the abstracts, scan the QR code at the right or go to the Annual Scientific Meeting page, www.fascrs.org. As part of the healthcare reform legislation, the Physician Payment Sunshine Act requires medical device, biologic, and drug companies to publicly disclose gifts and payments made to physicians, as of August 1, 2013. To help our exhibitors and industry partners in fulfilling the mandatory reporting provisions of the Sunshine Act, ASCRS has requested US healthcare provider attendees to supply their 10-digit NPI (National Provider Identifier) number when registering for the 2015 Annual Scientific Meeting. The NPI will be imbedded in the bar code data on the attendee’s badge. Exhibitors can download the NPI information by scanning the badge through a lead retrieval system so that they can record and track any reportable transactions. For more information on the capturing of the NPI number; please visit the ASCRS website Annual Meeting Mobile App Download the FREE mobile app to maximize your time at the Annual Meeting. Easily view the schedule, exhibitors, speakers, and more! This mobile app is available for all smartphones and tablet platforms – iPhone, Blackberry and Android. Download the free ASCRS Mobile App by scanning one of the two QR Codes below: iPhone or iPad Android, or Blackberry Child Care Services http://ativ.me/6b8 Please contact the concierge at the hotel at which you are staying for a list of bonded independent babysitters and babysitting agencies. http://ativ.me/6b9 Badge Designations Blue . . . . . . . . . . . .Member/Fellow Physicians Lime . . . . . . . . . . . .Member Resident/CR Fellows Green . . . . . . . . . . .Member Allied Health/Nurses Purple . . . . . . . . . .Non-Members Orange . . . . . . . . .Non-Physicians Red . . . . . . . . . . . . .Technical Exhibitors Teal . . . . . . . . . . . . .Guests Lt Orange . . . . . . .Press Gray . . . . . . . . . . . .Meeting Technician/Workers Fuchsia . . . . . . . . .Staff Replacement badges – $10.00 each Dinner Dance Tickets Full-paying members and fellows who requested a ticket for the Wednesday evening Dinner Dance will receive a voucher as part of their packet. This voucher must be exchanged for assigned table seating by noon, Tuesday. Non-members and others who wish to purchase tickets may do so at the ASCRS Registration Desk. Please do so as early as possible in order to meet the ticket exchange deadline. ePoster Displays Boston Visitors Desk ePoster viewing stations are located in Hall C (ePoster area), Hall D (near booth #736), Hall C Foyer (by registration), outside Ballroom B (3rd Floor) and outside Room 304 (3rd Floor). A Boston Visitors desk will be available to all attendees to make restaurant reservations, assist with city information and provide maps and brochures. This booth is located in Hall C Foyer (2nd Floor) and will be available during the following hours: ePosters of Distinction will be presented during scheduled breaks in the Exhibit Hall. See pages 109-111. Saturday . . . . . . . . . . . . . . . . . . .9:00 am – 5:00 pm Sunday . . . . . . . . . . . . . . . . . . . .9:00 am – 5:00 pm Monday . . . . . . . . . . . . . . . . . . . .9:00 am – 5:00 pm Tuesday . . . . . . . . . . . . . . . . . . . .9:00 am – 5:00 pm Wednesday . . . . . . . . . . . . . . . .9:00 am – 2:00 pm Authors of ePosters have been assigned a specific time frame to be at a designated monitor and available for questions. See page 112-113 for more information. 12 Exhibit Hall Photography/Video Recordings More than 85 technical and scientific exhibitors will display their products and services in Exhibit Halls C&D (2nd Floor) throughout the convention. By registering for this meeting, attendees acknowledge and agree that ASCRS or its agents may take photographs during events and may freely use those photographs in any media for ASCRS purposes, including but not limited to news and promotional purposes. ASCRS appreciates the support of its exhibitors and urges all registrants to visit the displays. The presentations, slides, and handouts provided in this program are the property of ASCRS or used by permission. Meeting participants may not photograph, videotape, audiotape or otherwise record or reproduce any of the presentations without express written permission from ASCRS. Any attendee believed to be violating this restriction will be removed from the session and may be prohibited from participating in future ASCRS meetings. Exhibit hours: Sunday . . . . . . . . . . . . . . . . . . . .3:00 pm – 5:00 pm Monday . . . . . . . . . . . . . . . . . . . .9:00 am – 4:30 pm Tuesday . . . . . . . . . . . . . . . . . . .9:00 am – 2:00 pm First Aid Station A First Aid Station is located on Level 1 of the Hynes Convention Center and is available during the following hours: Registration Desk Hours Saturday . . . . . . . . . . . . . . . . . . .6:00 am – 6:30 pm Sunday . . . . . . . . . . . . . . . . . . . .6:00 am – 7:30 pm Monday . . . . . . . . . . . . . . . . . . . .5:15 am – 7:30 pm Tuesday . . . . . . . . . . . . . . . . . . . .5:15 am – 7:30 pm Wednesday . . . . . . . . . . . . . . . .5:15 am – 6:30 pm The ASCRS Registration Desk is located in the Hynes Convention Center, Hall C Foyer (2nd Floor). Saturday . . . . . . . . . . . . . . . . . . .6:00 am – 6:00 pm Sunday . . . . . . . . . . . . . . . . . . . .6:30 am – 6:00 pm Monday . . . . . . . . . . . . . . . . . . . .6:00 am – 4:30 pm Tuesday . . . . . . . . . . . . . . . . . . . .6:15 am – 4:00 pm Wednesday . . . . . . . . . . . . . . . .6:15 am – 4:00 pm Index of Participants The names of all program speakers, with page numbers to indicate their scheduled appearances, are listed on pages 154-155. Replacement badges – $10.00 each Social Events Networking Goes Viral with #ASCRS15 The ASCRS and the Research Foundation invite you to attend the Welcome Reception on Sunday from 7:00 – 8:30 pm in the Grand Ballroom at the Sheraton Boston Hotel. This event is complimentary to all registered attendees. Enjoy hors d’oeuvres, refreshments and networking. Be a part of the Annual Meeting conversation! Use hashtag #ASCRS15 in your meeting related tweets. Follow twitter.com/ fascrs_updates or facebook.com/fascrs and wear a special meeting ribbon showing your support. Share Facebook posts about the meeting from facebook.com/fascrs. This year the Welcome Reception will be known as “Jersey Night.” Make sure to wear your team’s favorite jersey (collegiate or professional) to show your colleagues which team you root for! New Members New members of the ASCRS will be identified by a special ribbon affixed to their name badge. We encourage you to introduce yourself and make our new members welcome. The Annual Dinner Dance is scheduled on Wednesday, with the reception beginning at 7:00 pm and the dinner at 8:00 pm in the Grand Ballroom at the Sheraton Boston Hotel. There is no additional cost for a ticket for full–paying members and fellows. Please remember to exchange your Dinner Dance voucher for a seat assignment no later than noon on Tuesday. The cost for others is $75 per ticket. QR Code A “QR Code” enables your smartphone or tablet to instantly access direct links on the internet. To use it, download a free QR app (available from your phone’s app store) if you don’t already have one. Next, take a photo of the printed QR code and you’ll be instantly connected to additional information. 13 G E N E R A L I N F O R M AT I O N General Information General Information Package #2 ($55) includes: Speaker Ready Room Welcome Reception, 7:00 – 8:30 pm, Sunday, Grand Ballroom, Sheraton Boston Hotel All presentations MUST be made using submitted PowerPoint or Keynote files. Please bring your presentation to the Speaker Ready Room at least EIGHT hours (preferably 24 hours) prior to the start of the session in which you are speaking. Presentations from laptops and iPads will NOT be permitted. Exhibit Hall Admission Webcast Sessions Selected sessions will be captured and made available as webcasts on the ASCRS website following the meeting. The Speaker Ready Room is located in Room 201 and is available to all program participants. Speakers are requested to take advantage of this opportunity prior to their presentation to review their slides. WiFi – FREE Friday . . . . . . . . . . . . . . . . . . . . .3:00 pm – 6:00 pm Saturday . . . . . . . . . . . . . . . . . . .6:00 am – 6:30 pm Sunday . . . . . . . . . . . . . . . . . . . .6:30 am – 6:30 pm Monday . . . . . . . . . . . . . . . . . . . .6:30 am – 6:30 pm Tuesday . . . . . . . . . . . . . . . . . . . .6:30 am – 6:00 pm Wednesday . . . . . . . . . . . . . . . .6:30 am – 5:00 pm Free WiFi is provided to all ASCRS attendees at the Hynes Convention Center. To access the free WiFi simply: • Open your wireless connection • Click continue and you will be connected to the internet Spouse/Guest Registration Options Package #1 ($100) includes: Welcome Reception, 7:00 – 8:30 pm, Sunday, Grand Ballroom, Sheraton Boston Hotel Annual Reception, 7:00 – 8:00 pm, Wednesday, Grand Ballroom Foyer, Sheraton Boston Hotel Annual Dinner Dance, 8:00 – 10:30 pm, Wednesday Grand Ballroom, Sheraton Boston Hotel Exhibit Hall Admission Welcome Reception • Jersey Night! 7:00 – 8:30 pm • Grand Ballroom, Sheraton Boston Hotel Wear your favorite team’s jersey to show your colleagues which team you support. Complimentary to all registered attendees. 14 Norman D. Nigro, MD, Research Lectureship Parviz Kamangar Humanities in Surgery Lectureship Sunday, May 31 • 4:45 – 5:15 pm Auditorium (2nd Floor) Dr. Norman Nigro is recognized for his many contributions to the care of patients with diseases of the colon and rectum; for his significant research in the prevention of large bowel cancer and treatment of squamous cell carcinoma of the anus and for his leadership role in his chosen specialty and allied medical organizations. Dr. Nigro generously contributed many years of dedication and service to the specialty through his activities in the American Society of Colon and Rectal Surgeons (ASCRS) and the American Board of Colon and Rectal Surgery (ABCRS). Monday, June 1 • 4:15 – 4:45 pm Auditorium (2nd Floor) This unique lectureship is funded by Mr. Parviz Kamangar, a grateful patient, to remind physicians and surgeons to place compassionate care at the top of the list of priorities. Ernestine Hambrick, MD, Lectureship Tuesday, June 2 • 9:00 – 9:30 am Auditorium (2nd Floor) This lectureship honors Dr. Ernestine Hambrick for her dedication to patients with colon and rectal disorders, surgical students and trainees and the community at large. The first woman to be board certified in colon and rectal surgery, Dr. Hambrick provided excellent care to patients and mentored numerous students, residents and young surgeons during her clinical practice. Dr. Hambrick founded the STOP Foundation to promote screening and prevention of colon and rectal cancer. In addition, she has volunteered many hours working for the ASCRS including serving as Vice President. Harry E. Bacon, MD, Lectureship Monday, June 1 • 3:00 – 3:30 pm Auditorium (2nd Floor) Harry Ellicott Bacon was Professor and Chairman of the Department of Proctology at Temple University Hospital. His stellar contribution was the establishment of the Journal, Diseases of the Colon and Rectum, of which he was the Chief-Editor. He was a Past President of the American Society of Colon and Rectal Surgeons and the American Board of Colon and Rectal Surgery. Dr. Bacon was the founder of the International Society of University Colon and Rectal Surgeons. As a researcher and teacher of over 100 residents, he was innovative in some operations that are forerunners of sphincter saving procedures for cancer of the rectum (pull-through operation) and inflammatory bowel disease (ileoanal reservoir anastomosis). Take Your Meeting Mobile Target what you want to attend, learn and do at the ASCRS Annual Meeting with the ASCRS mobile app – the app is free and the options are endless! View all the annual meeting info right at your fingertips: Schedule of events Exhibitor list and details Speakers, sponsors and more Download the free app today and maximize your time at the meeting. To download a mobile version, scan one of the QR Codes on the right. For all other devices, go to http://ativ.me/6ba. 15 iPhone or iPad http://ativ.me/6b8 Android, or Blackberry http://ativ.me/6b9 G E N E R A L I N F O R M AT I O N Annual Named Lectures Masters in Colorectal Surgery Masters in Colorectal Surgery This lectureship has been established to honor a different senior surgeon each year who has made a considerable contribution to the specialty and the Society. The following physicians have been honored as Masters in Colorectal Surgery. This year’s Masters in Colorectal Surgery Lecture will take place on Tuesday from 11:45 am – 12:15 pm, in the Auditorium (2nd Floor) and will be presented by Patricia L. Roberts, MD. 2015 David J. Schoetz, Jr., MD 2014 2013 2012 Eugene P. Salvati, MD Victor W. Fazio, MD Herand Abcarian, MD 2011 2010 Philip H. Gordon, MD Stanley M. Goldberg, MD 16 Colorectal Society Regional Awards The following awards will be chosen at the 2015 Annual Meeting and announced shortly after. Each recipient will be given a plaque and a $500 cash award from the regional society sponsoring the award. Awards are given for the best basic science or clinical paper presented from the podium or as a poster. Chesapeake Society of Colon & Rectal Surgeons Award (Basic Science/Poster) Harry E. Bacon Foundation Award (Basic Science/Podium) Michigan Society of Colon & Rectal Surgeons Award (Clinical/Podium) New Jersey Society of Colon & Rectal Surgeons Award (Basic Science/Poster) New York Society of Colon & Rectal Surgeons Award (Clinical/Podium) Northwest Society of Colon & Rectal Surgeons Award (Clinical/Podium) Piedmont Society of Colon & Rectal Surgeons Award (Clinical/Podium) Southern California Society of Colon & Rectal Surgeons Award (Clinical/Poster) ASCRS Award Best Paper Award The recipient of this award will attend the Annual Meeting of the European Society of Coloproctology in Dublin, Ireland, September 22-25, 2015. Call for 2016 Abstracts 2016 ASCRS Annual Meeting April 30 – May 4, 2016 Los Angeles Convention Center Los Angeles, CA Online Submission Site Opens July 15th Online Submission Site Closes November 8th, 11:59 pm CST Program Chair: Kirsten Wilkins, MD Program Vice-Chairs: Joshua Bleier, MD and Scott Steele, MD 17 G E N E R A L I N F O R M AT I O N Awards Non-CME Corporate Forums Following the close of Monday and Tuesday’s scientific session, all registrants are invited to attend the special Corporate Forums at the Sheraton Boston Hotel. NOT FOR CREDIT Corporate Forums are non-CME promotional offerings organized by industry and designed to enhance your educational experience. Monday, June 1 7:00 – 8:30 pm Constitution Ballroom (2nd Floor) Supported by Mallinckrodt Pharmaceuticals OFIRMEV (acetaminophen) Injection: A Non-Opioid, Non-NSAID Foundation for Multimodal Analgesia in the Perioperative Patient Presented by: Frank T. Sconzo, Jr., MD This program will be a discussion of OFIRMEV (acetaminophen) Injection: a Non-Opioid Foundation for Multimodal Analgesia in the Perioperative Patient. The program will go over the safety and efficacy of this product while also utilizing case studies for discussion. Also, visit Mallinckrodt Pharmaceuticals at Booth #329. Tuesday, June 2 7:00 – 8:30 pm Constitution Ballroom (2nd Floor) 7:00 – 8:30 pm Republic Ballroom (2nd Floor) Supported by Intuitive Surgical, Inc. Supported by Medtronic, plc UNCOVER Da Vinci® – New Technology for Advancing Minimally Invasive Surgery Sacral Neuromodulation – A Systemic Solution for the FI Patient Presented by: Joshua Bleier, MD, and Prof P. Ronan O’Connell, MD, FRCSI, FRCS (Glas), FRCS (Edin) This event will focus on all aspects of robotic technology: Ways to improve clinical outcomes, tips & tricks to increase efficiency, as well as a glimpse at future technology. We will begin with a presentation highlighting the clinical experience with the latest robotic technology, followed by a “behind the scenes” look at robotic technologies under development. Hors d’oerves and beverages will be served. Sacral Neuromodulation has become an established therapy for the treatment of chronic fecal incontinence. This program will present the safety, efficacy, and durability of Sacral Neuromodulation and explore the theory of Mechanism of Action. It will also examine the clinical use of the therapy through a discussion of case studies. Also, visit Intuitive Surgical, Inc. at Booth #401. Also, visit Medtronic, plc at Booth #311. 18 ASCRS is grateful to the following companies and organizations for their generous support of the following projects and programs this year: ACell, Inc. Ethicon Co-supporter of the Monday Symposium on New Technologies**. Supporter of Tuesday’s Women in Colorectal Surgery Luncheon… an advertisement in the Convention Program Guide**… promotional e-Blasts**… Escalator Clings**… co-supporter of Saturday's Laparoscopic Colectomy Workshop*… the Sunday Symposium on Laparoscopic Nuts and Bolts and Robotic Rivets… the Sunday Symposium on Quality Initiatives in Clinical Practice… the Monday Symposium on Rectal Cancer: Optimizing Outcomes through Techniques… the Monday Symposium on New Technologies**… and the Wednesday Symposium on Enhanced Perioperative Care Pathways and Postoperative Pain Management. American Medical Systems Partial support of the Sunday Symposium on Current Advances in the Management of Fecal Incontinence… and co-supporter of the Saturday’s Workshop on Optimal Management of Fecal Incontinence*. Applied Medical Co-supporter Saturday's Laparoscopic Colectomy Workshop*… the Saturday Workshop on Transanal Endoscopic Surgery*… the Sunday Symposium on Laparoscopic Nuts & Bolts and Robotic Rivets… the Sunday Symposium on Quality Initiatives in Clinical Practice… and partial support of the Tuesday Symposium on Controversies in Rectal Cancer Management. Intuitive Surgical, Inc. Supporter of Saturday's Symposium and Workshop on Robotic Colon and Rectal Surgery: Tips, Tricks, and Simulation*… an advertisement in the Convention Program Guide**… Non-CME Corporate Forum**… Product Theater**… promotional e-blasts**… co-supporter of the Monday Symposium on New Technologies**… and partial support of the Monday symposium on Robotic Colorectal Surgery. BK Ultrasound Co-supporter of the Saturday Workshop on Optimal Management of Fecal Incontinence*. Carl Zeiss Meditec KARL STORZ Endoscopy-America, Inc. In-kind support of Saturday's Workshop on AIN and HRA: What the Colorectal Surgeon Needs to Know*. Co-supporter of the Saturday Workshop on Transanal Endoscopic Surgery*… in-kind support of Saturday's Laparoscopic Colectomy Workshop*. CONMED In-kind support of Saturday's Workshop on AIN and HRA: What the Colorectal Surgeon Needs to Know*. LABORIE Co-supporter of the Saturday Workshop on Optimal Management of Fecal Incontinence*. ConvaTec, Inc. Supporter of a Product Theater**. LifeCell, an Acelity Company Co-supporter of the Tuesday Symposium on Ostomies: Location, Creation and Complications. CooperSurgical In-kind support of Saturday's Workshop on AIN and HRA: What the Colorectal Surgeon Needs to Know*. Mallincrodt Pharmaceuticals Supporter of an advertisement in the Convention Program Guide**… Non-CME Corporate Forum**… promotional e-blasts**… and co-supporter of the Wednesday Symposium on Enhanced Perioperative Care Pathways and Postoperative Pain Management. Edwards Lifesciences Co-supporter of Wednesday’s Symposium on Enhanced Perioperative Care Pathways and Postoperative Pain Management. Medtronic, plc Supporter of a Non-CME Corporate Forum**… Badge Lanyards**… and co-supporter of the Saturday Workshop on Optimal Management of Fecal Incontinence*. *In-kind support **Promotional support 19 G E N E R A L I N F O R M AT I O N Thanks to our Corporate Supporters Thanks to our Corporate Supporters ASCRS is grateful to the following companies and organizations for their generous support of the following projects and programs this year: Medtronic & Covidien Salix Pharmaceuticals, Inc. Supporter of the Hotel Key Card**… co-supporter the Saturday Laparoscopic Colectomy Workshop*… and the Saturday Workshop on Transanal Endoscopic Surgery*. Co-supporter of the Saturday Workshop on Optimal Management of Fecal Incontinence. Seiler Instrument & Manufacturing Co, Inc. Merck & Co., Inc. Co-supporter of the Wednesday Symposium on Enhanced Perioperative Care Pathways and Postoperative Pain Management. In-kind support of Saturday's Workshop on AIN and HRA: What the Colorectal Surgeon Needs to Know*. Stryker Endoscopy Novadaq Technologies, Inc. In-kind support of Saturday's Transanal Endoscopic Surgery Workshop*. Co-supporter of the Monday Symposium on New Technologies**. THD America Olympus Corporation of the Americas Co-supporter of the Monday Symposium on New Technologies**. Co-supporter of Saturday's Laparoscopic Colectomy Workshop*. The Prometheus Group Pacira Pharmaceuticals, Inc. Co-supporter of the Saturday Workshop on Optimal Management of Fecal Incontinence*. Co-supporter of the Monday Symposium on New Technologies**. Torax Medical, Inc. Redfield Corporation Co-supporter of the Saturday Workshop on Optimal Management of Fecal Incontinence*… and the Monday Symposium on New Technologies**. In-kind support of Saturday's Workshop on AIN and HRA: What the Colorectal Surgeon Needs to Know*. Richard Wolf Medical Instruments Corporation Zinnanti Surgical Design Group Inc. In-kind support of Saturday's Workshop on AIN and HRA: What the Colorectal Surgeon Needs to Know*. Co-supporter of Saturday’s Transanal Endoscopic Surgery Workshop*. The ASCRS Research Foundation thanks the following for their support of the 2015 Meet the Challenge Fundraiser (list current as of April 6, 2015): Chesapeake Colorectal Society Chicago Society of Colon & Rectal Surgeons Michigan Society of Colon & Rectal Surgeons Midwest Society of Colon & Rectal Surgeons New England Society of Colon & Rectal Surgeons New Jersey Society of Colon & Rectal Surgeons New York Society of Colon & Rectal Surgeons Niagara Frontier Society of Colon & Rectal Surgeons Northwest Society of Colon & Rectal Surgeons Pennsylvania Society of Colon & Rectal Surgeons Piedmont Society of Colon & Rectal Surgeons Southern California Society of Colon & Rectal Surgeons *In-kind support **Promotional support 20 The following videos will be available for viewing in Room 210 (Convention Center), Saturday through Wednesday. STATION 1 STATION 3 Surgical Approaches in the Reoperative Abdomen VR1 M.E. Kwiatt, C. Horne, D. Liska, F. Remzi, Cleveland, OH Laparoscopic Splenic Flexure and Sigmoid Resection for Adenocarcinoma and Diverticulitis VR12 F. Stipa, E. Soricelli, A. Burza, P. Delle Site, Rome, Italy Gracilis Muscle Interposition for the Management of Recto Urethral Fistula Consequent to Radiotherapy VR2 D.F. Soares, R.A. Pinto, S.C. Nahas, C.S. Nahas, C.S. Marques, M. Srougi, F.F. Busnardo, Sao Paulo, Brazil A Technique of Laparoscopic Lateral Pelvic Lymph Node Dissection Based on Vesicohypogastric Fascia and Ureterohypogastric Nerve Fascia for Advanced Low Rectal Cancer VR13 A. Matsumoto, K. Arita, Tsuchiura City, Japan Laparoscopic Repair of Ureteric Injury: Psoas Hitch With Ureteric Reimplantation VR3 A. Wong, Kensington, Australia, E. Gorgun, G. Haber, M.A. Abbas, Cleveland, OH The Single Port Hartmann’s Reversal: The Real Benefit of Single Port in Colorectal Surgery S. Malakorn, Bangkok, Thailand VR4 Using New Technology to Improve Postoperative Outcomes: Fluorescent Angiography for Assessment of Perfusion in Colorectal Surgery J.R. Flores-Gonzalez, D.S. Keller, J. Nieto, E.M. Haas, Houston, TX VR5 Laparoscopic Retro Rectal Tumor M. Barussaud, Poitiers, France Redo Ileal J Pouch Surgery for Mechanical Pouch Dysfunction VR15 E.A. Myers, D. Liska, J. Ashburn, F. Remzi, Cleveland, OH Retromuscular Repair of Parastomal Hernias with Transversus Abdominis Release: A Single Center Experience with a Novel Technique VR16 M. Wilson, J.S. Winder, L. Piper, E. Messaris, E. Pauli, Hershey, PA STATION 4 STATION 2 A Novel Technique of Perfoming a Stapled Anastomosis Following Transanal Total Mesorectal Excision E. Bracey, N.C. Buchs, O. Jones, N. Mortensen, R. Hompes, Oxford, UK Robotic Transanal Surgery With Endoscopic Suturing for Local Excision of a Rectal Neoplasm VR10 S. Atallah, S. Annaberdyev, B. Martin-Perez, S. Larach, Winter Park, FL, R. Hawes, Orlando, FL Transvaginal Specimen Extraction after Combined Robotic Anterior Resection and Hysterectomy: A Natural Orifice Specimen Extraction Approach to Rectal Cancer VR11 A.W. Chae, E. Raskin, St. Louis Park, MN Robotic Transanal Excision of Large Rectal Mass J.N. Harr, V. Obias, Washington, DC Bascom Cleft Lift Procedure: Step by Step I. Gribovskaja-Rupp, M. Sun, C.O. Finne, Minneapolis, MN Transanal TME for Low Rectal Tumors in Males: Avoiding Urethral Injury P. Sylla, L. Bordeianou, D. Berger, Boston, MA VR6 VR17 VR18 VR19 Transanal Total Mesorectal Excision: Working Towards a Standardized Approach by Highlighting Technical Aspects in Colorized Videoclips VR20 E. Deleus, J. Knol, Hasselt, Belgium, S. Wexner, Weston, FL Modification of TAMIS Procedure VR7 S.J. Marecik, J. Kaminski, T. Kamal, J. Park, L. Prasad, G. Melich, Park Ridge, IL Robotic LAR converted to Subtotal Colectomy: Use of the Right Colon to Salvage a Difficult Colorectal Anastomosis Due to Poor Collateral Perfusion VR8 M.H. Hanna, A. Pigazzi, Orange, CA Robotic Reduced-Port Anterior Resection for Left-Sided Colon Cancer using the Da Vinci Single-Site® Platform S. Bae, W. Jeong, O. Bae, S. Baek, Daegu, Korea VR14 Endoscopic Stenting of Rectosigmoid Cancer VR21 A.A. Alkhatib, G. Santoro, M.A. Abbas, Abu Dhabi, United Arab Emirates VR9 21 G E N E R A L I N F O R M AT I O N On-Going Video Display Daily Schedule All programs are held in the Hynes Convention Center unless otherwise noted. HOURS ROOM Saturday, May 30 6:00 am – 6:00 pm Registration for ASCRS Annual Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hall C Foyer (2nd Floor) 6:00 am – 6:30 pm Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201 6:30 am – 6:30 pm On-Going Video Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .210 7:00 – 8:25 am Transanal Endoscopic Surgery Workshop . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200 7:00 – 9:00 am AIN and HRA: What the Colorectal Surgeon Needs to Know . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .311 7:30 – 11:45 am Laparoscopic Colectomy Symposium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 7:30 am – noon Optimal Management of Fecal Incontinence Symposium . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor) 8:00 am – noon Robotic Colon and Rectal Surgery: Tips, Tricks and Simulation Symposium / Group A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .302-304 8:00 am – noon Robotic Colon and Rectal Surgery: Tips, Tricks and Simulation Hands-on Lab / Group B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .306 8:00 am – noon Executive Council Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fairfax (3rd Floor – Sheraton) 8:30 am – noon Transanal Endoscopic Surgery Hands-on Lab / Group A . . . . . . . . . . . . . . . . . . . . . . . . . . . .202, 203, 204, 206 8:30 am – noon Transanal Endoscopic Surgery Workshop / Group B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200 9:00 am – 12:15 pm AIN and HRA: Group 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .311 9:00 am – 12:15 pm AIN and HRA: Group 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .313 9:00 am – 12:15 pm AIN and HRA: Group 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .312 10:05 – 10:15 am Laparoscopic Colectomy Symposium Refreshment Break . . . . . . . . . . . . . . .Ballroom BC Foyer (3rd Floor) 10:05 – 10:15 am Robotic Colon and Rectal Surgery Refreshment Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .302-304 Foyer 10:40 – 11:00 am Optimal Management of Fecal Incontinence Refreshment Break . . . . . . . . .Ballroom A Foyer (3rd Floor) 11:45 am – 12:30 pm Laparoscopic Colectomy Luncheon (lab registrants only) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .301 Noon – 12:30 pm Robotic Colon and Rectal Surgery Luncheon (lab registrants only) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .305 Noon – 12:30 pm Optimal Management of Fecal Incontinence Luncheon (lab registrants only) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .207 Noon – 1:00 pm Transanal Endoscopic Surgery Lunch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200 Noon – 1:00 pm Alliance / American College of Surgeons Investigators Meeting . . . . . . .Hampton (3rd Floor – Sheraton) 12:15 – 12:30 pm AIN and HRA: What the Colorectal Surgeon Needs to Know . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .311 12:30 – 3:30 pm Question Writing Workshop: How to Write Exam Questions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .310 12:30 – 4:00 pm Symposium: Advanced Endoscopy and Endoluminal Surgery . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 12:30 – 4:30 pm Robotic Colon and Rectal Surgery: Tips, Tricks and Simulation Hands-on Lab / Group A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .306 12:30 – 4:30 pm Robotic Colon and Rectal Surgery: Tips, Tricks and Simulation Symposium / Group B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .302-304 1:00 – 4:30 pm Laparoscopic Colectomy Hands-on Session for Lab Registrants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site 1:00 – 4:30 pm Optimal Management of Fecal Incontinence Hands-on Session for Lab Registrants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site 1:00 – 4:30 pm Transanal Endoscopic Surgery Workshop / Group A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200 1:00 – 4:30 pm Transanal Endoscopic Surgery Hands-on Lab / Group B . . . . . . . . . . . . . . . . . . . . . . . . . . . .202, 203, 204, 206 2:20 – 2:30 pm Robotic Colon and Rectal Surgery Refreshment Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .302-304 Foyer 3:45 – 4:15 pm Refreshment Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC Foyer (3rd Floor) 22 Daily Schedule All programs are held in the Hynes Convention Center unless otherwise noted. HOURS ROOM Saturday, May 30 (continued) 4:00 – 5:30 pm Symposium: Improving Outcomes-Identifying and Managing the Complex Surgical Patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 5:00 – 6:00 pm OSTRiCh Consortium General Assembly . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .310 5:30 – 6:30 pm Self-Assessment Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300 6:30 am – 6:00 pm Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hall C Foyer (2nd Floor) 6:30 am – 6:30 pm Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201 6:30 am – 6:30 pm On-Going Video Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .210 7:00 – 8:00 am CREST Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300 7:00 – 8:00 am Quality Assessment Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .203 7:00 – 9:00 am Research Foundation Board of Trustees Meeting . . . . . . . . . . . . . . . . . . . . . . . .Fairfax (3rd Floor – Sheraton) 7:15 – 9:30 am Core Subject Update . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 8:00 – 9:45 am Symposium: Healthcare Economics in the ACA Era . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 8:00 – 10:00 am New Technologies Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200 8:30 – 9:30 am Professional Outreach Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .202 9:00 – 11:00 am Research Foundation Research Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . .Gardner (3rd Floor – Sheraton) 9:00 – 11:00 am Symposium: Quality Initiatives in Clinical Practice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor) 9:15 – 9:45 am Refreshment Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium Foyer (2nd Floor) & Ballroom BC Foyer (3rd Floor) 9:30 – 11:30 am ACS Advisory Council . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Exeter (3rd Floor – Sheraton) 9:30 – 11:45 am Symposium: Laparoscopic Nuts & Bolts and Robotic Rivets . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 9:45 – 11:45 am Symposium: Complications: Prevention and Management . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 11:00 am – 12:30 pm DC&R Editorial Board Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300 11:30 am – 12:30 pm Residents Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .202 11:30 am – 1:00 pm ISUCRS Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hampton (3rd Floor – Sheraton) 11:45 am – 1:00 pm Research Foundation Fundraising Assistance Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .203 11:45 am – 1:15 pm Luncheon Symposium: Current Advances in the Management of Fecal Incontinence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 11:45 am – 1:15 pm Luncheon Symposium: The Genetics of Colorectal Cancer and Cancer Related Syndromes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .302-306 Noon – 1:00 pm Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .205 Noon – 1:00 pm Continuing Education Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200 Noon – 1:00 pm Membership Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .206 1:15 – 2:00 pm Welcome and Opening Announcements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 2:00 – 3:30 pm Abstract Session: Neoplasia I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor) 2:00 – 4:00 pm Symposium: Technical Pearls – How it's Really Done . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 3:00 – 5:00 pm Exhibit Hours . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 4:00 – 4:45 pm Refreshment Break in Exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) Continued next page 23 D A I LY S C H E D U L E Sunday, May 31 Daily Schedule All programs are held in the Hynes Convention Center unless otherwise noted. HOURS ROOM Sunday, May 31 (continued) 4:00 – 4:45 pm ePoster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 4:45 – 5:15 pm Norman D. Nigro, MD, Research Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 5:15 – 6:30 pm After Hours Debate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 5:30 – 6:30 pm International Council of Coloproctology Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .310 7:00 – 8:30 pm Welcome Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Grand Ballroom (2nd Floor – Sheraton) 8:30 – 11:30 pm Young Surgeons Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site (Dillon's Restaurant) 9:30 pm – midnight E.P. Salvati Society Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fairfax (3rd Floor – Sheraton) 6:00 – 7:00 am “Meet the Professor” Breakfasts Monday, June 1 M-1 HNPCC and Polyposis: Knowing When to Operate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200 M-2 Quality Metrics and Colorectal Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .202 M-3 Coding Pearls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .203 M-4 The Management of T1 Rectal Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .206 M-5 How to Produce a High Quality Manuscript for Scientific Journals . . . . . . . . . . . . . . . . . . . . . . . .207 M-6 Rectal Prolapse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300 6:00 – 7:00 am Residents' Breakfast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Constitution Ballroom (2nd Floor – Sheraton) 6:00 – 7:00 am History of ASCRS Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .301 6:00 am – 4:30 pm Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hall C Foyer (2nd Floor) 6:30 am – 6:30 pm Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201 6:30 am – 6:30 pm On-Going Video Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .210 7:00 – 8:00 am OSTRiCh Council Business Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .303 7:00 – 9:15 am Symposium: Robotic Colorectal Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 7:00 – 9:15 am Symposium: Rectal Cancer: Optimizing Outcomes through Techniques . . . . . . . . .Auditorium (2nd Floor) 8:00 – 9:00 am Rectal Cancer Coordinating Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .303 9:00 am – 4:30 pm Exhibit Hours . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 9:15 – 9:45 am Memorial Lectureship Honoring John M. MacKeigan, MD . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 9:45 – 10:15 am Presidential Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 10:15 – 11:00 am Refreshment Break in Exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 10:15 – 11:00 am ePoster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 11:00 am – 12:30 pm Symposium: Navigating a Career Path in Colon and Rectal Surgery – Orchestrating and Optimizing Career Transitions at All Levels . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 11:00 am – 12:30 pm Abstract Session: Benign Colonic Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor) 11:30 am – 12:30 pm Social Media Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .303 12:30 – 1:30 pm Complimentary Box Lunch in Exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 12:30 – 1:30 pm ePoster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 12:30 – 1:30 pm Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .205 12:30 – 1:30 pm Website Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300 24 Daily Schedule All programs are held in the Hynes Convention Center unless otherwise noted. HOURS ROOM 12:30 – 1:30 pm Young Surgeons Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .301 12:30 – 1:30 pm Past Vice Presidents' Luncheon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .305 12:35 – 1:30 pm Product Theater: Intuitive Surgical, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 1:30 – 3:00 pm Symposium: Past Presidents' Panel: Controversies and Cases . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 1:30 – 3:00 pm Abstract Session: Pelvic Floor / Anorectal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor) 2:00 – 3:30 pm Public Relations Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200 3:00 – 3:30 pm Harry E. Bacon, MD, Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 3:30 – 4:15 pm Ice Cream and Refreshment Break in Exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 3:30 – 4:15 pm ePoster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 4:00 – 5:00 pm Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .205 4:15 – 4:45 pm Parviz Kamangar Humanities in Surgery Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 4:45 – 5:15 pm Special Lecture: The Trials and Tribulations of Clinical Research: Why Johnny Can't Add . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 5:15 – 5:20 pm What Receiving the Scholarship Means to Me . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 5:20 – 6:45 pm New Technologies Symposium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 5:30 – 6:30 pm Healthcare Economics Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200 7:00 pm Chicago Society of Colon & Rectal Surgeons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site 7:00 pm Lahey Clinic Alumni Dinner . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site 7:00 pm Minnesota Alumni Dinner . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site 7:00 pm Ochsner Alumni Dinner . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Off-Site 7:00 – 8:30 pm Non-CME Corporate Forum: Mallinckrodt Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . .Constitution Ballroom (2nd Floor – Sheraton) 7:00 – 8:30 pm Ferguson Surgical Society Cocktail Hour . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hampton (3rd Floor – Sheraton) 7:00 – 8:30 pm Lehigh Valley Health Network Alumni Reception . . . . . . . . . . . . . . . . . . . . . .Fairfax B (3rd Floor – Sheraton) 7:00 – 9:00 pm Cleveland Clinic Annual Alumni Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Back Bay Ballroom Salon A (2nd Floor – Sheraton) 7:00 – 9:00 pm Icahn School of Medicine at Mount Sinai Division of Colon & Rectal Surgery Alumni Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Café Apropos (Sheraton) 7:00 – 9:00 pm Washington University Colon & Rectal Surgery Fellowship Alumni Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Gardner (3rd Floor – Sheraton) 7:00 – 10:00 pm Colon & Rectal Clinic of Orlando Alumni Dinner . . . . . . . . . . . . . . . . . . . . . . .Berkeley (3rd Floor – Sheraton) 6:15 am – 4:00 pm Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hall C Foyer (2nd Floor) 6:30 – 7:30 am “Meet the Professor” Breakfasts Tuesday, June 2 T-1 Enterocutaneous Fistulas, Anastomotic Leaks and other Catastrophes . . . . . . . . . . . . . . . . . . . .200 T-2 Modern Management of Fecal Incontinence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .202 T-3 Nonhealing Perineal Wounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .203 T-4 Controversies: The Management of Intestinal Crohn's Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . .206 Continued next page 25 D A I LY S C H E D U L E Monday, June 1 (continued) Daily Schedule All programs are held in the Hynes Convention Center unless otherwise noted. HOURS ROOM Tuesday, June 2 (continued) 6:30 – 7:30 am “Meet the Professor” Breakfasts (continued) T-5 Pouch Problems and Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .207 T-6 Rectal Cancer: Difficult Cases and Controversies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300 T-7 Colitis and Dysplasia Surveillance and Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .313 6:30 – 7:30 am International Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .305 6:30 am – 6:00 pm Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201 6:30 am – 6:00 pm On-Going Video Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .210 7:30 – 9:00 am Symposium: Anorectal Disorders: Balancing Innovation with Conventional Wisdom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 7:30 – 9:00 am Symposium: Update on Inflammatory Bowel Disease . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 8:00 – 9:00 am Exhibitor's Advisory Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .301 8:30 – 9:30 am Operative Competency Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .303 9:00 – 9:30 am Ernestine Hambrick, MD, Lectureship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 9:00 am – 2:00 pm Exhibit Hours . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 9:30 – 10:15 am Refreshment Break in Exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 9:30 – 10:15 am ePoster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 10:15 – 11:45 am Symposium: Controversies in Rectal Cancer Management . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 10:15 – 11:45 am Symposium: Ostomies: Location, Creation and Complications . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 10:15 – 11:45 am Abstract Session: General Surgery Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor) 11:45 am – 12:15 pm Masters in Colorectal Surgery Lectureship Honoring David J. Schoetz, Jr., MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 12:15 – 12:45 pm Past Presidents' and Spouses of Past Presidents' Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .202 12:15 – 1:30 pm Complimentary Box Lunch in Exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 12:15 – 1:30 pm ePoster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 12:15 – 1:30 pm Women in Colorectal Surgery Luncheon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .304-306 12:15 – 1:30 pm Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .205 12:15 – 1:30 pm Regional Society Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .303 12:15 – 1:30 pm Video Based Education Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .301 12:15 – 2:00 pm Clinical Practice Guidelines Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200 12:15 – 2:00 pm Fundamentals of Rectal Cancer Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300 12:20 – 1:30 pm Product Theater: ConvaTec, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Halls C & D (2nd Floor) 12:45 – 1:30 pm Past Presidents' Luncheon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .203 12:45 – 1:30 pm Spouses of Past Presidents' Luncheon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .204 1:30 – 3:00 pm Symposium: Anal Cancer: Prevention, Diagnosis and Treatment . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 1:30 – 3:00 pm Abstract Session: Inflammatory Bowel Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 1:30 – 3:00 pm Abstract Session: Research Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom A (3rd Floor) 3:00 – 4:30 pm Symposium: Medical Legal Symposium: How to Protect Yourself . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 3:00 – 4:30 pm Symposium: Anal Fistulas: Diagnosis, Imaging and Therapy – Rational Approaches . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 26 Daily Schedule All programs are held in the Hynes Convention Center unless otherwise noted. HOURS ROOM 4:00 – 5:00 pm Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201 4:30 – 5:00 pm Refreshment Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium Foyer (2nd Floor) 5:00 – 6:15 pm After Hours Debate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 6:30 – 8:00 pm Residents' Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Back Bay Ballroom Salons CD (2nd Floor – Sheraton) 7:00 – 8:30 pm Non-CME Corporate Forum: Intuitive Surgical, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Constitution Ballroom (2nd Floor – Sheraton) 7:00 – 8:30 pm Non-CME Corporate Forum: Medtronic, plc . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Republic Ballroom (2nd Floor – Sheraton) 6:15 am – 4:00 pm Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Hall C Foyer (2nd Floor) 6:30 – 7:30 am “Meet the Professor” Breakfasts W-1 Complex Fistula . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .200 W-2 Stage 4 Cancer (What to Do) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .202 W-3 Pilonidal Disease: Options and Outcomes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .203 W-4 Enhanced Recovery Pathways . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .206 W-5 Non-Operative Management of Rectal Cancer – the Right Patient . . . . . . . . . . . . . . . . . . . . . . . .207 W-6 Parastomal Hernia and Stoma Complications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .300 6:30 am – 5:00 pm Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201 6:30 am – 5:00 pm On-Going Video Display . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .210 7:30 – 9:00 am Symposium: Colon Cancer: Staging, Techniques and the Role of Adjuvant Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 7:30 – 9:00 am Abstract Session: Outcomes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 9:00 – 10:30 am ASCRS/SSAT Symposium: Challenges and Controversies: Surgical Management of Advanced Disease and Recurrent Cancer . . . . . . . . . . . .Auditorium (2nd Floor) 9:00 – 10:30 am Abstract Session: Video Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 10:30 – 11:00 am Refreshment Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium Foyer (2nd Floor) & Ballroom BC Foyer (3rd Floor) Wednesday, June 3 11:00 am – 12:30 pm Symposium: Optimizing Treatment for Rectal Prolapse, Constipation and Obstructed Defecation Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 11:00 am – 12:30 pm Abstract Session: Neoplasia II . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ballroom BC (3rd Floor) 12:30 – 1:30 pm Lunch Break . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .On Your Own 12:30 – 1:30 pm Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .205 1:30 – 3:00 pm Symposium: Enhanced Perioperative Care Pathways and Postoperative Pain Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 3:00 – 4:30 pm Symposium: Is there a Pardigm Shift in the Management of Diverticular Disease? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Auditorium (2nd Floor) 4:30 – 5:30 pm ASCRS Annual Business Meeting and State of the Society Address . . . . . . . . . . . . . .Ballroom A (3rd Floor) 7:00 – 8:00 pm ASCRS Annual Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Grand Ballroom Foyer (2nd Floor – Sheraton) 8:00 – 10:30 pm ASCRS Annual Dinner Dance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Grand Ballroom (2nd Floor – Sheraton) 27 D A I LY S C H E D U L E Tuesday, June 2 (continued) Schedule-at-a-Glance SATURDAY, MAY 30 6:00 AM 6:15 AM 6:30 AM 6:45 AM 7:00 AM 7:15 AM 7:30 AM 7:45 AM 8:00 AM 8:15 AM 8:30 AM 8:45 AM 9:00 AM 9:15 AM 9:30 AM 9:45 AM 10:00 AM 10:15 AM 10:30 AM 10:45 AM 11:00 AM 11:15 AM 11:30 AM 11:45 AM 12:00 NOON 12:15 PM 12:30 PM 12:45 PM 1:00 PM 1:15 PM 1:30 PM 1:45 PM 2:00 PM 2:15 PM 2:30 PM 2:45 PM 3:00 PM 3:15 PM 3:30 PM 3:45 PM 4:00 PM 4:15 PM 4:30 PM 4:45 PM 5:00 PM 5:15 PM 5:30 PM 5:45 PM 6:00 PM 6:15 PM 6:30 PM 6:45 PM 7:00 PM 7:15 PM 7:30 PM 7:45 PM 8:00 PM 8:15 PM 8:30 PM 8:45 PM 9:00 PM 9:15 PM 9:30 PM 9:45 PM 10:00 PM Laparoscopic Colectomy Symposium and Workshop (Didactic) 7:30 – 11:45 AM Optimal Management of Fecal Incontinence Symposium and Workshop (Didactic) AIN and HRA: What the Colorectal Surgeon Needs to Know Workshop 7:00 AM – 12:30 PM 7:30 AM – NOON Transanal Endoscopic Surgery Workshop Robotic Colon and Rectal Surgery: Tips, Tricks, and Simulation Symposium and Workshop 7:00 AM – 4:30 PM 8:00 AM – 4:30 PM SYMPOSIUM: Laparoscopic Hands-on-Lab (Off-site) 1:00 – 4:30 PM Advanced Endoscopy and Endoluminal Surgery Optimal Management of Fecal Incontinence Hands-on-Lab (Off-site) Question Writing Workshop 12:30 – 3:30 PM 12:30 – 4:00 PM 1:00 – 4:30 PM SYMPOSIUM: Improving OutcomesIdentifying and Managing the Complex Surgical Patients 4:00 – 5:30 PM 28 6:00 AM 6:15 AM 6:30 AM 6:45 AM 7:00 AM 7:15 AM 7:30 AM 7:45 AM 8:00 AM 8:15 AM 8:30 AM 8:45 AM 9:00 AM 9:15 AM 9:30 AM 9:45 AM 10:00 AM 10:15 AM 10:30 AM 10:45 AM 11:00 AM 11:15 AM 11:30 AM 11:45 AM 12:00 NOON 12:15 PM 12:30 PM 12:45 PM 1:00 PM 1:15 PM 1:30 PM 1:45 PM 2:00 PM 2:15 PM 2:30 PM 2:45 PM 3:00 PM 3:15 PM 3:30 PM 3:45 PM 4:00 PM 4:15 PM 4:30 PM 4:45 PM 5:00 PM 5:15 PM 5:30 PM 5:45 PM 6:00 PM 6:15 PM 6:30 PM 6:45 PM 7:00 PM 7:15 PM 7:30 PM 7:45 PM 8:00 PM 8:15 PM 8:30 PM 8:45 PM 9:00 PM 9:15 PM 9:30 PM 9:45 PM 10:00 PM Schedule-at-a-Glance MONDAY, JUNE 1 Meet the Professor Breakfasts Residents’ Breakfast 6:00 – 7:00 AM 6:00 – 7:00 AM SYMPOSIUM: Core Subject Update Rectal Cancer: Optimizing Outcomes through Techniques SYMPOSIUM: 8:00 – 9:45 AM SYMPOSIUM: SYMPOSIUM: Complications: Prevention and Management 9:30 – 11:45 AM 9:45 – 11:45 AM SYMPOSIUM: 11:45 AM – 1:15 PM 9:00 – 11:00 AM LUNCHEON SYMPOSIUM: LUNCHEON SYMPOSIUM: Current Advances in the Management of Fecal Incontinence Memorial Lectureship Honoring John M. MacKeigan, MD 9:15 – 9:45 AM Quality Initiatives in Clinical Practice Laparoscopic Nuts and Bolts and Robotic Rivets 7:00 AM – 9:15 PM 7:00 – 9:15 AM Healthcare Economics in the ACA Era 7:15 – 9:30 AM SYMPOSIUM: Robotic Colorectal Surgery The Genetics of Colorectal Cancer and Cancer Related Syndromes Presidential Address 9:45 – 10:15 AM Refreshment Break and ePoster Presentations in Exhibit Hall 10:15 – 11:00 AM SYMPOSIUM: Navigating a Career Path in Colon and Rectal Surgery – Orchestrating and Optimizing Career Transitions at All Levels ABSTRACT SESSION: Benign Colonic Disease 11:00 AM – 12:30 PM 11:00 AM – 12:30 PM Complimentary Box Lunch and ePoster Presentations in Exhibit Hall 11:45 AM – 1:15 PM 12:30 – 1:30 PM Welcome and Opening Announcements 1:15 – 2:00 PM SYMPOSIUM: Technical Pearls – How it’s Really Done ABSTRACT SESSION: SYMPOSIUM: ABSTRACT SESSION: Past Presidents’ Panel: Controversies and Cases Pelvice Floor/ Anorectal 1:30 – 3:00 PM 1:30 – 3:00 PM Neoplasia I 2:00 – 3:30 PM Harry E. Bacon, MD, Lectureship 3:00 – 3:30 PM 2:00 – 4:00 PM Ice Cream & Refreshment Break and ePoster Presentations in Exhibit Hall Refreshment Break and ePoster Presentations in Exhibit Hall 3:30 – 4:15 PM Parviz Kamangar Humanities in Surgery Lectureship 4:00 – 4:45 PM 4:15 – 4:45 PM Norman D. Nigro, MD, Research Lectureship The Trials and Tribulations of Clinical Research: Why Johnny Can’t Add 4:45 – 5:15 PM 4:45 – 5:15 PM International Scholarship Recipient Presentation After Hours Debate 5:15 – 6:30 PM New Technologies Symposium 5:20 – 6:45 PM Welcome Reception 7:00 – 8:30 PM 29 5:15 – 5:20 PM 6:00 AM 6:15 AM 6:30 AM 6:45 AM 7:00 AM 7:15 AM 7:30 AM 7:45 AM 8:00 AM 8:15 AM 8:30 AM 8:45 AM 9:00 AM 9:15 AM 9:30 AM 9:45 AM 10:00 AM 10:15 AM 10:30 AM 10:45 AM 11:00 AM 11:15 AM 11:30 AM 11:45 AM 12:00 NOON 12:15 PM 12:30 PM 12:45 PM 1:00 PM 1:15 PM 1:30 PM 1:45 PM 2:00 PM 2:15 PM 2:30 PM 2:45 PM 3:00 PM 3:15 PM 3:30 PM 3:45 PM 4:00 PM 4:15 PM 4:30 PM 4:45 PM 5:00 PM 5:15 PM 5:30 PM 5:45 PM 6:00 PM 6:15 PM 6:30 PM 6:45 PM 7:00 PM 7:15 PM 7:30 PM 7:45 PM 8:00 PM 8:15 PM 8:30 PM 8:45 PM 9:00 PM 9:15 PM 9:30 PM 9:45 PM 10:00 PM D A I LY S C H E D U L E SUNDAY, MAY 31 6:00 AM 6:15 AM 6:30 AM 6:45 AM 7:00 AM 7:15 AM 7:30 AM 7:45 AM 8:00 AM 8:15 AM 8:30 AM 8:45 AM 9:00 AM 9:15 AM 9:30 AM 9:45 AM 10:00 AM 10:15 AM 10:30 AM 10:45 AM 11:00 AM 11:15 AM 11:30 AM 11:45 AM 12:00 NOON 12:15 PM 12:30 PM 12:45 PM 1:00 PM 1:15 PM 1:30 PM 1:45 PM 2:00 PM 2:15 PM 2:30 PM 2:45 PM 3:00 PM 3:15 PM 3:30 PM 3:45 PM 4:00 PM 4:15 PM 4:30 PM 4:45 PM 5:00 PM 5:15 PM 5:30 PM 5:45 PM 6:00 PM 6:15 PM 6:30 PM 6:45 PM 7:00 PM 7:15 PM 7:30 PM 7:45 PM 8:00 PM 8:15 PM 8:30 PM 8:45 PM 9:00 PM 9:15 PM 9:30 PM 9:45 PM 10:00 PM Schedule at a Glance TUESDAY, JUNE 2 6:00 AM 6:15 AM 6:30 AM 6:45 AM 7:00 AM 7:15 AM 7:30 AM 7:45 AM 8:00 AM 8:15 AM 8:30 AM 8:45 AM 9:00 AM 9:15 AM 9:30 AM 9:45 AM 10:00 AM 10:15 AM 10:30 AM 10:45 AM 11:00 AM 11:15 AM 11:30 AM 11:45 AM 12:00 NOON 12:15 PM 12:30 PM 12:45 PM 1:00 PM 1:15 PM 1:30 PM 1:45 PM 2:00 PM 2:15 PM 2:30 PM 2:45 PM 3:00 PM 3:15 PM 3:30 PM 3:45 PM 4:00 PM 4:15 PM 4:30 PM 4:45 PM 5:00 PM 5:15 PM 5:30 PM 5:45 PM 6:00 PM 6:15 PM 6:30 PM 6:45 PM 7:00 PM 7:15 PM 7:30 PM 7:45 PM 8:00 PM 8:15 PM 8:30 PM 8:45 PM 9:00 PM 9:15 PM 9:30 PM 9:45 PM 10:00 PM WEDNESDAY, JUNE 3 Meet the Professor Breakfasts Meet the Professor Breakfasts 6:30 – 7:30 AM 6:30 – 7:30 AM SYMPOSIUM: SYMPOSIUM: SYMPOSIUM: Anorectal Disorders: Balancing Innovation with Conventional Wisdom Update on Inflammatory Bowel Disease Colon Cancer: Staging, Techniques and the Role of Adjuvant Therapy 7:30 – 9:00 AM 7:30 – 9:00 AM 7:30 – 9:00 AM Ernestine Hambrick, MD, Lectureship ASCRS/SSAT SYMPOSIUM: 9:00 – 9:30 AM Challenges and Controversies: Surgical Management of Advanced Disease and Recurrent Cancer Refreshment Break and ePoster Presentations in Exhibit Hall 9:30 – 10:15 AM 7:30 – 9:00 AM ABSTRACT SESSION: Video Session 9:00 – 10:30 AM 9:00 – 10:30 AM SYMPOSIUM: SYMPOSIUM: ABSTRACT SESSION: Outcomes Ostomies: Controversies in Location, Rectal Cancer Creation and Management Complications 10:15 – 11:45 AM Refreshment Break in Foyer ABSTRACT SESSION: General Surgery Forum 10:15 – 11:45 AM 10:15 – 11:45 AM Masters in Colorectal Surgery Lectureship 11:45 AM – 12:15 PM Honoring David Schoetz, Jr., MD Women in Complimentary Box Lunch Colorectal and ePoster Presentations Surgery in the Exhibit Hall Luncheon 12:15 – 1:30 PM 10:30 – 11:00 AM SYMPOSIUM: Optimizing Treatment for Rectal Prolapse, Constipation and Obstructed Defecation Syndrome ABSTRACT SESSION: Neoplasia II 11:00 AM – 12:30 PM 11:00 AM – 12:30 PM Lunch on own 12:30 – 1:30 PM 12:15– 1:30 PM SYMPOSIUM: Anal Cancer: Prevention, Diagnosis and Treatment ABSTRACT SESSION: ABSTRACT SESSION: Inflammatory Bowel Disease Research Forum 1:30 – 3:00 PM 1:30 – 3:00 PM SYMPOSIUM: Enhanced Perioperative Care Pathways and Postoperative Pain Management 1:30 – 3:00 PM 1:30 – 3:00 PM SYMPOSIUM: Medical Legal Symposium: How to Protect Yourself SYMPOSIUM: SYMPOSIUM: Anal Fistulas: Diagnosis, Imaging and Therapy – Rational Approaches Is there a Paradigm Shift in the Management of Diverticular Disease? 3:00 – 4:30 PM 3:00 – 4:30 PM 3:00 – 4:30 PM Refreshment Break in Foyer 4:30 – 5:00 PM ASCRS Annual Business Meeting and State of the Society Address 4:30 – 5:30 PM After Hours Debate 5:00 – 6:15 PM Residents’ Reception 6:30 – 8:00 PM ASCRS Annual Reception and Dinner Dance Reception: 7:00 – 8:00 PM Dinner Dance: 8:00 – 10:30 PM 30 6:00 AM 6:15 AM 6:30 AM 6:45 AM 7:00 AM 7:15 AM 7:30 AM 7:45 AM 8:00 AM 8:15 AM 8:30 AM 8:45 AM 9:00 AM 9:15 AM 9:30 AM 9:45 AM 10:00 AM 10:15 AM 10:30 AM 10:45 AM 11:00 AM 11:15 AM 11:30 AM 11:45 AM 12:00 NOON 12:15 PM 12:30 PM 12:45 PM 1:00 PM 1:15 PM 1:30 PM 1:45 PM 2:00 PM 2:15 PM 2:30 PM 2:45 PM 3:00 PM 3:15 PM 3:30 PM 3:45 PM 4:00 PM 4:15 PM 4:30 PM 4:45 PM 5:00 PM 5:15 PM 5:30 PM 5:45 PM 6:00 PM 6:15 PM 6:30 PM 6:45 PM 7:00 PM 7:15 PM 7:30 PM 7:45 PM 8:00 PM 8:15 PM 8:30 PM 8:45 PM 9:00 PM 9:15 PM 9:30 PM 9:45 PM 10:00 PM ASCRS and Research Foundation Committee Meetings HOURS ROOM Saturday 8:00 am – noon 5:30 – 6:30 pm Executive Council Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fairfax (3rd Flr – Sheraton) Self-Assessment Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 300 7:00 – 8:00 am 7:00 – 8:00 am 7:00 – 9:00 am 8:00 – 10:00 am 8:30 – 9:30 am 9:00 – 11:00 am 11:00 am –12:30 pm 11:30 am –12:30 pm 11:45 am – 1:00 pm Noon – 1:00 pm Noon – 1:00 pm Noon – 1:00 pm 5:30 – 6:30 pm CREST Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 300 Quality Assessment Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 203 Research Foundation Board of Trustees Meeting . . . . . . . . . . . . .Fairfax (3rd Flr – Sheraton) New Technologies Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 200 Professional Outreach Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 202 Research Foundation Research Committee . . . . . . . . . . . . . . . . .Gardner (3rd Flr – Sheraton) DC&R Editorial Board Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 300 Residents Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 202 Research Foundation Fundraising Assistance Committee . . . . . . . . . . . . . . . . . . . . .Room 203 Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 205 Continuing Education Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 200 Membership Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 206 International Council of Coloproctology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 310 Monday 6:00 – 7:00 am 8:00 – 9:00 am 11:30 am – 12:30 pm 12:30 – 1:30 pm 12:30 – 1:30 pm 12:30 – 1:30 pm 2:00 – 3:30 pm 4:00 – 5:00 pm 5:30 – 6:30 pm History of ASCRS Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 301 Rectal Cancer Coodinating Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 303 Social Media Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 303 Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 205 Website Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 300 Young Surgeons Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 301 Public Relations Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 200 Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 205 Healthcare Economics Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 200 Tuesday 6:30 – 7:30 am 8:00 – 9:00 am 8:30 – 9:30 am 12:15 – 1:30 pm 12:15 – 1:30 pm 12:15 – 1:30 pm 12:15 – 2:00 pm 12:15 – 2:00 pm 1:30 – 3:30 pm 4:00 – 5:00 pm International Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 305 Exhibitor’s Advisory Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 301 Operative Competency Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 303 Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 205 Regional Society Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 303 Video Based Education Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 301 Clinical Practice Guidelines Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 200 Fundamentals of Rectal Cancer Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 300 Research Foundation Young Researchers Committee . . . . . . . . . . . . . . . .Ballroom A (3rd Flr) Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 205 Wednesday 12:30 – 1:30 pm Awards Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Room 205 31 D A I LY S C H E D U L E Sunday ASCRS Past Presidents *1978-1979 Donald M. Gallagher *1899-1900 Joseph M. Mathews *1938-1939 Dudley Smith *1900-1901 James P. Tuttle *1939-1940 Martin S. Kleckner *1901-1902 Thomas C. Martin *1940-1941 Clement J. Debere *1902-1903 Samuel T. Earle *1941-1942 Frederick B. Campbell *1903-1904 William M. Beach *1942-1944 Homer I. Silvers *1904-1905 J. Rawson Pennington *1944-1946 William H. Daniel 1983-1984 Stanley M. Goldberg *1905-1906 Lewis H. Adler, Jr. *1946-1947 Joseph W. Ricketts *1984-1985 A.W. Martin Marino, Jr. *1906-1907 Samuel G. Gant *1947-1948 George H. Thiele *1907-1908 A. Bennett Cooke *1948-1949 Harry E. Bacon *1986-1987 H. Whitney Boggs, Jr. *1908-1909 George B. Evans *1949-1950 Louis E. Moon 1987-1988 Frank J. Theuerkauf *1909-1910 Dwight H. Murray *1950-1951 Hoyt R. Allen 1988-1989 Herand Abcarian *1910-1911 George J. Cooke *1951-1952 Robert A. Scarborough *1911-1912 John L. Jelks *1952-1953 Newton D. Smith 1990-1991 Peter A. Volpe *1912-1913 Louis J. Hirschman *1953-1954 W. Wendell Green 1991-1992 Robert W. Beart, Jr. *1913-1914 Joseph M. Mathews *1954-1955 A.W. Martin Marino, Sr. 1992-1993 W. Patrick Mazier *1914-1915 Louis J. Krause *1955-1956 Stuart T. Ross 1993-1994 Samuel B. Labow *1915-1916 T. Chittenden Hill *1956-1957 Rufus C. Alley 1994-1995 Philip H. Gordon *1916-1917 Alfred J. Zobel *1957-1958 Julius E. Linn 1995-1996 Victor W. Fazio *1917-1919 Jerome M. Lynch *1958-1959 Karl Zimmerman 1996-1997 David A. Rothenberger *1919-1920 Collier F. Martin *1959-1960 Hyrum R. Reichman 1997-1998 Ira J. Kodner *1920-1921 Alois B. Graham *1960-1961 Walter A. Fansler 1998-1999 Lee E. Smith *1921-1922 Granville S. Hanes *1961-1962 Merrill O. Hines 1999-2000 H. Randolph Bailey *1922-1923 Emmett H. Terrell *1962-1963 Robert J. Rowe * 2000-2001 John M. MacKeigan *1923-1924 Ralph W. Jackson *1963-1964 Robert A. Scarborough 2001-2002 Robert D. Fry *1924-1925 Frank C. Yeomans *1964-1965 Garnet W. Ault 2002-2003 Richard P. Billingham *1925-1926 Descum C. McKenney *1965-1966 Norman D. Nigro 2003-2004 David J. Schoetz, Jr. *1926-1927 William H. Kiger *1966-1967 Maus W. Stearns, Jr. 2004-2005 Bruce G. Wolff *1927-1928 Louis A. Buie *1967-1968 Raymond J. Jackman 2005-2006 Ann C. Lowry *1928-1929 Edward G. Martin *1968-1969 Neil W. Swinton 2006-2007 Lester Rosen *1929-1930 Walter A. Fansler *1969-1970 James A. Ferguson *1930-1931 Dudley Smith *1970-1971 Walter Birnbaum 2008-2009 Anthony J. Senagore *1931-1932 W. Oakley Hermance *1971-1972 Andrew Jack McAdams 2009-2010 James W. Fleshman *1932-1933 Curtice Rosser *1972-1973 John E. Ray 2010-2011 David E. Beck *1933-1934 Curtis C. Mechling *1973-1974 John H. Remington 2011-2012 Steven D. Wexner *1934-1935 Louis A. Buie *1974-1975 Rupert B. Turnbull 2012-2013 Alan G. Thorson *1935-1936 Frank G. Runyeon *1975-1976 Patrick H. Hanley 2013-2014 Michael J. Stamos *1936-1937 Marion C. Pruitt *1976-1977 John R. Hill *1937-1938 Harry Z. Hibshman *1977-1978 Alejandro F. Castro *Deceased 32 1979-1980 Stuart H.Q. Quan *1980-1981 Malcolm C. Veidenheimer 1981-1982 Bertram A. Portin *1982-1983 Eugene S. Sullivan 1985-1986 Eugene P. Salvati *1989-1990 J. Byron Gathright, Jr. * 2007-2008 W. Douglas Wong Saturday, May 30 UT SOLD O Transanal Endoscopic Surgery Workshop 1 2 6 8.5 CME 7:00 am – 4:30 pm Room 200 Fee: $495 • Limit: 48 participants • Lunch Included • Registration Required Didactic Session: 7:00 – 8:25 am Transanal excision of tumors of the rectum has been limited by the technical difficulties of operating in a confined space with inadequate instrumentation. Access to lesions higher than 6 cm from the anal verge is not feasible with standard transanal techniques. Transanal endoscopic microsurgery (TEM) was designed to overcome these limitations and has proven to be an invaluable endoscopic tool in treating rectal lesions which might otherwise require proctectomy. Over the last several years, the armamentarium of transanal approach has increased with the development of two new platforms, Transanal Endoscopic Operations (TEO) and Transanal Minimally Invasive Surgery (TAMIS). These platforms offer other options for advanced transanal surgery. Radical resection of the rectum for benign and malignant neoplasms is associated with rates of perioperative complications and functional disorders that largely exceed the morbidity associated with other types of bowel resections. This has led surgeons to attempt less invasive surgical alternatives including transanal excision and traditional endoscopic approaches. Standard transanal excisional techniques are limited by instrumentation and anatomy to the distal 6-12 cm of the rectum and are associated with substantial recurrence rates for benign and malignant disease. In the early 1980’s, transanal endoscopic microsurgery (TEM) was described. In the past decade, its acceptance has increased and several authors have demonstrated decreased recurrence rates for benign and early stage malignant neoplasms when compared to standard transanal excision. Morbidity for TEM has been low and similar to transanal excision. With the recent introduction of new devices (TEO, TAMIS/SILS) to perform transanal endoscopic resections, surgeons now have more flexibility in terms of equipment and operative setup. Surgeons experienced in transanal endoscopic surgery (TES) have learned valuable lessons in patient selection, operative setup, technical pearls and troubleshooting, and postoperative management that can accelerate learning for those interested in adopting this technique. Existing Gaps What Is: Despite increased acceptance of TES and reported decreased rates of recurrence compared to standard transanal excision, many colorectal surgeons have not adopted TES into their practices. What Should Be: Comprehensive review of indications for transanal endoscopic microsurgery and of all devices currently available, and hands-on practice in an inanimate lab training session under the guidance of experts, will allow for more surgeons to adopt TES and offer it to patients as an alternative to radical resection when clinically indicated. Objectives: At the conclusion of this session, participants should be able to: a) Recognize the surgical indications and preoperative preparation for TES; b) Recall the operative set up, transanal devices and equipment currently used to perform TES; c) Demonstrate how to troubleshoot technical difficulties during TES; d) Explain intraoperative complications and postoperative management of patients undergoing TES; e) Demonstrate the technical skills necessary to perform TES and become familiar with all the available transanal devices; f ) Chart how to bill appropriately for the various TES techniques; g) Describe the requirements necessary to start a TES program at their institution. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 33 Continued next page S AT U R D AY Supported by independent educational grants and loaned durable equipment from: Applied Medical KARL STORZ Endoscopy-America, Inc. Medtronic & Covidien Richard Wolf Medical Instruments Corporation Stryker Endoscopy Saturday, May 30 Transanal Endoscopic Surgery Workshop (Continued) Room 200 Co-Director: Peter Cataldo, MD, Burlington, VT Co-Director: Joshua Bleier, MD, Philadelphia, PA 7:00 am Introduction to TES: Past and Present Peter Cataldo, MD, Burlington, VT 7:05 am 7:20 am 7:35 am 7:50 am Indications for TES, Patient Selection Dana Sands, MD, Weston, FL Excision and Suturing Techniques (all platforms) Peter Cataldo, MD, Burlington, VT 8:05 am Oncology Results Joshua Bleier, MD, Philadelphia, PA Complications Scott Steele, MD, Fort Lewis, WA 8:25 am Break into Groups Setup and Positioning (all platforms) Theodore Saclarides, MD, Maywood, IL Group A – Hands-on Lab Group B – TES Panel Discussion with Videos 8:30 am – noon Rooms 202, 203, 204, 206 8:30 am – noon Room 200 Peter Cataldo, MD, Lab Director Joshua Bleier, MD, Workshop Director TEO (Room 203) Skandan Shanmugan, MD, Philadelphia, PA; Patricia Sylla, MD, New York, NY; Brian Valerian, MD, Albany, NY Panel: Liliana Bordeianou, MD, Boston, MA; Rodrigo Perez, MD, Sao Paulo, Brazil; Theodore Saclarides, MD, Maywood, IL; Mark Whiteford, MD, Portland, OR TEM (Room 202) Traci Hedrick, MD, Charlottesville, VA; Dana Sands, MD, Weston, FL; Elizabeth Raskin, St. Paul, MN Participants are welcome to bring questions and difficult cases to the panel. Noon Lunch (Room 200) SILS (Room 206) Eric Haas, MD, Houston, TX; Jaime Sanchez, MD, Tampa, FL; Scott Steele, MD, Fort Lewis, WA TAMIS (Room 204) Sergio Larach, MD, Orlando, FL; Elisabeth McLemore, MD, Los Angeles, CA; Theodoros Voloyiannis, MD, Houston, TX Noon Lunch (Room 200) Continued next page 34 Saturday, May 30 Transanal Endoscopic Surgery Workshop (Continued) Group A – TES Panel Discussion with Videos Group B – Hands-on Lab 1:00 – 4:30 pm Room 200 1:00 – 4:30 pm Rooms 202, 203, 204, 206 Joshua Bleier, MD, Workshop Director Peter Cataldo, MD, Lab Director Panel: Charles Finne, MD, Minneapolis, MN; Jorge Marcet, MD, Tampa, FL; Bruce Orkin, MD, Chicago, IL; Theodore Saclarides, MD, Maywood, IL; Mark Whiteford, MD, Portland, OR TEO (Room 203) Elisabeth McLemore, MD, Los Angeles, CA; Patricia Sylla, MD, New York, NY; Brian Valerian, MD, Albany, NY TEM (Room 202) Traci Hedrick, MD, Charlottesville, VA; Dana Sands, MD, Weston, FL; Elizabeth Raskin, St. Paul, MN Participants are welcome to bring questions and difficult cases to the panel. Adjourn SILS (Room 206) Eric Haas, MD, Houston, TX; Jaime Sanchez, MD, Tampa, FL; Scott Steele, MD, Fort Lewis, WA TAMIS (Room 204) Sergio Larach, MD, Orlando, FL; Theodoros Voloyiannis, MD, Houston, TX 4:30 pm 35 Adjourn S AT U R D AY 4:30 pm Saturday, May 30 UT SOLD O AIN and HRA: What the Colorectal Surgeon Needs to Know Workshop 1 2 4 6 5.25 CME 7:00 am – 12:30 pm Rooms 311, 312, 313 Fee: $495 • Limit: 45 participants • Registration Required Supported by independent educational grants consisting of loaned durable equipment from: Carl Zeiss Meditec CONMED CooperSurgical Redfield Corporation Seiler Instrument & Manufacturing Co, Inc. Zinnanti Surgical Design Group Inc. The incidence of anal cancer is increasing due to rising rates of human papilloma virus (HPV) infection. HPV infection can lead to anal intraepithelial neoplasia (AIN) that can be identified with high-resolution anoscopy (HRA). While colon and rectal surgeons are very familiar with the evaluation and treatment of anal cancer, many do not know how to identify the anal cancer precursor, AIN, with HRA. Through a didactic and hands-on educational initiative, we will review HPV infections and the indications and use of HRA for AIN. The participants will be divided into three groups and will have rotations between didactic, hands-on and video sessions. Existing Gaps What Is: While colon and rectal surgeons understand the evaluation and treatment of anal cancer, many are not skilled at the evaluation and treatment of AIN and use of HRA. What Should Be: Colon and rectal surgeons should have a thorough understanding of AIN. In addition, colon and rectal surgeons should have an understanding of how to use HRA to evaluate and treat AIN. Finally, surgeons should know all the treatment options available for patients with AIN. Director: Stephen Goldstone, MD, New York, NY Assistant Director: Naomi Jay, NP, PhD, San Francisco, CA Room 311 7:00 am Welcome Stephen Goldstone, MD, New York, NY 7:05 am Intro to HPV: Scope of the Problem Joel Palefsky, MD, San Francisco, CA 7:20 am How to Diagnose AIN: Screening and Diagnostics J. Michael Berry-Lawhorn, MD, San Francisco, CA Naomi Jay, NP, PhD, San Francisco, CA 7:40 am HRA Findings of AIN Naomi Jay, NP, PhD, San Francisco, CA *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 36 8:00 am HRA Guided Treatment Options Stephen Goldstone, MD, New York, NY Joel Palefsky, MD, San Francisco, CA 8:40 am Panel Discussion/Questions J. Michael Berry-Lawhorn, MD, San Francisco, CA Stephen Goldstone, MD, New York, NY Naomi Jay, NP, PhD, San Francisco, CA Joel Palefsky, MD, San Francisco, CA Continued next page Saturday, May 30 AIN and HRA: What the Colorectal Surgeon Needs to Know Workshop (continued) 9:00 am 9:30 am Group 2 Lesion Identification (understanding lesion patterns to differentiate LG from HG) (Room 311) Naomi Jay, NP, PhD, San Francisco, CA Hands-on Workshop: HRA Including Use of the Colposcope and Biopsy Techniques (Room 312) J. Michael Berry-Lawhorn, MD, San Francisco, CA Stephen Goldstone, MD, New York, NY 9:00 am HRA the Movie (Room 313) Joel Palefsky, MD, San Francisco, CA 9:30 am Lesion Identification (understanding lesion patterns to differentiate LG from HG) (Room 311) Naomi Jay, NP, PhD, San Francisco, CA 10:00 am HRA the Movie (Room 313) Joel Palefsky, MD, San Francisco, CA 10:00 am Hands-on Workshop: HRA Including Use of the Colposcope and Biopsy Techniques (Room 312) J. Michael Berry-Lawhorn, MD, San Francisco, CA Stephen Goldstone, MD, New York, NY 10:30 am Refreshment Break in Foyer 10:30 am Refreshment Break in Foyer 10:45 am IRC and Hyfrecator Movie (Room 313) Stephen Goldstone, MD, New York, NY 10:45 am Cases: Identifying Lesions, Determining Sites for Biopsies (Room 311) J. Michael Berry-Lawhorn, MD, San Francisco, CA 11:15 am Hands-on Workshop: HRA Treatment (Room 312) Naomi Jay, NP, PhD, San Francisco, CA Joel Palefsky, MD, San Francisco, CA 11:15 am IRC and Hyfrecator Movie (Room 313) Stephen Goldstone, MD, New York, NY 11:45 am Hands-on Workshop: HRA Treatment (Room 312) Naomi Jay, NP, PhD, San Francisco, CA Joel Palefsky, MD, San Francisco, CA 11:45 am Cases: Identifying Lesions, Determining Sites for Biopsies (Room 311) J. Michael Berry-Lawhorn, MD, San Francisco, CA Continued next page 37 S AT U R D AY Group 1 Saturday, May 30 AIN and HRA: What the Colorectal Surgeon Needs to Know Workshop (continued) Group 3 9:00 am 9:30 am Groups 1-3 Room 311 Hands-on Workshop: HRA Including Use of the Colposcope and Biopsy Techniques (Room 312) J. Michael Berry-Lawhorn, MD, San Francisco, CA Stephen Goldstone, MD, New York, NY 12:15 pm Panel Discussion/Questions J. Michael Berry-Lawhorn, MD, San Francisco, CA Stephen Goldstone, MD, New York, NY Naomi Jay, NP, PhD, San Francisco, CA Joel Palefsky, MD, San Francisco, CA HRA the Movie (Room 313) Joel Palefsky, MD, San Francisco, CA 12:30 pm Adjourn 10:00 am Lesion Identification (understanding lesion patterns to differentiate LG from HG) (Room 311) Naomi Jay, NP, PhD, San Francisco, CA 10:30 am Refreshment Break in Foyer 10:45 am Hands-on Workshop: HRA Treatment (Room 312) Naomi Jay, NP, PhD, San Francisco, CA Joel Palefsky, MD, San Francisco, CA 11:15 am Cases: Identifying Lesions, Determining Sites for Biopsies (Room 311) J. Michael Berry-Lawhorn, MD, San Francisco, CA 11:45 am IRC and Hyfrecator Movie (Room 313) Stephen Goldstone, MD, New York, NY Objectives: At the conclusion of this session, participants should be able to: a) Describe the prevalence of anal HPV infection; b) Recognize how to best diagnose AIN; c) Demonstrate how to perform high resolution anoscopy; d) Identify treatment options available for AIN. 38 Saturday, May 30 UT SOLD O Laparoscopic Colectomy Symposium and Workshop 2 4.25 MOC 4 6 * 4.25 CME Didactic Session: 7:30 – 11:45 am Didactic is open to all registrants (Complimentary) Ballroom BC (3rd Floor) Didactic Session: 7:30 – 11:45 am The utilization of laparoscopic techniques to perform colon and rectal resections has been expanding for years, and will continue to do so in the face of new technological developments and advancement in instrumentation. Thought and opinion leaders continue to develop new techniques that simplify laparoscopic colorectal procedures and foster adoption of minimally invasive approaches. In the effort to ensure the best outcomes for our patients, it is essential that practicing colorectal surgeons have a solid grasp on key concepts for the performance of laparoscopic colorectal surgery. The many issues often encountered when performing minimally invasive colon and rectal surgery will be addressed: • Technical Descriptions - Medial to lateral approach - Lateral to medial approach - Stapling - Safe Energy utilization - Hand assist colectomy • New Technologies - Single site - Florescence imaging • New Techniques • Review of Laparoscopic and Anatomic Principles • Port Placement Philosophy • Procedural Reviews - Right colectomy - Left colectomy - Proctectomy - Rectopexy - Hartmann reversal - Peristomal hernia repair This symposium will address laparoscopic colectomy techniques, with an emphasis on creative and excellence in teaching followed by a workshop that will allow for hands-on experience. Co-Director: Amir Bastawrous, MD, Seattle, WA Co-Director: Eric K. Johnson, MD, Fort Lewis, WA 7:30 am Right Colectomy, the Laparoscopic Gateway Drug Marc Singer, MD, Chicago, IL 8:00 am Video Presentation Medial to Lateral Right Colectomy Nell Maloney Patel, MD, New Brunswick, NJ 7:45 am Video Presentation Inferior to Superior Right Colectomy Imran Hassan, MD, Iowa City, IA 8:15 am Anastomotic Options Alan Harzman, MD, Columbus, OH 8:30 am Panel Discussion *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 39 Continued next page S AT U R D AY Supported by independent educational grants and loaned durable equipment from: Applied Medical Ethicon KARL STORZ Endoscopy-America, Inc. Medtronic & Covidien Olympus Corporation of the Americas Saturday, May 30 Laparoscopic Colectomy Symposium and Workshop (Continued) Ballroom BC (3rd Floor) 8:45 am Laparoscopic Left Colectomy, the Next Challenge Konstantin Umanskiy, MD, Chicago, IL 9:00 am Video Presentation – Medial to Lateral Left Colectomy Tal Raphaeli, MD, Humble, TX 9:15 am Video Presentation – Splenic Flexure Approaches John Griffin, MD, Salt Lake City, UT 9:30 am HALS-Role and Advantages Darren Pollock, MD, Seattle, WA 9:45 am 10:30 am Video Presentation – TME Slawomir Marecik, MD, Park Ridge, IL 10:45 am Video Presentation – Tips for the Difficult Pelvis Daniel Herzig, MD, Portland, OR 11:00 am Panel Discussion 11:15 am Complications and Challenges Eric K. Johnson, MD, Fort Lewis, WA 11:45 am Adjourn 11:45 am Lunch Provided for Hands-on Lab Participants (Room 301) Panel Discussion 12:30 pm Bus Departs for Tufts Medical Center from the Lower Level of the Hynes Convention Center 10:05 am Refreshment Break in Foyer 10:15 am Laparoscopic Proctectomy and TME, the Differentiator Joseph Carmichael, MD, Orange, CA Continued next page 40 Saturday, May 30 Laparoscopic Colectomy Symposium and Workshop (Continued) UT SOLD O Hands-on Lab Session: 1:00 – 4:30 pm • Limit 20 • Fee: $595 Lunch Included for Hands-on Lab Registrants • Registration Required Location for Hands-on Lab: Tufts Medical Center, 136 Harrison Avenue, Boston, MA 02111 Transportation will be provided 3.5 CME Existing Gaps What Is: Despite the evidence supporting improved outcomes with the use of minimally invasive techniques, adoption has been slow. At least 50% of colectomies continue to be performed utilizing traditional open techniques. Even among fellowship of trained colon and rectal surgeons, most do not use laparoscopy routinely in their practice. While some cases require an open approach, many more do not. These techniques cannot be learned from a textbook. 12:30 pm – Bus departs from the Lower Level, Boylston Street entrance of the Hynes Convention Center UT SOLD O 1:00 – 4:30 pm (Off Site) Hands-on Session for Lab Registrants Tufts Medical Center, 136 Harrison Avenue, Boston, MA 02111 (Registration Required) Demonstrate the knowledge you aquired during the morning symposium to strengthen your skills. We will begin with laparoscopic right colectomy, then left colectomy, then low anterior resection, hand assist, and SILS. Faculty for hands-on session includes: Amir Bastawrous, MD, Seattle, WA; Joseph Carmichael, MD, Orange, CA; John Griffin, MD, Salt Lake City, UT; Alan Harzman, MD, Columbus, OH; Imran Hassan, MD, Cedar Rapids, IA; Daniel Herzig, MD, Portland, OR; Eric K. Johnson, MD, Fort Lewis, WA; Nell Maloney Patel, MD, New Brunswick, NJ; Slawomir Marecik, MD, Park Ridge, IL; Darren Pollock, MD, Seattle, WA; Tal Raphaeli, MD, Humble, TX; Marc Singer, MD, Chicago, IL; Konstantin Umanskiy, MD, Chicago, IL Objectives: At the conclusion of this session, participants should be able to: a) Discuss the potential advanced approaches to complex situations encountered during laparoscopic colorectal resection; b) Describe the appropriate utilization of available stapling and energy technology; c) Reproduce the basic approaches to right and left colectomy; d) Explain tips and tricks of laparoscopic rectal mobilization and e) Describe potential advantages to the robotic approach to pelvic dissection. 41 S AT U R D AY What Should Be: New and experienced colorectal surgeons should have access to quality educational material as well as the opportunity to take a hands-on approach to learning the most up-to-date minimally invasive techniques for colorectal resection. Because of the nature of many of the problems encountered, experts in several fields should be able to personally pass on knowledge built from experience with these issues. A better understanding of basic and complex principles will assist the surgeon in providing quality care, optimizing outcomes and ensuring future personal, practice, and institutional revenue in a competitive market. Saturday, May 30 Optimal Management of Fecal Incontinence Symposium and Workshop 1 4.25 MOC 2 4 5 6 * 4.25 CME Didactic Session: 7:30 am – noon Ballroom A (3rd Floor) Didactic is open to all registrants (Complimentary) Supported by independent educational grants and loaned durable equipment from: American Medical Systems BK Ultrasound LABORIE Medtronic, plc Salix Pharmaceuticals, Inc. The Prometheus Group Torax Medical, Inc. Didactic Session: 7:30 am – noon The prevalence of fecal incontinence is difficult to estimate as it is frequently underreported due to embarrassment and reluctance of patients to discuss symptoms with their physicians. Patients with fecal incontinence can benefit from specialized assessment with ultrasound, manometry, motility testing and defecography. The surgical treatment of fecal incontinence in the United States has been limited. Sphincter repair has good short-term results, but continence tends to deteriorate over time. The placement of an artificial bowel sphincter has a high morbidity and revision rate. Diverting colostomy is generally a last resort. Both sacral nerve stimulation (SNS) and the injection of bulking agents have been used for many years in the urologic field. These treatment modalities have recently become recognized in the field of colorectal surgery for the treatment of fecal incontinence. In addition to these new procedures, there are additional procedures being investigated such as the pelvic sling and magnetic anal sphincter. Through a didactic course and hands-on laboratory session, we will address the workup and management of patients with fecal incontinence including the review of both traditional as well as emerging procedures that are used to treat this condition. The lecture portion will be followed by a workshop that will allow for hands-on experience as well as the discussion of cases. Existing Gaps What Is: Anorectal and physiology testing play an important role in the assessment of patients with anorectal and pelvic floor disorders. The accuracy of these examinations depends upon the operator’s ability to perform the exam and properly interpret the results. Despite the introduction of new treatment modalities into the field of colorectal surgery, many colorectal surgeons have not adopted either procedure into their practice. What Should Be: It is important that colorectal surgeons develop hands-on expertise in the use of anorectal ultrasound in order to effectively manage patients with fecal incontinence. Objectives: At the conclusion of this session, participants should be able to: a) Explain the initial assessment and management of patients with fecal incontinence; b) Demonstrate and interpret endorectal ultrasound; c) Identify with the interpretation of anal manometry; d) Describe and interpret defecography; e) Distinguish the operative setup, identification of landmarks and steps for optimal lead placement in the performance of SNS; f ) Recall the postoperative management of patients with an Interstim implant including troubleshooting difficulties; g) Recognize when and how to inject bulking agents into the anal canal; h) Outline the clinical results of procedures for fecal incontinence; i) Distinguish alternatives to these procedures. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 42 Continued next page Saturday, May 30 Optimal Management of Fecal Incontinence Symposium and Workshop (Continued) Co-Director: Anders Mellgren, MD, PhD, Chicago, IL Co-Director: Kelly Garrett, MD, New York, NY Lab Assistants: Susan Asuncion, RN, Chicago, IL; Ashley Gabion, RN, Minneapolis, MN Mary Roen, RN, Minneapolis, MN; and Ester Trinos, NP, Chicago, IL Introductions Anders Mellgren, MD, PhD, Chicago, IL Kelly Garrett, MD, New York, NY 7:40 am Initial Assessment of Patients with Fecal Incontinence Joshua Bleier, MD, Philadelphia, PA 7:50 am Ultrasound Technique and Image Interpretation Johan Nordenstam, MD, PhD, Chicago, IL 8:10 am Normal Anorectal Ultrasound Anatomy Andreas Kaiser, MD, Los Angeles, CA 8:20 am Normal Pelvic Floor Ultrasound Anatomy Giulio Santoro, MD, PhD, Abu Dhabi, United Arab Emirates 8:30 am Ultrasound in the Assessment of Patients with Fecal Incontinence Liliana Bordeianou, MD, Boston, MA 8:40 am Ultrasound in the Assessment of Pelvic Floor Disorders Sthela Murad-Regadas, MD, PhD, Fortaleza, Brazil 8:50 am Radiologic Evaluation of Pelvic Floor Amy Thorsen, MD, Minneapolis, MN 9:00 am Anorectal Manometry Technique and Interpretation Sarah Vogler, MD, Minneapolis, MN 9:30 am Non-surgical Treatment of Fecal Incontinence Kelly Garrett, MD, New York, NY 9:40 am 9:50 am 10:00 am Injectable Bulking Agents: Clinical Results Wilhelm Graf, MD, PhD, Uppsala, Sweden 10:10 am Sacral Nerve Stimulation: Steps of the Procedure Margarita Murphy, MD, Pleasant, SC 10:20 am Sacral Nerve Stimulation: Postoperative Complications and Troubleshooting Steven Siegel, MD, St. Paul, MN 10:30 am Sacral Nerve Stimulation: Clinical Results Klaus Matzel, MD, Erlangen, Germany 10:40 am Refreshment Break in Foyer 11:00 am The Role of Secca in the Management of Fecal Incontinence Mariana Berho, MD, Hollywood, FL 11:20 am Treat the Prolapse! The Role of Ventral Rectopexy Andre D’Hoore, MD, PhD, Leuven, Belgium 11:30 am When to Consider an Artificial Bowel Sphincter Shane McNevin, MD, Spokane, WA 11:40 am Emerging Therapies: Topas Sling Procedure and Initial Results Massarat Zutshi, MD, Cleveland, OH 11:50 am Emerging Therapies: Magnetic Anal Sphincter and Initial Results Paul-Antoine Lehur, MD, PhD, Nantes, France The Role of Overlapping Sphincteroplasty Ian Paquette, MD, Cincinnati, OH Noon Adjourn Noon Lunch Provided for Hands-on Lab Participants (Room 207) 12:30 pm Bus Departs for Tufts Medical Center from the Lower Level of the Hynes Convention Center Injectable Bulking Agents: How I do It Mitchell Bernstein, MD, New York, NY Continued next page 43 S AT U R D AY 7:30 am Saturday, May 30 Optimal Management of Fecal Incontinence Symposium and Workshop (Continued) Hands-on Lab Session: 1:00 – 4:30 pm • Limit 80 • Fee: $495 Lunch Included for Hands-on Lab Registrants • Registration Required 3.0 CME Location for Hands-on Lab: Tufts Medical Center, 136 Harrison Avenue, Boston, MA 02111 Transportation will be provided 12:30 pm – Bus departs from the Lower Level, Boylston Street entrance of the Hynes Convention Center Hands-on Training 1:00 – 2:40 pm Hands-on Sessions Groups 1-9 1:00 pm 1:15 pm 1:35 pm SNS Dr. Siegel Group 1 Injectional Therapy Dr. Graf Group 2 Ultrasound Dr. Santoro Manometry ABS Dr. Bordeianou Group 3 Ultrasound Dr. Santoro Group 4 SNS Dr. Paquette Injectional Therapy Dr. Bernstein Group 5 Ultrasound Dr. Murad-Regadas Group 7 SNS Dr. Murphy Injectional Therapy Dr. Vogler Injectional Therapy Dr. Graf SNS Dr. Paquette Injectional Therapy Dr. Bernstein Manometry ABS Dr. McNevin Ultrasound Dr. Thorsen SNS Dr. Murphy Injectional Therapy Dr. Vogler 2:10 pm 2:25 pm Injectional Therapy Dr. Graf Manometry ABS Dr. Bordeianou Ultrasound Dr. Santoro Manometry ABS Dr. Bordeianou Ultrasound Dr. Murad-Regadas Manometry ABS Dr. Zutshi Ultrasound Dr. Thorsen Group 9 SNS Dr. Siegel Manometry ABS Dr. McNevin Group 6 Group 8 1:50 pm Manometry ABS Dr. Zutshi SNS Dr. Siegel Injectional Therapy Dr. Bernstein Manometry ABS Dr. McNevin Ultrasound Dr. Murad-Regadas SNS Dr. Paquette Injectional Therapy Dr. Vogler Manometry ABS Dr. Zutshi Ultrasound Dr. Thorsen SNS Dr. Murphy Case Discussions Groups 10-18 2:40 pm Drs. Joshua Bleier, Kelly Garrett, Paul-Antoine Lehur, Klaus Matzel, Anders Mellgren, Steven Siegel, Amy Thorsen, Steven Wexner Break Continued next page 44 Saturday, May 30 Optimal Management of Fecal Incontinence Symposium and Workshop (Continued) Hands-on Training 2:50 – 4:30 pm Hands-on Sessions 2:50 pm Injectional Therapy Dr. Graf Manometry ABS Dr. Bordeianou Ultrasound Dr. Santoro Group 13 SNS Dr. Paquette Injectional Therapy Dr. Bernstein Ultrasound Dr. Murad-Regadas Group 16 SNS Dr. Murphy Injectional Therapy Dr. Vogler Injectional Therapy Dr. Graf SNS Dr. Paquette Injectional Therapy Dr. Bernstein Manometry ABS Dr. McNevin Ultrasound Dr. Thorsen SNS Dr. Murphy Injectional Therapy Dr. Vogler 4:00 pm 4:15 pm Injectional Therapy Dr. Graf Manometry ABS Dr. Bordeianou Ultrasound Dr. Santoro Manometry ABS Dr. Bordeianou Ultrasound Dr. Murad-Regadas Manometry ABS Dr. Zutshi Ultrasound Dr. Thorsen Group 18 SNS Dr. Siegel Manometry ABS Dr. McNevin Group 15 Group 17 3:40 pm Ultrasound Dr. Santoro Group 12 Group 14 3:25 pm SNS Dr. Siegel Group 10 Group 11 3:05 pm Manometry ABS Dr. Zutshi SNS Dr. Siegel Injectional Therapy Dr. Bernstein Ultrasound Dr. Murad-Regadas SNS Dr. Paquette Injectional Therapy Dr. Vogler 4:30 pm SNS Dr. Murphy Drs. Joshua Bleier, Kelly Garrett, Paul-Antoine Lehur, Klaus Matzel, Anders Mellgren, Steven Siegel, Amy Thorsen, Steven Wexner Adjourn 45 Manometry ABS Dr. Zutshi Ultrasound Dr. Thorsen Case Discussions Groups 1-9 Manometry ABS Dr. McNevin S AT U R D AY Groups 10-18 Saturday, May 30 UT SOLD O Robotic Colon and Rectal Surgery: Tips, Tricks, and Simulation Symposium and Workshop 1 2 6 * 4.0 - 8 CME.0 Didactic Session 8:00 am – noon or 12:30 – 4:30 pm Didactic is open to all meeting registrants (complimentary). Rooms 302 – 304 4.0 MOC Supported by an independent educational grant and loaned durable equipment from Intuitive Surgical, Inc. Hands-on Lab Session: 8:00 am – noon or 12:30 – 4:30 pm • Limit 36 • Fee: $495 Lunch Included for Hands-on Lab Registrants • Registration Required Robotic colon and rectal surgery has slowly gained interest and traction among the membership. New instruments, technology, and techniques are constantly being added to the field. A combination of video and lectures highlighting the new techniques and instruments will provide an opportunity for surgeons to learn about the advances in the field. Existing Gaps What Is: Robotic surgery has slowly gained acceptance for use in rectal cancer and in pelvic surgery, but many colon and rectal surgeons have not adopted robotics into their practices. What Should Be: Studies have demonstrated the effectiveness of the use of simulation combined with videos and lectures to facilitate adoption of a new or advanced technique. The speakers will attempt to bridge the knowledge gap associated with the implementation, use, and outcomes of robotics to educate colon and rectal surgeons on how best to use and adopt robotics into their practice. Co-Director: Vincent Obias, MD, Washington, DC Co-Director: Elizabeth Raskin, MD, St. Paul, MN Lab Assistants: Jamie Cannon, MD, Birmingham, AL; Joseph Martz, MD, New York, NY; John Byrn, MD, Iowa City, IA; and Cesar Santiago, MD, Tampa, FL Group A Group B 8:00 am – noon Didactic Lectures (complimentary) (Rooms 302 – 304) 8:00 am – noon Hands-on with Robotic Simulators (Room 306) 12:30 – 4:30 pm Hands-on with Robotic Simulators (Room 306) 12:30 – 4:30 pm Didactic Lectures (complimentary) (Rooms 302 – 304) Objectives: At the conclusion of this session, participants should be able to: a) Describe the basic techniques of robotic port placement and docking; b) Define the anatomy of the colon, its vasculature and retroperitoneum from a robotic perspective; c) Explain the sequence of steps necessary to perform robotic procedures safely; and d) Identify what new technology there is concerning robotics, and how it can help their patients. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 46 Continued next page Saturday, May 30 Robotic Colon and Rectal Surgery: Tips, Tricks, and Simulation Symposium and Workshop (Continued) Group A – Didactic Group B – Hands-on with Simulators Ticket Required Rooms 302-304 8:00 am – noon Robotic Surgery – Starting Up Jeffrey S. Cohen, MD, Marietta, GA 8:25 am Tips in Docking the Robot and How to do Safe Robotic Surgery Deborah Nagle, MD, Boston, MA 8:50 am Robotic Low Anterior Resection John Marks, MD, Wynnewood, PA 9:15 am Robotic Abdominoperineal Resection George Chang, MD, Houston, TX 9:40 am Panel Discussion Group B – Didactic Rooms 302-304 12:30 – 4:30 pm 12:30 pm Robotic Surgery-Starting Up Jeffrey S. Cohen, MD, Marietta, GA 10:05 am Refreshment Break in Foyer 12:55 pm Tips in Docking the Robot and How to do Safe Robotic Surgery Deborah Nagle, MD, Boston, MA 10:15 am Robotic Surgery for Pelvic Floor Diseases I. Emre Gorgun, MD, Cleveland, OH 10:30 am Robotic Multiport Right Hemicolectomy with Intracorporeal Anastamosis Robert Cleary, MD, Ann Arbor, MI 10:55 am Novel New Techniques in Robotics – Single Incision, Parastomal Hernia Repair, J pouch, Transanal Surgery Jorge Lagares-Garcia, MD, Charleston, SC 11:20 am Robotic New Instruments: Firefly, Stapler, Vessel Sealer, and Xi Eduardo Parra-Davila, MD, Celebration, FL 1:20 pm Robotic Low Anterior Resection John Marks, MD, Wynnewood, PA 1:50 pm Robotic Abdominoperineal Resection George Chang, MD, Houston, TX 2:10 pm Panel Discussion 2:20 pm Refreshment Break in Foyer 2:30 pm Robotic Surgery for Pelvic Floor Diseases I. Emre Gorgun, MD, Cleveland, OH 2:55 pm Robotic Multiport Right Hemicolectomy with Intracorporeal Anastamosis Robert Cleary, MD, Ann Arbor, MI 3:20 pm Novel New Techniques in Robotics – Single Incision, Parastomal Hernia Repair, J pouch, Transanal Surgery Jorge Lagares-Garcia, MD, Charleston, SC 3:45 pm Robotic New Instruments: Firefly, Stapler, Vessel Sealer, and Xi Eduardo Parra-Davila, MD, Celebration, FL 4:10 pm Panel Discussion 4:30 pm Adjourn 11:45 am Panel Discussion Group A – Hands-on with Simulators Ticket Required Room 306 Noon – Complimentary Lunch (Room 305) 12:30 – 4:30 pm 47 S AT U R D AY 8:00 am Room 306 8:00 am – noon Noon – Complimentary Lunch (Room 305) Saturday, May 30 Symposium Advanced Endoscopy and Endoluminal Surgery 1 2 5 6 * 3.5 CME 12:30 – 4:00 pm Ballroom BC (3rd Floor) There has been significant expansion of new techniques and instrumentations for advancement of endoscopic procedures. These techniques broaden our ability to perform more complex procedures in much less invasive ways. As colorectal surgeons, we are uniquely positioned to adopt these techniques and to lead in this field. A number of new, advanced endoscopic techniques have been developed over the past few years. These techniques have not only broadened the ability of the endoscopist to successfully scope all patients but they also allow identification and treatment of colonic pathologies such as polyps, cancer, and inflammatory bowel disease. New endoscopic techniques have resulted in higher cecal intubation rates and lesion identification. Enhanced imaging technology increases polyp detection. Endoscopic clipping can control bleeding and treat colonic perforation. Colonic stenting is a non-operative means of treating colonic obstruction and can convert a two-stage operation into a one-stage procedure. Extended submucosal dissection and the use of both CO2 and laparoscopic assistance have allowed surgeons to resect more complex colonic lesions without major surgery. Existing Gaps What Is: Colorectal surgeons may be unfamiliar with several new techniques to improve the success rate of colonoscopy as well as imaging techniques for lesion identification. A significant number of surgeons are not performing endoscopic submucosal resection of colorectal neoplasia or combined laparo-endoscopic resection. With the continued advances of technology in endoluminal therapy, surgeons will need training to incorporate these methods into their practice. What Should Be: Surgeons need to have a comprehensive understanding of the newer visualization techniques as well as the indications and uses for endoscopic submucosal resection, colonic stenting, and endoscopic clipping. This important learning session will provide the basis for the meaningful implementation of these newer endoluminal techniques and improve their patients’ colorectal care. Co-Director: Peter Marcello, MD, Burlington, MA Co-Director: Sang Lee, MD, New York, NY 12:30 pm Introductions Peter Marcello, MD, Burlington, MA 1:10 pm 12:35 pm Difficult Colonoscopy: Tricks and New Techniques for Getting to the Cecum Daniel Feingold, MD, New York, NY Endoscopic Submucosal Dissection: Another Perspective I. Emre Gorgun, MD, Cleveland, OH 1:25 pm 12:45 pm Advanced Endoscopic Imaging: Polyps and Dysplasia Detection David Rivadeneira, MD, Woodbury, NY The Future of ESD and Full Thickness Endoluminal Resection with Closure Sergey Kantsevoy, MD, PhD, Baltimore, MD 1:50 pm Panel Discussion/Questions 2:10 pm Combine Endoscopic Laparoscopic Surgery (CELS) Sang Lee, MD, New York, NY 12:55 pm Beyond Polypectomy: EMR and ESD Richard Whelan, MD, New York, NY *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 48 Continued next page Saturday, May 30 Advanced Endoscopy and Endoluminal Surgery (Continued) 2:25 pm Technical Tips for Endoluminal Stenting Maher Abbas, MD, Abu Dhabi, United Arab Emirates 3:10 pm Future Endoscopic Tool Box: New Tools, Changing Paradigms? Jeffrey Milsom, MD, New York, NY 2:40 pm Colonic Stenting Jeffrey Marks, MD, Cleveland, OH 3:25 pm Panel Discussion/Questions 4:00 pm Adjourn 2:55 pm Endoluminal Management of Anastomotic Complications Govind Nandakumar, MD, New York, NY Photo Credit: Greater Boston Convention & Visitors Bureau S AT U R D AY Objectives: At the conclusion of this session, participants should be able to: a) Demonstrate methods to improve cecal intubation rates and lesion detection; b) State the available enhanced endoscopic visualization techniques; c) Recognize the indications and uses for endoscopic submucosal resection for colorectal neoplasia; d) Recognize the indications and technical aspects of combined laparoscopic and endoscopic resection of colorectal neoplasia; e) Outline the indication and utility of colonic stent placement and f ) Recall all available techniques for endoscopic closure of bowel wall. Hynes Convention Center 49 Saturday, May 30 Question Writing Workshop: How to Write Exam Questions 2 3 4 * 12:30 – 3:30 pm Room 310 Limit 70 • Registration Required 2.75 CME There are multiple areas of examination in the realm of colon and rectal surgery that require written questions to assess knowledge. These include the certifying written exam, the recertification exam, CARSITE, and CARSEP among others. Despite looking straightforward, it is extremely difficult to write a good exam question. Many concepts are controversial and what is not controversial can become trivial. There are basic guidelines that help the writer and this is a skill that can be learned and improve with practice. In recent years emphasis has been placed on how to write an acceptable exam question and guidelines have been published by organizations such as the National Board of Medical Examiners. Existing Gaps What Is: Most professionals such as colon and rectal surgeons feel that it is easy to write high quality questions. However the majority of questions that are submitted for review each year are rejected or have fundamental flaws that require significant revisions before they can be accepted for use. What Should Be: There should be many interested members that are able to write high quality questions that can be used with minimal to no revisions. Director: Tracy Hull, MD, Cleveland, OH 12:30 pm Introduction Tracy Hull, MD, Cleveland, OH 1:45 pm Fundamental Problems with Questions Marcus Burnstein, MD, Toronto, ON, Canada 12:45 pm What Is a Key Concept? Najjia Mahmoud, MD, Philadelphia, PA 2:05 pm Refreshment Break in Foyer 2:15 pm Let's Write Questions 3:00 pm Questions Review 3:15 pm Conclusion 3:30 pm Adjourn 1:05 pm Formatting the Stem: Tips Shane McNevin, MD, Spokane, WA 1:25 pm Formatting the Answers: Avoiding Common Errors Glenn Ault, MD, Los Angeles, CA Objectives: At the conclusion of this session, participants should be able to: a) Identify fundamental problems with construction of written questions; b) Explain the sequential thinking process used to write an acceptable question and understand key concepts; c) Demonstrate how to write a stem for a question; d) Prepare a twostep question that combines diagnosis and management and format the answers in an acceptable form; and e) Recall what happens to a question after it is submitted by a writer before it is used in a test. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 50 Saturday, May 30 Symposium Improving Outcomes-Identifying and Managing the Complex Surgical Patients 1 2 4 5 6 * 1.5 CME 4:00 – 5:30 pm Ballroom BC (3rd Floor) 1.5 MOC In this symposium, by making use of evidence-based recommendations, each lecture will include not only diagnostic and therapeutic guidelines, but will also provide a narrative by the presenter (where appropriate) on his/her operative technical details and perioperative “tips and tricks” that they utilize in the management of these complex surgical challenges. In other cases, they will lend their personal insight into situations where data may be more sparse, but individual and collective experience is paramount to making sound decisions and thereby optimizing patient outcomes. Furthermore, we will focus on the initial assessment of risk and intervention methods utilized to minimize perioperative complications. The presenters will focus on expanding the audience’s understanding of the details that make these situations challenging, while offering evidence and experience-based solutions for surgeons of all levels to better care for these complex patients. The underlying focus will be on providing pragmatic and understandable solutions that can be readily implemented by surgeons of varying experience to successfully treat complex colorectal problems. Existing Gaps What Is: Surgeons are faced with complex decisions in determining the optimal care for patients with difficult colorectal surgery disease. Multiple options exist regarding the assessment, optimization, surgical treatment, and post-operative management of these patients, while less is understood about what the ideal method is. What Should Be: This symposium will be useful to colorectal, general and oncologic surgeons who are increasingly called upon to care for patients with complex colorectal diseases. Furthermore, this symposium will be of particular interest to the surgeons-in-training, and the general and colorectal surgeon who is often called upon to manage a variety of complications and dilemmas that may be outside of his or her specialty or niche within colorectal surgery. Director: Scott Steele, MD, Fort Lewis, WA Assistant Director: Sean Langenfeld, MD, Omaha, NE 4:00 pm Introduction Scott Steele, MD, Fort Lewis, WA 4:03 pm 4:15 pm 4:27 pm 4:39 pm Perioperative Risk Assessment: Who, What, When and Why? W. Donald Buie, MD, Calgary, AB, Canada Functional Problems after Colorectal Surgery: When the Surgery Goes “Great” but Problems Arise: Now What? Liliana Bordeianou, MD, Boston, MA 4:51 pm The Body’s Response to Surgical Stress: What Every Clinician Should Know Anjali Kumar, MD, Washington, DC Enhanced Recovery Pathways: Beyond the Basics Conor Delaney, MD, PhD, Cleveland, OH 5:03 pm Cases/Panel Discussion 5:30 pm Adjourn Intra-operative Nightmares: The Intraoperative Consult When Things Go Wrong Bradley Davis, MD, Cincinnati, OH Objectives: At the conclusion of this session, participants should be able to: a) Discuss the ideal preoperative risk assessment and how to identify high-risk patients, optimize patients and maximize outcomes; b) Describe the importance of the body’s response to surgical stress and how to minimize the negative aspects of this natural phenomenon; c) Describe the multimodal and surgical approach to technical failures and challenging situations that arise intra-operatively and methods to minimize secondary complications; d) Discuss options for patients with functional problems following colorectal surgery in the presence and absence of complications; and e) Identify the components and importance of enhanced recovery pathways and how the outcomes extend beyond the benefits of individual element to the collective care plan. 51 S AT U R D AY This multidisciplinary symposium will serve as a comprehensive discussion of the topics listed above with emphasis on the pathologic assessment, surgical technique, adjuvant therapy, and genetic testing to improve outcomes. Sunday, May 31 Core Subject Update 1 2 6 * 2.25 CME 7:15 – 9:30 am Auditorium (2nd Floor) The Core Subject Update was developed to assist in the education and recertification of colon and rectal surgeons. Twenty-four core subjects have been chosen and are presented in a four-year rotating cycle. Presenters are experts on their selected topics and present evidence-based reviews on the current diagnosis, treatment and controversies of these diseases. Following each presentation, a brief discussion period is moderated by the course director. A written summary of each talk is available on the ASCRS website, and questions developed from each presentation are included in the American Board of Colon and Rectal Surgery’s recertification question bank. Director: Justin Maykel, MD, Worcester, MA 7:15 am Anatomy/Physiology/Complications Todd Francone, MD, Burlington, MA 8:21 am Crohn’s Disease Karim Alavi, MD, Worcester, MA 7:32 am Discussion 8:38 am Discussion 7:37 am STD’s Cindy Kin, MD, Stanford, CA 8:43 am Endoscopy/Polyps Rebecca Hoedema, MD, Grand Rapids, MI 7:54 am Discussion 9:00 am Discussion 7:59 am Constipation Amy Thorsen, MD, Minneapolis, MN 9:05 am Advanced Colon and Rectal Cancer Gregory Kennedy, MD, PhD, Madison, WI 8:16 am Discussion 9:22 am Discussion 9:30 am Adjourn Objectives: At the conclusion of this session, participants should be able to a) Recognize the complications commonly associated with colorectal surgical procedures and understand the methods of prevention and treatment; b) Describe the common sexually transmitted diseases of the anorectum and be able to provide comprehensive treatment plans; c) Explain the different types of constipation as well as the evaluation process and medical and surgical treatment options; d) Demonstrate an understanding of Crohn’s disease including the presentation, medical management and surgical options for small intestine, colon, rectal, and anal involvement; e) Recognize the indications for endoscopic evaluation of the colon as well as endoscopic options for lesion diagnosis and treatment; and f ) Describe the presentation, evaluation, surgical treatment and oncologic management of advanced colon and rectal cancer. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 52 Sunday, May 31 Symposium Healthcare Economics in the ACA Era 3 4 5 6 * 1.75 CME 8:00 – 9:45 am Ballroom BC (3rd Floor) The Affordable Care and Accountability Act of 2012 (ACA) set in motion changes to the American Healthcare system, the likes of which have never been seen before in the United States. These changes are significantly altering the way medicine is delivered by providers, including hospitals and individual physicians. While the primary thrust of the legislation was to increase access to healthcare for millions of Americans, implementation of the ACA has ushered in a variety of other measures that are dramatically changing how medicine is practiced. Existing Gaps What Is: The Affordable Care Act and critical elements that are related to it including value-based purchasing, ICD-10, valuebased care and the Acountable Care organization, meaningful use, and the two midnight rule. What Should Be: Surgeons need to have an understanding about key environmental changes impacting their practice. Understanding the ACA and critical initiatives that are creating significant change in the healthcare environment will help to make them much more successful. Director: James Merlino, MD, Chicago, IL Assistant Director: David O’Brien, MD, Portland, OR Affordable Care Act: What it Means and How We Can Cope Stephen Sentovich, MD, Duarte, CA 8:20 am Moving from Volume to Value; How We will be Paid Differently Frank Opelka, MD, New Orleans, LA 8:30 am Meaningful Use and its Impact on the Physician Practice Guy Orangio, MD, New Orleans, LA 8:40 am ICD-10; Delayed, but Not Forgotten David Maron, MD, Weston, FL 8:50 am New Models of Care Delivery Jeffrey L. Cohen, MD, Hartford, CT 9:00 am Update on the Two Midnight Rule W. Brian Perry, MD, San Antonio, TX 9:20 am Discussion 9:45 am Adjourn S U N D AY 8:00 am Objectives: At the conclusion of this session, participants should be able to: a) Discuss the impact of the Affordable Care Act on providers; b) Describe and understand the importance of value-based-care delivery; c) Recall how critical elements of the affordable care act relate to physician practice; d) Describe and understand updates on value-based purchasing, meaningful use, ICD-10, and the two-midnight rule. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 53 Sunday, May 31 Symposium Quality Initiatives in Clinical Practice 1 5 6 * 9:00 – 11:00 am Ballroom A (3rd Floor) 2.0 CME Supported by independent educational grants from: Applied Medical Ethicon Quality improvement is integral to clinical practice. Ongoing efforts to improve the quality of surgical care have had a significant and positive impact on patient outcomes. While participation in national initiatives such as SCIP and NSQIP is important, it is crucial that we actively use data to change quality of care within our own institutions and practices. Existing Gaps What Is: Although surgeons are aware of national quality initiatives, few have the tools to implement quality initiatives within their own institution. What Should Be: Surgeons should understand the quality improvement process, be able to implement quality initiatives and access data to evaluate effectiveness. Co-Director: Arden Morris, MD, Ann Arbor, MI Co-Director: Larissa Temple, MD, New York, NY 9:00 am Building the Systems and Culture of Prevention Elizabeth Wick, MD, Baltimore, MD 9:10 am Six Sigma, Lean, Rapid Results: What Do They All Mean? Nancy Baxter, MD, PhD, Toronto, ON, Canada 9:20 am Steps to a Successful Quality Improvement Project Robert Cima, MD, Rochester, MN 9:40 am Measuring Success of Quality Improvement Genevieve Melton-Meaux, MD, Minneapolis, MN 9:50 am Leveraging IT to Improve Outcomes Allison McCoy, PhD, New Orleans, LA 10:00 am Improving Outcomes: Decreasing Readmission Deborah Nagle, MD, Boston, MA 10:08 am Improving Outcomes: Decreasing Length of Stay Julie Thacker, MD, Durham, NC 10:16 am Improving Processes: Leveraging the Electronic Medical Record Stefan Holubar, MD, Lebanon, NH 10:25 am Panel Discussion 11:00 am Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Identify the principals of a culture of safety and quality improvement; b) Recognize methods used to develop quality improvement initiatives; c) Describe the practical steps to implementing and maintaining a quality improvement project; d) Define how to evaluate the success of a quality improvement initiative. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 54 Sunday, May 31 Symposium Laparoscopic Nuts & Bolts and Robotic Rivets 1 2.25 MOC 2 5 6 * 2.25 CME 9:30 – 11:45 am Auditorium (2nd Floor) Supported by independent educational grants from: Applied Medical Ethicon Laparoscopic and robotic surgical techniques are an integral part of modern colorectal surgical practice. The education of surgeons in these techniques occurs in a variety of settings including fellowship training, industrysponsored training programs, and professional society continuing medical education programs. In this symposium, state of the art laparoscopic and robotic approaches to common colorectal conditions are presented by experts in the field. The educational format will be short videos followed by question and answer sessions. The aim of this symposium is to expand the knowledge base in the areas of laparoscopic and robotic colorectal surgery. Existing Gaps What Is: Laparoscopic and robotic colorectal surgical techniques are developing at a rapid pace. Continuing medical education for surgeons in practice to learn these techniques are limited. What Should Be: Periodic educational programs that allow practicing surgeons to learn basic and advanced laparoscopic and robotic colorectal surgical techniques. 9:35 am Lap Right Colectomy: Complete Mesocolic Excision Hermann Kessler, MD, PhD, Cleveland, OH 10:20 am Splenic Flexure: The Inside Passage, IMV Gateway to the Lesser Sac Armando Melani, MD, Barretos, Brazil 9:40 am Single Incision Colectomy: Steps to Success for the Right and Transverse Colon Jamie Murphy, MD, London, United Kingdom 10:25 am Splenic Flexure: Give Me a Hand (HALS) Kelly Garrett, MD, New York, NY 9:45 am Taking Control: Clip, Seal, or Staple the Large Vessels? Karin Hardiman, MD, PhD, Ann Arbor, MI 10:30 am Splenic Flexure: A Robot in Your Corner Meagan Costedio, MD, Cleveland, OH 10:35 am TME: A Hand for the Holy Planes (HALS) Matthew Mutch, MD, St. Louis, MO 9:50 am Laparoscopic Ileocolic Resection for Crohn’s Disease: What to Do When It’s Really Stuck Sanghyun Kim, MD, New York, NY 10:40 am TME: Mr. Roboto David Etzioni, MD, Phoenix, AZ 9:55 am Laparoscopic Hartmann’s Reversal Armen Aboulian, MD, Cleveland, OH 10:45 am TME: Laparoscopic Cylindrical APR. Nothing to Waist Yi-Qian Nancy You, MD, Houston, TX 10:00 am Laparoscopic IPAA: Making the Pouch Reach Every Time David Larson, MD, Rochester, MN 10:50 am Panel Discussion 10:05 am Panel Discussion *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 55 Continued next page S U N D AY Director: Mark Whiteford, MD, Portland, OR Assistant Director: Jon Vogel, MD, Aurora, CO Sunday, May 31 Laparoscopic Nuts & Bolts and Robotic Rivets (Continued) 11:00 am Laparoscopic Parastomal Hernia Repair Scott Steele, MD, Fort Lewis, WA 11:20 am Laparoscopic Rectopexy: Anterior or Posterior Approach? Christopher Cunningham, MBChB, Oxford, United Kingdom 11:05 am Laparoscopic Stapling of the Low Rectum: Maximizing the Odds of Using a Minimum of Staple Loads David Maron, MD, Weston, FL 11:25 am Panel Discussion 11:45 am Adjourn 11:10 am Laparoscopic Colorectal Anastomosis: There’s an Air-Leak. Now What? Jason Hall, MD, Burlington, MA 11:15 am Robotic Mishaps: Getting Into and Out of Trouble Alessio Pigazzi, MD, PhD, Orange, CA Photo Credit: Greater Boston Convention & Visitors Bureau Objectives: At the conclusion of this session, participants should be able to: a) Perform basic and advanced laparoscopic and robotic colorectal surgical techniques while avoiding surgical complications; b) Identify complications that can occur while recognizing various approaches to common and extraordinary surgical problems; c) Describe to their patients the pros and cons of laparoscopic and robotic techniques. The USS Constitution was nicknamed "Old Ironsides," after the War of 1812, when shots from the British appeared to bounce off her thick oak hull as if it were made from iron. 56 Sunday, May 31 Symposium Complications: Prevention and Management 1 2.0 MOC 2 6 * 9:45 – 11:45 am Ballroom BC (3rd Floor) 2.0 CME Complication prevention and management guides every aspect of our treatment paradigms. Although the preoperative assessment is a broad, more global patient evaluation, it is comprised of many data points, including the pathology, aspects of the particular planned procedure, the current and past health issues of the patient and postoperative care. The challenge to the surgeon is to take this detailed evaluation and use it to optimize operative outcomes while minimizing perioperative and postoperative morbidity. The increasing complexity of our patient’s medical and surgical issues and the expectation for perfect outcomes makes management evermore daunting. Furthermore, the increasing oversight of surgical outcomes, individual and institutional costs, and patient satisfaction make the prevention and management of surgical complications crucial to the successful practice of surgery in the current era. Existing Gaps What Is: The increasingly complex nature of patient care and the lack of evidenced based treatment algorithms for complications in colon and rectal surgery make management of the varied complications challenging. What Should Be: Treatment algorithms for colorectal surgical complications should be evidence and consensus based to allow for management that optimizes outcomes, limits costs and improves patient satisfaction. Co-Director: John Eggenberger, MD, Ypsilanti, MI Co-Director: Harry Reynolds, MD, Cleveland, OH 9:57 am Locally Advanced and Recurrent Rectal Cancers: Avoiding and Treating Complications in the Difficult Pelvis Heidi Nelson, MD, Rochester, MN 10:45 am Global Surgery Challenges in 2015 Rudolph Rustin, MD, Huye, Rwanda 10:57 am How Do We Prevent Perioperative Anastomotic Complications: Surgical Technique and/or Manipulation of the Microbiome? John Alverdy, MD, Chicago, IL The Problematic Low Rectal Anastomosis: Dealing with Stacking, Stenosis, Bleeding and Disruption Kirk Ludwig, MD, Milwaukee, WI 11:09 am Optimization of Patient Satisfaction Despite Adversity: Complication Prevention and Management in the Era of Surgical Outcome Tracking James Merlino, MD, Chicago, IL 10:09 am Management of the Stenotic, Bleeding, Leaking or Fistulizing Colonic Anastomosis Michael McGee, MD, Chicago, IL 10:21 am Understanding Perioperative Anticoagulation with Emphasis on Novel Anticoagulants, Antiplatlet Agents, Drug Eluting Stents, and DVT Teresa Carman, MD, Cleveland, OH 11:22 am Panel Discussion 11:45 am Adjourn 10:33 am C. Dificile Colitis: Resect, Divert, Antibiotics, or Transplant? Mark Manwaring, MD, Greenville, NC Objectives: At the conclusion of this session, participants should be able to: a) Define strategies to avoid and manage complications arising during resections of locally advanced or recurrent rectal cancers; b) Describe strategies to avoid and treat complications of coloanal anastomoses, including stenosis, bleeding, and disruption with presacral abscess and chronic fistula; c) Discuss management strategy in the patient with ileocolic, colocolic, or colorectal anastomotic bleeding, leak, obstruction and fistula; d) Manage and limit complications in the urgent operation of patients on novel anticoagulation agents, antiplatelet agents and drug eluting stents; e) Explain how gut bacteria and subsequent host pathogen interactions may influence anastomotic healing; f ) Describe optimal prevention and management of parastomal and ventral hernias in the colorectal surgical patient; g) Establish medical and surgical treatment algorithms for the management of difficile infection; and h) Develop strategies of complication prevention and management that optimize patient outcomes, expectations and the “patient experience” in an era in which, increasingly, surgeons are being measured and compared with their peers by hospitals, third party payers and governmental agencies. 57 S U N D AY 9:45 am Sunday, May 31 Luncheon Symposium Parallel Session 1-A Current Advances in the Management of Fecal Incontinence 1 2 6 * 1.5 CME 11:45 am – 1:15 pm Ballroom BC (3rd Floor) Supported in part by an independent educational grant from American Medical Systems Control of fecal material is a complex process that involves coordinated interaction of the colon, rectum, and anus. Also, there are many aspects of fecal incontinence which include various degrees of control for gas, liquid, and solid material. This is further complicated when there is associated urgency. Campaigns designed to make patients and caregivers aware of the debility associated with fecal incontinence have led to more patients seeking help. Many times patients have searched the internet and come with many questions that caregivers may not be able to address. Existing Gaps What Is: There are many treatments available and unclear recommendations when a treatment should be considered for a patient. What Should Be: Caregivers should be aware of all current treatment options and what is projected to be available in the future. They also should be able to individualize treatment to meet the needs and symptoms of the specific patient. Director: Tracy L. Hull, MD, Cleveland, OH Assistant Director: Liliana Bordeianou, MD, Boston, MA 11:45 am How Do We Assess Fecal Incontinence to Individualize Treatment Plans? Ian Paquette, MD, Cincinnati, OH 12:25 pm What are the Options when the Primary Surgical Options Fail (an Algorithm for Choices) Alex Ky, MD, New York, NY 11:55 am What About Sphincter Repair, Radiofrequency, and the Artificial Bowel Sphincter? Anders Mellgren, MD, PhD, Chicago, IL 12:35 pm Are Stem Cells Going to be Available Soon? Massarat Zutshi, MD, Cleveland, OH 12:10 pm What are the Newest Treatments (Injectables and Sacral Nerve Stimulation)? Klaus Matzel, MD, Erlangen, Germany 12:45 pm Panel and Case Presentations 1:15 pm Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Name acceptable treatments for fecal incontinence; b) Recall where injectable therapy and sacral nerve stimulation fit into the treatment options; c) Prepare an acceptable algorithm for treatment options for fecal incontinence when the primary option fails; d) Describe the limitations of multiple treatments and alternative therapies and; e) Define the development of stem cells for fecal incontinence treatment. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 58 Sunday, May 31 Luncheon Symposium Parallel Session 1-B The Genetics of Colorectal Cancer and Cancer Related Syndromes 1 2 3 6 * 1.5 CME 11:45 am – 1:15 pm Rooms 302-306 1.5 MOC Central to our understanding of colorectal cancer biology are the cellular genetic alterations that lead to the development of cancer, whether these are related to a hereditary or acquired gene mutation. Roughly one third of colorectal cancers have some hereditary component, and approximately 10% are related to a hereditary colorectal cancer syndrome such as non-polyposis (Lynch syndrome and hereditary nonpolyposis colorectal cancer (HNPCC)) or polyposis syndromes (adenomatous polyposes (like FAP and MYH-associated polyposis), hamartomatous polyposes, and serrated polyposis). Multiple strategies have emerged to help identify these hereditary syndromes through screening and other methods. Once the diagnosis is made, timing and extent of surgical treatment as well as the subsequent surveillance of the patient and their families is dependent on an understanding of the implications of the outcomes of genetic testing. It is essential that the ASCRS membership be up-to-date regarding the genetics of colorectal cancer, the means to diagnose the most common hereditary cancer syndromes, the application of genetic knowledge to patient care, and the latest surgical and surveillance strategies for the most common syndromes. Existing Gaps What Is: In their routine daily practice, clinicians do not often appreciate the relevance of understanding cancer genetics and its impact on cancer development, and thus patients and families with hereditary cancer syndromes frequently go unrecognized. As a result, these patients and their families are not diagnosed and therefore do not receive appropriate treatment, surveillance, and/or genetic counseling. What Should Be: Patients with hereditary cancer syndromes are readily identified and offered appropriate counseling and medical and surgical therapy. Surgical strategies should also include understanding of the appropriate timing and extent of resection as well as appropriate post-operative surveillance. 11:45 am Introduction Paul Wise, St. Louis, MO 12:20 pm Lynch Syndrome/HNPCC: When to Operate, How Much to Take, and Why Molly Cone, MD, Nashville, TN 11:50 am Colorectal Cancer Genetics: Making Sense of the Alphabet Soup James Church, MD, Cleveland, OH Noon 12:30 pm Hereditary Cancer Syndrome Surveillance: You’ve Done the Colectomy, So Now What? Craig Messick, MD, Houston, TX Recognizing the Red Flags: Does My Patient Have Hereditary Colorectal Cancer? Heather Hampel, MS, LGC, Columbus, OH 12:40 pm Panel and Case Discussion 1:15 pm Adjourn 12:10 pm Polyposis Syndromes: When to Operate, How Much to Take, and Why Timothy Sadiq, MD, Chapel Hill, NC Objectives: At the conclusion of this session, participants should be able to: a) Identify the genetics of colorectal cancer and the genetics of the various hereditary colorectal cancer syndromes; b) Describe the methods by which patients with hereditary colorectal cancer syndromes might be identified in a surgical practice, including screening methods to diagnose the most common syndrome(s); c) Define the appropriate operations for the polyposis and non-polyposis syndromes, the best timing for those operations, why they should be performed, and the evidence to support these decisions; d) Describe the post-colectomy surveillance routines for the hereditary colorectal cancer syndromes as well as any practical extracolonic surveillance routines and the evidence to support them. 59 S U N D AY Director: Paul Wise, MD, St. Louis, MO Assistant Director: Matthew Kalady, MD, Cleveland, OH Sunday, May 31 Welcome and Opening Announcements 1:15 – 2:00 pm Auditorium (2nd Floor) Terry Hicks, MD, New Orleans, LA President, ASCRS Paul Shellito, MD, Boston, MA Kelly Tyler, MD, Springfield, MA Local Arrangements Co-Chairs David Margolin, MD, New Orleans, LA Program Chair Steven Wexner, MD, Weston, FL President, ASCRS Research Foundation H. David Vargas, MD, New Orleans, LA Program Vice-Chair Roberta Muldoon, MD, Nashville, TN Public Relations Chair Photo Credit: Greater Boston Convention & Visitors Bureau Jason Hall, MD, Burlington, MA Awards Chair Faneuil Hall Marketplace 60 Sunday, May 31 Symposium Parallel Session 2-A Technical Pearls – How it’s Really Done 1 2.0 MOC 2 6 * 2.0 CME 2:00 – 4:00 pm Auditorium (2nd Floor) It is clear that master surgeons exist, and that these surgeons perform operations with techniques they have learned from experience. These learned “tricks” often allow a surgeon to perform operations in a way that most cannot. When asked to describe what they do to complete these procedures, the master surgeon often cannot verbalize it as these techniques have become a part of their muscle memory. In this symposium, we will ask these surgical masters to demonstrate these techniques in this open forum. Different approaches to these maneuvers will then be reviewed and discussed. Existing Gaps What Is: Surgical skill varies widely resulting in disparate patient outcomes for the treatment of many common surgical diseases. What Should Be: A patient undergoing surgical treatment of common disease should be able to get treatment in their community and expect the same high level treatment as the patient treated by the surgical master for the same common disease. 2:00 pm Transabdominal Approaches to Rectal Prolapse – Cutting Edge vs Tried and True Mark Arnold, MD, Columbus, OH 2:50 pm Laparoscopy in the Super Obese – Tips to Get it Done Conor Delaney, MD, PhD, Cleveland, OH 2:10 pm Approaches to Complex Fistula Disease: Outcomes and My Preferred Options Susan Gearhart, MD, Baltimore, MD 3:00 pm A Simple Operation that Needs More Work – the Perfect Ileostomy John Pemberton, MD, Rochester, MN 2:20 pm Bowel Preservation in Crohn’s Disease – Complex Decisions for Complex Procedures Robin McLeod, MD, Toronto, ON, Canada 3:15 pm Transanal Excision and Tumor Scatter – How to Achieve a Negative Margin Theodore Saclarides, MD, Maywood, IL 2:30 pm Parastomal Hernia Repair – Local Repair versus Stoma Resite Kirk Ludwig, MD, Milwaukee, WI 3:25 pm Gracilis Interposition to Treat Complex Fistula Disease Steven Wexner, MD, Weston, FL 2:40 pm Finding the Ureter and Taking Down the Splenic Flexure in the Reoperative Abdomen Charles Friel, MD, Charlottesville, VA 3:35 pm Panel Discussion 4:00 pm Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Identify the approach of a surgical master to rectal prolapse; b) Describe principles of prevention of injury to the spleen when mobilizing the splenic flexure; c) State the proper technique to performing a gracilis interposition procedure d) Name the options available to perform a loop ileostomy; e) Describe the role of novel approaches to rectopexy; and f ) Recognize the factors that need to be considered in the management of colonic polyps. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 61 S U N D AY Co-Director: Michael Stamos, MD, Orange, CA Co-Director: Gregory Kennedy, MD, PhD, Madison, WI Sunday, May 31 Abstract Session Parallel Session 2-B Neoplasia I 1 2 * 1.5 CME 2:00 – 3:30 pm Ballroom A (3rd Floor) Co-Moderators: Melanie Morris, MD, Birmingham, AL and Jennifer Ayscue, MD, Washington, DC 2:00 pm Impact of Hospital Volume on Quality Indices for Rectal Cancer Surgery in British Columbia, Canada S1 R. McColl*, M.J. Raval, T.P. Phang, A.A. Karimuddin, C.J. Brown, C. Mcgahan, E. Cai, Vancouver, BC, Canada 2:07 pm Discussion 2:10 pm Transanal Endoscopic Microsugery (TEM) following Neoadjuvant Chemoradiation for Rectal Cancer – Is Salvaging Local Recurrences Too Little Too Late? R. Perez, A. Habr-Gama*, G.P. São Julião, I. Proscurshim, L.M. Fernandez, J. GamaRodrigues, Sao Paulo, Brazil S2 2:17 pm Discussion 2:20 pm Transanal Total Mesorectal Excision: The Oxford Experience S3 N.C. Buchs*, G. Nicholson, T. Yeung, N. Mortensen, C. Cunningham, O. Jones, S. Ashraf, R. Guy, R. Hompes, Oxford, United Kingdom 2:27 pm Discussion 2:30 pm Determining the Optimal Timing for Initiation of Adjuvant Chemotherapy after Resection for Stage II/III Colon Cancer S4 Z. Sun*, M. Abdelgadir Adam, J. Kim, D. Nussbaum, E. Benrashid, C.R. Mantyh, J. Migaly, Durham, NC 2:37 pm 2:40 pm Observation versus Surgical Resection in Patients with Rectal Cancer Who Achieved Complete Clinical Response after Neoadjuvant Chemoradiotherapy: Preliminary Results of a Randomized Trial (NCT02052921) S.C. Nahas, C.S. Nahas*, U. Ribeiro, Jr., C. Sparapan Marques, G. C. Cotti, C. Ortega, R. Azambuja, A. Chen, P. Hoff, I. Cecconello, Sao Paulo, Brazil 2:47 pm Discussion 2:50 pm Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer without Metastasectomy is Associated with Improved Overall Survival Compared to Chemotherapy/Radiation Therapy Alone B.C. Gulack*, D. Nussbaum, J.E. Keenan, A.M. Ganapathi, Z. Sun, M. Worni, J. Migaly, C. Mantyh, Durham, NC S5 S6 2:57 pm Discussion 3:00 pm Correlation between Extramural Vascular Invasion (EMVI) and DNA Hypermethylation in Rectal Cancer S7 H.G. Jones*, R. Radwan, G. Jenkins, N. Williams, P. Griffiths, J. Beynon, D. Harris, Swansea, United Kingdom 3:07 pm Discussion Discussion Continued next page *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 62 *Presenting Author Sunday, May 31 Neoplasia I (Continued) Waist Hip Ratio Better Predicts Oncological Quality of Resection and Outcome after Colon Cancer Surgery than Body Mass Index S8 N. Hetsch, D. Leonard*, A. Kartheuser, A. van Maanen, Brussels, Belgium; H. Paterson, Edinburgh, United Kingdom; F. Penninckx, Leuven, Belgium 3:17 pm Discussion 3:20 pm Q&A 3:30 pm Adjourn Objectives: At the conclusion of this session, participants should be able to: (S1) Identify the volume of rectal cancer surgery being performed in British Columbia, Canada; explain how rectal cancer surgery is performed at high versus low volume hospitals in British Columbia, Canada; describe the impact hospital volume has on achieving quality indices in rectal cancer surgery; (S2) State the challenges in salvage resection for recurrent rectal cancer following CRT and TEM; describe the oncological outcomes of patients with unfavorable pathological features following CRT and TEM; (S3) Demonstrate the technical details and the outcomes following TATME; explain the advantages of this approach; (S4) Describe the importance of timely administration of adjuvant chemotherapy after oncologic colon resection; develop measures to improve adjuvant therapy utilization rates in colon cancer; (S5) Recall whether conservative (non operative) approach is similar to total mesorectal excision (TME) in patients with complete clinical response after neoadjuvant chemoradiotherapy (CRT); identify all the strict criteria that define a patient with a rectal cancer treated by neoadjuvant chemoradiotherapy as a complete clinical responder; (S6) Discuss the potential benefits of a noncurative resection in stage IV colorectal cancer; discuss the prognosis for patients with stage IV colorectal cancer; (S7) Recall further understanding in the field of epigenetics; recognize a need for biological markers to define treatment choice of cancer patients and; (S8) Analyze the influence of obesity on the oncological outcome after colon cancer surgery; define knowledge in colon cancer prognostic factors. Refreshment Break in Exhibit Hall & ePoster Presentations S U N D AY 3:10 pm (See pages 112-113 for schedule.) 4:00 – 4:45 pm Norman D. Nigro, MD, Research Lectureship 4:45 – 5:15 pm Auditorium (2nd Floor) The Evolution of Minimally Invasive Surgery for Colorectal Cancer: Past, Present, and Future Professor Antonio Lacy, MD, PhD Barcelona, Spain Introduction: Steven Wexner, MD 63 .5 CME Sunday, May 31 After Hours Debate 1 2 * 1.25 CME 5:15 – 6:30 pm Auditorium (2nd Floor) REFRESH MENTS W I L L B E S ERV ED All surgical specialties have certain topics/diseases that contain controversy. Understanding the optimal treatment plan for patients often depends on a physician’s ability to see clarity in these lines of gray. Debates are excellent tools to show differences in perspective and opinion regarding these topics. They effectively challenge and break down surgical dogma and open people to new points of view. They often help audience members crystalize their own values and beliefs. Speakers with passionate views about opposing treatment, with clear guidelines for the debate, can effectively create an effective and novel learning environment. Furthermore, an assertive and experienced moderator can challenge the speakers and engage the audience to both optimize critical thinking and illustrate what treatment plan may be best for different scenarios. Existing Gaps What Is: The role of surgical skills testing is an area of evolving discussion. There are different and often opposing views on it’s appropriateness, indication and it’s utility in surgical education and certification. Surgeons are unsure what effect this will have in the future. While laparoscopic surgery has become more and more mainstream, there is still some question about the efficacy and outcomes of laparoscopic node positive rectal cancer surgery. What Should Be: Surgeons should have a clearer vision of the role of skill testing in relation to certification and recertification. They also need a better understanding of the role of laparoscopic rectal cancer surgery as opposed to colon cancer surgery. Moderator: James Fleshman, MD, Dallas, TX 5:15 pm Surgical Skills Testing Helen MacRae, MD, Toronto, ON, Canada vs Charles Whitlow, MD, New Orleans, LA 5:45 pm Laparoscopic Surgery for Stage 3 Rectal Cancer Richard Whelan, MD, New York, NY vs Scott Steele, MD, Fort Lewis, WA 6:30 pm Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Recognize the role of skill testing in relation to certification and recertification; b) Describe the evidence and practical implications for performing or avoiding mechanical bowel preparation; and c) Explain the outcomes in minimally invasive surgery for the treatment of node positive rectal cancer. Welcome Reception 7:00 – 8:30 pm Grand Ballroom • Sheraton Boston Hotel • Jersey Night! • Wear your favorite team’s jersey to show your colleagues which team you support. The Welcome Reception will be held at the Sheraton Boston Hotel and is complimentary to all registered attendees. The event will feature hors d’oeuvres, cocktails and entertainment. The Research Foundation will join forces with ASCRS to welcome all at this reception. 64 Monday, June 1 Meet the Professor Breakfasts 6:00 – 7:00 am Limit: 30 per breakfast • Fee $40 • Tickets Required • Continental Breakfast Registrants are encouraged to bring problems and questions to this informal discussion. Code Subject/Faculty M-1 HNPCC and Polyposis: Knowing When to Operate Charles Ternent, MD, Omaha, NE Matthew Kalady, MD, Cleveland, OH M-2 M-3 Code Subject/Faculty Room Room 200 M-4 UT SOLD O The Management of T1 Rectal Cancer Robert Madoff, MD, Minneapolis, MN Maher Abbas, MD, Abu Dhabi, United Arab Emirates Quality Metrics and Colorectal Surgery Juan Nogueras, MD, Weston, FL Rocco Ricciardi, MD, Burlington, MA Room 202 M-5 How to Produce a High Quality Room 207 Manuscript for Scientific Journals Thomas Read, MD, Burlington, MA W. Donald Buie, MD, Calgary, AB, Canada Coding Pearls Guy Orangio, MD, New Orleans, LA Stephen Sentovich, MD, Duarte, CA Room 203 M-6 Rectal Prolapse Room 300 Stanley Goldberg, MD, Minneapolis, MN Brooke Gurland, MD, Cleveland, OH Room 206 Objectives: At the conclusion of this session, participants should be able to: a) Describe the procedures and approaches discussed in this session. Residents’ Breakfast 6:00 – 7:00 am Constitution Ballroom Sheraton Boston Hotel 1.0 CME The Road Less Traveled or the High Road? Charting a Path to Success Michael Stamos, MD Chair Department of Surgery University of California, Irvine Health Orange, CA Open to Residents Only Registration Required 65 M O N D AY UT SOLD O Room 1.0 CME Monday, June 1 Symposium Parallel Session 3-A Robotic Colorectal Surgery 1 2.25 MOC 2 5 6 * 2.25 CME 7:00 – 9:15 am Ballroom BC (3rd Floor) Supported in part by an independent educational grant from Intuitive Surgical, Inc. While the practice of surgery continues to evolve with respect to new techniques and technology, it remains critical that the attention of surgeons and society as a whole focus on improving the quality of patient care. Innovations therefore must be assessed through science and experience in order that these goals are achieved. Controversy over the cost, potential complications, training, highlighted in both the lay press and scientific publications, demonstrate the need for this discussion. These unanswered questions regarding the use of robotic surgery represent fertile ground from which a robust discussion can ensue. Therefore, a need exists to review the current state of the robotics in order that surgeons are informed of ongoing and future studies pertaining to the use of robotic surgery. Existing Gaps What Is: The approach and use of robotic surgery remains varied and diverse. To date, few institutions exist with large experiences in colorectal disease. Moreover, the appropriate application of robotics is often based on local prevailing customs and expertise due to limited data and training. What Should Be: Surgeons should understand the appropriate application of robotic technics and a basis for literature reported outcomes in colorectal surgery. In addition, surgeons should have a basic understanding of the potential pitfalls and costs associated with this approach. Director: David Larson, MD, Rochester, MN Assistant Director: Scott Kelley, MD, Rochester, MN 7:00 am What's New with the Robot (Tools, Capabilities) and How Might it Improve My Practice Howard Ross, MD, Philadelphia, PA 7:15 am The Evidence: Where are We? David Jayne, MD, Leeds, United Kingdom 7:30 am Role of Robotics in Colon Surgery? Julio Garcia-Aguilar, MD, PhD, New York, NY 7:45 am The Costs of Robotics, Pitfalls and Economics Robert Cleary, MD, Ann Arbor, MI 8:00 am Complex Pelvic Surgery, Techniques and Tricks Amir Bastawrous, MD, Seattle, WA 8:15 am Robotic Rectal Cancer Surgery and RoboticIntersphincteric Resection Jin Cheon Kim, MD, Seoul, South Korea 8:30 am Economics of Robotics Craig Rezac, MD, New Brunswick, NJ 8:45 am Questions and Panel Discussion 9:15 am Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Identify the capabilities and tools associated with different robotic technologies; b) Describe the principles derived from the literature on the benefit or lack of benefit from a robotic approach; c) Recall the proper technical issues of both abdominal and pelvic robotic surgery; d) Describe the current and ongoing trials of robotic surgery; and e) Distinguish the financial burden associated with robotic surgery and the opportunities for cost savings. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 66 Monday, June 1 Symposium Parallel Session 3-B Rectal Cancer: Optimizing Outcomes through Techniques 1 2 5 6 * 2.25 CME 7:00 – 9:15 am Auditorium (2nd Floor) Supported in part by an independent educational grant from Ethicon With continued technological advancements and their implementation into surgical practice, the number of surgical approaches for the management of rectal cancer continues to expand. Depending on the stage and location of the rectal cancer and patient co-morbidities and wishes, one surgical approach may be preferred over another. Nevertheless, regardless of surgical approach, short-term and long-term oncological and functional results are greatly dependent on surgical technique. The purpose of this symposium is to present expert commentaries by high-volume surgeons on the essential technical components of a broad range of specific open and minimally invasive surgical approaches commonly used for the management of rectal cancer. Existing Gaps What Is: Although colorectal surgeons are trained in all the different surgical options for rectal cancer management, the science and art in a specific surgical technique are mastered after years of practice and experience. What Should Be: This Symposium aims to highlight and disseminate optimal surgical techniques used by expert high volume surgeons in the surgical management of rectal cancer. 7:00 am Introduction José Guillem, MD, New York, NY 7:05 am Open Low Anterior Resection Robert Madoff, MD, Minneapolis, MN 7:15 am Open Ultra-Low Resection with Coloanal Anastomosis: Mucosectomy vs Intersphincteric Resection Thomas Read, MD, Burlington, MA 7:25 am 7:35 am Abdominal Perineal Resection: Prone Position/Cylindrical Approach: When and How? Torbjörn Holm, MD, Stockholm, Sweden ALaCaRT: Australian Laparoscopic Cancer of the Rectum Trial Andrew Stevenson, MD, Chermside, Australia 7:45 am Discussion and Cases 8:00 am Robotic Rectal Cancer Resections Slawomir Marecik, MD, Park Ridge, IL 8:10 am TEM/TAMIS Sergio Larach, MD, Orlando, FL 8:20 am Transanal Total Mesorectal Excision Antonio Lacy, MD, PhD, Barcelona, Spain 8:30 am Results of Robotic vs Laparoscopic Resection for Rectal Cancer: ROLARR Study Alessio Pigazzi, MD, PhD, Orange, CA 8:40 am Discussion 9:15 am Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Describe the most commonly performed and evolving open and minimally invasive surgical approaches for rectal cancer with an emphasis on proper patient selection and optimal surgical technique; and b) Identify specific preferred techniques, potential technical difficulties and pitfalls in order to assure optimal oncological and functional outcome. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 67 M O N D AY Director: José Guillem, MD, New York, NY Assistant Director: Patricia Sylla, MD, New York, NY Monday, June 1 Memorial Lectureship Honoring John M. MacKeigan, MD 9:15 – 9:45 am Auditorium (2nd Floor) A Short Walk Through the History of the Quality Movement .5 CME Martin Luchtefeld, MD Chief, Div. of Colon and Rectal Surgery Clinical Asst. Professor, MSU College of Medicine Ferguson Clinic-Spectrum Health Medical Group Spectrum Health Grand Rapids, MI Introduction: Anthony Senagore, MD Presidential Address 9:45 – 10:15 am Auditorium (2nd Floor) A Surgeon’s Puzzle: “The Missing Pieces” .5 CME Terry C. Hicks, MD Vice Chair, Dept. of Colon and Rectal Surgery Ochsner Clinic Clinical Professor of Surgery, LSU, School of Medicine New Orleans, LA Introduction: Michael Stamos, MD Refreshment Break in Exhibit Hall & ePoster Presentations (See pages 112-113 for schedule.) 10:15 – 11:00 am 68 Monday, June 1 Symposium Parallel Session 4-A Navigating a Career Path in Colon and Rectal Surgery – Orchestrating and Optimizing Career Transitions at All Levels 3 4 * 11:00 am – 12:30 pm Auditorium (2nd Floor) 1.5 CME Surgeons at all phases of their career face difficult decisions about potential transitions in their professional and personal lives. The optimal strategic approach to these life changing events can be elusive and may lead to a “trial by error” experience with dramatic consequences. We must try to understand that these changes come from the demands of our conscience and not from our mental resolution. Furthermore, not every opportunity is growth, as all movement is not forward. Existing Gaps What Is: Graduating colorectal residents and attending surgeons looking for a career change receive very little counseling and pragmatic advice to assist them in their potential transition to a new position. What Should Be: Career transitions should be approached and handled by an individual with a team of mentors and advisors. The absence of this “team” can be balanced by national courses and symposia with speakers well educated in this arena. Director: Bradley Champagne, MD, Cleveland, OH Assistant Director: Andrew Russ, MD, Knoxville, TN 11:00 am Life after Training – You are Now the Attending of Record! Mark Manwaring, MD, Greenville, NC 11:36 am A View from Above – How to Effectively Lead a Team! Michael Stamos, MD, Orange, CA 11:12 am Mid-Life Crisis, Build your Own or Lead from the Center! Gregory Kennedy, MD, PhD, Madison, WI 11:48 am Emotional Intelligence – The Real Key to Success James Fleshman, MD, Dallas, TX 11:24 am From Private Practice to Hospital Acquisition – Lifestyle, Dollars and Sense! Wayne Ambroze, MD, Atlanta, GA Noon Question and Answer 12:30 pm Adjourn thoughtful and strategic approach to the first years in practice after training; b) Describe the key components to the decision making process when a surgeon is deciding between moving to another position with potential leadership opportunities vs. staying in their current role; c) Identify the current challenges with private practice and why hospital based practice may be advantageous; d) Recognize how to turn a vision into reality by effective implementation of the strategic plan; and e) Identify that mental toughness and emotional intelligence are difficult to measure but are the cornerstone of personal and professional success. Complimentary Box Lunch in Exhibit Hall & ePoster Presentations (See pages 112-113 for schedule.) 12:30 – 1:30 pm *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 69 M O N D AY Objectives: At the conclusion of this session, participants should be able to: a) Recognize the importance of a Monday, June 1 Abstract Session Parallel Session 4-B Benign Colonic Disease 1 3 * 1.5 CME 11:00 am – 12:30 pm Ballroom A (3rd Floor) Co-Moderators: Maher Abbas, MD, Abu Dhabi, UAE and Jennifer Rea, MD, Lexington, KY 11:39 am Conservatively Treated Diverticular Abscess Associated with High Risk of Recurrence and Disease Complications S13 B. Devaraj, W. Liu*, K. Cologne, A.M. Kaiser, Los Angeles, CA 11:00 am Surgical Site Infection following Colorectal Surgery: In the Eye of the Beholder? S9 T.L. Hedrick*, A. Harrigan, B. Umapathi, R. Sawyer, C.M. Friel, Charlottesville, VA 11:07 am Discussion 11:46 am Discussion 11:09 am Diverticulitis in the United States: A Decade Analysis of Changing Trends S10 M.H. Hanna*, Z. Moghadamyeghaneh, G. Hwang, L. Malellari, S.D. Mills, J.C. Carmichael, M.J. Stamos, A. Pigazzi, Orange, CA 11:49 am Killingback Award Winner High vs low Urine Output Targets in Elective Surgical Patients: A Randomized Clinical Trial S15 J. Puckett*, J. De Zoysa, M. Kluger, Auckland, New Zealand; S. Palmer, .J Pickering, Z. Endre, Christchurch, New Zealand; M. Soop, Auckland, New Zealand 11:16 am Discussion 11:19 am Sigmoid Colectomy for Acute Diverticulitis in Immunosuppressed vs. Immunocompetent Patients: Outcomes from the ACS-NSQIP Database S11 A. Al-Khamis*, J. Abou Khalil, C. Vasilevsky, N. Morin, G. Ghitulescu, P. Gordon, M. Demian, J. Faria, M. Boutros, Montreal, QC, Canada 11:56 am Discussion 11:59 am The Current State of Colorectal Surgery Training: A Survey of Program Directors, Current Colorectal Residents, and Recent Colorectal Graduates. S16 M.B. Bailey*, P.E. Miller, S. Pawlak, M. Thomas, H. Vargas, T. Hicks, C. Whitlow, D. Beck, D. Margolin, New Orleans, LA 11:26 am Discussion 11:29 am The Readmission After Acute Diverticulitis (RAD) Score – A Nomogram for Determining 60-day Readmission Risk for Diverticulitis Patients Using 145,325 Admissions from the State Inpatient Database (SID) (2006-2011). S12 V. Chakravorty*, K. Mahendraraj, R.S. Chamberlain, Livingston, NJ 12:06 pm Discussion 12:09 pm Q&A 12:30 pm Adjourn 11:36 am Discussion Continued next page *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 70 *Presenting Author Monday, June 1 Benign Colonic Disease (Continued) Objectives: At the conclusion of this session, participants should be able to: (S9) Define the ASEPSIS score for evaluating surgical site infection; recognize the inter-rater variability between surgeons in defining surgical site infection; (S10) Recognize changing trends in incidence and treatment of diverticulitis nationwide; identify risk factors for mortality in the middle-ages and elderly patient groups with diverticulitis; (S11) Recognize the impact of immunosuppression on mortality following colectomies for acute sigmoid diverticulitis in the emergency; describe the impact of immunosuppression on morbidity following colectomies for acute sigmoid diverticulitis in the emergency; (S12) Analyze the demographic and clinical factors that increase the risk of readmission following an index admission for acute; define a predictive nomogram capable of identifying and stratifying patients at greatest risk of readmission based upon factors present during the index admission; (S13) Analyze the natural course and outcomes of intermediate severity cases of diverticulitis, i.e. patients with abscess at time of presentation; analyze the impact of CT-guided drainage of diverticular abscess on the overall outcome; (S15) Recognize that a low perioperative UO target is not inferior to a high UO target and; (S16) Identify current trends in colorectal training; review objective data on the competitiveness of colorectal training. Complimentary Box Lunch in Exhibit Hall & ePoster Presentations (See pages 112-113 for schedule.) M O N D AY 12:30 – 1:30 pm 71 Monday, June 1 Symposium Parallel Session 5-A Past Presidents’ Panel: Controversies and Cases 1 2 4 * 1.5 CME 1:30 – 3:00 pm Auditorium (2nd Floor) The management of complicated colorectal disorders is what differentiates this specialty from general surgery. Colorectal surgeons are often called upon to manage complex medical and surgical conditions, especially reoperative surgery. This session will highlight the strategies of senior colorectal surgeons’ management of the most complicated reoperative conditions addressed by our specialty. • Recurrent Anal Fissures • Recurrent Rectal Cancer • Hemorrhoid Disease • Inflammatory Bowel Disease • Complex Fistula Existing Gaps What Is: Many surgeons are comfortable with the straightforward management of common colorectal conditions. Complex cases, reoperative surgery and those with complications are often referred to a tertiary care center. What Should Be: Surgeons should be familiar with the management options for complicated colorectal diseases and the potential interventions necessary to provide satisfactory outcomes. Director: Steven Wexner, MD, Weston, FL 1:30 pm Recurrent Anal Fissures Richard Billingham, MD, Seattle, WA 2:15 pm Inflammatory Bowel Disease Michael Stamos, MD, Orange, CA 1:45 pm Recurrent Rectal Cancer H. Randolph Bailey, MD, Houston, TX 2:30 pm Complex Fistula Ann Lowry, MD, St. Paul, MN 2:00 pm Hemorrhoid Disease Lester Rosen, MD, West Palm Beach, FL 2:45 pm Roundtable Discussion 3:00 pm Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Recognize the management options of recurrent anal fissures, complex anal fistula, hemorrhoid disease, rectal cancer and IBD; and b) Identify the technique of colonoscopy and how to manage potential complicated lesions endoscopically. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 72 Monday, June 1 Abstract Session Parallel Session 5-B Pelvic Floor/Anorectal 1 2 * 1.5 CME 1:30 – 3:00 pm Ballroom A (3rd Floor) Co-Moderators: Jason Mizell, MD, Little Rock, AR and Amy Halverson, MD, Chicago, IL Treatment of Fecal Incontinence with Gatekeeper™ Implantation S18 A. Heydari*, E. Merolla, S. Giuratrabocchetta, M. Piccoli, G. Melotti, Modena, Italy; R. Fazlalizadeh, Orange, CA 2:09 pm Long Term Efficacy of Sacral Nerve Stiumlation for Fecal Incontinence – A Single Center Experience J.B. Cowley*, P.W. Waudby, H. O'Grady, G.S. Duthie, Beverley, United Kingdom 1:37 pm Discussion 2:16 pm Discussion 1:39 pm The Impact of a Novel Vaginal Bowel Control System on Bowel Function S19 M.G. Varma*, San Francisco, CA; C.A. Matthews, Chapel Hill, NC; H. Richter, Birmingham, AL 2:19 pm 1:46 pm Discussion Percutaneous Tibial Nerve Stimulation has Sustained Benefit in the Treatment of Fecal Incontinence at 12 Months S23 J.B. Cowley*, P.W. Waudby, H. O'Grady, G.S. Duthie, Beverley, United Kingdom 1:49 pm The Effect of Coexisting Pelvic Floor Disorders on Fecal Incontinence Quality of Life Scores: A Prospective Survey-Based Study S20 L. Bordeianou, C.W. Hicks*, A. Olariu, L.R. Savitt, S.J. Pulliam, M. Weinstein, P. Sylla, M.M. Wakamatsu, Boston, MA; T. Rockwood, Minneapolis, MN; J. Kuo, Waltham, MA 2:26 pm Discussion 2:29 pm Outcomes of Re-Implantation of Sacral Neurostimulation for Fecal Incontinence are Similar to Those of First Time Implants S24 A. Cracco*, A. Chadi, S. Wexner, F. Rodrigues, G. DaSilva, Weston, FL; M. Zutshi, B. Gurland, Cleveland, OH S22 1:56 pm Discussion 2:36 pm Discussion 1:59 pm The TOPAS™ Treatment for Fecal Incontinence: A Close Look at Complications S21 M. Zutshi*, Cleveland, OH; A. Mellgren, Chicago, IL; D.E. Fenner, Ann Arbor, MI; V. Lucente, Allentown, PA; P. Culligan, Summit, NJ; M. Nihira, Oklahoma City, OK 2:39 pm 2:06 pm Discussion Use of Biofeedback Combined with Diet for Treatment of Obstructed Defecation Associated with Paradoxical Contraction of Puborectalis Muscles (Anismus). Predictive Factors and Short-term Outcome S25 S.M. Murad-Regadas*, F.S. Regadas, C. Bezerra, M.C. Oliveira, F. Regadas Filho, R. Vasconcelos, S. Almeida, G. Fernandes, Ceara, Brazil 2:46 pm Discussion Continued next page *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 73 *Presenting Author M O N D AY 1:30 pm Monday, June 1 Pelvic Floor/Anorectal (Continued) 2:49 pm Ligation of Intersphincteric Fistula Tract (LIFT) versus LIFT-Plug Procedure in Patients with Transsphincteric Anal Fistula: A Multicenter Prospective Randomized Trial. S26 Z. Wang*, J. Han, Y. Zheng, J. Cui, C. Chen, Beijing, China; X. Wang, X. Che, Shan'xi, China; W. Song, Tianjin, China 2:56 pm Discussion 3:00 pm Adjourn Objectives: At the conclusion of this session, participants should be able to: (S18) distinguish the possible complications after the Fecal Incontinence treatment; describe minimal invasive approach for fecal incontinence treatment; distinguish the possible complications after the fecal incontinence treatment; (S19) Describe the vaginal bowel control (VBC) system; describe the impact of the VBC system on bowel function; (S20) Describe the association between severity of fecal incontinence and fecal incontinence quality of life; recognize how coexisting pelvic floor disorders affect fecal incontinence quality of life scores among patients with fecal incontinence; (S21) Examine the local and distant complications related to the TOPAS procedure; evaluate if mesh related complications in the Urogyn literature apply to the Topas System; (S22) Recognize the long term efficacy of SNS; develop their practice regarding the long term use of SNS for fecal incontinence; (S23) Analyze the effect of PTNS over a 1 year period; recognize alternative therapies and their success in the treatment of faecal incontinence; (S24) Detect the outcomes of reimplantation of Sacral Neurostimulation for Fecal Incontinence; recognize that the outcomes of reimplantation of SNS for fecal in-continence are comparable to the first implantation; (S25) Analyze the effect of biofeedback combined with diet in treating patients with obstructed defecation associated anismus; identify factors influencing the outcomes in biofeedback associated with diet in the treatment of obstructed defecation due to anismus; (S26) Describe effect of LIFT and LIFT-plug for transsphincteric anal fistula; explain the difference in outcome of LIFT and LIFT-plug for transsphincteric anal fistula. 74 Monday, June 1 Harry E. Bacon, MD, Lectureship 3:00 – 3:30 pm Auditorium (2nd Floor) Changes in Student and Residency Education in Surgery: Unanticipated Consequences and Challenges .5 CME Hiram C. Polk, Jr., MD Ben A. Reid, Sr. Professor of Surgery, Emeritus Former Chair, Department of Surgery, School of Medicine, University of Louisville Louisville, KY Introduction: Terry Hicks, MD Ice Cream & Refreshment Break in Exhibit Hall & ePoster Presentations (See pages 112-113 for schedule.) 3:30 – 4:15 pm Parviz Kamangar Humanities in Surgery Lectureship 4:15 – 4:45 pm Auditorium (2nd Floor) Spirituality and Faith in Serious Illness .5 CME Robert L. Fine, MD, FACP, FAAHPM Clinical Director Office of Clinical Ethics and Palliative Care Baylor Scott and White Health, Dallas, TX Clinical Associate Professor of Internal Medicine and Medical Humanities, Texas A&M College of Medicine M O N D AY Introduction: Ira Kodner, MD 75 Monday, June 1 Special Lecture 4:45 – 5:15 pm Auditorium (2nd Floor) The Trials and Tribulations of Clinical Research: Why Johnny Can’t Add Thomas Read, MD Lahey Hospital and Medical Center Dept. of Colon and Rectal Surgery Burlington, MA 5:15 – 5:20 pm Auditorium (2nd Floor) What Receiving the Scholarship Means to Me Alex Emmanuel Elobu, MD Mulago Hospital Kampala, Uganda ASCRS International Scholarship Recipient 76 .5 CME Monday, June 1 No CME Credit Awarded New Technologies Symposium REFRESH MENTS W I L L B E S ERV ED 5:20 – 6:45 pm Auditorium (2nd Floor) Supported by independent educational grants from: ACell, Inc. Novadaq Technologies, Inc. Pacira Pharmaceuticals, Inc. THD America Torax Medical, Inc. The New Technologies Session is dedicated to the principle that through imagination and innovation, many of the most challenging problems in the field of colon and rectal surgery can be solved. Impactful new innovations in the area of colorectal surgery; pharma, devices, prototypes, techniques and approaches will be the focus of this session. This session will feature presentations on the latest advances in colorectal surgery. Existing Gaps What Is: No platform to discuss emerging technologies exists for colorectal surgery today. What Should Be: The ASCRS annual meeting will serve as a major conduit through which new and emerging technologies for colorectal surgery will be showcased. This session will also serve as an educational platform to learn about drug and device development and process for FDA approval. 5:20 pm Welcome Eric Haas, MD, Houston, TX and Sonia Ramamoorthy, MD, La Jolla, CA 5:57 pm Advances in Surgical Stapling: ECHELON FLEX™ GST System David Longcope, MD, Denver, CO 5:21 pm Anorectal Fistula Closure with the New OTSC Proctology R.L. Prosst, W. Ehni, Stuttgart, Germany; A.K. Joos, D. Bussen, A. Herold, Mannheim, Germany 6:04 pm Future Robotic Single Port System Vincent Obias, MD, Washington, DC 6:11 pm New Advances in Fluorescent Imaging Ovunc Bardakcioglu, MD, Las Vegas, NV Pilot Study of a Novel Multimodal Pain Management Strategy – Evaluating the Impact on Patient Outcomes Deborah Keller, MD, Houston, TX 6:18 pm Regenerative Medicine in Problematic Colorectal Applications Vincent Obias, MD, Washington, DC Sylys: A Novel Surgical Sealant with the Potential to Reduce Anastomotic Leaks Deborah Nagle, MD, Boston, MA 6:25 pm 5:43 pm Five Years of Sphincter Preserving Anal Fistula Repair Using the FiLaC Laser System A. Wilhelm, Cologne, Germany Transanal Hemorrhoidal Deasterialization: Advances on Technique and New Data Samir Agarwal, MD, Washington, DC 6:32 pm 5:50 pm FENIX® – A Magnetic Sphincter Augmentation Device for Fecal Incontinence: An “Attractive” Approach” Paul-Antoine Lehur, MD, PhD, Nantes, France Are You Ready to Repair Hernias Differently? The First Hybrid Hernia-Repair Device Eric Johnson, MD, Fort Lewis, WA 6:39 pm Clinical Value of the Olympus 3D Imaging Solution I. Emre Gorgun, MD, Cleveland, OH 6:45 pm Adjourn 5:29 pm 5:36 pm Objectives: At the conclusion of this session, participants should be able to: a) Identify and employ emerging technologies relating to colorectal surgical issues; b) Recognize personal gaps in knowledge which will lead to further independent study; and c) Recognize safe and effective strategies to correct common colorectal disease processes. 77 M O N D AY Co-Director: Sonia Ramamoorthy, MD, La Jolla, CA Co-Director: Eric Haas, MD, Houston, TX Tuesday, June 2 Meet the Professor Breakfasts 6:30 – 7:30 am Limit: 30 per breakfast • Fee $40 • Tickets Required • Continental Breakfast Registrants are encouraged to bring problems and questions to this informal discussion. Code Subject/Faculty T-1 UT SOLD O Enterocutaneous Fistulas, Anastomotic Leaks and other Catastrophes David Beck, MD, New Orleans, LA Joseph Carmichael, MD, Orange, CA T-2 UT SOLD O Modern Management of Fecal Incontinence Kelly Garrett, MD, New York, NY Amy Halverson, MD, Chicago, IL Room 1.0 CME Code Subject/Faculty Room 200 T-5 Pouch Problems and Solutions Feza Remzi, MD, Cleveland, OH David Larson, MD, Rochester, MN Bonnie Alvey, APRN, WOCN, ACNS-BC, New Orleans, LA Room 207 Room 202 T-6 Rectal Cancer: Difficult Cases and Controversies James Fleshman, MD, Dallas, TX Kirk Ludwig, MD, Milwaukee, WI Room 300 T-3 Nonhealing Perineal Wounds Room 203 Martin Luchtefeld, MD, Grand Rapids, MI Jon Hourigan, MD, Lexington, KY T-7 T-4 Controversies: The Management of Intestinal Crohn's Disease Sandra Beck, MD, Lexington, KY Phillip Fleshner, MD, Los Angeles, CA Colitis and Dysplasia Surveillance Room 313 and Management David Etzioni, MD, Phoenix, AZ Randolph Steinhagen, MD, New York, NY Room 206 Room Photo Credit: Greater Boston Convention & Visitors Bureau Objectives: At the conclusion of this session, participants should be able to: a) describe the procedures and approaches discussed in this session. Situated on the waterfront, the JFK Library & Musuem offers glorious unobstructed views of the city and the ocean. 78 Tuesday, June 2 Symposium Parallel Session 6-A 1 1.5 MOC 2 5 6 T U E S D AY Anorectal Disorders: Balancing Innovation with Conventional Wisdom * 1.5 CME 7:30 – 9:00 am Ballroom BC (3rd Floor) Billions of dollars are spent annually in the U.S. by patients on their own and as prescribed by a physician to manage the symptoms of a wide range of anorectal conditions. Surgical treatments include state of the art technologies and methods that have remained unchanged since the time of Shakespeare and even the Pharaohs. Do the newer approaches to these conditions provide better outcomes at reasonable cost, or just novelty and an opportunity to advance one’s practice by being the “first kid on the block to have the newest toy?” This symposium seeks to juxtapose the newest advances against the tried and true. We plan to review the emerging technologies with regard to outcomes and efficacy and also “bang for the buck” look at the improvements and innovation vs cost. There will be an in-depth discussion of how to integrate new technology into your anorectal practice and when to stick with what you were taught in fellowship. Existing Gaps What Is: A variety of emerging techniques and technologies that span the practice of anorectal surgery. The adoption and support for these changes in practice is often industry driven. The distinct benefit at possibly increased cost is not always known by the patient or the practitioner. Many different approaches, new and old, are currently applied across practices. What Should Be: Surgeons adopting the newest innovative treatments and technologies should know the benefits and costs of these newer approaches in comparison to proven methods. The practitioners should be aware of potential risks or benefits of adopting new methods. Evolving changes in surgical techniques need to be compared to established standards using an evidence based approach, free from commercial bias. Director: Thomas Cataldo, MD, Boston, MA Assistant Director: Vitaliy Poylin, MD, Boston, MA 7:30 am Latest Advances in Guided Hemorrhoid Ligation Vincent Obias, MD, Washington, DC 8:10 am Management of Fistula-in-Ano: From Shakespeare to the Space Shuttle Brian Kann, MD, New Orleans, LA 7:40 am Hemorrhoidectomy – Do We Need to Reinvent the Wheel? Syed Husain, MD, Columbus, OH 8:20 am Ventral Rectopexy for Obstructed Defecation P. Ronan O'Connell, MD, Dublin, Ireland 8:30 am Discussion 7:50 am Management of Chronic Anal Fissures, to Rub on, Inject in, or Cut Through Elizabeth Raskin, MD, St. Paul, MN 9:00 am Adjourn 8:00 am Injectable and Implantable Treatments for Fecal Incontinence Nishit Shah, MD, Providence, RI Objectives: At the conclusion of this session, participants should be able to: a) Identify the newest techniques for management of symptomatic hemorrhoids, fistula-in-ano, anal fissure, rectal prolapse and incontinence; b) Review the newest innovations with respect to cost, risk, complications and success compared to well established techniques and technologies; and c) Plan for incorporation of innovative methods for management of anorectal conditions in the existing practice of colorectal surgery. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 79 Tuesday, June 2 Symposium Parallel Session 6-B Update on Inflammatory Bowel Disease 1 2 5 6 * 7:30 – 9:00 am Auditorium (2nd Floor) 1.5 MOC 1.5 CME The management of Crohn’s disease and ulcerative colitis continues to evolve as we learn more about the genetics of these diseases. Additionally, our management of patients with IBD has changed greatly with new drug development, which then has downstream impact on their surgical therapy. Therefore, it is crucial to have a comprehensive understanding of these aspects of Crohn’s disease and ulcerative colitis in order to provide the most comprehensive care for these patients. Our understanding of the genetics of Crohn’s disease and to a lesser extent, ulcerative colitis, has grown greatly in the past decade. The advances have to do with the discovery of the NOD2 gene and advances in technology such as the high throughput genetics. This understanding has led to improvement in identifying high-risk patients, and defining disease phenotypes. The introduction and expansion of biologic agents in the treatment of inflammatory bowel disease (IBD) has provided an effective alternative to long-term steroid therapy. Immunomodulator therapy is so widespread that it is uncommon for any patient with Crohn’s or ulcerative colitis to not be treated with one of these agents. Data clearly supports its use in the acute and maintenance settings, but the long-term impact of the drugs on these patients regarding the need for surgery and quality of life remains controversial. Pouchitis is the most common complication associated with restorative proctocolectomies. The majority of cases are easily treated with antibiotics but a subset of these patients develops chronic pouchitis that is antibiotic dependent or requires immunomodulators to treat. We are gaining an increasing understanding of the pathophysiology of pouchitis and its treatments. Perianal Crohn’s disease presents some of the greatest challenges to the patient and surgeon. The main goal for treating patients with perianal disease is focused control of symptoms and rarely on cure or eradication. It remains unclear how the widespread use of biologic therapy has impacted the surgical management of these patients. Restorative proctocolectomy with an ileal anal pouch has become the surgical standard of care for patients with ulcerative colitis. This procedure can be done in one, two or three stages, and the best approach remains controversial. Existing Gaps What Is: Our understanding of the genetics, pathophysiology, medical therapy and surgical therapy of IBD is constantly changing. What Should Be: Surgeons should understand the genetic basis, the indications and outcomes associated with medical management, and the surgical principles for the treatment of IBD in today’s world of medicine. Director: Matthew Mutch, MD, St. Louis, MO Assistant Director: Marc Singer, MD, Chicago, IL 7:30 am Introduction Matthew Mutch, MD, St. Louis, MO 7:36 am 7:49 am 8:02 am 8:19 am Genetics of IBD – What Have We Learned? David Stewart, Sr., MD, Hershey, PA Perianal Crohn’s Disease – Has Biologic Therapy Changed our Surgical Principles? Justin Maykel, MD, Worcester, MA 8:28 am Immunomodulators and Biologic Agents for Intestinal Disease – Surgery vs Drugs Sekhar Dharmarajan, MD, St. Louis, MO Restorative Proctocolectomy – 3 Stage vs 2 Stage vs 1 Stage Timothy Geiger, MD, Nashville, TN 8:41 am Panel Discussion/Questions 9:00 am Adjourn Chronic Pouchitis – What Is it and How Do I Treat it? David Dietz, MD, Cleveland, OH Objectives: At the conclusion of this session, participants should be able to: a) Recognize the genetics of IBD; b) Identify the impact of medical therapy on the treatment of Crohn’s disease; c) Recognize the pathophysiology and treatment of chronic pouchitis; d) Describe the principle of managing perianal Crohn’s disease; and e) Evaluate the indications for 3 stage, 2 stage, and 1 stage restorative proctocolectomy. 80 Tuesday, June 2 9:00 – 9:30 am Auditorium (2nd Floor) Diverticulitis: What’s New .5 CME Lisa Strate, MD, MPH Associate Professor of Medicine Department of Medicine Division of Gastroenterology University of Washington Harborview Medical Center Seattle, WA Introduction: Ann Lowry, MD Refreshment Break in Exhibit Hall & ePoster Presentations (See pages 112-113 for schedule.) Photo Credit: Greater Boston Convention & Visitors Bureau 9:30 – 10:15 am 81 T U E S D AY Ernestine Hambrick, MD, Lectureship Tuesday, June 2 Symposium Parallel Session 7-A Controversies in Rectal Cancer Management 1 2 5 6 * 10:15 – 11:45 am Auditorium (2nd Floor) 1.5 CME Supported in part by an independent educational grant from Applied Medical Rectal cancer management is changing as new evidence emerges regarding the benefits of multidisciplinary treatment and techniques for optimizing surgical outcomes. Specifically, the need of routine preoperative radiotherapy, the role for long-course chemoradiotherapy versus short course radiotherapy alone, the management of patients with complete clinical response following chemoradiation, and the role of adjuvant therapy following neoadjuvant chemoradiation, are all unsolved clinical dilemmas. Some of this debate has been informed by improvements in surgical outcomes and our improved understanding of the impact of circumferential margins at resection, for both proximal and distal rectal cancers. Existing Gaps What Is: Current treatment guidelines for patients with rectal cancer do not account for the underlying heterogeneity of rectal cancers with respect to treatment response or risk for recurrence. What Should Be: Surgeons should have an understanding about the determinants of outcomes following multidisciplinary treatment for rectal cancer and how treatment may be tailored to maximize oncologic outcome while minimizing the risk for unnecessary toxicity. Director: George Chang, MD, Houston, TX Assistant Director: Fergal Fleming, MD, Rochester, NY 10:15 am The CRM is Widely Clear: Is Routine Preoperative Radiotherapy Still Necessary? Peter Sagar, MD, Leeds, United Kingdom 11:15 am Adjuvant Chemotherapy Following Neoadjuvant CXRT for Rectal Cancer: Does Anybody Benefit? Yi-Qian Nancy You, MD, Houston, TX 10:30 am Preoperative Radiotherapy for Rectal Cancer: When to Go Short and When to Go Long. Alexander Heriot, MD, Melbourne, VIC, Australia 11:30 am Discussion 11:45 am Adjourn 10:45 am I Don’t See Residual Tumor, What Should I Do? Julio Garcia-Aguilar, MD, PhD, New York, NY 11:00 am Managing Minimally Invasive TME: Top Down or Bottom Up? John R.T. Monson, MD, Rochester, NY Objectives: At the conclusion of this session, participants should be able to: a) Discuss treatment heterogeneity among patients with rectal cancer; b) Describe issues in the management of rectal cancer patients with a clinical complete response to neoadjuvant chemoradiation therapy; c) Discuss the evidence regarding adjuvant chemotherapy for rectal cancer patients following neoadjuvant chemoradiation therapy; d) Discuss critical issues related to circumferential resection margins during rectal cancer surgery; and e) Discuss the critical issues within the evolving area of transanal TME. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 82 Tuesday, June 2 Symposium Parallel Session 7-B 1 2 3 5 * 10:15 – 11:45 am Ballroom BC (3rd Floor) 1.5 MOC 1.5 CME Supported in part by an independent educational grant from LifeCell, an Acelity Company Despite improvements in surgical technique and enterostomal therapy care, complications following stoma creation are very common. The rate of stoma-specific complications in the literature varies between 10% and 70%, and is dependent on the length of follow-up and the definition of “complication.” Complications include peristomal skin irritation, leakage, high output, dehydration, ischemia, retraction, stenosis, and recurrence of the disease for which a stoma was created, such as Crohn’s disease. Participants will be updated on how to construct intestinal stomas as well as how to prevent and treat stoma-related complications. This symposium will discuss the techniques of stoma siting and marking, stoma construction, prevention and management of complications including parastomal hernia, and management of patients with high-volume outputs. Technical tips to avoid complications and facilitate construction will be emphasized. Quality of life for patients with stomas will also be discussed. Existing Gaps What Is: Construction and management of stomas remains challenging and stoma-related complications remain high. Often the surgeon is the primary provider in the management of these complications, and many surgeons lack the experience necessary to adequately treat them. What Should Be: Surgeons should know multiple options for stoma creation. Additionally, physicians should have an understanding of how to prevent and treat stoma-related complications. Co-Director: Deborah Nagle, MD, Boston, MA Co-Director: Joseph Carmichael, MD, Orange, CA 10:15 am Patient Education and Stoma Site Selection A. Murray Corliss, RN, CWOCN, Boston MA 11:00 am Other Stoma Complications Other Than Hernia Walter Peters, Jr., MD, Columbia, MO 10:30 am Ostomy Selection, Construction and Technical Challenges Neil Hyman, MD, Chicago, IL 11:15 am Complicated Cases/Panel Discussion 10:45 am 11:45 am Adjourn Parastomal Hernias: The Controversy Continues Michael Rosen, MD, Cleveland, OH Objectives: At the conclusion of this session, participants should be able to: a) Discuss the preoperative optimization of patient to prevent stoma-related complications; b) Describe methods to medically manage common peristomal problems; c) Describe techniques to prevent and repair parastomal hernias; d) Discuss methods of managing patients with stoma retraction, stenosis, prolapse, and peristomal skin problems; and e) Describe methods of managing patients with high-volume output stomas. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 83 T U E S D AY Ostomies: Location, Creation and Complications Tuesday, June 2 Abstract Session Parallel Session 7-C General Surgery Forum 1.5 CME 10:15 – 11:45 am Ballroom A (3rd Floor) Co-Moderators: Lisa Haubert, MD, Houston, TX and Brian Valerian, MD, Albany, NY 10:15 am Bariatric Surgery Modulates IBDAssociated Microbiome Patterns in a Murine Model GS1 A. Vinci*, S. Li, M.J. Stamos, A. Pigazzi, Orange, CA; S. Jellbauer, M. Raffatellu, Irvine, CA 10:48 am Adjuvant Chemoradiation in the Management of T2N0 Rectal Cancer: A Population Based Clinical Outcomes Study Involving 4,054 Patients from the Surveillance Epidemiology and End Result (SEER) Database (1973–2010) GS4 K. Mahendraraj*, V. Chakravorty, N. Ghalyaie, R.S. Chamberlain, West Orange, NJ 10:21 am Discussant Elizabeth He, MD, Maywood, IL 10:24 am Discussion 10:54 am Discussant Melissa Felinski, MD, Cincinnati, OH 10:26 am Combining Old with New: Bowel Rest and Biologic Therapy Aid in the Surgical and Medical Management of Penetrating Ileocolic Crohn’s Disease GS2 M.D. Wagner*, M. McNally, J. Duncan, Bethesda, MD, N. Jaqua, M. Ally, J. Betteridge, Bethesda, MD 10:57 am Discussion 10:59 am Does Cyanoacrylate Glue Reinforcement Reduce Anastomotic Failure? Results of an Experimental Comparative Study GS5 W. Gaertner, Minneapolis, MN; E. Nunez-Garcia, I. Baley-Spindel, J. MedinaLeon, R. Sordo-Mejia*, Mexico City, DF, Mexico 10:32 am Discussant Jessica Cohan, MD, San Francisco, CA 11:05 am Discussant Christine Choi, MD, Hershey, PA 10:35 am Discussion 10:37 am Laparoscopic Radical Resection after Transanal Endoscopic Microsurgery: Is it Feasible and Safe? M. Masse*, A. Bouchard, A. Laliberté, A. Lebrun, S. Drolet, Quebec, QC, Canada 11:08 am Discussion GS3 11:10 am Colonoscopy after Left-Sided Diverticulitis: Utility or Futility? GS6 A.S. Walker*, J. Bingham, K. Janssen, E.K. Johnson, S.R. Steele, Tacoma, WA; J.A. Maykel, Worcester, MA; O. Ocampo, West Fairview, Quezon City, Philippines; J.P. Gonzalez, Cebu, Philippines 10:43 am Discussant Ira Leeds, MD, Baltimore, MD 10:46 am Discussion 11:16 am Discussant Grace Hwang, MD, Orange, CA 11:19 am Discussion *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 84 Continued next page *Presenting Author General Surgery Forum (Continued) 11:21 am Robotic versus Open Total Mesorectal Excision: A Comparison of Clinical and Pathologic Outcomes J.L. Agnew* F.M. Chory, P.D. Strombom, G. Bonomo, New York, NY; K.A. Melstrom, W.E. Enker, J.E. Martz, New York, NY 11:32 am Relative Benefits and Risks of Alternative Modes of Bowel Preparation to Prevent SSI following Elective Colorectal Resection GS8 N. Esnaola, Philadelphia, PA; S. Koller*, R. Smith, S. Jayarajan, M. Philp, H.M. Ross, H. Pitt, Philadelphia, PA GS7 11:27 am Discussant Benjamin Crawshaw, MD, Cleveland, OH 11:38 am Discussant Mark Hanna, MD, Orange, CA 11:30 am Discussion 11:41 am Discussion 11:45 am Adjourn Objectives: At the conclusion of this session, participants should be able to: (GS1) Identify intestinal bacterial flora and molecular patterns in Inflammatory bowel disease; the complex interplay between the proinflammatory state of obesity and IBD; recognize that IBD-associated microbiome patterns may be a possible beneficial target of bariatric surgery, and this therapeutic approach may modulate the mechanisms of specific commensal-host interactions and immune responses; (GS2) Recognize the sub population of Crohn's patients with penetrating phenotype; develop a plan of management for Crohn's patients presenting with fistula and/or abscess that potentially minimizes surgical risk and improves outcome; (GS3) Recognize the necessity for radical resection in some patient after TEM; determine the feasibility of laparoscopic TME after TEM; (GS4) Determine whether patients with T2N0 rectal cancer (stage IB) derive similar survival benefit from adjuvant therapy as T3/T4 or N1 disease; determine additional factors influencing survival in T2N0 rectal cancer (stage IB); (GS5) Analyze the experimental use of N-butyl-2-cyanoacrylate glue for anastomotic reinforcement; analyze the impact of N-butyl-2-cyanoacrylate glue on peritoneal healing, specifically adhesion formation; (GS6) Identify those patients that require a colonoscopy after an acute episode of diverticulitis; advocate counseling to patients on the follow-up plan after an episode of diverticulitis; build to the literature regarding post diverticulitis colonoscopy; (GS7) Analyze the surgical and pathologic outcomes of robotic and open total mesorectal excisions performed for rectal adenocarcinoma; compare differences in short-term clinical outcomes after open and robotic total mesorectal excisions; and (GS8) Recognize the ways in which different types of bowel preparations are associated with surgical site infections following elective colorectal resections. 85 T U E S D AY Tuesday, June 2 Tuesday, June 2 Masters in Colorectal Surgery Lectureship Honoring David J. Schoetz, Jr., MD 11:45 am – 12:15 pm Auditorium (2nd Floor) The Value of Mentorship .5 CME Patricia L. Roberts, MD Chair, Division of Surgery, Lahey Hospital and Medical Center, Burlington, MA Professor of Surgery, Tufts University School of Medicine, Boston, MA Introduction: Thomas Read, MD Complimentary Box Lunch in the Exhibit Hall & ePoster Presentations (See pages 112-113 for schedule.) 12:15 – 1:30 pm Women in Colorectal Surgery Luncheon 12:15 – 1:30 pm Complimentary • Registration Required Rooms 304 – 306 The Women’s Luncheon offers an opportunity to renew friendships and make new contacts. Female surgeons, residents and medical students attending the Annual Meeting are welcome. Trainees are particularly encouraged to attend as the Women’s Luncheon provides an opportunity to meet experienced colon and rectal surgeons from a variety of settings. Supported by Ethicon 86 Tuesday, June 2 Symposium Parallel Session 8-A 1 2 5 6 * 1.5 CME 1:30 – 3:00 pm Auditorium (2nd Floor) Anal cancer, unlike colorectal cancer, has been increasing in prevalence over the last 20 years. While the treatment of anal cancer has largely remained unchanged, the definitions of what constitutes an anal cancer have changed. Further, the terminology for the anal cancer precursor lesion, high-grade squamous intraepithelial lesion (HSIL) has been standardized. Finally, studies have shown that untreated precursor lesions may progress to anal cancer substantiating the proposal that treatment of precursor lesions may decrease anal cancer rates. This session will review the current understanding of prevention, diagnosis and treatment of premalignant and malignant lesions of the anus and perianus. Existing Gaps What Is: There is confusion about how to define lesions in the perianus as anal or perianal; along with confusion about efficacy and the need for treatment of premalignant lesions of the perianus. There is mixed usage of old terminology for anal and perianal lesions. What Should Be: There will be a common understanding of what constitutes anal and perianal. There will be a common of standard terminology that applies to the lower anogenital tract and has been promulgated by the American College of Pathology. Director: Mark Welton, MD, Stanford, CA Assistant Director: Janice Rafferty, MD, Cincinnati, OH 1:30 pm Introductions Mark Welton, MD, Stanford, CA Janice Rafferty, MD, Cincinnati, OH 1:35 pm Anatomic and Histologic Definitions John Migaly, MD, Durham, NC 1:50 pm Who Should be Screened for Anal Cancer? Rocco Ricciardi, MD, Burlington, MA 2:05 pm How to Do the Screening and Who Should Do It? Bruce Robb, MD, Indianapolis, IN 2:20 pm How Do We Manage Pre-Cancerous Lesions? Natalie Kirilcuk, MD, Stanford, CA 2:35 pm What Is the Treatment and Expected Outcomes of Patients with Anal Cancer Both Immuncompetent and Immunocompromised? Larissa Temple, MD, New York, NY 2:50 pm Panel Discussion 3:00 pm Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Explain the current terminology surrounding histologic findings of squamous lesions of the anus and perianus; b) Explain the current terminology used to define lesions of the anus and perianus as either anal or perianal; and c) Describe the current treatment recommendations for anal and perianal cancer. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 87 T U E S D AY Anal Cancer: Prevention, Diagnosis and Treatment Tuesday, June 2 Abstract Session Parallel Session 8-B Inflammatory Bowel Disease 1 2 * 1.5 CME 1:30 – 3:00 pm Ballroom BC (3rd Floor) Co-Moderators: Imran Hassan, MD, Cedar Rapids, IA and Feza Remzi, MD, Cleveland, OH 1:30 pm IBD: A Growing and Vulnerable Cohort of Hospitalized Patients with Clostridium Difficile Infection S27 A. Mabardy*, J. Coury, L. Ozcan, J. McCarty, A. Merchant, C. Armstrong, A. Hackford, H. Dao, Boston, MA 1:37 pm Discussion 1:40 pm Clostridium Difficile Infection in Ulcerative Colitis: Can Alteration of the Gut-Associated Microbiome Contribute to Pouch Failure? S28 K. Skowron*, M. Rubin, R.D. Hurst, N. Hyman, K. Umanskiy, Chicago, IL; B. Lapin, Evanston, IL 1:47 pm Discussion 1:50 pm Does Stool Leakage Increase in Aging Ileal Pouches? H. Kim*, L. Sun, B. Gurland, T.L. Hull, M. Zutshi, Cleveland, OH Discussion 2:00 pm Proctocolectomy: Impact on Relationship Quality in Ulcerative Colitis Patients and their Partners S30 J.N. Cohan*, J. Rhee, E. Finlayson, M.G. Varma, San Francisco, CA Discussion 2:10 pm Rates of Colectomy for Ulcerative Colitis in the Era of Biologic Therapy C. Kin*, M.L. Welton, C. Woo, Stanford, CA; A.L. Lightner, Los Angeles, CA Discussion 2:20 pm ESCP Best Paper The Healing Effect of Mesenchymal Adipose-Tissue-Derived Stem Cells on Colonic Anastomosis Under Ischaemic Condition S32 Tony W.C. Mak*, Don W.C. Chin, Janet F.Y. Lee, Paul B.S. Lai, Anthony W.I. Lo, Ping Kuen Lam, Simon S.M. Ng, Shatin, Hong Kong 2:27 pm Discussion 2:30 pm Kono-S Anastomosis Devised for Aurgical Prophylaxis of Anastomotic Recurrence in Crohn’s Disease: A Multicenter Study in Japan and the United States S33 T. Kono*, Sapporo, Japan; A. Fichera, M. Krane, Seattle, WA; K. Maeda, Nagoya, Japan;Y. Sakai, Kyoto, Japan; H. Ohge, Hiroshima, Japan; M. Shimada, Tokushima, Japan; D. Rubin, Chicago, IL; A. Maemoto, Sapporo, Japan; F. Michelassi, New York, NY 2:37 pm Discussion 2:40 pm Ileostomy Closure Site Fascial Reinforcement with Cross Linked Acellular Porcine Dermis Biologic Mesh Yields No Incisional Hernias at 1 Year of Follow-Up M. Brozovich*, Wexford, PA S29 1:57 pm 2:07 pm 2:17 pm S31 2:47 pm Discussion 2:50 pm Q&A 3:00 pm Adjourn S34 Objectives: At the conclusion of this session, participants should be able to: (S27) Describe recent trends in the prevalence of inflammatory bowel disease in hospitalized patients with Clostridium difficile infection; compare the mortality and colectomy rates associated with inflammatory bowel disease for hospitalized patients with Clostridium difficile infection; (S28) Analyze the association of C. difficile colitis with pouch failure; assess the risk of pouch reconstruction after Clostridium difficile colitis in the native colon; (S29) Analyze the occurrence of severe fecal incontinence in IPAA patients in long-term; describe the risk factors for fecal incontinence after IPAA in long-term; (S30) Discuss changes in ulcerative colitis patients' personal relationships after proctocolectomy; consider the role of gender in relationship quality before and after proctocolectomy in patients with ulcerative colitis; (S31) Recognize the likelihood of a surgical hospitalization for ulcerative colitis since the approval of infliximab; discuss the factors that increase the odds of an operation for ulcerative colitis; (S32) Describe the use of adipose-derived stem cells effectiveness; (S33) Describe a novel anastomotic technique for surgical prophylaxis of anastomotic recurrence in Crohn’s disease; develop a surgical plan of management for Crohn’s disease; (S34) Demonstrate how to improve outcomes; explain how to reduce hernia rate and reoperation. *Presenting Author 88 Tuesday, June 2 Parallel Session 8-C Research Forum 1.5 CME 1:30 – 3:00 pm Ballroom A (3rd Floor) Co-Moderators: Emily Finlayson, MD, San Francisco, CA and David Stewart, Sr., MD, Hershey, PA 1:30 pm Lymph Node Stromal Cell Microvesicles Mediate Colon Cancer Metastasis RF1 D. Margolin, P.E. Miller, H. Green-Matrana, E. Flemington, X. Zhang, L. Li*, New Orleans, LA 2:09 pm Discussant Melissa Times, MD, Detroit, MI 2:12 pm Discussion 2:14 pm Mesenchymal Stem Cells following Local Electrical Stimulation Improves Function in a Rat Anal Sphincter Injury Model at a Time Remote from Injury RF5 L. Sun*, Z. Xie, M. Zutshi, M. Damaser, Cleveland, OH 1:36 pm Discussant Evan Messaris, MD, Hershey, PA 1:39 pm Discussion 1:41 pm Diverticulitis and Crohn’s Disease Have Distinct But Overlapping Tumor Necrosis Superfamily 15 (TNFSF15) Haplotypes RF2 T.M. Connelly*, Dublin, Ireland; C.S. Choi, A. Berg, J. Coble, W. Koltun, Hershey, PA 2:20 pm Discussant Joseph Carmichael, MD, Orange, CA 2:33 pm Discussion 1:47 pm Discussant Mukta Krane, MD, Seattle, WA 2:25 pm 1:50 pm Discussion 1:52 pm Combination Therapy for Colorectal Cancer Metastasis using an Orthotopic Xenograft Model RF3 D. Margolin, B.A. Reuter, L. Li*, X. Zhang, New Orleans, LA Antitumor Activity of Dietary Phytochemicals in Colorectal Cancer RF6 B. Megna*, C. Diaz-Diaz, P. Carney, M. Nukaya, G.D. Kennedy, Madison, WI 2:31 pm Discussant Jason Hall, MD, Burlington, MA 2:34 pm Discussion 2:36 pm Mesna and Hydroxypropyl Methylcellulose Assists in Delayed Submucosal dDssection in a Rabbit Cecal Model RF7 G. Subhas*, M. Patel, J.S. Bhullar, V. Mittal, Southfield, MI 2:42 pm Discussant Konstantin Umanskiy, MD, Chicago, IL 2:45 pm Discussion 1:58 pm Discussant Fergal Fleming, MD, Rochester, NY 2:01 pm Discussion 2:03 pm Depletion of let-7 microRNAs in the Intestinal Epithelium Promotes Upregulation of Oncofetal mRNAs and Intestinal Carcinogenesis RF4 A.N. Jeganathan*, R. Mizuno, A.K. Rustgi, Philadelphia, PA; B.B. Madison, St. Louis, MO Continued next page *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 89 *Presenting Author T U E S D AY Abstract Session Tuesday, June 2 Research Forum (Continued) 2:47 pm Genetic Heterogeneity in Rectal Cancer – Identification of Subpopulations of Tumor Cells Resistant to Neoadjuvant CRT RF8 R. Perez*, F. Bettoni, A. Camargo, E. Donnard, B. Correia, F. Koyama, P. Galante, A. Habr-Gama, J. Gama-Rodrigues, Sao Paulo, Brazil 2:53 pm Discussant Anne Lin, MD, Los Angeles, CA 2:56 pm Discussion 3:00 pm Adjourn Objectives: At the conclusion of this session, participants should be able to: (RF1) Describe the role microvesicles play in cell to cell communication; explain the role lymph node stroma plays in colorectal cancer; (RF2) Gain an understanding of the concept of a genetic haplotype using a well-established Crohn's disease haplotype; review the data suggesting a role for a genetic predisposition in diverticulitis, including the TNFSF15 gene; (RF3) Analyze the ability of AMD3100 to inhibit CRC metastasis to the liver in a mouse model; differentiate primary tumor burden from metastatic tumor burden, and appreciate the biochemical basis for this differentiation; (RF4) Demonstrate the effects of let-7 miRNA downregulation in the intestinal epithelium as pertaining to carcinogenesis; identify Hmga2, an oncofetal mRNA, as an enhancer of stem cell phenotype and a marker of invasive adenocarcinoma; (RF5) Describe the therapeutic implications of using low grade electrical stimulation at a time remote from injury as a stimulus for mesenchymal stem cell directed sphincter muscle regeneration; evaluate a rat model of chronic anal sphincter injury and minimal-invasive therapy for muscle regeneration; (RF5) Explain the antitumor effects of cruciferous vegetable metabolites against human colorectal cancer cells in vitro, and the potential role for the aryl hydrocarbon receptor in their mechanism; evaluate a rat model of chronic anal sphincter injury and minimal-invasive therapy for muscle regeneration; (RF6) Explain the antitumor effects of cruciferous vegetable metabolites against human colorectal cancer cells in vitro, and the potential role for the aryl hydrocarbon receptor in their mechanism; describe the clinical chemopreventive potential that dietary phytochemicals could have in the setting of colon and rectal cancer; (RF7) Explain the option of endoscopic submucosal dissection for large polyps which are not amenable for simple snare polypectomy; describe chemicals such as Mesna and Hydroxypropyl Methycellulose can be used to assist delayed submucosal dissection; and (RF8) Describe specific mutations may be associated with resistance or sensitivity to CRT in rectal cancer; realize there may be a subpopulation of cancer cells that is enriched among tumours that are unresponsive to CRT. 90 Tuesday, June 2 Symposium Parallel Session 9-A 3 1.5 MOC 4 * 1.5 CME 3:00 – 4:30 pm Ballroom BC (3rd Floor) Although traditionally physicians have focused on professional liability related to medical care delivery, the world has become more complex and now legal exposure extends to many other interactions. Physicians must understand the importance to maintain a professional and constructive relationship with their patients, while accurately and contemporaneously documenting the facts of the encounter. An accurate and complete medical record is essential to confirm both the thought process at the time but also the immediately available facts. However, all surgeons will face complications and managing both the discussion around the occurrence and the management of the complication are important components for reducing the risk of litigation. There is a current trend at the institutional level to “apologize”; however, this process must be managed well to avoid confusing adverse outcome from actual error in the minds of the patient and his/her family. The complexity of the medical billing process is another area of increasing risk to the colorectal surgeon. Once again accurate documentation is essential to support a claim submission. The surgeon should also understand the process for correct code selection, use of tracking codes, and modifier use to support accurate reimbursement. Existing Gaps What Is: Communication is an important component which reduces the risk of having a medical malpractice claim filed against you. However, given the current climate even recognized treatment complications are a potential risk of such action. Currently, many colorectal surgeons are unfamiliar with the value of appropriate, timely, and accurate documentation of clinical encounters to reduce exposure should a malpractice claim be filed. The entire process from discovery through trial is something generally unfamiliar to many colorectal surgeons and these topics are rarely taught during training. In addition, most colorectal surgeons are unfamiliar with the various rules and regulations related to both documentation of clinical encounters and claims submissions. These gaps include knowledge of criteria for E/M code selection, modifier use, and implementation of correct coding initiative rules to allow accurate and complete claims submission. Similarly, the majority of colorectal surgeons have little knowledge or understanding of employment contract law and the interactions of these requirements with Stark provisions and other complex issues related to moving from private practice to corporate employment. Finally, direct contracting with large payors is a major challenge for colorectal surgeons. It is important to fully understand the complex language surrounding patient volumes, quality indicators and reporting, preauthorization rules, claims denials and claims adjudication. What Should Be: The colorectal surgeon should understand his/her role and the specific components of clinical documentation and claim submission for patient encounters. Equally so, the colorectal surgeon considering selling his/her practice or directly entering corporate employment after training should be able to discuss the key components of a contract for such employment. Colorectal surgeons should fully understand their rights and privileges under contractual relationships with insurers to assure full and complete reimbursement while limiting unnecessary administrative overhead. Objectives: At the conclusion of this session, participants should be able to: a) Formulate the role of timely and accurate clinical documentation in reducing exposure in a medical liability action against a colorectal surgeon; b) Explain the process of a medical liability action against a colorectal surgeon; c) Implement appropriate clinical documentation, code selection, and modifier use for accurate claim submission to insurance payors; d) Review the components of employment contracts and the rights and privileges expected by a colorectal surgeon transitioning from either private practice or residency training into full time corporate employment; and e) Define the components of contractual relationships with payors to assure full and prompt reimbursement while avoiding legal exposures (ie Stark regulations etc). *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 91 Continued next page T U E S D AY Medical Legal Symposium: How to Protect Yourself Tuesday, June 2 Medical Legal Symposium: How to Protect Yourself (Continued) Co-Director: Conor Delaney, MD, PhD, Cleveland, OH Co-Director: Kyle Cologne, MD, Los Angeles, CA Professional Liability Michael Stamos, MD, Orange, CA 4:00 pm Insurance Contracting Frank Opelka, MD, New Orleans, LA 3:20 pm Medical Documentation Billing Guy Orangio, MD, New Orleans, LA 4:20 pm Panel Discussion 4:30 pm Adjourn 3:40 pm Employment Contracting Martin Luchtefeld, MD, Grand Rapids, MI Photo Credit: Greater Boston Convention & Visitors Bureau 3:00 pm 92 Tuesday, June 2 Symposium Parallel Session 9-B 1 2 5 6 T U E S D AY Anal Fistulas: Diagnosis, Imaging and Therapy – Rational Approaches * 1.5 CME 3:00 – 4:30 pm Auditorium (2nd Floor) Anal fistula represents one of the most common and challenging anorectal diseases encountered by surgeons. The principles of successful treatment include appropriate diagnosis, destruction of the internal opening with preservation of sphincter function. Primary lay-open fistulotomy has a high success rate in treating fistulas; however, most surgeons are reluctant to perform this procedure in instances where substantial impairment of continence may result. As a result, several alternative treatments have been pursued which do not involve anal sphincter division. Rectal mucosal advancement flap, lateral intersphincteric fistula transaction (LIFT), and collagen plug have all been described as sphincter sparing fistula treatments with varying degrees of success. Understanding the indications, limitations, and success rates of the various treatment modalities would allow for more effective and efficient treatment of fistula in ano. Existing Gaps What Is: There are many treatment options for the treatment of anal fistulas. The goals of fistula resolution and sphincter preservation appear to be at odds given current treatments. Multiple options are available in the management of chronic anal fissures. What Should Be: Surgeons will understand the appropriate diagnosis indications, success rates, and complications of the treatments available for anal fistulas. Director: Charles Whitlow, MD, New Orleans, LA Assistant Director: Jennifer Beaty, MD, Omaha, NE 3:00 pm Fistulotomy – Does it Still Have a Place? M. Benjamin Hopkins, MD, Raleigh, NC 3:52 pm LIFT Sean Langenfeld, MD, Omaha, NE 3:13 pm Setons – How and When Jason Hall, MD, Burlington, MA 4:05 pm New Innnovations for Fistulas James McCormick, DO, Pittsburgh, PA 3:26 pm Advancement Flaps – 90% Success! Really? Donald Kim, MD, Grand Rapids, MI 4:18 pm Discussion 4:30 pm Adjourn 3:39 pm Fistula Plugs and Glue Michael Snyder, MD, Houston, TX Objectives: At the conclusion of this session, participants should be able to: a) Define the different treatment modalities available for anal fistula; and b) Develop an algorithm for the management of different types of anal fistula. Refreshment Break in Auditorium Foyer 4:30 – 5:00 pm *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 93 Tuesday, June 2 After Hours Debate 1 REFRESH MENTS W I L L B E S ERV ED * 2 1.25 CME 5:00 – 6:15 pm Auditorium (2nd Floor) All surgical specialties have certain topics/diseases that contain controversy. Understanding the optimal treatment plan for patients often depends on a physician’s ability to see clarity in these lines of gray. Debates are excellent tools to show differences in perspective and opinion regarding these topics. They effectively challenge and break down surgical dogma and open people to new points of view. They often help audience members crystalize their own values and beliefs. Speakers with passionate views about opposing treatment, with clear guidelines for the debate, can effectively create an effective and novel learning environment. Furthermore, an assertive and experienced moderator can challenge the speakers and engage the audience to both optimize critical thinking and illustrate what treatment plan may be best for different scenarios. Existing Gaps What Is: Treatment of chronic anal fissure has evolved to the point that surgery is studiously avoided in favor of different medical regimens. Rectal prolapse surgery in the form of transabdominal rectopexy has become a minimally invasive procedure – including increasing use of the robot. What Should Be: Treatment of anal fissures should be appropriately balanced between operative and non-operative approaches. Operations with the robot should be justifiable with respect to outcomes and cost. Moderator: David Schoetz, Jr., MD, Burlington, MA 5:00 pm Anal Fissure – Is It a Surgical Disease? Debating: Phillip Fleshner, MD, Los Angeles, CA vs Neil Hyman, MD, Chicago, IL 5:30 pm Rectal Prolapse in the Robotic Age Debating: Bradley Champagne, MD, Cleveland, OH vs Todd Francone, MD, Burlington, MA 6:15 pm Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Develop a sensible approach to the cure of chronic anal fissure; and b) Evaluate the appropriate operative techniques for performance of transabdominal rectopexy. Residents’ Reception 6:30 – 8:00 pm Back Bay Ballroom Salons CD Sheraton Boston Hotel General Surgery residents will have an opportunity to network and interact with colorectal program directors. Open to general surgery residents and colorectal program directors only. 94 Wednesday, June 3 Meet the Professor Breakfasts Code Subject/Faculty W-1 UT SOLD O Complex Fistula Ann Lowry, MD, St. Paul, MN Scott Strong, MD, Cleveland, OH W-2 Room 1.0 CME Code Subject/Faculty Room 200 W-5 Stage 4 Cancer (What to Do) Room 202 Eric Szilagy, MD, Detroit, MI Julio Garcia-Aguilar, MD, PhD, New York, NY Non-Operative Management of Room 207 Rectal Cancer – the Right Patient Robert Fry, MD, Philadelphia, PA Rodrigio Perez, MD, PhD, Sao Paulo, Brazil W-6 Parastomal Hernia and Stoma Complications W. Brian Perry, MD, San Antonio, TX Walter Peters, Jr., MD, Columbia, MO W-3 Pilonidal Disease: Options and Outcomes Richard Billingham, MD, Seattle, WA Eric Johnson, MD, Fort Lewis, WA Room 203 W-4 Enhanced Recovery Pathways Room 206 Craig Reickert MD, Detroit, MI Conor Delaney, MD, PhD, Cleveland, OH Objectives: At the conclusion of this session, participants should be able to: a) Describe the procedures and approaches discussed in this session. 95 Room Room 300 W E D N E S D AY 6:30 – 7:30 am Limit: 30 per breakfast • Fee $40 • Tickets Required • Continental Breakfast Registrants are encouraged to bring problems and questions to this informal discussion. Wednesday, June 3 Symposium Parallel Session 10-A Colon Cancer: Staging, Techniques and the Role of Adjuvant Therapy 1 2 5 6 * 1.5 CME 7:30 – 9:00 am Auditorium (2nd Floor) 1.5 MOC The past 50 years has seen substantial progress in our understanding and in the management of colon and rectal cancer (CRC). Surveillance colonoscopy with resection of premalignant polyps has led to a decreased incidence of CRC even though compliance with the recommendations is suboptimal. Epidemiologic and genetic information allow us to identify individuals at risk for cancer and should allow us to prevent the disease in many individuals. Patients diagnosed with advanced CRC live much longer than in the past, and many are cured. This is attributed to many factors, including cross-sectional imaging that properly stages patient and identifies metastases earlier, new surgical approaches and numerous new chemotherapies. Higher resolution imaging modalities have improved the ability to properly stage patients; surgical advances include minimally invasive procedures and laparoscopic-assisted procedures and safer and more extensive lymphatic clearance. Biologic therapies have not yet been maximized, but we are learning when and where some should be used. Soon we expect to be staging patients by biologic and genetic characteristics rather than by gross pathology-treating patients based on biologic features but preferably identifying people at risk and preventing CRC altogether. Existing Gaps What Is: Colon cancer surgery is performed by a large number of general and colorectal surgeons in the country. Even in the elective setting a large number of cases are performed through a laparotomy, with incomplete preoperative staging and limited lymphatic clearance. Furthermore the use of adjuvant chemotherapy varies extensively across specialties, practice types and patient populations. What Should Be: Surgeons should understand proper staging and surgical techniques, indications for adjuvant therapy and the need for a multidisciplinary evaluation and management of colon cancer patients. Director: Alessandro Fichera, MD, Seattle, WA Assistant Director: Martin Weiser, MD, New York, NY 7:30 am Introduction Martin Weiser, MD, New York, NY 7:35 am 7:50 am 8:05 am 8:20 am Preoperative Staging: What Does the Surgeon Need to Know? Lawrence Schwartz, MD, New York, NY Stage II Colon Cancer. Who Needs Adjuvant Chemo and Why? Blase Polite, MD, Chicago, IL 8:35 am Going Beyond MIS in Colon Cancer Surgery: Less is More Peter Marcello, MD, Burlington, MA Molecular Classification of Colorectal Cancer: Current Status David Shibata, MD, Tampa, FL 8:50 am Panel Discussion 9:00 am Adjourn Total Mesocolic Resection for Colon Cancer: Magic Bullet? Hermann Kessler, MD, PhD, Cleveland, OH Objectives: At the conclusion of this session, participants should be able to: a) Describe the use of imaging for preoperative staging; b) Identify when to recommend MIS in the management of colon cancer; c) Define basic theories of lymphatic clearance; and d) Recognize new criteria and prognostic factors as indication for adjuvant therapy. *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 96 Wednesday, June 3 Abstract Session Parallel Session 10-B Outcomes 1.5 CME 7:30 – 9:00 am Ballroom BC (3rd Floor) 7:30 am Frailty Predicts Death, Disability and Institutionalization in Patients Undergoing Elective Colectomy S35 D. Mukkai Krishnamurty*, Z. Torgersen, S.J. Langenfeld, A. Kallam, J. Johanning, R.A. Forse, Omaha, NE 7:37 am Discussion 7:39 am Decreased Narcotic Consumption with the Addition of IV-Acetaminophen in Colorectal Patients: A Prospective, Randomized, Double-Blinded, PlaceboControlled Study S36 C. Juergens , C. Ogg, W. Sergent, J. Ying, A.H. Aryaie*, S. Lalezari, T. Husted, C. Ratermann, Cincinnati, OH 7:59 am The Temporary Cessation of Clopidogrel and the Risk of Thrombotic or Bleeding Events in Patients Undergoing Colonoscopy S38 P.E. Miller*, M. Bailey, M. Thomas, S. Pawlak, D. Beck, T. Hicks, H. Vargas, C. Whitlow, D. Margolin, New Orleans, LA 8:06 am Discussion 8:09 am Extending the Mandate for ExtendedDuration Thromboprophylaxis: Risk Factors for Post-Discharge Venothromboembolism in Colorectal Resections S39 J.C. Iannuzzi*, C.T. Aquina, A.S. Rickles, B.J. Hensley, K. Noyes, J. Monson, F. Fleming, Rochester, NY 7:46 am Discussion 8:16 am Discussion 7:49 am Patients Prefer Propofol for Conscious Sedation at Colonoscopy When Compared to Midazolam and Fentanyl S37 C. Schroeder*, R. Tocco-Bradley, J. Obear, C. Kaoutzanis, R.K. Cleary, K. Welch, Ann Arbor, MI 8:19 am A Model of Cost Reduction and Standardization: Improved Cost Savings While Maintaining the Quality of Care S40 M. Guzman*, K. Umanskiy, Chicago, IL; M. Gitelis, J.G. Linn, M.B. Ujiki, J.P. Muldoon, Evanston, IL 8:26 am Discussion 7:56 am Discussion Continued next page *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 97 *Presenting Author W E D N E S D AY Co-Moderators: Sekhar Dharmarajan, MD, St. Louis, MO and Eric Szilagy, MD, Detroit, MI Wednesday, June 3 Outcomes (Continued) 8:29 am 8:36 am Failing to Prepare is Preparing to Fail: A Single Blinded Randomized Controlled Trial to Determine the Impact of a Preoperative Instructional Video on Resident's Ability to Perform Laparoscopic Colectomy S41 B. Crawshaw*, C.P. Delaney, W.C. Mustain, A.J. Russ, S. Shanmugan, B.J. Champagne, Cleveland, OH; S.R. Steele, Tacoma, WA; D. Lee, Albany, NY 8:39 am Surgical Specialization Increases Lymph Node Yield: Evidence From a National Database A.N. Jeganathan*, S. Shanmugan, J. Bleier, G.M. Hall, E.C. Paulson, Philadelphia, PA 8:46 am Discussion 8:56 am Q&A 9:00 am Adjourn Discussion Objectives: At the conclusion of this session, participants should be able to: (S35) Recognize the effect of frailty on outcomes after elective colectomy; advocate assessment of frailty as a part of pre-operative evaluation of patients undergoing elective colectomy procedures; (S36) Evaluate effect of IV acetaminophen on decreasing post-operative opioid consumption in patients undergoing colo-rectal surgeries; evaluate return of GI function, length of hospital stay and occurrence of ileus when IV acetaminophen is used in patients undergoing colorectal surgeries; (S37) Analyze the difference in patient satisfaction in receiving Propofol in comparison to Midazolam and Fentanyl; analyze the difference in recovery time in patients receiving Propofol in comparison to Midazolam and Fentanyl; (S38) Analyze the risk of thrombotic event when Clopidogrel is temporarily stopped prior to colonoscopy; analyze the post-polypectomy bleeding risk when plavix is restarted during the postprocedure period; determine if the risk of stopping plavix is greater than the benefit provided by minimal reduction in bleeding events; (S39) Determine risk factors for post-discharge venothromboembolism following colorectal resections; analyze whether ulcerative colitis is a high risk group that should be considered for postdischarge thromboprophylaxis; (S40) Describe the causes of cost variability in performing laparoscopic appendectomy; explain the framework for improving operative cost savings; (S41) Determine the challenges of general surgery training in the setting of limited work hours; explain the benefits of brief additional preparatory material including an instructional video prior to surgery on the performance and training of general surgery residents and; (S42) Define the role of fellowship training in lymph node recovery following surgery for colorectal cancer; identify hospital-related factors conferring significant increases in nodal identification. 98 S42 Wednesday, June 3 ASCRS/SSAT Symposium Parallel Session 11-A Challenges and Controversies: Surgical Management of Advanced Disease and Recurrent Cancer 2 5 6 * 1.5 CME 9:00 – 10:30 am Auditorium (2nd Floor) The surgical and medical treatment of early stage colon and rectal cancer is fairly straightforward and a number of guidelines exist (NCCN, American Cancer Society, ASCRS) to help clinicians manage their patients with cancer. However, there are many complex situations that are difficult to manage and strategies for dealing with locally advanced disease, various patterns of distant metastatic disease and recurrent disease are not covered in guidelines. In addition, advances in chemotherapy mean that patients with advanced disease are surviving for longer periods of time and during these extended survival periods, surgeons are not infrequently asked to intervene in ways that in the past may have not been considered even remotely reasonable. In this setting, clinicians face issues that require discussion and direction. The aim of this session will be to offer evidence-based guidance to clinicians faced with difficult issues centered on treating advanced and recurrent colon and rectal cancer. Existing Gaps What Is: There are many complex situations that are difficult to manage, and strategies for dealing with locally advanced disease, various patterns of distant metastatic disease and recurrent disease are not covered in guidelines. That, with advances in chemotherapy allowing patients to live longer, means surgeons are asked to intervene in ways that in the past may have not been reasonable. What Should Be: Surgeons should be able to use evidence-based guidance when faced with difficult issues centered on treating advanced and recurrent colon and rectal cancer. Director: Kirk Ludwig, MD, Milwaukee, WI Assistant Director: Julio Garcia-Aguilar, MD, PhD, New York, NY 9:00 am New Chemotherapy Paradigms for Stage 4 Disease: Can the Surgeon Help by Reducing Tumor Burden and Does this Make Sense? Cathy Eng, MD, Houston, TX 9:36 am Contemporary Management of Carcinomatosis from Colon or Rectal Cancer: What Is Reasonable and Possible? Kiran Turaga, MD, Milwaukee, WI 9:12 am Epithelial-Mesenchymal Transition and Somatic Alteration in Colorectal Cancer with and without Peritoneal Carcinomatosis Yury Shelygin, MD, Moscow, Russia 9:48 am Chasing Advanced Lymph Node Disease: When and Why? Alessandro Fichera, MD, Seattle, WA 9:24 am Managing Liver Metastases: Staged Resection, Combined Resection, or Liver First? Michael D'Angelica, MD, New York, NY 10:00 am Case Discussion and Questions 10:30 am Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Explain new chemotherapeutic regimens for treating Stage 4 colorectal cancer and the role of the surgeon in treating Stage 4 disease; b) Describe contemporary management of carcinomatosis from colorectal cancer; and c) Explain when and why it might be reasonable to do extended dissections and lymph node dissections for colorectal cancer. Refreshment Break in Foyer 10:30 – 11:00 am 99 W E D N E S D AY 1 Wednesday, June 3 Abstract Session Parallel Session 11-B Video Session 1.5 CME 9:00 – 10:30 am Ballroom BC (3rd Floor) Co-Moderators: Konstantin Umanskiy, MD, Chicago, IL and Brian Valerian, MD, Albany, NY 9:00 am Martius Flap For BEST VIDEO Rectovaginal Fistulas WV1 K. Kniery*, E.K. Johnson, S. Steele, Tacoma, WA 9:07 am Discussion 9:10 am Robotic-Assisted Repair of Rectal Prolapse WV2 J. Mino*, M. Zutshi, B. Gurland, Cleveland, OH 9:17 am Discussion 9:20 am Transperineal Minimally Invasive Approach in Miles Operation WV3 S. Hasegawa*, R. Takahashi, K. Hida, K. Kawada, Y. Sakai, Kyoto, Japan; S. Kato, Y. Kadokawa, Y. Asao, Tenri, Japan 9:27 am Discussion 9:30 am Laparoscopic Repair of Perineal Hernia S. Brathwaite*, S. Husain, A. Harzman, Columbus, OH 9:37 am Discussion 9:40 am Full Thickness Excision for Benign Colon Polyps Using Combined Endoscopic Laparoscopic Surgery WV5 P.R. O'Mahoney*, J.W. Milsom, J.D. Smith, S.W. Lee, New York, NY 9:47 am Discussion 9:50 am Robotic-Assisted Low Anterior Resection with Transanal Extraction: Single Stapling Technique and Fluorescence Evaluation of Bowel Perfusion M.D. Jafari*, J.C. Carmichael, A. Pigazzi, Orange, CA WV4 9:57 am Discussion 10:00 am Transanal Minimally Invasive Surgery with Inadvertent Rectal Injury and Repair M. Harfouche*, M. Philp, H.M. Ross, Philadelphia, PA WV7 10:07 am Discussion 10:10 am Laparoscopic Low Anterior Resection, Transanal Total Mesorectal Endoscopic Resection for Low Rectal Cancer WV8 M.H. Hanna*, G. Hwang, L. Malellari, A. Pigazzi, Orange, CA 10:17 am Discussion 10:20 am Wide Local Excision of Perianal Paget’s Disease with Gluteal Flap Reconstruction WV9 G. Melich*, K. Kochar, J. Calata, A. Pai, J. Park, L. Prasad, S. Marecik, Park Ridge, IL 10:27 am Discussion 10:30 am Adjourn WV6 Continued next page *Presenting Author 100 Wednesday, June 3 Objectives: At the conclusion of this session, participants should be able to: (WV1) Describe the preoperative considerations that must be accounted for to allow the bulbocavernosus flap the greatest chance of success at resolving a rectovaginal fistula; explain the key operative techniques to successfully repair a rectovaginal fistula with a Martius flap; (WV2) Demonstrate the technique of abdominal ventral rectopexy; demonstrate the benefits of robotic assistance in abdominal ventral rectopexy; (WV3) Clarify better visualization of surgical anatomy around anal canal; describe how to perform minimally invasive transperineal approach for Miles operation; (WV4) Identify patients at high risk for post-operative perineal hernia; identify the operative steps necessary to perform laparoscopic repair of perineal hernia with mesh placement; (WV5) Explain the minimally invasive treatment options available to avoid colectomy in challenging benign colon polyps; describe the technical steps involved in full thickness excision of benign colon polyps using combined endoscopic laparoscopic surgery; (WV6) Demonstrate the anatomy and technical steps of a low anterior resection using not only a robotic assisted laparoscopic technique, but also to demonstrate single stapling technique with transanal extraction; practice the use of endoscopy in conjunction with fluorescence imaging to assess tissue viability; demonstrate the change in resection margin secondary to the use of fluorescence imaging despite good perfusion under white/visible light; (WV7) Identify a patient population and disease process that is amenable to Transanal Minimally Invasive Surgery (TAMIS); recognize the unique challenges of performing TAMIS; recall how to avoid rectal injury during TAMIS, and how to manage it if it occurs; (WV8) Explain the method of resection of low rectal cancer with a combination of a laparoscopic and transanal endoscopic technique allowing for sphincter preservation and complete mesorectal excision; demonstrate transanal specimen extraction allowing specimen retrieval without the need for an abdominal incision; and (WV9) Describe necessary preoperative workup of perianal Paget’s disease; discuss technical issues involved in wide local excision and anal reconstruction for perianal Paget’s disease. Refreshment Break in Foyer 10:30 – 11:00 am 101 W E D N E S D AY Video Session (Continued) Wednesday, June 3 Symposium Parallel Session 12-A Optimizing Treatment for Rectal Prolapse, Constipation and Obstructed Defecation Syndrome 1 2 5 6 * 1.5 CME 11:00 am – 12:30 pm Auditorium (2nd Floor) 1.5 MOC The management of rectal prolaspe has been the debate for 100 years since Moschowitz first described its pathogenesis. Since that time, over 100 operations have been described for the correction of prolapse of the rectum. The operative approaches can be roughly divided into abdominal and perineal categories. The evaluation process and decision making with respect to the choice of surgical procedure and specific techniques will be reviewed. The surgical management of constipation requires a thorough understanding of both colonic function and the evacuatory mechanism. The evaluation of patients with these disorders and their surgical treatment options will be presented. Existing Gaps What Is: Many surgeons are unfamiliar with all of the new approaches to repair rectal prolapse. They do not have experience with different fixation and minimally invasive techniques available. Surgeons frequently are not familiar with the physiologic testing available for the evaluation of constipation and their significance and impact on surgical decision making. What Should Be: Surgeons should be comfortable with several fixation techniques to repair prolapse. They should have an understanding of the different repairs available and their utility in treating different patient populations. Surgeons should be familiar with the physiologic evaluation tools available for constipated patients and have a strategy for surgical management. Director: Dana Sands, MD, Weston, FL Assistant Director: Virginia Shaffer, MD, Atlanta, GA 11:00 am Functional Disorders: What Tests are Necessary? Heidi Bahna, MD, Miami, FL 11:45 am Constipation: Surgical Indications and Outcomes Massarat Zutshi, MD, Cleveland, OH 11:15 am Rectal Prolapse Abdominal Repairs: Fixation and Resection Techniques Brooke Gurland, MD, Cleveland, OH Noon 11:30 am Rectal Prolapse Perineal Repairs: Still Relevant in the Era of Laparoscopy? Joseph Carmichael, MD, Orange, CA 12:15 pm Discussion Obstructed Defecation: Is it Surgically Correctable? Liliana Bordeianou, MD, Boston, MA 12:30 pm Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Describe the abdominal approaches and different fixation techniques available for treatment of rectal prolapse; b) Explain the perineal approaches and different resection techniques for the treatment of rectal prolapse; c) Describe the value of laparoscopy in the management of prolapse; d) Identify the tools available to evaluate constipation and evacuatory dysfunction; and e) Plan a treatment algorithm for the management of constipation in different clinical settings. Lunch on your own 12:30 – 1:30 pm *This session addresses MOC requirements as explained on page 11. See pages 149-153 for disclosures. 102 Wednesday, June 3 Abstract Session Parallel Session 12-B Neoplasia II 1.5 CME 11:00 am – 12:30 pm Ballroom BC (3rd Floor) 11:00 am Colorectal Specialization Improves Survival in Colorectal Cancer S44 G.M. Hall*, J. Bleier, A.N. Jeganathan, S. Shanmugan, E.C. Paulson, Philadelphia, PA 11:07 am Discussion 11:11 am Enhanced Recovery Protocols in Colorectal Scheduled Surgery: Could We Do Better By Doing Less? J. Ramirez*, E. Redondo, P. Royo, J. Gracia, B. Calvo, P. Carrera, Zaragoza, Spain 11:51 am Relative Value of Restaging MRI, CT and PET after Preoperative Chemoradiation for Rectal Cancer S49 D. Schneider*, A.C. Lynch, S. Warrier, A.G. Heriot, T. Akhurst, M. Michael, S. Ngan, East Melbourne, VIC, Australia 11:58 am Discussion S45 11:18 am Discussion 11:21 am Does CD10 Expression Predict Lymph Node Metastasis in Colorectal Cancer? S46 I. Bernescu*, A. Reichstein, M. Luchtefeld, J. Ogilvie, A. Davis, W. Chopp, Grand Rapids, MI 11:28 am Discussion 11:31 am Robotic Colorectal Surgery: How Honest are the Authors’ Conclusions? An Assessment of Reporting and Interpretation of the Primary Outcomes S47 B. Howe, J. Van Koughnett, London, ON, Canada; S.V. Patel, New York, NY; S. Wexner, Weston, FL 11:38 am Discussion 11:41 am Features Associated with Metastases Among Well-Differentiated Neuroendocrine (Carcinoid) Tumors of the Appendix: The Significance of Small Vessel Invasion in Addition to Size S48 D.A. Kleiman*, B.M. Finnerty, T. Beninato, R. Zarnegar, G. Nandakumar, T.J. Fahey, III, S.W. Lee, New York, NY 12:01 pm Predictors of Outcome for Endoscopic Colorectal Stenting S50 M.A. Abbas*, G. Kharabadze, Abu Dhabi, United Arab Emirates 12:08 pm Discussion 12:11 pm British Traveling Fellow Outcome of Robotic versus Laparoscopic Abdominoperial Resection and Evaluation of Early Experience of Robotic Colorectal Surgery S51 R. Mathew*, S.C. Chaudhri, Leicester, UK, S.H. Kim, Seoul, South Korea 12:17 pm Discussion 12:20 pm Surgical Site Infection Rates following Implementation of a Colorectal Closure Bundle in Elective Colorectal Surgeries A. Ghuman*, C.J. Brown, A.A. Karimuddin, M.J. Raval, T.P. Phang, Vancouver, Canada S52 12:27 pm Discussion 12:30 pm Adjourn 11:48 am Discussion Continued next page *Presenting Author 103 W E D N E S D AY Co-Moderators: Badma Bashankaev, MD, Moscow, Russia and Eric Weiss, MD, Weston, FL Wednesday, June 3 Neoplasia II (Continued) Objectives: At the conclusion of this session, participants should be able to: (S44) Advocate the difference in colorectal cancer survival between colorectal specialists and general surgeons; explain factors of colorectal specialization that contribute to improved outcomes in colorectal cancer; (S45) Analyze the components of an ERAS protocol in order to know the weight each one has in the success of it; arrange to help surgeons to employ current best practice to enhance the recovery of patients undergoing major colorectal surgery; (S46) Explain the benefit of identifying biomarkers able to better predict lymph node metastasis in colorectal cancer; analyze the controversial status of CD10 as one of the biomarkers that could correlate with presence or absence of lymph node metastasis in colorectal cancers; (S47) Recognize common methods of misinterpretation in studies with equivocal results; recognize how frequent misinterpretation occurs in robotic surgery studies; (S48) Describe the natural history and typical presentation of well-differentiated neuroendocrine tumors of the appendix; identify histopathologic risk factors for metastatic disease which may aid in the selection of patients for additional surgical resection to clear regional lymph nodes; (S49) Compare the impact of different imaging modalities on restaging rectal cancers post neoadjuvant therapy; evaluate the effect of PET restaging on management and stage changes after neoadjuvant therapy for rectal cancer; (S50) Determine short and longterm outcome of endoscopic colorectal stenting; list the factors that impact outcome; differentiate between technical and clinic success and; (S52) Recognize critical appraisal of colorectal care bundles; identify risk factors associated with higher SSI rates in colorectal surgery. Lunch on your own 12:30 – 1:30 pm 104 Wednesday, June 3 Symposium Enhanced Perioperative Care Pathways and Postoperative Pain Management 2 5 6 * 1.5 CME 1:30 – 3:00 pm Auditorium (2nd Floor) Supported by independent educational grants from: Edwards Lifesciences Ethicon Mallinckrodt Pharmaceuticals Merck & Co., Inc. Enhanced recovery perioperative care principles are widely reported to decrease complications and to improve outcomes such as length of stay and cost. Many protocol examples are reported, and significant protocol differences exist. Unless involved in creating a protocol before now, one will find the current literature and recommendations intimidating, and in some aspects, conflicting. The impact reputedly reported and the importance of implementation of evidence based practices, however, require that we critically consider these principles in our practices. In this symposium, the basic and controversial elements defined in the enhanced recovery literature, including postoperative pain management, will be discussed. Systematic implementation strategies will be shared, and case examples will be used to critically discuss care elements. Existing Gaps What Is: The literature of enhanced recovery abounds with varied examples rather than practice parameters or practical guides. What Should Be: A systematic guide to implementing enhanced recovery would allow broad adoption of essential evidence based best care elements and would improve outcomes, decrease variability, and lower costs of colorectal surgery. Director: Julie Thacker, MD, Durham, NC Assistant Director: David Beck, MD, New Orleans, LA 1:30 pm Essential Elements Robin Anderson, BSN, RN, Durham, NC 2:15 pm Critical Review of Published Protocols Elizabeth Wick, MD, Baltimore, MD 1:45 pm Head of the Table – The Role of the Anesthesiologist in Achieving Success Robert Thiele, MD, Charlottesville, VA 2:30 pm Details and Outcomes Conor Delaney, MD, PhD, Cleveland, OH 2:45 pm Debate and Discussion 2:00 pm Multimodality Postoperative Pain Management Eric Haas, MD, Houston, TX 3:00 pm Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Explain the current evidence of enhanced recovery principles; b) Define for their practices, the elements most essential to implement; c) Define for their health care systems the best implementation strategy; d) Describe available methods to manage postoperative pain; and e) Recognize the outcomes they are most likely to impact with enhanced recovery implementation and how to monitor these outcomes. 105 W E D N E S D AY 1 Wednesday, June 3 Symposium Is there a Paradigm Shift in the Management of Diverticular Disease? 1 2 5 6 * 1.5 CME 3:00 – 4:30 pm Auditorium (2nd Floor) The management of diverticular disease has significantly changed in the past 10 years. More patients are managed with antibiotics and drainage for acute complicated diverticulitis, and avoiding emergent trips to the operating room. Even among those who are taken to the operating room, the traditional resection with Hartmann’s closure of the rectum is being replaced by washout and drain placement, or even resection with primary anastomosis. Even the use of antibiotics in uncomplicated disease is changing, with data showing no benefit of the treatment to the disease process. Those who are conservatively managed, undergo washout, or have recurrences will then present for consideration of elective resection. This has created a shift in the outpatient management as more patients present after hospitalization for complex disease. Deciding who will benefit from surgery has become more complex over time. Existing Gaps What Is: Who needs an operation, who can be medically managed, and what are the risks of each approach? What Should Be: A clearer approach to both emergent and elective disease management. Director: Timothy Geiger, MD, Nashville, TN Assistant Director: Mukta Krane, MD, Seattle, WA 3:00 pm Learning from History – The Evolution of the Management of Diverticulitis Patricia Roberts, MD, Burlington, MA 3:15 pm Epidemiology and Etiology of Diverticular Disease – More than Nuts and Seeds Cary Aarons, MD, Philadelphia, PA 3:30 pm Emergent Management of Acute Diverticulitis Scott Strong, MD, Cleveland, OH 3:45 pm Elective Management of Diverticular Disease – Who Needs Surgery? David Flum, MD, Seattle, WA 4:00 pm Right-Sided Disease, Postoperative Recurrences, Diverticular Disease in Younger Patients and Other Unusual Presentations James Yoo, MD, Boston, MA 4:15 pm Discussion 4:30 pm Adjourn Objectives: At the conclusion of this session, participants should be able to: a) Recognize the current literature on the etiology of diverticulosis and risks of recurrent disease; b) Distinguish the management of acute diverticulitis both in the hospitalized patient and in the outpatient settings; c) Recognize the current surgical approaches for acute diverticulitis, and the literature supporting each procedure; and d) Assemble a logical approach for management of recurrent disease. 106 Wednesday, June 3 ASCRS Annual Business Meeting and State of the Society Address ASCRS Annual Reception and Dinner Dance Reception 7:00 – 8:00 pm Grand Ballroom Foyer Sheraton Boston Hotel Dinner Dance 8:00 – 10:30 pm Grand Ballroom Sheraton Boston Hotel Tickets Required Future Meetings April 30 – May 4, 2016 May 19 – 23, 2018 Los Angeles Convention Center J.W. Marriott L.A. Live Los Angeles, CA Music City Center Omni Nashville Hotel Nashville, TN June 10 – 14, 2017 June 1 – 5, 2019 Washington State Convention Center Sheraton Seattle Hotel Seattle, WA Cleveland Convention Center Hilton Cleveland Downtown Hotel Cleveland, OH 107 W E D N E S D AY 4:30 – 5:30 pm Ballroom A (3rd Floor) Wednesday, June 3 ASCRS Annual Business Meeting and State of the Society Address 4:30 – 5:30 pm • Ballroom A (3rd Floor) Agenda I. II. III. IV. V. VI. VII. VIII IX. X. XI. XII. XIII. XIV. XV. XVI. XVII. XVIII. Call to Order – Dr. Terry Hicks Approval of 2014 Business Meeting Minutes – Dr. Terry Hicks Memorials – Dr. Tracy Hull Treasurer’s Report – Dr. Patricia Roberts Scientific Program Report – Drs. David Margolin and H. David Vargas DC&R Editor-in-Chief Report – Dr. Robert Madoff Awards Committee Report – Dr. Jason Hall Website Committee Report – Dr. David Margolin Barton Hoexter Best Video Award – Dr. Terry Hicks Research Foundation Report – Dr. Steven Wexner The American Board of Colon and Rectal Surgeons – Dr. David Schoetz Election and Elevations of Members State of the Society Address – Dr. Terry Hicks Nominating Committee Report – Dr. Michael Stamos New Business Introduction of New President Next Meeting: April 30 – May 4, 2016, Los Angeles Convention Center, Los Angeles, CA Adjourn 2015 – 2016 ASCRS Slate of Officers and Members-at-Large The ASCRS Nominating Committee submits the following slate of Officers and Members-at-Large for election: President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Charles E. Littlejohn, MD President Elect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Patricia L. Roberts, MD Vice President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Guy R. Orangio, MD Secretary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Tracy L. Hull, MD Treasurer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Neil H. Hyman, MD Members-at-Large: Julio Garcia-Aguilar, MD, PhD (2015-2018) Samuel C. Oommen, MD (2015-2018) Feza H. Remzi, MD (2015-2018) 108 ePoster Presentations ePosters of Distinction: The following ePosters have been designated as “ePosters of Distinction” and will be presented from the ePoster Theater in the Exhibit Hall, at the dates and times indicated. They can be accessed from any of the ePoster viewing monitors in the exhibit hall and in various common areas. Moderator: Luca Stocchi, MD, Cleveland, OH PD1006 Effect of Surgery on Quality of Life of Patients with Locally Recurrent Rectal Cancer Monday, 10:30 am ePoster Theater Neoplastic Disease G. Pellino*, G. Sciaudone, G. Candilio, S. Canonico, F. Selvaggi, Naples, Aversa (CE), Italy PD1000 A Surgical Decision Aid for Patients with Ulcerative Colitis Sunday, 4:10 pm ePoster Theater Inflammatory Bowel Disease J.N Cohan*, M.G. Varma, E. Finlayson, E. Ozanne, J.L. Sewell, U. Mahadevan, D. Dohan, San Francisco, CA, Lebanon, NH PD1001 Total Proctocolectomy with Ileal Pouch Anal Anastomosis: Does Disease Influence Outcomes? Sunday, 4:15 pm ePoster Theater Inflammatory Bowel Disease A. Murray*, R.P. Kiran, D.E. Estrada Trejo, J. Rein, C. Chiuzan, New York, NY PD1008 Risk Factors for Perineal Wound Complications after Abdominoperinal Resection: Analysis of the ACS NSQIP Database Monday, 10:40 am ePoster Theater Neoplastic Disease A. Althumairi*, J. Canner, S. Gearhart, B. Safar, S.H. Fang, E. Wick, J. Efron, Baltimore, MD PD1002 Effect of Complex Surgical Interventions on Postoperative Recurrence in Patients with Crohn’s Disease Sunday, 4:20 pm ePoster Theater Inflammatory Bowel Disease R.A. Hodin*, L. Bordeianou, A. Ananthakrishnan, D. Nguyen, J. Sauk, V. Yajnik, A. Olariu, Boston, MA PD1009 T4N0 Colon Cancer: Does Natural History Warrant Adjuvant Chemotherapy? Monday, 10:45 am ePoster Theater Neoplastic Disease J.L. Agnew*, F.M. Chory, P.D. Strombom, G. Bonomo, G. Aharonoff, K.A. Melstrom, W.E. Enker, J.E. Martz, New York, NY PD1003 Racial Disparities in Readmissions for Patients with Inflammatory Bowel Disease (IBD) after Colorectal Surgery Sunday, 4:25 pm ePoster Theater Inflammatory Bowel Disease D. Gunnells*, M.S. Morris, A. DeRussy, A.A. Gullick, J.A. Cannon, M.T. Hawn, D.I. Chu, Birmingham, AL Moderator: John Migaly, MD, Durham, NC PD1004 Expression of Cystathionine-β-Synthase in Normal Colonic Mucosa, Colon Adenocarcinoma, and Inflammatory Bowel Disease Sunday, 4:30 pm ePoster Theater Inflammatory Bowel Disease P. Johnson*, A.A. Mrazek, J.R. Zatarain, C. Chao, M.R. Hellmich, I.V. Pinchuk, G. Luthra, C. Szabo, Galveston, TX PD1010 Hybrid PET/MRI versus PET/CT in the Staging and Restating of Colorectal Cancer: Initial Clinical Experience Monday, 12:35 pm ePoster Theater Neoplastic Disease B. Crawshaw*, C.P. Delaney, H.L. Reynolds, N. Nguyen, S. Krishnamurthi, R.M. Paspulati, Cleveland, OH, Pittsburgh, PA PD1005 Small Bowel Adenocarcinoma of Crohn’s Disease Patients in the United States Monday, 10:25 am ePoster Theater Neoplastic Disease N.E. Wieghard*, J.I. Young, B.C. Sheppard, V.L. Tsikitis, S.I. Mongoue-Tchokote, M. Mori, Biostatistics, Portland, OR *All ePoster presenters are listed first unless otherwise noted. 109 EPOSTERS PD1007 Considering Value in Rectal Cancer Surgery: An Analysis of Costs and Outcomes Based on the Open and Laparoscopic and Robotic Approach for Protectomy Monday, 10:35 am ePoster Theater Neoplastic Disease J. Silva Velazco*, D. Dietz, L. Stocchi, M. Costedio, E. Gorgun, M. Kalady, H. Kessler, I. Lavery, Cleveland, OH ePoster Presentations PD1011 The Usefulness of Anorectal and Endovaginal 3D Ultrasound in the Evaluation of Sphincter and Pubovisceral Muscles Defects Using a Novel Scoring Systems in Women with Fecal Incontinence after Vaginal Delivery Monday, 12:40 pm ePoster Theater Other Benign Disease S.M. Murad-Regadas*, F.S. Regadas, G. Fernandes, I. Dealcanfreitas, M.C. Oliveira, L.V. Rodrigues, F. Regadas Filho, M. Cruz, Fortaleza, Ceara, Brazil PD1017 Training Model for Transanal TME Using a Human Cadaver Model: Initial Experience. Monday, 1:10 pm ePoster Theater Other Benign Disease P. Sylla*, M. Whiteford, Boston, MA Portland, OR PD1018 PERFACT Procedure (Proximal superficial cauterization, emptying regularly of fistula tracts and curettage of tracts): A New Concept to Treat Highly Complex Anal Fistula Monday, 1:15 pm ePoster Theater Other Benign Disease P. Garg*, V. Gupta, P. lakhtaria, Haryana, India, Chandigarh, India, New York, NY PD1012 CT Mesenteric Angiography and Embolisation in Bleeding Diverticular Disease – It Works for Us, it May Work for You Monday, 12:45 pm ePoster Theater Other Benign Disease N. Thiruchelvam*, J. Ngu, Singapore Moderator: Robert Sinnott, DO, Allentown, PA PD1019 Does Sacral Neuromodulation for Slow Transit Constipation Work in the Long Term? A Single Centre Experience Monday, 3:45 pm ePoster Theater Other Benign Disease V. Garimella*, R. Padwick, M. Spencer, D. Latham, M. Farmer, Leamington Spa, United Kingdom PD1013 Safety and Efficacy of Stapled Hemorrhoidopexy over Conventional Hemorrhoidectomy – A Prospective Randomized Trial. Monday, 12:50 pm ePoster Theater Other Benign Disease S.S. Nahid*, K. Azad, G.M. Salahuddin, N.H. Masum, Dhaka, Bangladesh PD1020 Management of Diverticular Abscesses with Non-Surgical Drainage: Is There a Need for Interval Resection? Monday, 3:50 pm ePoster Theater Other Benign Disease C. Knapp, M.I. Brand*, B.A. Orkin, Chicago, IL PD1014 Clinical Experience of Anorectal Myectomy in the Treatment of Internal Anal Sphincter Achalasia in Young Adults Monday, 12:55 pm ePoster Theater Other Benign Disease I.H. Ozerhan, E. Samadov*, N. Ersoz, M.F. Can, G. Yagci, Ankara, Turkey PD1021 Impact of Obesity on Short-term Outcomes after Laparoscopic Colorectal Resections: A Multivariate Analysis. Monday, 3:55 pm ePoster Theater Outcomes A. Harzman, M. Arnold, S. Husain, Y. Lianbo, S. Tuthill*, Columbus, OH PD1015 Doppler-guided Hemorrhoidal Artery Ligation with Suture Mucopexy vs. Suture Mucopexy Alone for Treatment of Hemorrhoids Grade III. A Prospective-Randomized Controlled Trial. Monday, 1:00 pm ePoster Theater Other Benign Disease F. Aigner*, J. Pratschke, I. Kronberger, A. Loizides, L. Gruber, H. Gruber, Berlin, Germany, Innsbruck, Austria PD1022 Variations in Laparoscopic Colectomy Utilization in Different Hospitals in the United States Monday, 4:00 pm ePoster Theater Outcomes Z. Moghadamyeghaneh*, J.C. Carmichael, S.D. Mills, A. Pigazzi, M.J. Stamos, Orange, CA PD1016 Is Sacral Nerve Stimulation on Patients with Anal Sphincter Defects More than 60 Degrees Helpful? Monday, 1:05 pm ePoster Theater Other Benign Disease R. Wei*, A. Vogler, C. Jensen, M.P. Spencer, Hong Kong, Minneapolis, MN PD1023 Post Hospital Discharge Venous Thromboembolism in Colorectal Surgery Monday, 4:05 pm ePoster Theater Outcomes Z. Moghadamyeghaneh*, J.C. Carmichael, S.D. Mills, A. Pigazzi, M.J. Stamos, Orange, CA *All ePoster presenters are listed first unless otherwise noted. 110 ePoster Presentations Moderator: Jonathan Efron, MD, Baltimore, MD PD1031 Impact of the Specific Extraction-Site Location on the Risk of Incisional Hernia and Wound Infection after Laparoscopic Colorectal Resection Tuesday, 12:30 pm ePoster Theater Outcomes C. Benlice*, L. Stocchi, M. Costedio, E. Gorgun, H. Kessler, Cleveland, OH PD1024 Rates of Complications and Outcomes after Interhospital Transfer versus Direct Admission in Colorectal Surgery: Implications for Pay-forPerformance Models Tuesday, 9:40 am ePoster Theater Outcomes S.P. Sharp*, D. Ata, D.B. Johnson, S.L. Bestle, D. Chismark, D.J. Canete, D.T. Valerian, D. Lee, Albany, NY PD1025 Patient Preferences for Outcomes following Abdominal Surgery: GI Symptom Tolerance Tuesday, 9:45 am ePoster Theater Outcomes T. Kauf, M.H. Potashman; C. Poulos*, J. Posner, A.B. Hauber, E. Viscusi, M. Aeder, Lexington, MA, Philadelphia, PA, Cleveland, OH, Research Triangle Park, NC PD1033 Home Hospitalization Care (HHC) as implementation of Enhanced Recovery after Colorectal Surgery (ERACS) program Tuesday, 12:40 pm ePoster Theater Outcomes C. Cagigas-Fernández*, A. Calero-Lillo, M. Gomez Ruiz, J. Alonso Martin, J. Manuel Palazuelos, I. Martín-Parra, J. Castillo-Diego, M. Gomez Fleitas, Santander, Cantanbria, Spain PD1026 Can Electroacupuncture Reduce the Duration of Postoperative Ileus and Hospital Stay after Laparoscopic Surgery for Mid and Low Rectal Cancer? A Prospective Cohort Study with Matched Historic Controls Tuesday, 9:50 am ePoster Theater Outcomes S.S. Ng*, W. Leung, T.W. Mak, S.S. Hon, D.K. Ngo, S. Chu, N.O. Mak, J.F. Lee, Hong Kong PD1034 High Variability in Nosocomial Clostridium Difficile Infection Rates among Both Surgeons and Hospitals following Colorectal Resection Tuesday, 12:45 pm ePoster Theater Outcomes C.T. Aquina*, C.P. Probst, B.J. Hensley, J.C. Iannuzzi, K. Noyes, J. Monson, F.J. Fleming, Rochester, New York PD1028 Risk of Surgical Site Infection Varies Based on Location of Disease and Segment of Colorectal Resection for Cancer: Time to Adjust QualityMonitoring Metrics? Tuesday, 9:55 am ePoster Theater Outcomes A. Murray*, R. Teja Pasam, D.E. Estrada Trejo, D. Feingold, S. Lee-Kong, R.P. Kiran, New York, NY PD1035 Racial Disparities in Hospital Length-of-Stay (LOS) for Patients after Elective Colorectal Surgery Tuesday, 12:50 pm ePoster Theater Outcomes D.I. Chu*, A. DeRussy, D. Gunnells, A.A. Gullick, J.A. Cannon, M.T. Hawn, M.S. Morris, Birmingham, AL Moderator: Ovunc Bardakcioglu, MD, Las Vegas, NV PD1029 3-D Laparoscopic Colorectal Surgery - The Robot of the Future? Tuesday, 12:20 pm ePoster Theater Outcomes M.N. Lamb, K. Cologne, A.M. Kaiser*, Los Angeles, CA PD1037 Comparison of LIFT and Fistulotomy in Treatment of Intersphincteric and Low Transsphincteric Anal Fistula: Prospective Randomized Study Tuesday, 12:55 pm ePoster Theater Other Benign Disease E. Yardimci*, M. Hasbahceci, E. Aysan, H. Bektasoglu, U.O. Idiz, M. Muslumanoglu, G. Cipe, Istanbul, Turkey PD1030 Risk Factors and Predictors of Prolonged Postoperative Ileus after Colectomy: An Assessment from Nationwide ProcedureTargeted Cohort Tuesday, 12:25 pm ePoster Theater Outcomes A. Rencuzogullari*, C. Benlice, M. Costedio, X. Liu, F. Remzi, E. Gorgun, Cleveland, OH *All ePoster presenters are listed first unless otherwise noted. 111 EPOSTERS PD1032 Reinforcement of Fascial Closure by Polyglactin-Mesh to Prevent Abdominal Wound Dehiscence following Open Colorectal Surgery Tuesday, 12:35 pm ePoster Theater Outcomes L. Lesalnieks*, Surgery, M. Baladov, K. Ikhlawi, Gelsenkirchen, Germany, Munich, Germany ePoster Presentations General ePosters: The authors of each ePoster have been assigned a specific time frame to be at a designated monitor and available for questions. The following ePosters can be accessed from any of the ePoster viewing monitors in the exhibit hall and in various common areas. The viewing screens will feature user-friendly touch screen controls to allow you to easily select the poster you want to view. ePoster Presentations MONITOR #1 located in Hall C Sunday, 4:00 – 4:45 pm P1063, P1081, P1109, P1283, P1296, P1298 Monday, 10:15 – 11:00 am P1080, P1082, P1084, P1086, P1088, P1090, P1092, P1093, Monday, 12:30 – 1:30 pm P1091, P1111, P1161, P1186, P1195, P1221, P1244, P1263, P1352, P1358 Monday, 3:30 – 4:15 pm P1180, P1229, P1237, P1250, P1266, P1275 Tuesday, 9:30 – 10:15 am P1070, P1072, P1129, P1183, P1214, P1219 Tuesday, 12:15 – 1:30 pm P1132, P1207, P1210, P1216, P1217, P1247, P1264, P1268 MONITOR #2 located in Hall C Sunday, 4:00 – 4:45 pm P1321, P1322, P1333, P1334, P1337, P1355, P1372 Monday, 10:15 – 11:00 am P1064, P1128, P1171, P1201, P1227, P1243, P1262, P1274, P1277, P1294 Monday, 12:30 – 1:30 pm P1119, P1136, P1146, P1148, P1164, P1165, P1166, P1205, P1209 Monday, 3:30 – 4:15 pm P1112, P1232, P1312, P1328, P1346, P1349 Tuesday, 9:30 – 10:15 am P1156, P1168, P1208, P1223, P1236, P1278 Tuesday, 12:15 – 1:30 pm P1130, P1158, P1170, P1190, P1202, P1212, P1215, P1272 MONITOR #3 located in Hall C Sunday, 4:00 – 4:45 pm P1051, P1059, P1313, P1325, P1373, P1398, P1406 Monday, 10:15 – 11:00 am P1144, P1167, P1172, P1191, P1194, P1254, P1256 Monday, 12:30 – 1:30 pm P1060, P1138, P1151, P1176, P1222, P1249 Monday, 3:30 – 4:15 pm P1285, P1290, P1295, P1303, P1304, P1327, P1426 Tuesday, 9:30 – 10:15 am P1074, P1240, P1293, P1300, P1314, P1396, P1419 Tuesday, 12:15 – 1:30 pm P1348, P1363, P1389, P1390, P1392 MONITOR #4 located in Hall C Sunday, 4:00 – 4:45 pm P1127, P1155, P1178, P1188, P1196, P1224, P1259 Monday, 10:15 – 11:00 am P1117, P1133, P1139, P1147, P1149, P1152, P1185, P1203, P1218 Monday, 12:30 – 1:30 pm P1065, P1077, P1085, P1098, P1326, P1407 Monday, 3:30 – 4:15 pm P1052, P1068, P1198, P1204, P1256, P1260 Tuesday, 9:30 – 10:15 am P1078, P1120, P1174, P1175, P1181, P1193, P1226, P1234, P1241, P1246, P1416 Tuesday, 12:15 – 1:30 pm P1076, P1162, P1192, P1225, P1248 MONITOR #5 located in Hall C Sunday, 4:00 – 4:45 pm P1058, P1106, P1114, P1141, P1177, P1286, P1287, P1292, P1302, P1323, P1361, P1376 Monday, 10:15 – 11:00 am P1121, P1125, P1145, P1200, P1206, P1230, P1233, P1235, P1271 Monday, 12:30 – 1:30 pm P1104, P1331, P1332, P1360, P1414 Monday, 3:30 – 4:15 pm P1116, P1118, P1124, P1126, P1137, P1157, P1163, P1169 Tuesday, 9:30 – 10:15 am P1061, P1067, P1073, P1089, P1110, P1123, P1150, P1306 Tuesday, 12:15 – 1:30 pm P1097, P1122, P1336, P1356, P1368, P1375, P1377, P1386, P1399, P1415 MONITOR #6 located in Hall D Sunday, 4:00 – 4:45 pm P1099, P1351, P1383, P1385, P1394, P1410 Monday, 10:15 – 11:00 am P1083, P1280, P1281, P1305, P1353, P1365, P1366 Monday, 12:30 – 1:30 pm P1057, P1075, P1103, P1105, P1299, P1309, P1316, P1335 Monday, 3:30 – 4:15 pm P1131, P1182, P1187, P1228, P1257, P1267 Tuesday, 9:30 – 10:15 am P1108, P1342, P1359, P1369, P1384, P1395, P1418, P1421 *All ePoster presenters are listed first unless otherwise noted. 112 ePoster Presentations ePoster Presentations (continued) P1050 MONITOR #8 located outside Ballroom B Sunday, 4:00 – 4:45 pm P1050, P1115, P1173, P1184, P1378, P1379, P1380, P1381, P1382 Monday, 10:15 – 11:00 am P1101, P1211, P1252, P1270, P1279, P1319, P1339 Monday, 12:30 – 1:30 pm P1054, P1056, P1142, P1143, P1154, P1160, P1231, P1238, P1239 Monday, 3:30 – 4:15 pm P1102, P1317, P1329, P1338, P1367, P1405, P1413 Tuesday, 9:30 – 10:15 am P1055, P1071, P1100, P1284, P1291, P1297, P1310, P1318, P1324 Clinical Effectiveness and Outcome of Diversion in Refractory Crohn’s Colitis with and without Perianal Fistula Sunday Monitor #8, Outside Ballroom B Inflammatory Bowel Disease K. Mathis, J. Pemberton, E. Tiret, W. Bemelman, F. Michelassi, J. Soderholm, T. Oresland, F. Remzi, A. D’Hoore, Rochester, MN; Paris, France; Amsterdam, Netherlands; New York, NY; Linkoping, Sweden; Oslo, Norway; Cleveland, OH; Leuven, Belgium P1051 Tumor Regression Grade after Preoperative Chemoradiotherapy in Rectal Cancer: Is it Related to Nodal Staging? Sunday Monitor #3, located in Hall C Neoplastic Disease C. Vaccaro, H. Vaccarezza, J. Santino, M. Falconi, D. Beder, F. Yazyi, G. Ojea Quintana, G. Rossi, Buenos Aires, Argentina P1052 Inpatient Hospital Readmission Based on Discharge Destination after Colorectal Surgery Monday Monitor #4, located in Hall C Outcomes A. Gabre-Kidan, A. Murray, M. Lightfoot, R. Kiran, New York, NY MONITOR #9 located outside Room 304 Monday, 10:15 – 11:00 am P1140, P1213, P1220, P1242, P1251, P1258, P1403 Monday, 12:30 – 1:30 pm P1062, P1066, P1094, P1153, P1159, P1199, P1340, P1357, P1320, P1402 Monday, 3:30 – 4:15 pm P1053, P1069, P1301, P1307, P1347, P1364, P1393, P1417 Tuesday, 9:30 – 10:15 am P1341, P1350, P1371, P1374, P1387, P1388, P1401, P1404 P1053 Colorectal Cancer Pathology Reporting: A Regional Audit (1996-2010) Monday Monitor #9, located outside Room 304 Neoplastic Disease R. Birch, P. Finan, E. Morris, P. Quirke, Leeds, United Kingdom P1054 Open versus Laparoscopic Colostomy Creation: An ACS-NSQIP Study Monday Monitor #8, Outside Ballroom B Outcomes S. Ivatury, S. Holubar, Lebanon, NH P1055 Transanal Endoscopic Microsurgery (TEM) versus Total Mesorectal Excision (TME) Radical Resection for T1 or T2 Rectal Cancer – A Meta-analysis. Tuesday Monitor #8, Outside Ballroom B Neoplastic Disease V. Chakravorty, R. Chamberlain, N. Ghlayiae, Livingston; Tuscon, AZ P1056 Impact of Operative Approach on Postoperative Outcomes following Colectomy for Colon Cancer Monday Monitor #8, Outside Ballroom B Outcomes C. Papageorge, E. Foley, C. Heise, B. Harms, E. Carchman, G. Kennedy, Madison, WI *All ePoster presenters are listed first unless otherwise noted. 113 EPOSTERS MONITOR #7 located in Hall C Foyer (by registration) Sunday, 4:00 – 4:45 pm P1095, P1282, P1288, P1289, P1330, P1343, P1354 Monday, 10:15 – 11:00 am P1079, P1179, P1362, P1400, P1411, P1425, P1427 Monday, 12:30 – 1:30 pm P1087, P1113, P1370, P1391, P1397, P1408, P1409, P1412 Monday, 3:30 – 4:45 pm P1096, P1107, P1135, P1197, P1308, P1311, P1315, P1344, P1345 Tuesday, 9:30 – 10:15 am P1134, P1422, P1423, P1424 ePoster Presentations P1057 P1058 P1059 P1060 P1061 P1062 Biological Difference of Right versus Left Colon Cancer: An Analysis of the National Cancer Database (NCDB) and Surveillance, Epidemiology and End Results (SEER) Monday Monitor #6, located in Hall D Neoplastic Disease S. Saha, L. Berbiglia, M. Shaik, J. Gernand, S. Saha, M. Hicks, M. Arora, D. Wiese, Flint, MI; East Lansing, MI; Boston, MA Patients Undergoing Abdominoperineal Resection for Rectal Cancer with Flap Reconstruction – Do They Benefit? Sunday Monitor #5, located in Hall C Outcomes M. Bailey, P. Miller, M. Thomas, D. Beck, T. Hicks, H. Vargas, C. Whitlow, D. Margolin, New Orleans, LA Does One Size Fit All? Risks and Benefits of Neoadjuvant Chemoradiation in Patients with Clinical Stage II Rectal Cancer Requiring Abdominoperineal Resection Sunday Monitor #3, located in Hall C Neoplastic Disease X. Xhaja, D. Benson, D. Dietz, L. Stocchi, M. Kalady, J. Ashburn, I. Lavery, F. Remzi, Cleveland, OH P1063 Prognostic Implications of Threatened Circumferential Resection Margin of Locally Advanced Rectal Cancer Sunday Monitor #1, located in Hall C Neoplastic Disease M. Albandar, M. Cho, N. Kim, Seoul, Korea P1064 The Learning Curve of Robotic Rectal Surgery Can Be Minimized with Expert Assistance Monday Monitor #2, located in Hall C Outcomes S. Shah, D. Maun, R. Melbert, T. Reidy, O. Johansen, B. Tsai, Indianapolis, IN P1065 Number of Regional Negative Lymph Nodes Affects Survival in Rectal Cancer Patients Treated for Cure at King Faisal Specialist Hospital & Research Centre, Saudi Arabia Monday Monitor #4, located in Hall C Neoplastic Disease M. Mohammed, N. Alsanea, A. Abduljabbar, L. Ashari, S. Alhomoud, A. Alwusaibie, Riyadh, Saudi Arabia P1066 Robotic Colon and Rectal Surgery Results in Shorter Lengths of Stay and Operative Times Compared to Open and Laparoscopic Surgery Monday Monitor #9, located outside Room 304 Outcomes A. Bastawrous, C. Neighorn, Seattle, WA; Portland, OR P1067 Long-Term Survival from Colorectal Cancer in Jamaica Tuesday Monitor #5, located in Hall C Neoplastic Disease J. Plummer, Kingston, Jamaica P1068 Readmission Risk Profiles for Colorectal Patients Differ Significantly Based on Indication for Colectomy Monday Monitor #4, located in Hall C Outcomes M. Morris, A. DeRussy, A. Gullick, D. Gunnells, J. Cannon, M. Hawn, D. Chu, Birmingham, AL P1069 Relationship between Socioeconomic Status and Receipt of Chemotherapy for Advanced Stage Colorectal Cancer at an Urban Academic Institution Monday Monitor #9, located outside Room 304 Neoplastic Disease M. Harfouche, A. Willis, Philadelphia, PA Predictors of Length of Stay and Cost in Enhanced Recovery Colorectal Surgery Protocol Monday Monitor #3, located in Hall C Outcomes M. Abdelgadir Adam, Z. Sun, J. Migaly, C. Mantyh, J. Thacker, Durham, NC Oncologic Benefits of Adjuvant Chemotherapy in Patients with Good Tumor Response (ypT02N0) after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Tuesday Monitor #5, located in Hall C Neoplastic Disease J. Al Sabilah, M. Cho, N. Kim, Seoul, Korea The Use of Robotic and Laparoscopic Surgical Stapling Devices during Minimally Invasive Colon and Rectal Surgery – A Comparison Monday Monitor #9, located outside Room 304 Outcomes J. Holzmacher, M. Aziz, S. Luka, S. Agarwal, V. Obias, Washington, DC *All ePoster presenters are listed first unless otherwise noted. 114 P1070 Socioeconomic Disparities Lead to Increased Length of Stay and Mortality in Colon and Rectal Cancers Tuesday Monitor #1, located in Hall C Outcomes J. Harris, V. Vichez, D. Davenport, S. Beck, Lexington, KY P1077 Lymph Node Identification following Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Do Numbers Matter? Monday Monitor #4, located in Hall C Neoplastic Disease B. Ecker, E. Paulson, J. Datta, A. Jeganathan, C. Aarons, R. Kelz, N. Mahmoud, Philadelphia, PA P1071 Transanal Total Mesorectal Excision (taTME) by Transanal Endoscopic Microsurgery (TEM) as an Alternative to Abdominoperineal Resection (APR) in Selected Cases: A Pilot Study Tuesday Monitor #8, Outside Ballroom B Neoplastic Disease E. Lezoche, S. Quaresima, A. Balla, G. D’Ambrosio, M. Guerrieri, G. Lezoche, A. Paganini, Rome, Italy; Ancona, Italy P1078 The Effectiveness of a Fecal Diverting Device for the Prevention of Septic Complication in Case of Colonic Anastomotic Leakage Tuesday Monitor #4, located in Hall C Outcomes J. Kim, S. Kim, S. Jung, Daegu, Korea P1079 Prospective Analysis of the Learning Curve for Laparoscopic Colorectal Cancer Resections Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease F. Blanco-Antona, S. Bahamonde, L. Blanco, Valladolid, Spain; Salamanca, Spain P1080 Anorectal Tuberculosis In the Biologic Therapy Era Monday Monitor #1, located in Hall C Case Report J. Contreras, M. Blas-Franco, M. Pichardo-Farfan, E. Mora-Canas, Mexico City, Mexico P1081 Balancing Harm and Benefit: Oncologic Outcomes and Quality of Life in Rectal Cancer Patients with Poor Response to Neoadjuvant Chemoradiation Sunday Monitor #1, located in Hall C Neoplastic Disease L. Duraes, L. Stocchi, D. Dietz, I. Lavery, M. Kalady, Cleveland, OH P1082 A Case of a T1 Poorly-Differentiated Rectal Adenocarcinoma Masquerading as a Submucosal Lipoma Monday Monitor #1, located in Hall C Case Report S. Koh, H. Yamamoto, C. Tsang, West Hollywood, CA; Yakushiji, Japan; Singapore P1083 Detection of Suspicious Families of Lynch Syndrome within a Colorectal Cancer Screening Program in Chile Monday Monitor #6, located in Hall D Neoplastic Disease L. Paqui, A. Ponce, K. Alvarez, A. Zarate, E. Pinto, A. Wielandt, H. Kawachi, U. Kronberg, F. LopezKostner, Santiago, Chile P1072 Racial Disparity in Short-Term Outcomes after Colon Resection for Cancer – A NSQIP Analysis Tuesday Monitor #1, located in Hall C Outcomes R. Venkat, N. Choudhury*, V. Nfonsam, Tucson, AZ P1073 Long-term Quality of Life after Elective Colorectal Cancer Surgery: A Prospective Cohort Study Tuesday Monitor #5, located in Hall C Neoplastic Disease T. Poskus, D. Kazanavicius, A. Bausys, S. Mikalauskas, E. Poskus, N. Samalavicius, Z. Saladzinskas, K. Strupas, Vilnius, Lithuania; Kaunas, Lithuania P1074 P1075 P1076 Transfusion-Free Colorectal Surgeries in Jehovah’s Witnesses: Rational Approach vs. Surgical Extremism Tuesday Monitor #3, located in Hall C Outcomes B. Devaraj, H. Fish, A. Kaiser, Los Angeles, CA Emergency Surgery for Obstructing Colonic Cancers: A Comparison between Right-Sided and Left-Sided Lesions in 71 Consecutive Patients Monday Monitor #6, located in Hall D Neoplastic Disease J. Faucheron, B. Paquette, Grenoble, France Transitional Care after Discharge: Does Preoperative Anemia Predict Discharge Status? Tuesday Monitor #4, located in Hall C Outcomes C. Papageorge, G. Leverson, G. Kennedy, Madison, WI *All ePoster presenters are listed first unless otherwise noted. 115 EPOSTERS ePoster Presentations ePoster Presentations P1084 Colon Mantle Cell Lymphoma: A Case Report Monday Monitor #1, located in Hall C Case Report J. Aycinena, J. Cobar, Somerset, PA P1085 Is Tumor Location a Predictor for Lymph Node Metastasis in T1 Colorectal Cancer? Monday Monitor #4, located in Hall C Neoplastic Disease E. Aytac, E. Gorgun, M. Costedio, L. Stocchi, F. Remzi, H. Kessler, Cleveland, OH P1086 P1087 P1088 Ischioanal Sarcomas: A Tertiary Center’s Experience with a Rare Tumor Monday Monitor #1, located in Hall C Case Report S. Hwang, P. Haigh, E. McLemore, V. Attaluri, Los Angeles, CA Radical versus Ultra-Radical Surgical Strategy in the Management of Locally Recurrent Rectal Cancer Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease D. Harji, B. Griffiths, S. Peter, Leeds, United Kingdom Colonic Tuberculosis Masquerading as Colorectal Malignancy Monday Monitor #1, located in Hall C Case Report D. Sarma, London, United Kingdom P1089 Survival Benefits of Salvage Surgery for Distant Treatment Failure in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiation and CurativeI-Intent Resection Tuesday Monitor #5, located in Hall C Neoplastic Disease J. Liles, Y. You, A. Cuddy, M. Rodriguez-Bigas, J. Skibber, G. Chang, Houston, TX P1090 A Novel Use for Transanal Endoscopic Microsurgery: Retrieval of Impacted Rectosigmoid Foreign Bodies Monday Monitor #1, located in Hall C Case Report M. Tomassi, D. Klaristenfeld, A. Exume, San Diego, CA P1091 P1092 Chronic Partial Small Bowel Obstruction since Early Infancy Continuing into Adulthood: 2 Complex Cases Monday Monitor #1, located in Hall C Case Report R. Gagliano, R. Serrona, T. Gillespie, Phoenix, AZ P1093 The Circular Stapler Ostomy Creation: A Novel Approach to Standardized Ostomy Creation. Monday Monitor #1, located in Hall C Case Report S. Chan, K. Alavi, D. Czerniach, J. Davids, J. Maykel, W. Sweeney, P. Sturrock, Worcester, MA P1094 Natural Orifice Transanal Endoscopic Total Mesorectal Excision using Robotic and Laparoscopic Assistance Monday Monitor #9, located outside Room 304 Neoplastic Disease G. Molina, L. Bordeianou, D. Berger, P. Sylla, Boston, MA P1095 Radiographic Predictors of Response to HighDose Rate Endoluminal Brachytherapy for the Treatment of Rectal Cancer Sunday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease R. Craig-Schapiro, M. Sacerdote, M. Pittman, J. Canner, E. Schneider, I. Kamel, J. Herman, S. Gearhart, Baltimore, MD P1096 Surveillance Colonoscopy at One Year following Colectomy for Colorectal Cancer is Low Yield for Detection of Advanced Neoplasia Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease N. Cherng, R. Damle, D. Baldor, J. Maykel, P. Sturrock, J. Davids, W. Sweeney, K. Alavi, Worcester, MA P1097 Metformin Enhances the Response to Radiotherapy in Rectal Cancer Tuesday Monitor #5, located in Hall C Neoplastic Disease J. Oh, B. Oh, H. Kim, W. Lee, Y. Cho, Y. Park, S. Yun, J. Huh, Seoul, Korea P1098 Fat Clearance Technique in Colorectal Cancer Histopathology Assessment. Single Center Experience over 7 Years Monday Monitor #4, located in Hall C Neoplastic Disease J. Roos, H. Andrew, K. Abbas, N. Woodcock, S. Stojkovic, York, United Kingdom Colectomy for Colon Cancer in Obese Patients Monday Monitor #1, located in Hall C Neoplastic Disease T. Ishii, S. Yamaguchi, Hidaka, Japan *All ePoster presenters are listed first unless otherwise noted. 116 P1099 The Addition of a Staging PET-CT Alters Anal Cancer Treatment Sunday Monitor #6, located in Hall D Neoplastic Disease C. Johnson, J. Longo, B. Erickson, K. Ludwig, T. Ridolfi, Milwaukee, WI P1100 P1101 P1102 P1103 P1104 P1105 P1106 Total Mesorectal Excision Assisted by Transanal Approach: Preliminary Series of a University Hospital Tuesday Monitor #8, Outside Ballroom B Neoplastic Disease M. Abedrapo, G. Montesinos, M. Diaz, R. Azolas, J. Llanos, G. Bocic, S. Cortes, Santiago, Chile Early Outcomes with the Use of Intensity Modulated Radiation Therapy with Simultaneous Integrated Boost (IMRT-SIB) as a Part of Neoadjuvant Therapy with Concurrent Chemotherapy for Advanced Stage Rectal Cancers – Central Texas Experience Sunday Monitor #5, located in Hall C Neoplastic Disease R. Essani, Temple, TX P1107 Palliative Surgery by Colorectal Surgeons for Resuming Oral Intake for Patients with Malignant Bowel Obstruction from NonColorectal Origin Cancers: Impact on Overall Survival Monday Monitor #8, Outside Ballroom B Neoplastic Disease Y. Kwon, K. Park, J. Seung-Yong, S. Ryoo, J. Park, E. Han, B. Park, J. Kim, Seoul, Korea Successful Endoscopic Polypectomy in Cases Referred for Surgical Excision: A Case-Matched Series Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease K. Cologne, L. Liwanag, D. Rosen, G. Hwang, A. Sahakian, A. Senagore, Los Angeles, LA P1108 Hyperglycemia Increases Surgical Site Infections following Colorectal Resections for Malignancy in a Standardized Patient Cohort Tuesday Monitor #6, located in Hall D Neoplastic Disease N. Saur, S. Chadi, D. Bekele, H. Amer, E. Weiss, G. DaSilva, S. Wexner, Weston, FL P1109 Abundant Mesorectal Volume and Narrow Pelvis Correlate with Anastomotic Leakage in Anterior Resection for Rectal Cancer Sunday Monitor #1, located in Hall C Neoplastic Disease Y. Asada, M. Tsuruta, H. Hasegawa, K. Okabayashi, T. Shimada, Y. Kitagawa, Tokyo, Japan P1110 Outcome of Ultralow Anterior Resection and Coloanal Anastomosis for Distal Rectal Cancer: The Impact of Minimally Invasive Surgery Tuesday Monitor #5, located in Hall C Neoplastic Disease W. Law, R. Wei, K. Ng, C. Foo, Hong Kong P1111 Impact of Weight Loss after Bariatric Surgery on Adenoma Detection Rate in Colonoscopy: A Case Control Study Monday Monitor #1, located in Hall C Neoplastic Disease S. Wexner, A. Cracco, K. Tandon, F. Rodrigues, M. Imam, R. Rosenthal, F. Castro, G. DaSilva, Weston, FL Characterizing Short-Term Outcomes following Surgery for Rectal Cancer: The Role of Race and Insurance Status Monday Monitor #8, Outside Ballroom B Neoplastic Disease P. Suwanaol, R. Damle, J. Davids, W. Sweeney, P. Sturrock, J. Maykel, K. Alavi, Worcester, MA Left versus Right Laparoscopic Colectomy: Does Side Make Any Difference? Monday Monitor #6, located in Hall D Neoplastic Disease P. Pellegrini, J. Campana, R. Mentz, G. Rossi, C. Vaccaro, Buenos Aires, Argentina Is Extended Lymphadenectomy for Colon Cancer Warranted? Outcomes of D2 Lymphadenectomy in Right Colon Cancer Monday Monitor #5, located in Hall C Neoplastic Disease G. Clifton, G. Chang, Y. You, J. Skibber, B. Feig, S. Nguyen, M. Rodriguez-Bigas, Houston, TX Laparoscopic versus Open Resection for T4 Colon Cancer: A Case-Matched Control Study Monday Monitor #6, located in Hall D Neoplastic Disease X. Li, Shanghai, China *All ePoster presenters are listed first unless otherwise noted. 117 EPOSTERS ePoster Presentations ePoster Presentations P1112 Serrated Polyps and Mucus: A Prospective Study Monday Monitor #2, located in Hall C Neoplastic Disease R. Charles, Cleveland, OH P1113 Improved Surgical Results and Oncologic Outcomes for Rectal Cancer Over Two Decades: The Impact of Minimally Invasive Surgery and Neoadjuvant Therapy Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease W. Law, C. Foo, R. Wei, O. Lo, Hong Kong P1114 P1115 Abdominoperineal Resection as a Negative Predictor of Adjuvant Chemotherapy Sunday Monitor #5, located in Hall C Neoplastic Disease D. Shaw, C. Ternent, J. Beaty, G. Blatchford, N. Bertelson, M. Shashidharan, J. Bikhchandani, A. Thorson, Omaha, NE Dysplasia following Stapled Restorative Proctolectomy for Ulcerative Colitis: Is There a Correlation between Preop Colorectal Dysplasia and Development of Postop Dysplasia in the Rectal Cuff Mucosa? Sunday Monitor #8, Outside Ballroom B Neoplastic Disease T. Elarini, A. Chadi, G. DaSilva, M. Berho, S. Wexner, Weston, FL P1116 The Impact of Mode of Delivery, Parity and Age in the Prevalence of Posterior Pelvic Floor Abnormalities in Female with Obstructed Defecation Syndrome Monday Monitor #5, located in Hall C Other Benign Disease S. Murad-Regadas, F. Regadas, D. Morano, D. Lima, L. Rodrigues, A. Vilarinho, J. Siebra, M. Oliveira, R. Barreto, Fortaleza, Brazil; Cascavel, Brazil P1117 How Often is a Cryptoglandular Fistula the Cause of an Anal Abscess? Results from a Single Anorectal Department. Monday Monitor #4, located in Hall C Other Benign Disease J. Jongen, J. Schumacher, H. Peleikis, V. Kahlke, Kiel, Germany P1118 Outcomes of Minimally Invasive Sacrocolpopexy with Ventral Mesh Rectopexy for Combined Vaginal and Rectal Prolapse Monday Monitor #5, located in Hall C Other Benign Disease M. Gross, A. Hayman, M. Whiteford, B. Osmundsen, Portland, OR P1119 Understanding the Connection between Internal Intussusception and Rectal Prolapse: A Prospective Study Monday Monitor #2, located in Hall C Other Benign Disease A. Hawkins, A. Olariu, L. Savitt, S. Gingipally, M. Wakamatsu, S. Pulliam, M. Weinstein, B. Nath, L. Bordeianou, Boston, MA P1120 Endoscopic Assisted Colostomy with Percutaneous Colopexy: An Experimental Study Tuesday Monitor #4, located in Hall C Other Benign Disease L. Bustamante-Lopez, M. Sulbaran, P. Sakai, E. Moura, C. Nahas, C. Marques, C. Sakai, I. Cecconello, R. Pinto, S. Nahas, Sao Paulo, Brazil P1121 Traumatic Pelvic GI-GU Fistula in Wounded Warriors: Case Series of Complicated Injuries with Complex Surgical Solutions Monday Monitor #5, located in Hall C Other Benign Disease W. Kucera, B. O’Brien, G. Stackhouse, J. Jezior, J. Duncan, Bethesda, MD P1122 Locally Released Matrix Metalloproteinase Inhibitor (Doxycylcline) Does Not Enhance Healing in Stapled Colorectal Anastomosis in Porcine Model Tuesday Monitor #5, located in Hall C Other Benign Disease M. Luchtefeld, S. Khoo, R. Nickolov, G. Hostetter, N. Jrebi, Grand Rapids, MI; Morgantown, WV; Fayetteville, NC P1123 Laparoscopic Resection Confers a Survival Benefit for Stage III Colorectal Cancer Patients Compared to Open Resection Tuesday Monitor #5, located in Hall C Neoplastic Disease J. Chiew, B. Lieske, Singapore *All ePoster presenters are listed first unless otherwise noted. 118 P1124 Bilateral Transcutaneous Posterior Tibial Nerve Stimulation for Functional Anorectal Pain Monday Monitor #5, located in Hall C Other Benign Disease S. Takano, Kumamoto, Japan P1125 Gracilis Muscle Interposition Repair for Complicated Colonic Pouch-Vaginal Fistula after Radical Resection of Low Rectal Cancer Monday Monitor #5, located in Hall C Other Benign Disease T. Ono, Asiya City, Japan P1126 P1127 P1128 P1129 P1130 P1131 Endoscopic Pilonidal Sinus Treatment with Additional Crystalized Phenol Monday Monitor #6, located in Hall D Other Benign Disease I. Gecim, U. Goktug, H. Celasin, Ankara, Turkey; Kavaklidere, Turkey P1132 Rectal Dissection Simulator for da Vinci Surgery – Construct, Face, and Content Validation Tuesday Monitor #1, located in Hall C Outcomes G. Melich, R. Shoela, A. Pai, K. Kochar, S. Patel, J. Park, L. Prasad, S. Marecik, Park Ridge, IL P1133 Multicenter Observational Study with Porcine Collagen Paste Fistula Treatment: Preliminary Results Monday Monitor #4, located in Hall C Other Benign Disease F. Da Pozzo, A. Stuto, A. Braini, P. Narisetty, L. Lenisa, A. Rusconi, A. Pulvirenti D’Urso, Pordenone, Italy; Milano, Italy; Catania, Italy P1134 Less is More: A Pilot Study Using a Novel, Affordable Simulator to Teach Residents Anorectal Surgery Monday Monitor #2, located in Hall C Other Benign Disease S. Langenfeld, J. Thompson, C. Are, S. Steele, Omaha, NE; Fort Lewis, WA Is There Anything We Can Modify among Factors Associated with Morbidity following Elective Laparoscopic Sigmoidectomy for Diverticulitis? Tuesday Monitor #7, located in Hall C Foyer (by registration) Other Benign Disease J. Silva Velazco, L. Stocchi, M. Costedio, E. Gorgun, H. Kessler, F. Remzi, Cleveland, OH P1135 A Cross-Sectional Survey of Health and Quality of Life of Patients Awaiting Colorectal Surgery in Canada Tuesday Monitor #1, located in Hall C Outcomes A. Karimuddin, T. Phang, C. Brown, M. Raval, G. Liu, R. Crump, J. Sutherland, Vancouver, BC, Canada; Milwaukee, WI Differences in Cognitive Function between Propofol and Midazolam following Colonoscopy Monday Monitor #7, located in Hall C Foyer (by registration) Outcomes E. Changchien, S. Paim, J. Hughes, M. Murday, J. Waldron, A. Crume, J. Griffin, Salt Lake City, UT P1136 Patient Goals in Rectal Prolapse Monday Monitor #2, located in Hall C Other Benign Disease S. Adams, T. Curran, T. Cataldo, V. Poylin, D. Nagle, Boston, MA Clinical Study of the TST STARR Plus in the Treatment of Obstructed Defecation Syndrome Monday Monitor #5, located in Hall C Other Benign Disease Z. Zhang, Xuzhou, China Perineal Antropyloric Transposition for Total Anorectal Reconstruction: Predictors of Graft Survival and Functional Outcomes Sunday Monitor #4, located in Hall C Other Benign Disease A. Chandra, S. Kumar, V. Gupta, S. Singh, N. M., B. Mishra, U. Ghoshal, A. Kumar, Lucknow, India Long-Term Outcomes of Conservative Management following Successful Nonoperative Treatment of Acute Diverticulitis with Abscess: A Systematic Review Tuesday Monitor #2, located in Hall C Other Benign Disease A. Kugler, A. Al-Khamis, N. Morin, P. Gordon, C. Vasilevsky, G. Ghitulescu, J. Faria, M. Demian, M. Boutros, Montreal, QC, Canada *All ePoster presenters are listed first unless otherwise noted. 119 EPOSTERS ePoster Presentations ePoster Presentations P1137 Outcomes after Transvaginal Rectocoele Repair and Levatorplasty Monday Monitor #5, located in Hall C Other Benign Disease M. Osman, A. Hainsworth, A. Schizas, A. Williams, London, United Kingdom P1138 Implementation of an ERAS Pathway in an Academic Medical Center: Measurement of Compliance and Results Monday Monitor #3, located in Hall C Outcomes A. Henry, M. Stopfkuchen-Evans, L. Wolf, A. Bader, J. Goldberg, R. Kelley, R. Bleday, Boston, MA P1139 Does Ligation of Intersphincteric Fistula Tract (LIFT) Stand the Test of Time? An Extended Review of our Experience with Complex Fistulain-ano Monday Monitor #4, located in Hall C Other Benign Disease B. MacLaughlin, W. Liu, A. Aboulian, R. Kumar, Torrance, CA P1140 A Fading Threat? Does the Severity of FAPassociated Desmoid Tumors Decline with Age? Monday Monitor #9, located outside Room 304 Other Benign Disease X. Xhaja, J. Church, Cleveland, OH P1141 Predictors of Perineal Wound Complications and Prolonged Time to Perineal Wound Healing after Abdominoperineal Resection Sunday Monitor #5, located in Hall C Outcomes A. Althumairi, J. Canner, J. Sacks, S. Gearhart, B. Safar, E. Wick, S. Fang, J. Efron, Baltimore, MD P1142 P1143 Open vs. Laparoscopic Colectomy for Sigmoid Volvulus: An Assessment from the ACS NSQIP Monday Monitor #8, Outside Ballroom B Other Benign Disease E. Myers, E. Aytac, H. Kessler, Cleveland, OH P1144 Neutrophil-Lymphocyte Ratio and PlateletLymphocyte Ratio in Chronic Anal Fissure (CAF) Patients Monday Monitor #3, located in Hall C Other Benign Disease G. Bugdayci, N. Sengul, O. Arisoy, A. Cakir, Bolu, Turkey P1145 Developing a Diagnostic Paradigm for Identification of Internal Intestinal Fistulas: An Appraisal of Common Imaging Modalities Monday Monitor #5, located in Hall C Other Benign Disease I. Esemuede, A. Goel, N. Latchana, A. Harzman, M. Arnold, S. Husain, Columbus, OH P1146 Recurrence of Rectal Prolapse following Rectopexy: A Pooled Analysis of 532 Individual Patient Data Monday Monitor #2, located in Hall C Other Benign Disease C. Anderson, M. Bishawi, S. Tou, R. Bergamaschi, Stony Brook, NY P1147 Anal Fistula Plug for Treatment of High Anal Fistula: MRI Evidence Monday Monitor #4, located in Hall C Outcomes A. Zubaidi, M. Al-Rowais, T. Teraiki, O. Alobeed, K. AlKhayal, M. Alkubair, Riyadh, Saudi Arabia P1148 Laparoscopic Total Abdominal Colectomy for Chronic Constipation has a Safe Complication Profile: Data from the National Surgical Quality Improvement Program (NSQIP) Monday Monitor #2, located in Hall C Other Benign Disease S. Ramakrishnan, C. Klos, M. Mutch, S. Hunt, E. Birnbaum, S. Dharmarajan, M. Silviera, P. Wise, S. Glasgow*, Saint Louis, MO P1149 Ligation of the Intersphicteric Fistula Tract (LIFT): Best Treatment Option for Complex Fistula-In-Ano Monday Monitor #4, located in Hall C Other Benign Disease R. Hegde, N. Kaur, Z. Zhang, Waterbury, CT Feasibility of Laparoscopic Extended Pelvic Surgery for Rectal Cancer Monday Monitor #8, Outside Ballroom B Outcomes H. Nakamura, K. Uehara, A. Arimoto, T. Kato, T. Ebata, Y. Yokoyama, M. Nagino, Nagoya, Japan *All ePoster presenters are listed first unless otherwise noted. 120 P1150 Oncologic Outcomes in Rectal Cancer Patients with Distal Resection Margins ≤ 1 cm Tuesday Monitor #5, located in Hall C Outcomes D. Kandg, H. Kwak, N. Sung, J. Kwak, J. Kim, S. Kim, Seoul, Korea P1151 Study of the Location of Low Perirectal Arteries during Doppler-Guided Hemorrhoidal Artery Ligation and Rectoanal Repair (HAL-RAR): The Principle of the Three Hemorrhoidal Cushions Revisited in 150 Consecutive Patients Monday Monitor #3, located in Hall C Other Benign Disease J. Faucheron, H. Pflieger, Grenoble, France P1152 P1153 P1154 P1155 Complete Preservation of the Anal Sphincter Complex in Treating Deep Postanal Space Abscesses and Fistulas: A Paramedian Approach Monday Monitor #4, located in Hall C Other Benign Disease S. Ryu, Seoul, Korea Comparison of Risk Factors for Unplanned Conversion from Laparoscopic and Robotic to Open Colorectal Surgery using the Michigan Surgical Quality Collaborative Database Monday Monitor #9, located outside Room 304 Outcomes A. Bhama, C. Kaoutzanis, S. Regenbogen, S. Collins, A. Mullard, J. Vandewarker, G. Krapohl, J. Byrn, R. Cleary, Ann Arbor, MI; Iowa City, IA Electrothermal Bipolar Vessel Sealing System versus Monopolar Scissors and Clips in Laparoscopic Sigmoidectomy for Diverticulitis: A Comparative Study in 191 Consecutive Patients Monday, P1154 Monitor #8, Outside Ballroom B Other Benign Disease J. Faucheron, B. Trilling, Grenoble, France Efficacy of Fiber Monotherapy as Initial Treatment for Fecal Incontinence Patients Sunday, P1155 Monitor #4, located in Hall C Other Benign Disease R. Andrew, A. Stokes, E. Messaris, F. Puleo, Hershey, PA P1156 Industry Payments to Faculty Surgeons as a Potential Conflict of Interest in Colorectal Surgery Programs: An Assessment of Payments Identified through the Physician Financial Transparency Reports Tuesday Monitor #2, located in Hall C Outcomes S. Patel, E. Pappou, T. Sonoda, New York, NY P1157 Laparoscopic Ventral Rectopexy with Biologic Mesh for ODS and Complex Pelvic Floor Disorders Monday Monitor #5, located in Hall C Other Benign Disease L. Lenisa, A. Stuto, A. Rusconi, A. Braini, F. Da Pozzo, J. Megevand, Milano, Italy; Pordenone, Italy P1158 Diverticular Abscess Managed with Long-Term Definitive Nonoperative Intent is Safe Tuesday Monitor #2, located in Hall C Other Benign Disease R. Garfinkle, A. Kugler, V. Pelsser, N. Morin, P. Gordon, C. Vasilevsky, G. Ghitulescu, J. Faria, L. Feldman, M. Boutros, Montreal, QC, Canada P1159 Laparoscopic and Robotic Colorectal Surgery: An Institutional Cost Comparison Monday Monitor #9, located outside Room 304 Outcomes A. Yang, R. Cleary, K. Welch, S. Winter, Ann Arbor, MI; Grand Rapids, MI P1160 Intestinal Obstruction, Totally Laparoscopic Approach. Texas Endosurgery Institute Experience Monday Monitor #8, Outside Ballroom B Other Benign Disease M. Hernandez, San Antonio, TX P1161 Outcome after Reversal of Hartmann Procedure by Body Mass Index (BMI) Monday Monitor #1, located in Hall C Other Benign Disease G. Hwang, D. Rosen, A. Glenn, A. Ortega, J. Carmichael, S. Mills, A. Pigazzi, K. Cologne, Orange, CA; Los Angeles, CA P1162 The Association of Modified Frailty Index (MFI) with Mortality in Patients Undergoing Ileostomy Creation Tuesday Monitor #4, located in Hall C Outcomes A. Chung, P. Nona, C. Reickert, S. Nalamati, Detroit, MI *All ePoster presenters are listed first unless otherwise noted. 121 EPOSTERS ePoster Presentations ePoster Presentations P1163 Comparison of Outcomes Undergoing Laparoscopic Ventral Mesh Rectopexy: Biological vs Synthetic Mesh Monday Monitor #5, located in Hall C Other Benign Disease R. Padwick, R. Evans, D. Latham, M. Farmer, V. Garimella, Leamington Spa, United Kingdom P1164 Sacral Nerve Stimulation for Chronic Constipation: Follow-up Results Monday Monitor #2, located in Hall C Other Benign Disease M. Antonelli, V. Giaccaglia, M. Mazzi, C. Ghini, M. Radicchi, A. Stazi, Velletri, Italy P1165 Therapeutic Evaluation of Biofeedback Therapy in the Treatment of Anterior Resection Syndrome after Sphincter-Saving Surgery for Rectal Cancer Monday Monitor #2, located in Hall C Outcomes Z. Liang, P. Du, L. Cui, Shanghai, China P1166 P1167 P1168 P1169 Sigmoid Resection Rectopexy with Concomitant Mesh Sacrocolpopexy: Review of Safety Profile Monday Monitor #2, located in Hall C Other Benign Disease A. Ghlandian, T. Li, B. Shanker, B. Murray, J. Gallagher, B. Kudish, K. Jones, A. Ferrara, Orlando, FL Be Acupuncture Combined with Biofeedback Superior to Biofeedback in Functional Anorectal Pain Treatment? A Retrospective Controlled Study from a Referral Center in China Monday Monitor #3, located in Hall C Other Benign Disease S. Ding, Y. Ding, Y. Xue, X. Jin, H. Zhou, Nanjing, China Access to Care Trends in Rectal Cancer from 2001 to 2012 using the National Cancer Database Tuesday Monitor #2, located in Hall C Outcomes K. Butler, C. Shaw, A. Iqbal, S. Tan, Gainesville, FL P1170 Outcomes in Diverticulitis Patients with Intramural Abscesses Tuesday Monitor #2, located in Hall C Other Benign Disease R. Bendl, M. Freitas, C. Littlejohn, Stamford, CT P1171 Making Sense of Collaboration and Quality in Colorectal Cancer Surgery – The Ottawa Communities of Practice (TO-CoP) Model Monday Monitor #2, located in Hall C Outcomes R. Helewa, M. Fung-Kee-Fung, M. Mamdani, R. Auer, S. Hawken, K. Abdulaziz, F. Haggar, R. Boushey, Ottawa, ON, Canada; Toronto, ON, Canada P1172 Toward the Ideal Anesthetic for Reducing the Rate of Urinary Retention after Anorectal Outpatient Procedures: Hyperbaric Spinal Anesthesia Monday Monitor #3, located in Hall C Other Benign Disease C. Johnson, M. Mahmoud, L. Kosinski, K. Ludwig, T. Ridolfi, Milwaukee, WI P1173 Clinical Implications of Paradoxical Contractions on Manometry in Patients with Ileal Pouch-Anal Anastomosis (IPAA) Sunday Monitor #8, Outside Ballroom B Other Benign Disease D. Seyidova Khoshknabi, T. Schroeder, B. Shen, F. Remzi, Cleveland, OH P1174 Stoma Prolapse – Is There a Superior Approach to Repair? Tuesday Monitor #4, located in Hall C Outcomes T. Jalouta, Grand Rapids, MI P1175 Open Retromuscular Repair of Parastomal Hernias Tuesday Monitor #4, located in Hall C Other Benign Disease J. Warren, A. Grant, A. Carbonell, C. McFadden, J. Rex, W. Cobb, Greenville, NC P1176 Medical vs. Surgical patients with Clostridium difficile Infection: Is There any Difference? Monday Monitor #3, located in Hall C Other Benign Disease J. Silva Velazco, T. Hull, C. Messick, J. Church, Cleveland, OH; Houston, TX Translevator Ventral Rectopexy: The PeriOperative and Short-Term Outcomes Monday Monitor #5, located in Hall C Other Benign Disease A. Techagumpuch, P. Kanjanasilp, S. Malakorn, J. Pattana-arun, Bangkok, Thailand *All ePoster presenters are listed first unless otherwise noted. 122 P1177 Does Flap Closure of the Perineal Wound Affect Organ Space Surgical Infection following Abdominoperineal Resection? Sunday Monitor #5, located in Hall C Outcomes P. Solan, R. Madoff, G. Melton-Meaux, M. Kwaan, St. Paul, MN P1184 Does One Score Fit All? Measuring Risk in Ulcerative Colitis Sunday Monitor #8, Outside Ballroom B Outcomes D. Keller, K. Cologne, R. Tahilramani, J. FloresGonzalez, A. Senagore, E. Haas, Los Angeles, CA; Cleveland, OH; Houston, TX P1178 Long-Term Results for 82 Consecutive Patients Undergoing Sacral Nerve Stimulation for Fecal Incontinence Sunday Monitor #4, located in Hall C Other Benign Disease B. Martin-Perez, C. Kang, T. deBeche-Adams, A. Bertot, K. Badillo, S. Annaberdyev, L. Hunter, G. Nassif, P. Mancuso, S. Larach, M. Albert, S. Atallah, Orlando, FL P1185 Video Endoscopic Treatment for Complex Anal Fistula: Long-Term Follow-up of the First Mexican Experience Monday Monitor #4, located in Hall C Other Benign Disease J. Villanueva-Herrero, M. Sandoval-Martinez, Y. Alarcon-Bernes, B. Jimenez-Bobadilla, Mexico City, Mexico P1186 P1179 Endosponge Treatment of Anastomotic Leaks Monday Monitor #7, located in Hall C Foyer (by registration) Other Benign Disease G. Milito, G. Lisi, Marino, Italy P1180 Evaluating Long-Acting Liposomal Bupivacaine on Clinical and Financial Outcomes in Laparoscopic Colorectal Surgery Monday Monitor #1, located in Hall C Outcomes D. Keller, R. Pedraza, R. Tahilramani, M. Ragupathi, J. Flores-Gonzalez, S. Ibarra, T. Pickron, E. Haas, Houston, TX Do Morbidly Obese Patients have More Clinical and Manometric Pelvic Floor Abnormalities in Comparison to Nonobese Patients? Results of a Case-Matched Study Monday Monitor #1, located in Hall C Other Benign Disease I. Correa Neto, R. Pinto, S. Nahas, J. Jorge, L. Bustamante-Lopez, C. Nahas, C. Sparapan Marques, I. Cecconello, San Paulo, Brazil P1187 Lay Open (Deroofing) Plus Curettage vs. Excision with Primary Closure as the Treatment of Pilonidal Sinus Disease: A MetaAnalysis of Randomized Controlled Trials and a Systematic Review of Lay Open (Deroofing) Plus Currettage Procedure for Pilonidal Sinus Monday Monitor #6, located in Hall D Other Benign Disease P. Garg, V. Gupta, P. Lakhtaria, Panchkula, India; Chandigarh, India, New York, NY P1188 Comparison between Sphincteroplasty and Sacral Nerve Stimulation for Treatment of Anal Incontinence Patients with Sphincter Injuries Sunday Monitor #4, located in Hall C Other Benign Disease S. Wexner, F. Rodrigues, S. Chadi, A. Cracco, G. DaSilva, D. Sands, Weston, FL P1190 Private Insurance may Influence Operative Managment in Acute Diverticulitis Tuesday Monitor #2, located in Hall C Other Benign Disease M. Coburn, J. Mayoral, S. Izfar, San Antonio, TX P1181 Parastomal Hernia Repairs: To Bring Chaos Into Order? Tuesday Monitor #4, located in Hall C Other Benign Disease L. Goldstein, S. Schechter, N. Shah, N. Gibson, Providence, RI P1182 Hemorrhoidectomy with Ligasure™ Monday Monitor #6, located in Hall D Other Benign Disease G. Milito, G. Lisi, Marino, Italy P1183 Evaluating Clinical and Economic Outcomes in Open versus Minimally Invasive Colorectal Surgery Tuesday Monitor #1, located in Hall C Outcomes D. Keller, L. Hashemi, C. Delaney, E. Haas, Cleveland, OH; Mansfield, MA; Houston, TX *All ePoster presenters are listed first unless otherwise noted. 123 EPOSTERS ePoster Presentations ePoster Presentations P1191 Anal Acoustic Reflectometry is a Test of the Internal Anal Sphincter? Monday Monitor #3, located in Hall C Other Benign Disease J. Nicholson, A. Worthington, W. deMello, K. Telford, E. Kiff, Manchester, United Kingdom P1198 Readmission Recidivism, Why and How Often? Monday Monitor #4, located in Hall C Outcomes B. Almussallam, P. Marcello, P. Roberts, D. Schoetz, L. Rusin, T. Read, J. Hall, T. Francone, R. Ricciardi, Burlington, MA P1192 Gunshot Wounds to the Colon: Predictive Risk Factors for the Development of Postoperative Complications during the Libyan Civil War 2011 (A Single Center Experience) Tuesday Monitor #4, located in Hall C Outcomes O. El-Faedy, R. Sehgal, S. Mansor, Kilkenny, Ireland; Benghazi, Libya P1199 Comparing Outcomes from Robotic, Laparoscopic, and Open Rectopexy: A Single Group Experience Monday Monitor #9, located outside Room 304 Other Benign Disease D. Halleran, D. Nesbitt, J. Nicholson, J. Zeigler, M. Moffa, M. Plocek, T. Ruddy, Syracuse, NY P1200 P1193 Making the Most of a Stoma: How Comfortable are Today’s General Surgery Residents with Stoma Marking and Perioperative Care Tuesday Monitor #4, located in Hall C Other Benign Disease L. Araujo, V. Pontieri-Lewis, N. Patel, C. Rezac, T. Eisenstat, S. Trooskin, East Brunswick, NJ Treatment of Supralevator Anal Fistula and Abscess with Electrocauterization of Internal Opening, Drainage and Curettage of the Tracts (PERFACT Procedure) Monday Monitor #5, located in Hall C Other Benign Disease P. Garg, V. Gupta, P. Lakhtaria, Panchkula, India; Chandigarh, India; New York, NY P1194 Response of the Anal Canal to Stretch and Anal Acoustic Reflectometry Monday Monitor #3, located in Hall C Other Benign Disease J. Nicholson, A. Sharma, K. Telford, E. Kiff, Manchester, United Kingdom P1201 P1195 Minimally Invasive Surgery in the Obese, Morbidly Obese and Super Obese Monday Monitor #1, located in Hall C Outcomes M. Ragupathi, J. LeFave, S. Ibarra, J. Sandhu, A. Mahmood, T. Pickron, L. Haubert, E. Haas, Houston, TX Quality Improvement Initiatives in Colorectal Surgery: Process Improvement or Hawthorne Effect? Monday Monitor #2, located in Hall C Outcomes J. Waters, P. Marcello, P. Roberts, D. Schoetz, T. Read, L. Rusin, J. Hall, T. Francone, R. Ricciardi, Burlington, MA P1202 Management of Complicated Diverticulitis: First is Worst Tuesday Monitor #2, located in Hall C Other Benign Disease P. White, J. Blumetti, V. Chaudhry, J. Harrison, J. Cintron, H. Abcarian, Chicago, IL P1203 Role of VAAFT (Video-Assisted Anal Fistula Treatment) in the Management of Primary and Recurrent Complex Anal Fistula Monday Monitor #4, located in Hall C Other Benign Disease A. Stazi, C. Ghini, V. Giaccaglia, M. Mazzi, M. Radicchi, M. Antonelli, P. Meinero, Velletri, Italy; Chiavarese, Italy P1204 Readmissions after Colectomy for Cancer – A NSQIP Analysis Monday Monitor #4, located in Hall C Outcomes R. Venkat, C. Martinez, V. Nfonsam, Tucson, AZ P1196 P1197 Factors Associated with Morbidity following Sacral Neurostimulation for Fecal Incontinence: Beware of the High Risk Groups Sunday Monitor #4, located in Hall C Other Benign Disease A. Cracco, A. Chadi, F. Rodrigues, M. Zutshi, B. Gurlanb, S. Wexner, G. DaSilva, Weston, FL; Cleveland, OH Colonoscopy in the Hispanic Community: Is Earlier Screening Warranted? Monday Monitor #7, located in Hall C Foyer (by registration) Other Benign Disease J. Harrison, J. Blumetti, V. Chaudhry, J. Cintron, H. Abcarian, Chicago, IL *All ePoster presenters are listed first unless otherwise noted. 124 P1205 Using Transcutaneous Neuromodulation Therapy of Posterior Tibial Nerve Stimulation (TENS) in Adult Patients with Encopresis Monday Monitor #2, located in Hall C Other Benign Disease M. Rosado, E. Vega Chavarria, H. Solares Sanchez, Mexico City, Mexico P1212 Elective Laparoscopic Sigmoidectomy for Complicated Diverticulitis in a UK Community Hospital Tuesday Monitor #2, located in Hall C Other Benign Disease I. Mallick, B. Bandyopadhyay, A. Rahimzada, K. Sasapu, Grimsby, United Kingdom P1206 Predictors of Outcome after Local Repairing Operation for Rectovaginal Fistulas: The Experience in a Single Institution Monday Monitor #5, located in Hall C Other Benign Disease J. Fu, P. Du, L. Cui, Shanghai, China P1213 P1207 Predictors of One-Year Outcomes after Abdominoperineal Resection Tuesday Monitor #1, located in Hall C Outcomes S. Binboga, M. Abbas, M. Costedio, L. Stocchi, D. Dietz, E. Gorgun, Cleveland, OH Irrigation of Incisions with 0.05% Chlorhexidine Reduces Surgical Site Infections in Colorectal Surgery Monday Monitor #9, located outside Room 304 Outcomes N. Dotson, S. Rasheid, J. Marcet, J. Sanchez, Tampa, FL P1214 A Population Based Comparison of NonElective Open vs. Minimally Invasive Complex Colorectal Procedures Tuesday Monitor #1, located in Hall C Outcomes A. Schlussel, M. Lustik, E. Johnson, J. Maykel, B. Champagne, A. Damle, H. Ross, S. Steele, Honolulu, HI; Fort Lewis, WA; Worcester, MA; Cleveland, OH; Philadelphia, PA P1215 Trends in Emergent Surgical Management of Diverticulitis: A National Study on Clinical and Financial Outcomes Tuesday Monitor #2, located in Hall C Other Benign Disease N. Madhoun, D. Keller, J. LeFave, L. Haubert, A. Mahmood, T. Pickron, E. Haas, Houston, TX P1216 Objective Prognostic Preoperative Prediction of a Difficult Pelvic Dissection: Pelvic Surgery Difficulty Index Tuesday Monitor #1, located in Hall C Outcomes A. Raza, A. Khan, S. Tan, S. Hughes, A. Iqbal, Gainesville, FL P1217 Patient Engagement and Colorectal Surgery: The Role of the NSQIP Risk Calculator Tuesday Monitor #1, located in Hall C Outcomes A. Chin, D. Galante, D. Hobson, C. Wu, E. Wick, Baltimore, MD P1208 P1209 P1210 P1211 Acute Healthcare Resource Utilization following Outpatient Anorectal Procedures Tuesday Monitor #2, located in Hall C Outcomes R. Brown, J. Fox, J. Tyler, Biloxi, MI; Philadelphia, PA Multi-Institutional Experience with Rectal Prolapse in Men – Functional Outcomes are Not Well Evaluated Monday Monitor #2, located in Hall C Other Benign Disease V. Poylin, M. Kapadia, R. Rahbar, J. Irani, Boston, MA; Iowa City, IA; Chapel Hill, NC Predictors of Wound Dehiscence and its Impact on Mortality after Abdominoperineal Resection: Data from the National Surgical Quality Improvement Program Tuesday Monitor #1, located in Hall C Outcomes S. Binboga, E. Gorgun, A. Rencuzogullari, G. Ozuner, H. Kessler, M. Abbas, Cleveland, OH EP4 Agonist Decreases the Risk of Anastomotic Leakage Caused by NSAIDs after Colorectal Surgery Monday Monitor #8, Outside Ballroom B Outcomes R. Mizuno, Y. Okuchi, Y. Sakai, Kyoto, Japan *All ePoster presenters are listed first unless otherwise noted. 125 EPOSTERS ePoster Presentations ePoster Presentations P1218 P1219 P1220 P1221 P1222 P1223 ”LIFT (Ligation of the Intersphincteric Fistula Tract) versus VAAFT (Video Assisted Anal Fistula Treatment): A Comparative Study of Two Minimally Invasive Procedures for Perianal Fistulas Treatment” Monday Monitor #4, located in Hall C Other Benign Disease V. Giaccaglia, M. Mazzi, C. Ghini, P. Meinero, M. Radicchi, M. Antonelli, A. Stazi, Velletri, Italy; Chiavarese, Italy Impact of Colorectal Specialization in Left Colonic Perforation – Learning Curve in a Reference Center over 10 Years Tuesday Monitor #1, located in Hall C Outcomes T. Golda, E. Kreisler, G. Rodriguez, R. Frago, L. Trenti, D. Fraccalvieri, J. Lopez-Borao, S. Biondo, L’Hospitalet de Llobregat, Spain Incidence of Ischemic Colitis after Abdominal Aortic Aneurysm Repair: Results from the National Surgical Quality Improvement Program database Monday Monitor #9, located outside Room 304 Outcomes M. Abou Khalil, J. Abou Khalil, M. Boutros, P. Gordon, D. Obrand, Montreal, QC, Canada The Impact of Obesity on the Management of Horseshoe Fistulas Monday Monitor #1, located in Hall C Other Benign Disease D. Hiller, J. Bohl, G. Waters, Winston-Salem, NC Process Improvement for Laparoscopic Colorectal Surgery with an Enhanced Recovery Pathway: Does Alvimopan Add Value? Monday Monitor #3, located in Hall C Outcomes J. LeFave, D. Keller, S. Ibarra, J. Flores-Gonzalez, M. Ragupathi, A. Mahmood, T. Pickron, E. Haas, Houston, TX Screening or Symptoms? How Do We Detect Colorectal Cancer in an Equal Access Health Care System? Tuesday Monitor #2, located in Hall C Outcomes Q. Hatch, K. Kniery, E. Johnson, D. Moiel, J. Thompson, S. Steele, Lakewood, WA, Tacoma, WA, Fort Lewis, WA, Portland, OR P1224 Long-Term Efficacy of the TOPAS™ System for Treatment of Fecal Incontinence Sunday Monitor #4, located in Hall C Other Benign Disease D. Fenner, M. Zutshi, V. Lucente, P. Culligan, A. Mellgren*, Ann Arbor, MI; Cleveland, OH; Morristown, NJ; Philadelphia, PA; Chicago, IL P1225 Creation of a Pharmacoeconomic Calculator for Clinical and Financial Outcomes in Colorectal Surgery Tuesday Monitor #4, located in Hall C Outcomes D. Keller, A. Smalarz, J. LeFave, R. Tahilramani, J. Flores-Gonzalez, S. Ibarra, R. Pedraza, E. Haas, Houston, TX P1226 Institution of a Preoperative Stoma Education Group Class Decreases Rates of Peristomal Complications in New Stoma Patients Tuesday Monitor #4, located in Hall C Outcomes A. Stokes, S. Tice, P. Wocn, W. Koltun, F. Puleo, Hershey, PA P1227 Venous Thromboembolism Outcomes after Partial Colectomies in Patients with Colon Cancer: The Role of Operative Time Monday Monitor #2, located in Hall C Outcomes N. Changoor, G. Ortega, D. Bezzini, T. Seyoum, R. Diaz-Acosta, L. Wilson, D. Ford, Washington, DC P1228 TSTstarr+ versus Stapled Hemorrhoidopexy for Grade III-IV Prolapsing Hemorrhoids: A Prospective Clinical Trial Monday Monitor #6, located in Hall D Other Benign Disease H. Lin, J. Li, D. Ren, Guangzhou, China P1229 Does Use of Alvimopan Facilitate Earlier Recovery after Loop Ileostomy Closure? Monday Monitor #1, located in Hall C Outcomes S. Chao, S. Schechter, J. Machan, A. Klipfel, M. Vrees, Providence, RI P1230 Failure of Initial Ligation of Intersphincteric Fistula Tract does not Preclude Ultimate Success Monday Monitor #5, located in Hall C Other Benign Disease F. Chen, U. Wallin, C. Jensen, S. Goldberg, Sylmar, CA; St. Paul, MN; Iowa City, IA *All ePoster presenters are listed first unless otherwise noted. 126 P1231 Primary vs. Delayed Perineal Proctectomy – There is No Free Lunch Monday Monitor #8, Outside Ballroom B Outcomes V. Poylin, T. Curran, T. Cataldo, D. Nagle, Boston, MA P1232 Sessile Serrated Adenoma Detection-Predictive Factors Monday Monitor #2, located in Hall C Outcomes R. Daigle, R. Hilsden, W. Buie, I. Datta, J. Heine, M. Brar, A. MacLean, Calgary, AB, Canada P1233 P1234 P1235 P1236 Rectovaginal Fistula Repair: What is the ”Gold Standard?” Monday Monitor #5, located in Hall C Other Benign Disease K. Stackhouse, T. Hull, A. Nowacki, B. Gurland, S. Shawki, M. Zutshi, Cleveland, OH Identifying and Evaluating Postoperative Complications and Morbidity in Ileostomy Patients Tuesday Monitor #4, located in Hall C Outcomes Y. van Loon, M. van Heijst, B. Langenhoff, I. Martijnse, D. Wasowicz, D. Zimmermann, Tilburg, Netherlands Intestinal Failure Secondary to Enterocutaneous Fistulae: Long-Term Outcomes in a Tertiary Referral Center – A 15-Year Experience Monday Monitor #5, located in Hall C Other Benign Disease M. Quinn, R. McKee, Glasgow, United Kingdom Age is an Important Determinant of Mortality following Curative Resections for Mid and Low Rectal Carcinoma: Results from ACS NSQIP Database Tuesday Monitor #2, located in Hall C Outcomes J. Makhlin, A. Kezouh, N. Morin, G. Ghitulescu, P. Gordon, C. Vasilevsky, M. Demian, M. Boutros, Montreal, QC, Canada P1237 A Randomized, Double-Blind, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron Injection of Nausea and Vomiting Associated with Patient-Controlled Analgesia in Colorectal Cancer Patients Undergoing Laparoscopic Colectomy Monday Monitor #1, located in Hall C Outcomes J. Lee, M. Kim, W. Kang, Seoul, Korea P1238 Hand-Assisted Laparoscopic Approach in Colorectal Surgery Monday Monitor #8, Outside Ballroom B Outcomes Z. Moghadamyeghaneh, M. Hanna, J. Carmichael, S. Mills, A. Pigazzi, M. Stamos, Orange, CA P1239 Incidence of Incisional Hernias following Multiport and Single Incision Robotic Colorectal Surgery Monday Monitor #8, Outside Ballroom B Other Benign Disease J. Harr, Y. Juo, S. Luka, S. Agarwal, F. Brody, V. Obias, Washington, DC P1240 Colorectal Stenting: A Nationwide Appraisal of Trends and Outcomes Tuesday Monitor #3, located in Hall C Outcomes M. Hanna, Z. Moghadamyeghaneh, G. Hwang, L. Malellari, S. Mills, M. Stamos, A. Pigazzi, J. Carmichael, Orange, CA P1241 A Randomized, Controlled Study of Stoma Intubation at the Time of Formation Tuesday Monitor #4, located in Hall C Outcomes D. Shaw, C. Ternent, J. Beaty, G. Blatchford, N. Bertelson, M. Shashidharan, J. Bikhchandani, A. Thorson, Omaha, NE P1242 Small Bowel Evaluation with Capsule Endoscopy and Deep Enteroscopy: Initial Experience of a Brazilian Teaching Hospital Monday Monitor #9, located outside Room 304 Other Benign Disease M. Camargo, C. Nagasako, C. Martinez, J. Fagundes, M. Ayrizono, J. Meirelles-Santos, R. Leal, C. Coy, Campinas, Brazil *All ePoster presenters are listed first unless otherwise noted. 127 EPOSTERS ePoster Presentations ePoster Presentations P1243 Preliminary Results of Postdischarge Venous Thromboembolism Prophylaxis of Patients Undergoing Colorectal Resections Monday Monitor #2, located in Hall C Outcomes Z. Gregg, C. Choi, G. Ortenzi, F. Puleo, D. Stewart, K. McKenna, W. Koltun, E. Messaris, Hershey, PA P1250 Effect of Exparel® TAP Infiltration on Postoperative Outcomes after Laparoscopic Colectomy Monday Monitor #1, located in Hall C Outcomes E. Lagergren, C. Bourean, J. Reynolds, J. Jaffe, G. Russell, G. Waters, J. Bohl, Winston Salem, NC P1244 Surgical Outcomes of Colorectal Cancer Surgery According to Specific Body Mass Index Groups Monday Monitor #1, located in Hall C Outcomes M. Jafari, F. Jafari, M. Phelan, M. Stamos, J. Carmichael, S. Mills, A. Pigazzi, Orange, CA P1251 P1245 Anoplasty for Fissures: Risk Factors for Recurrence and Complications Monday Monitor #3, located in Hall C Other Benign Disease A. Curry, J. Gallagher, A. Ferrara, M. Renee, P. Williamson, S. DeJesus, M. Soliman, A. Ghlandian, B. Shanker, R. Vegeler, J. Zakhaleva, Orlando, FL Compliance with Clinical Guidelines is the Most Important Prognostic Factor in Patients with Clostridium difficile Infection Monday Monitor #9, located outside Room 304 Other Benign Disease K. Crowell, K. Julian, M. Katzman, D. Stewart, W. Koltun, E. Messaris, Hummelstown, PA, Hershey, PA P1252 Assessment of Bowel End Perfusion after Mesenteric Division: Eye vs. SPY Monday Monitor #8, Outside Ballroom B Outcomes J. Bornstein, J. Deliz, D. Kruse, M. Sgouros, C. Chen, S. Khaitov, D. Chessin, T. Ferguson, S. Gorfine, J. Bauer, New York, NY; Greenville, NC P1246 Does a Protective Ileostomy Eliminate the Benefit of Alvimopan in Elective Surgery? Tuesday Monitor #4, located in Hall C Outcomes M. Sippey, K. Spaniolas, K. Kasten, M. Manwaring, Greenville, NC P1254 Short- and Long-Term Results of Anal Fissure Treatment with Botulinum Toxin Monday Monitor #3, located in Hall C Other Benign Disease G. Palominos, C. Villalon, D. Palominos, F. Bellolio, M. Molina, Santiago, Chile P1247 Neoadjuvant Treatment for Rectal Cancer Impacts Continence in Patients Undergoing Transanal Endoscopic Microsurgery Tuesday Monitor #1, located in Hall C Other Benign Disease J. Zakhaleva, A. Ferrara, J. Gallagher, S. DeJesus, M. Renee, M. Soliman, R. Vegeler, A. Ghlandian, Orlando, FL P1256 Risk Factors Associated with 30-Day Readmissions: A Snapshot of Regional Practice Experience in Colorectal Surgery Monday Monitor #4, located in Hall C Outcomes B. Hensley, R. Cooney, N. Hellenthal, J. Monson, K. Noyes, K. Kelly, F. Fleming, Rochester, NY; Syracuse, NY; Cooperstown, NY P1248 Effect of Transfusion Threshold on Infectious Complications after Rectal Cancer Surgery Tuesday Monitor #4, located in Hall C Outcomes V. Ozben, E. Gorgun, L. Stocchi, J. Ashburn, X. Liu, F. Remzi, Cleveland, OH P1257 The Association of Levator Ani Syndrome with Sacroiliac Dysfunction Monday Monitor #6, located in Hall D Other Benign Disease R. Cali, Tyler, TX P1258 P1249 Postoperative Ileus is a Significant Problem after Colorectal Surgery Even in an Enhanced Recovery Protocol Monday Monitor #3, located in Hall C Outcomes D. Estrada Trejo, A. van Dalen, R. Teja Pasam, A. Murray, J. Rein, S. Lee-Kong, D. Feingold, R. Kiran, New York, NY Does Early Removal of Urinary Catheter Affect Urinary Complications after Pelvic Colorectal Surgery? Practic Changes Monday Monitor #9, located outside Room 304 Outcomes C. Benlice, E. Gorgun, L. Stocchi, H. Kessler, F. Remzi, Cleveland, OH *All ePoster presenters are listed first unless otherwise noted. 128 P1259 Sacral Neuromodulation for Fecal Incontinence Associated with Obstetric Anal Sphincter Injury: Results from SNM-Test Sunday Monitor #4, located in Hall C Other Benign Disease M. Rydningen, T. Dehli, M. Stedenfeldt, M. Kumle, R. Lindsetmo, S. Norderval, Tromsoe, Norway; Narvik, Norway P1260 Readmission after Rectal Cancer Surgery: Does Ostomy Status Matter? Monday Monitor #4, located in Hall C Outcomes M. Hanna, G. Hwang, Z. Moghadamyeghaneh, M. Phelan, S. Mills, M. Stamos, A. Pigazzi, J. Carmichael, Orange, CA P1267 Treatment of Hemorrhoids and Obstructed Defecation Syndrome with a New Device: TST STARR Plus Monday Monitor #6, located in Hall D Other Benign Disease F. Pakravan, C. Helmes, K. Wolff, Duesseldorf, Germany P1268 Frailty as a Predictor of Discharge Destination following Colorectal Surgery Tuesday Monitor #1, located in Hall C Outcomes A. Stefanou, Y. Lin, K. Welch, R. Cleary, Ypsilanti, MI P1270 Increased Operative Time and Intraoperative Blood Transfusion are Associated with Postoperative Anastomotic Leak Monday Monitor #8, Outside Ballroom B Outcomes K. Gross, G. Alex, C. Cortina, J. Smolevitz, V. Fleetwood, S. Sarvepalli, S. Bakhsh, J. Poirier, M. Singer, J. Myers, B. Orkin, Chicago, IL P1262 Anorectal Function after Intersphincteric Resection for Ultra-low Rectal/Anal Cancer Can Improve in Long-term Recovery Monday Monitor #2, located in Hall C Outcomes Z. Gan, X. Wang, R. A, J. Nie, L. Li, Chengdu, China P1263 Functional Evaluation of Obese Patients with Pelvic Floor Disorders Monday Monitor #1, located in Hall C Other Benign Disease D. Lima, G. Kurachi, U. Sagae, F. Regadas, S. Murad-Regadas, Cascavel, Brazil; Fortaleza, Brazil P1271 Anal Fistulas without Internal Opening: Results of Treatmemt Compared to Anal Fistulas with Internal Opening Monday Monitor #5, located in Hall C Other Benign Disease E. Han, S. Ryoo, B. Park, J. Park, E. Choe, S. Moon, S. Jeong, K. Park, Seoul, Korea P1264 Utility of MELD Core as an Independent Predictor of Morbidity and Mortality following Rectal Surgery Tuesday Monitor #1, located in Hall C Outcomes G. Hwang, Z. Moghadamyeghaneh, M. Hanna, J. Carmichael, S. Mills, M. Stamos, A. Pigazzi, Orange, CA P1272 National Trends in Short-Term Outcomes following Surgery for Diverticular Disease Tuesday Monitor #2, located in Hall C Outcomes C. Papageorge, G. Kennedy, E. Foley, C. Heise, B. Harms, E. Carchman, Madison, WI P1274 A Qualitive Exploration of the Attitudes and Experiences of Patients Diagnosed with Advanced Stage Colorectal Cancer in a Safetynet Hospital System Monday Monitor #2, located in Hall C Outcomes S. Millas, M. Leal, B. Karanjawala, R. Escamilla, D. Lew, L. Kao, Houston,TX P1266 The Transversus Abdominis Plane Block: A Prospective Randomized Controlled Trial using EXPARELE Monday Monitor #1, located in Hall C Outcomes N. Jrebi, J. Ogilvie, T. Jaluta, R. Figg, N. Dujovny, M. Luchtefeld, P. Grady, A. Davis, T. Asgeirsson, Morgantown, WV; Grand Rapids, MI *All ePoster presenters are listed first unless otherwise noted. 129 EPOSTERS ePoster Presentations ePoster Presentations P1275 P1277 P1278 P1279 Intra-Incisional Depot Bupivacaine Reduces Pain Intensity and Opioid Consumption for 72 hours following Open Laparotomy, Compared with Bupivacaine HC Monday Monitor #1, located in Hall C Outcomes H. Papaconstantinou, J. Marcet, D. Ellis, J. Meisner, A. Hadj, Temple, TX; Tampa, FL; Cupertino, CA; Melbourne, VIC, Australia Pilot Study on the Safety, Usability and Performance of Lifeseal in Patients Undergoing an Elective Cicular Stapled Anastomosis within 10CM of the Anal Verge Monday, Monitor #2, located in Hall C Outcomes L. Pahlman, K. van der Speeten, J. Folkesson, Y. Van Nieuwenhove, I. Syk, A. Martling, H. Tulchinsky, A. D’Hoore, Uppsala, Sweden; Gent, Belgium; Stockholm, Sweden; Tel Aviv, Israel; Leuven, Belgium Colorectal Surgeons and Patient Hospital Experience. How Can HCAHPS Help to Understand This Relationship? Tuesday Monitor #2, located in Hall C Outcomes L. Duraes, L. Stocchi, F. Remzi, J. Merlino, B. Gurland, Cleveland, OH Determining the Indeterminate: One-Third of Indeterminate Pulmonary Nodules are Metastatic Cancer on Follow-Up Scans Monday Monitor #8, Outside Ballroom B Neoplastic Disease M. Oliveira-Cunha, M. Aslam, W. Thomas, Leicester, United Kingdom P1280 Histological Subtypes and KRAS Mutation Accentuates Poorer Prognosis in the Outcomes of Colorectal Cancer Peritoneal Carcinomatosis after Cytoreductive Surgery and HIPEC Monday Monitor #6, located in Hall D Neoplastic Disease A. Thien, Singapore P1281 Inhibition of NRF2 Sensitizes Colorectal Cancer Cells to Irinotecan Cytotoxicity Monday Monitor #6, located in Hall D Neoplastic Disease J. Evans, B. Winiarski, P. Sutton, P. Rooney, D. Palmer, N. Kitteringham, Chester, United Kingdom; Liverpool, United Kingdom P1282 Carcinoembryonic Antigen Level in the Setting of Microsatellite Instability Sunday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease M. Julien, K. Halm, H. Ellison, M. Shabahang, J. Blansfield, P. Meade, K. Quindlen, Danville, PA P1283 “Watch and Wait” Strategy after Complete Clinical Response following Neoadjuvant Chemoradiotherapy Results in a High Rate of Organ Preservation and Similar Oncological Outcomes Compared with Radical Surgery Sunday Monitor #1, located in Hall C Neoplastic Disease C. Vaccaro, J. Tognelli, G. Ojea Quintana, F. Bonadeo, F. Yazyi, R. Mentz, M. Sardi, G. Rossi, Buenos Aires, Argentina P1284 Local Excision Correlates with Poorer Prognosis in Patients with Anorectal Melanoma: A Bad Choice Maybe Tuesday Monitor #8, Outside Ballroom B Neoplastic Disease N. Chen, L. Wang, J. Gu, Beijing, China P1285 Cytoreductive Surgery and HIPEC Confers Prolonged Survival for Colorectal Peritoneal Metastases Monday Monitor #3, located in Hall C Neoplastic Disease G. Tan, C. Lim, C. Tham, K. Soo, M. Teo, Singapore P1286 Are Patients Willing to Accept an Increased Risk of Local Recurrence for Deferral of Surgery Relative to Abdominal Perineal Resection following Clinical Complete Response for Low Rectal Cancer? Sunday Monitor #5, located in Hall C Neoplastic Disease S. Schmocker, G. Heine, A. Borowiec, C. Brace, J. Victor, N. Baxter, R. McLeod, E. Kennedy, Toronto, ON, Canada; Kingston, ON, Canada; Edmonton, AB, Canada P1287 Neoadjuvant Therapy for Locally Advanced Rectal Adenocarcinoma: Relationship between Clinical and Pathological Responses Sunday Monitor #5, located in Hall C Neoplastic Disease C. Vaccaro, J. Santino, G. Ojea Quintana, F. Bonadeo, M. Falconi, F. Yazyi, R. Mentz, G. Rossi, Buenos Aires, Argentina *All ePoster presenters are listed first unless otherwise noted. 130 P1288 Prognostic Significance of Vascular Endothelial Growth Factor Receptor 3(VEGFR-3) Expression in Rectal Cancer Sunday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease S. Sokmen, C. Ulukus, A. Sirin, H. Ellidokuz, S. Sarioglu, M. Fuzun, Izmir, Turkey P1289 Defining the Rectosigmoid Junction Using MRI Sunday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease V. Tudyka, S. Balyasnikova, B. Moran, M. Abulafi, G. Brown, London, United Kingdom; Basingstoke, United Kingdom; Croydon, United Kingdom P1290 Lymphovascular Invasion and Perineural Invasion are Associated with Advanced Disease and Poor Survival in Colorectal Cancer Monday Monitor #3, located in Hall C Neoplastic Disease E. Al-Sukhni, K. Attwood, E. Gabriel, S. Nurkin, Buffalo, NY P1291 Design and Development of Prototype: Distractor Mechanic Endo AnoRectal. Experimental Test in Mixed Simulator and Cadaver of TEM without Pneumorectum Tuesday Monitor #8, Outside Ballroom B Neoplastic Disease J. Rodriguez-Garcia, P. Suarez, J. Sierra, S. Moral, A. Cabrera, Oviedo, Spain; Gijon, Spain P1292 Preoperative Short-Course Radiotherapy with Long Interval Surgery in a Series of High-Risk Patients with Locally Advanced Rectal Cancer Sunday Monitor #5, located in Hall C Neoplastic Disease M. Flanagan, I. Reynolds, D. McNamara, Dublin, Ireland P1293 Endoscopic Stenting of Bstructin Colorectal Cancer: A Suitable Therapeutic Option? A Review of Ten Years’ of Data from a Tertiary Referral Center Tuesday Monitor #3, located in Hall C Neoplastic Disease V. Chauhan, R. Padwick, M. Newman, J. Francombe, M. Osborne, Warwick, United Kingdom P1294 Early Removal of the Urinary Catheter after Total Mesorectal Excision for Rectal Cancer is Safe Monday Monitor #2, located in Hall C Neoplastic Disease H. Kim, B. Yoo, B. Kye, G. Kim, H. Cho, Suwon, Korea P1295 What is the Long-Term Prognosis of Cirrhotic Patients with a Colorectal Cancer: A CaseMatched Study Monday Monitor #3, located in Hall C Neoplastic Disease C. Sabbagh, J. Poirot, B. Chauffert, M. Fumery, J. Regimbeau, Amiens, France P1296 Perineal Wound Healing and Long-Term Outcomes after Salvage Abdominoperineal Resection for Local Failure of Anal Squamous Cell Carcinoma following Chemoradiation Sunday Monitor #1, located in Hall C Neoplastic Disease S. Agbroko, E. Aytac, L. Stocchi, F. Remzi, A. Al Chakaki, D. Dietz, M. Kalady, Parma Heights, OH; Cleveland, OH P1297 Transanal Endoscopic Microsurgery: Ten-Year Outcomes in a Tertiary Referral Center Tuesday Monitor #8, Outside Ballroom B Neoplastic Disease M. Quinn, L. Moyes, T. Chieng, R. McKee, Glasgow, United Kingdom P1298 Immediate Perineal Reconstruction Following Perineal, Abdominoperineal or Multivisceral Resection Using Inferior Gluteal Artery Perforator Flaps: 7-Year Experience and Follow-Up Sunday Monitor #1, located in Hall C Neoplastic Disease M. Pramateftakis, H. Creasy, P. Roblin, P. Mohanna, D. Ross, A. Schizas, M. George, London, United Kingdom P1299 T4 Colon Cancers – Elective versus Emergency in the Modern Era Monday Monitor #6, located in Hall D Neoplastic Disease D. Harji, J. Dixon, A. King, P. Sagar, Leeds, United Kingdom P1300 Colonic Stenting. A Worthwhile Option? Tuesday Monitor #3, located in Hall C Neoplastic Disease K. Bailey, M. Jha, N. Wadd, A. Reddy, Norton, United Kingdom *All ePoster presenters are listed first unless otherwise noted. 131 EPOSTERS ePoster Presentations ePoster Presentations P1301 Tumor Height and Tumor Position Predict TME Quality Monday Monitor #9, located outside Room 304 Neoplastic Disease M. Mendez, R. Wilcox, P. Callas, P. Cataldo, Burlington, MA P1302 Do All Patients Benefit from Chemoradiotherapy for Locally Advanced Rectal Cancer? A Propensity Score Analysis Sunday Monitor #5, located in Hall C Neoplastic Disease M. Kim, S. Park, D. Kim, S. Kim, J. Joo, O. Jae Hwan, Goyang, Korea P1303 P1304 P1305 Tumor Size as a Prognostic Factor in Patients with Early Stage Colon Cancer Monday Monitor #3, located in Hall C Neoplastic Disease G. Rizzo, F. Santullo, A. Biondi, D. D’Ugo, C. Mattana, C. Coco, R. Persiani, Rome, Italy Prognostic Impact of Retroperitoneal Resection Margin Involvement in Colon Cancer Monday Monitor #3, located in Hall C Neoplastic Disease S. Sokmen, M. Ozbilgin, O. Sagol, H. Ellidokuz, S. Sarioglu, Izmir, Turkey Efficacy of Sodium Hyaluronate Carboxymethylcellulose Absorbable Antiadhesion Barrier(Seprafilm®) on Abdominopelvic Adhesions in an Experimental Rat Peritonectomy Model Monday Monitor #6, located in Hall D Neoplastic Disease N. Arslan, S. Sokmen, M. Koskderelioglu, E. Ozkara, O. Yilmaz, S. Sarioglu, Izmir, Turkey P1306 Pathologic Complete Response (pCR) and Rectal Cancer: What Does it Really Mean? Tuesday Monitor #5, located in Hall C Neoplastic Disease S. Patel, A. Meyer, K. Kochar, A. Ralph, E. James, S. Marecik, J. Park, L. Prasad, Park Ridge, IL P1307 Multicentric Colorectal Cancer Screening in a Developing Country Monday Monitor #9, located outside Room 304 Neoplastic Disease F. Lopez-Kostner, A. Zarate, U. Kronberg, A. Ponce, C. Wainstein, H. Kawachi, K. Tanaka, T. Okada, M. Kobayashi, A. Wielandt, R. Estela, G. Bannura, S. Karelovic, S. Pasternak, H. Carrasco, S. Flores, Santiago, Chile; Tokyo, Japan; Punta Arenas, Chile P1308 Endoscopic Submucosal Dissection for Early Colorectal Neoplasms: Initial Experience of a Brazilian Teaching Hospital Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease M. Camargo, J. Meirelles-Santos, N. Miyajima, R. Leal, C. Martinez, J. Fagundes, M. Ayrizono, C. Coy, Campinas, Brazil P1309 Comparison between Surgical and Conservative Treatment of Colorectal Cancer in Patients at the Age of 90 or Greater Monday Monitor #6, located in Hall D Neoplastic Disease T. Chen, J. Liang, Hsinchu, Taiwan; Taipei, Taiwan P1310 Local Excision of Rectal Cancer following Neoadjuvant Therapy: ypT2 = Observation or Radical Surgery? Tuesday Monitor #8, Outside Ballroom B Neoplastic Disease N. Lopez-Acevedo, J. Marks, M. Johnson, J. Frenkel, S. Kakade, A. Denittis, G. Marks, Wynnewood,PA P1311 One-Year Follow-up Colonoscopy after Curative Resection of Colorectal Cancer: Is It Worthwhile? Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease M. Bun, L. Pereyra, F. Ocariz, N. Panigadi, D. La Salvia, C. Fischer, D. Cimmino, N. Rotholtz, Buenos Aires, Argentina P1312 Risk of Metachronous Advanced Neoplastic Lesions in Patients with Sessile Serrated Adenomas Undergoing Surveillance Colonoscopy Monday Monitor #2, located in Hall C Neoplastic Disease M. Bun, L. Pereyra, A. Sanchez Ruiz, E. Gomez, R. Gonzalez, A. Canelas, D. Cimmino, N. Rotholtz, Buenos Aires, Argentina P1313 Phase III Multicenter, Prospective, Controlled, Randomized Trial to Evaluate the Safety and Efficacy of Treatment of Rectal Cancer T2-T3s (Superficial) N0, M0 with Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery versus Total Mesorectal Sunday Monitor #3, located in Hall C Neoplastic Disease X. Serra-Aracil, L. Mora, C. Pericay, S. Delgado, E. Targarona, F. Vallribera, T. Golda, A. Reina, Sabadell, Spain; Barcelona, Spain; Almeria, Spain *All ePoster presenters are listed first unless otherwise noted. 132 P1314 Delayed Colon Perforation in the Presence of Self-Expanding Metal Stents (SEMS): A Common Event? Tuesday Monitor #3, located in Hall C Neoplastic Disease K. Blaker, J. Anandam, A. Abdelnaby, F. Araghizadeh, C. Olson, Dallas, TX P1321 Stage IV Rectal Cancer – Has Potential for Cure Improved Over Time? Sunday Monitor #2, located in Hall C Neoplastic Disease N. Rajendran, K. Yap, Y. Kaneko, B. Thomson, S. Ngan, A. Lynch, S. Warrier, A. Heriot, Melbourne, VIC, Australia P1315 Surveillance Interval after a Normal Screening Colonoscopy: Is It Really Ten Years? Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease M. Bun, L. Pereyra, E. Gomez, M. Omodeo, N. Panigadi, C. Fischer, D. Cimmino, N. Rotholtz, Buenos Aires, Argentina P1322 Pelvic Exenterative Surgery for Primary Rectal Carcinoma: A Single Center 22-Year Experience Sunday Monitor #2, located in Hall C Neoplastic Disease R. Radwan, H. Jones*, N. Rawat, M. Davies, M. Evans, D. Harris, J. Beynon, Swansea, United Kingdom P1323 P1316 From Laparoscopic-Assisted to Total Laparoscopic Right Colectomy with Intracorporeal Anastomosis: Is the Shift in Technique Justified? Monday Monitor #6, located in Hall D Neoplastic Disease U. Hameed, K. Beyfuss, V. Palter, PK Stotland, A. Okrainec, LV Klein, MA Aarts, S. Ashamalla, Toronto, ON, Canada Differential Clinical Benefits of 5-FluorouracilBased Adjuvant Chemotherapy for Patients with Stage III Colorectal Cancer according to Tumor Budding Status Sunday Monitor #5, located in Hall C Neoplastic Disease E. Shinto, A. Shikina, S. Fukazawa, H. Ueno, Y. Kajiwara, H. Tsuda, J. Yamamoto, K. Hase, Tokorozawa, Japan P1324 P1317 Supporting Quality Assurance Initiatives for Rectal Cancer: Is the CAP Protocol Enough? Monday Monitor #8, Outside Ballroom B Neoplastic Disease C. MacPherson, A. MacLean, W. Buie, Calgary, AB, Canada P1318 TEM-ESD: A New Standard Approach for Large Rectal Adenomas? Tuesday Monitor #8, Outside Ballroom B Neoplastic Disease J. Baral, K. Kouladouros, S. Fender, F. Pullig, M. Schon, Karlsruhe, Germany Transanal Minimally Invasive Surgery: A Multicenter Assessment of Feasibility, Safety and Learning Curve Tuesday Monitor #8, Outside Ballroom B Neoplastic Disease S. Clermonts, W. Brokelman, D. Lips, W. Zijlstra, J. Maring, D. Wasowicz, B. Langenhoff, D. Zimmermann, Den Bosch, Netherlands; Tilburg, Netherlands P1325 Primary Tumor Regression Grade after Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Its Prognostic Impact in Patients with ypTanyN+ Disease Sunday Monitor #3, located in Hall C Neoplastic Disease Y. Park, H. Kim, K. Jung, J. Huh, S. Yun, W. Lee, H. Chun, Seoul, Korea P1326 Prognostic Impact of Lymph Node Ratio on Rectal Cancer after Preoperative Chemoradiotherapy: A Multicenter Retrospective Study Monday Monitor #4, located in Hall C Neoplastic Disease B. Park, J. Park, E. Han, S. Ryoo, H. Park, J. SeungYong, S. Kang, O. Jae Hwan, K. Park, Seoul, Korea; Goyang, Korea; Seongnam, Korea; Anyang, Korea P1319 P1320 Management of Tumors of the Ischiorectal Fossa: Is Percutaneous Biopsy Essential? Monday Monitor #8, Outside Ballroom B Neoplastic Disease N. Buchs, N. Mortensen, R. Guy, M. Gibbons, B. George, Oxford, United Kingdom Comparison of Short-term Outcome between Robotic-assisted and Laparoscopic Total Mesorectal Excision for Mid to Low Rectal Cancer Monday Monitor #9, located outside Room 304 Neoplastic Disease C. Foo, W. Law, Hong Kong *All ePoster presenters are listed first unless otherwise noted. 133 EPOSTERS ePoster Presentations ePoster Presentations P1327 Oncologic and Surgical Outcomes in Colorectal Cancer Patients with Liver Cirrhosis Monday Monitor #3, located in Hall C Neoplastic Disease E. Han, S. Ryoo, B. Park, J. Park, E. Choe, S. Moon, S. Jeong, K. Park, Seoul, Korea P1328 Similar Polyp Detection Rates among Body Mass Index Categories at First Screening Colonoscopy Monday Monitor #2, located in Hall C Neoplastic Disease J. Terlizzi, A. Zheng, B. Phillips, S. Goldstein, G. Isenberg, Philadelphia, PA P1329 A Survey of Colorectal Surgeons on the Factors Influencing Implementation of the Rectal Cancer Patient Decision Aid Monday Monitor #8, Outside Ballroom B Neoplastic Disease R. Wu, R. Boushey, P. Roberts, D. Stacey, B. Potter, Ottawa, ON, Canada; Boston, MA P1330 Could Elevated Preoperative C-Reactive Protein Level Predict Oncologic Outcomes in Patients who Underwent Curative Resection after Chemoradiation in Rectal Cancer? Sunday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease W. KIM, S. Baek, H. Hur, B. Min, K. Lee, N. Kim, Seoul, Korea P1331 Extramesenteric Lymphadenectomy for Colon Cancer with Isolated Para-Aortic Lymph Node Metastasis Monday Monitor #5, located in Hall C Neoplastic Disease S. Bae, H. Hur, B. Min, S. Baik, K. Lee, N. Kim, Seoul, Korea; Daegu, Korea P1332 Prognostic Value of Lymph Node Number and Lymph Node Ratio Staging System in Stage 3 Rectal Cancer following Neoadjuvant Radiochemotherapy Monday Monitor #5, located in Hall C Neoplastic Disease D. Zhang, J. Gu, M. LI, Beijing, China P1333 Prognosis of T1-2N0M0 Rectal CancerAdjuvant Chemotherapy or Not Sunday Monitor #2, located in Hall C Neoplastic Disease D. Zhang, J. Gu, M. LI, Beijing, China P1334 Rectal Vascular Supply Anatomical Variability is Prognostic Factor of Lateral Node Metastasis in Patients with Rectal Cancer Sunday Monitor #2, located in Hall C Neoplastic Disease A. Zakharenko, M. Beliaev, Saint Petersburg, Russian Federation P1335 Functional Outcomes after Laparoscopic Very Low Anterior Resection Monday Monitor #6, located in Hall D Neoplastic Disease R. Matsunaga, Y. Nishizawa, M. Yokota, N. Saito, Kashiwa-shi, Japan P1336 Clinically Relevant Doses of Standard Chemotherapeutic Agents are well Tolerated in the Humanized Mouse Models (NSG/NRG) of Colon Cancer Tuesday Monitor #5, located in Hall C Neoplastic Disease J. Davids, J. Maykel, J. Liu, L. Schultz, D. Greiner, J. Houghton, Worcester, MA; Bar Harbor, MI P1337 “En-bloc” Seminal Vesicle Excision for Locally Advanced and Recurrent Sigmoid and Rectal Cancer Sunday Monitor #2, located in Hall C Neoplastic Disease S. Manning, J. Keating, R. Studd, E. Dennett, Wellington, New Zealand P1338 Preparing for the OSTRICH Consortium Proposed Standards for Excellence in Rectal Cancer Treatment: Are We Ready? Monday Monitor #8, Outside Ballroom B Neoplastic Disease L. Hernandez, A. Estep, T. Stahl, J. Ayscue, J. Fitzgerald, G. Sigle, A. Kumar, Washington, DC P1339 Incidental Appendiceal Cancer at Appendectomy: An Analysis of Incidence, Trends and Risk Factors Monday Monitor #8, Outside Ballroom B Neoplastic Disease M. Hanna, G. Hwang, Z. Moghadamyeghaneh, M. Phelan, J. Carmichael, S. Mills, M. Stamos, A. Pigazzi, Orange,CA P1340 Feasibility of Robotic Pelvic Exenteration Monday Monitor #9, located outside Room 304 Neoplastic Disease J. Au, C. Bergman, R. Viterbo, S. Reddy, S. Cohen, J. Meyer, E. Sigurdson, J. Farma, Philadelphia, PA *All ePoster presenters are listed first unless otherwise noted. 134 P1341 P1342 P1343 P1344 P1345 P1346 Endoluminal Loco-Regional Resection (ELRR) by Transanal Endoscopic Microsurgery (TEM): 22 year Experience Tuesday Monitor #9, located outside Room 304 Neoplastic Disease E. Lezoche, A. Balla, S. Quaresima, M. Guerrieri, G. D’Ambrosio, G. Lezoche, A. Paganini, Rome, Italy; Ancona, Italy Compare Anastomotic Recurrence of Colon Cancer and Rectal Cancer in Patients Performed Curative Resection Tuesday Monitor #6, located in Hall D Neoplastic Disease W. Jung, C. Yu, S. Lim, I. Park, Y. Yoon, C. Kim, J. Lee, J. Kim, Seoul, Korea Changes of Microbiota after Surgery for Colorectal Cancer may Affect the Risk of Surgical Site Infection Sunday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease S. Ohigashi, T. Taketa, S. Ohde, F. Sakamoto, K. Ohta, Tokyo, Japan The Effect of Preoperative Endoscopic Tattooing on Distal Surgical Margin and Ileostomy Rates in Laparoscopic Rectal Cancer Surgery: A Prospective Randomized Study Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease G. Cipe, M. Cengiz, U. Idiz, E. Yardimci, F. Malya, Y. Firat, M. Muslumanoglu, Istanbul, Turkey Are the Results of Magnifying Chromoendocopy Evaluation of Extra Peritoneal Rectal Tumors Comparable to Endorectal Three-Dimensional Ultrasound? Study Based on the Pathologic Comparison. Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease R. Pinto, F. Kawaguti, I. Correa Neto, S. Nahas, C. Nahas, C. Marques, U. Ribeiro Junior, I. Cecconello, Sao Paulo, Brazil P1347 Comparison of Gender Specific Differences in Pelvic Sizes using Magnetic Resonance Imaging (MRI) Monday Monitor #9, located outside Room 304 Neoplastic Disease N. Wong, B. Lieske, Singapore P1348 Prediction of Postoperative Mortality in Octogenarian Patients with Colorectal Cancer Tuesday Monitor #3, located in Hall C Neoplastic Disease D. Cuicchi, S. Vaccari, B. Pirrera, F. Lecce, E. De Raffele, M. Mirarchi, B. Cola, Bologna, Italy P1349 Advanced Synchronous Adenoma Predicts Metachronous Colonic Neoplasia in Follow-up Colonoscopy of Patients with Resected Colorectal Cancer Monday Monitor #2, located in Hall C Neoplastic Disease M. Bun, L. Pereyra, N. Panigadi, C. Fischer, A. Canelas, S. Guckenheimer, D. Cimmino, N. Rotholtz, Buenos Aires, Argentina P1350 Transanal Minimally Invasive Surgery (TAMIS): An Evolving Approach in the Treatment of Rectal Neoplasms Tuesday Monitor #9, located outside Room 304 Neoplastic Disease Y. Halwani, E. Vikis, Vancouver, BC, Canada P1351 Primary Squamous-Cell Carcinoma of the Colon: Current Guidelines and Institutional Experience Sunday Monitor #6, located in Hall D Neoplastic Disease Y. Hong, A. Chin, E. Hechenbleikner, C. Butler, K. Khazaeian, M. Bayasi, A. Chudzinski, Washington, DC P1352 Impact of Body Mass Index and Tumor Site on the Staging of Rectal Cancer with Endorectal Ultrasound Monday Monitor #1, located in Hall C Neoplastic Disease A. Alzahrani, Riyadh, Saudi Arabia P1353 MDSCs Accumulate Invasion Front of Primary Colorectal Cancer through CCL15-CCR1 Chemokine Axis, and Promote Tumor Progression Monday Monitor #6, located in Hall D Neoplastic Disease S. Inamoto, K. Kawada, Y. Itatani, T. Yamamoto, S. Minamiguchi, M. Taketo, Y. Sakai, Kyoto, Japan Are Some Advanced Adenomas More Advanced than Others? Monday Monitor #2, located in Hall C Neoplastic Disease M. Aljarabah, J. Church, Cleveland, OH *All ePoster presenters are listed first unless otherwise noted. 135 EPOSTERS ePoster Presentations ePoster Presentations P1354 Efficacy of Tridimensional Endorectal Ultrasound in Comparison to Histopathology for Evaluation Extra Peritoneal Rectal Neoplasms Sunday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease R. Pinto, I. Correa Neto, S. Nahas, C. Nahas, C. Marques, U. Ribeiro Junior, L. BustamanteLopez., D. Soares, I. Cecconello, Sao Paulo, Brazil P1360 Risk Factors of Lateral Lymph Node Metastasis in the Patients without Clinical Lateral Pelvic Lymph Node Metastasis Monday Monitor #5, located in Hall C Neoplastic Disease K. Komori, S. Fujita, J. Mizusawa, Y. Kanemitsu, N. Saito, Y. Kinugasa, M. Ohue, M. Ota, Nagoya, Japan; Utsunomiya, Japan; Tokyo, Japan; Osaka, Japan; Yokohama, Japan; Sunto-gun, Japan; Chiba, Japan P1355 Outcomes of Radical Resection of Adenocarcinoma of the Rectum following Neoadjuvant Therapy in a Midwest Community Hospital Setting: Optimizing Rectal Cancer Care in Small-Town and Rural America Sunday Monitor #2, located in Hall C Neoplastic Disease W. Cirocco, Columbus, OH P1361 Early Quality of Life Outcomes for Endoluminal Brachytherapy for the Treatment of Rectal Cancer Sunday Monitor #5, located in Hall C Neoplastic Disease A. Althumairi, F. Monn, J. Efron, B. Safar, E. Wick, J. Herman, S. Gearhart, Baltimore, MD P1362 P1356 Dysregulation of AHR in Colon Cancer: Does it Contribute to Chemosensitivity? Tuesday Monitor #5, located in Hall C Neoplastic Disease P. Carney, B. Megna, M. Nukaya, G. Kennedy, Madison, WI The Impact of Anastomotic Leakage on Anal Function following Intersphincteric Resection Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease M. Yokota, N. Saito, R. Matsunaga, Y. Nishizawa, A. Kobayashi, M. Ito, Chiba, Japan P1357 Robotic-Assisted Laparoscopic versus Open Lateral Lymph Node Dissection for Advanced Rectal Cancer Monday Monitor #9, located outside Room 304 Neoplastic Disease T. Yamaguchi, Y. Kinugasa, A. Shiomi, H. Tomioka, H. Kagawa, Sunto-gun, Japan P1363 P1358 The Difference of Prognostic Nutritional Index during Preoperative Concurrent ChemoRadiotherapy Predicts Long-Term Outcomes of Locally Advanced Rectal Cancer Monday Monitor #1, located in Hall C Neoplastic Disease Y. Lee, W. Kim, S. Baek, H. Hur, B. Min, K. Lee, N. Kim, Seoul, Korea A New Prediction Model for Local Recurrence after Curative Rectal Cancer Surgery Tuesday Monitor #3, located in Hall C Neoplastic Disease K. Hida, R. Okamura, S. Park, J. Park, S. Hasegawa, K. Kawada, R. Takahashi, S. Hisamori, G. Nishikawa, K. Murakami, G. Choi, Y. Sakai, Kyoto, Japan; Daegu, Korea P1364 Treatment and Outcomes of Colorectal Cancer in Patients too Young for Average-Risk Screening Monday Monitor #9, located outside Room 304 Neoplastic Disease Z. Abdelsattar, S. Wong, S. Regenbogen, K. Hardiman, S. Hendren, Ann Arbor, MI P1365 Is There a Role for Prophylactic Colectomy in Lynch Syndrome Patients with Inflammatory Bowel Disease? Monday Monitor #6, located in Hall D Neoplastic Disease K. McNamara, M. Aronson, Z. Cohen, Toronto, ON, Canada P1359 Quality of Life and Anorectal Function of Rectal Cancer Patients in Long-term Recovery Tuesday Monitor #6, located in Hall D Neoplastic Disease X. Wang, C. Brown, M. Raval, A. Karimuddin, T. Phang, Chengdu, China; Vancouver, BC, Canada *All ePoster presenters are listed first unless otherwise noted. 136 P1366 Intratumoral Heterogeneity of Epigenetic Factors in Colorectal Cancer: Implications for Clinical Practice Monday Monitor #6, located in Hall D Neoplastic Disease H. Jones, R. Radwan, N. Williams, P. Griffiths, G. Jenkins, J. Beynon, D. Harris, Cardiff, United Kingdom P1372 Risk Factors Affecting the Recurrence in Patients with Locally Advanced Rectal Cancer Treated with Total Mesorectal Excision following Neoadjuvant Chemoradiotherapy Sunday Monitor #2, located in Hall C Neoplastic Disease S. Park, W. Kim, Y. Han, S. Baek, H. Hur, B. Min, K. Lee, N. Kim, Seoul, Korea P1367 Involving Patients in the Rectal Cancer Surgery Consent Process: The Evaluation of the Rectal Cancer Decision Aid Monday Monitor #8, Outside Ballroom B Neoplastic Disease R. Wu, D. Stacey, A. Scheer, H. Moloo, R. Auer, S. Tadros, P. Roberts, B. Potter, R. Boushey, Ottawa, ON, Canada; Toronto, ON, Canada; Burlington, MA P1373 Preoperative Anal Dysfunction is a Predictor of Permanent Stoma in Rectal Cancer Patients: Results of the First Prospective Cohort Analysis of Clinically Relevant Risk Factors Sunday Monitor #3, located in Hall C Neoplastic Disease M. Ihn, S. Kang, J. Park, I. Son, H. Oh, D. Kim, Seongnam-si, Korea P1374 P1368 The Effects of Multiple Chemotherapeutic Agents Plus Hyperthermic Intraperitoneal Chemoperfusion on Colonic Anastomosis: An Experimental Study in a Rat Model Tuesday Monitor #5, located in Hall C Neoplastic Disease A. Aghayeva, C. Benlice, I. Bilgin, P. Atukeren, G. Dogusoy, F. Demir, B. Baca, Istanbul, Turkey Transanal Local Excision versus Radical Surgery for T1N0 Lower Rectal Adenocarcinom Tuesday Monitor #9, located outside Room 304 Neoplastic Disease Y. LIN, H. Hung, Taoyuan County, Taiwan P1375 Metformin Use Among Patients with Diabetes Improves Overall Survival after Surgery for Colorectal Cancer Tuesday Monitor #5, located in Hall C Neoplastic Disease T. Fransgaard, L. Thygesen, I. Gogenur, Cophenhagen, Denmark P1376 What is the Impact of Preoperative Chemoradiation on the Puborectal Thickness? Sunday Monitor #5, located in Hall C Neoplastic Disease C. Sabbagh, L. Tartar, C. Chivot, J. Regimbeau, Amiens, France P1377 A Novel Sierological Inflammatory Score as Possible Prognostic Marker in Colorectal Cancer Tuesday Monitor #5, located in Hall C Neoplastic Disease G. Di Caro, M. Carvello, S. Pesce, M. Sacchi, M. Erreni, F. Marchesi, P. Allavena, M. Montorsi, A. Spinelli, Rozzano Milano, Italy P1378 The Effectiveness of Biological Therapy in the Prevention of Reoperation in Patients with Luminal Crohn’s Disease Sunday Monitor #8, Outside Ballroom B Inflammatory Bowel Disease H. Kimura, R. Kunisaki, K. Tatsumi, K. Koganei, A. Sugita, I. Endo, Yokohama, Japan P1369 P1370 P1371 Resection vs. Nonresection Management for Colorectal Cancer: What About the Also-Rans? Tuesday Monitor #6, located in Hall D Neoplastic Disease H. James, G. Williams, Wolverhampton, United Kingdom Short-Term Outcomes following Turnbull-Cutait Procedure without Prophylactic, Covering Stoma for the Treatment of Inferior Rectal Cancer Compared to Inmediate Coloanal Anastomosis: A Case-Matched Study Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease C. Gallardo, A. Barrera, G. Bannura, F. Illanes, C. Melo, Santiago, Chile Transanal Minimally Invasive Surgery (TAMIS) for Local Excision for Rectal Adenocarcinoma Tuesday Monitor #9, located outside Room 304 Neoplastic Disease C. Kang, B. Martin-Perez, S. Annaberdyev, G. Nassif, T. deBeche-Adams, S. Larach, S. Atallah, M. Albert, Orlando, FL *All ePoster presenters are listed first unless otherwise noted. 137 EPOSTERS ePoster Presentations ePoster Presentations P1379 Acute Surgical Intervention in Crohn’s Disease Patients has no Difference in Postoperative Outcome Whether the Patients Presented for First Time or are Known with Crohn’s Disease Sunday Monitor #8, Outside Ballroom B Inflammatory Bowel Disease A. El-Hussuna, S. Hadi, I. Iesalnieks, Slagelse, Denmark; Munich, Germany P1380 Risk Factors for Fecal Diversion after SphincterPreserving Surgery for Fistula-in-Ano with Crohn’s Disease Sunday Monitor #8, Outside Ballroom B Inflammatory Bowel Disease Y. Watadani, H. Ohge, S. Uegami, N. Shigemoto, N. Shimada, N. Murao, Y. Kameda, N. Kondo, Y. Hashimoto, K. Uemura, Y. Murakami, T. Sueda, Hiroshima, Japan P1381 P1382 P1383 Salvage Surgery after Failure of Endoscopic Balloon Dilation for Ileocolonic Anastomotic Stricture Due to Recurrent Crohn’s Disease is Associated with Increased Perioperative Adverse Outcomes When Compared with Upfront Surgery Sunday Monitor #8, Outside Ballroom B Inflammatory Bowel Disease Y. Li, L. Stocchi, B. Shen, X. Liu, F. Remzi, Cleveland,OH Single Incision versus Multiport Laparoscopic Total Abdominal Colectomy for Medically Refractory Ulcerative Colitis: A Case Matched Study Sunday Monitor #8, Outside Ballroom B Inflammatory Bowel Disease E. Aytac, M. Costedio, R. Williams, L. Stocchi, H. Kessler, F. Remzi, E. Gorgun, Cleveland, OH Perianal Paget’s Disease and Associated Pathologic Findings: The Minnesota Experience Sunday Monitor #6, located in Hall D Neoplastic Disease S. Ivatury, K. Batts, A. Conway, C. Finne, Hanover, NH; Minneapolis, MN P1384 Impact of Intraoperative Blood Loss on Morbidity and Survival after Radical Surgery for Colorectal Cancer Patients Aged 80 Years or Older. Tuesday Monitor #6, located in Hall D Neoplastic Disease R. Okamura, K. Hida, S. Hasegawa, Y. Sakai, M. Hamada, M. Yasui, T. Hinoi, M. Watanabe, Kyoto, Japan; Kochi, Japan; Osaka, Japan; Hiroshima, Japan; Tokyo, Japan P1385 Outcomes of Abdominoperineal Resection for Management of Anal Cancer in HIV-Positive Patients Sunday Monitor #6, located in Hall D Neoplastic Disease I. Leeds, H. Alturki, E. Schneider, J. Efron, E. Wick, S. Gearhart, B. Safar, S. Fang, Baltimore, MD P1386 Intermediate Neoadjuvant Radiotherapy Combined with Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcome after a Median Follow-up of 5 Years Tuesday Monitor #5, located in Hall C Neoplastic Disease L. Wang, T. Zhan, Y. Li, H. Pan, M. LI, N. Chen, Y. Cai, J. Gu, Beijing, China P1387 Transanal Endoscopic Microsurgery for Unanticipated Malignancies – This Unexpected Finding Does Not Affect Final Outcomes Tuesday Monitor #9, located outside Room 304 Neoplastic Disease C. Chernos, E. Crocker, D. Hochman, Winnipeg, MB, Canada P1388 Transanal Endoscopic Microsurgery for Giant Rectal Polyps Tuesday Monitor #9, located outside Room 304 Neoplastic Disease C. Chernos, E. Crocker, D. Hochman, Winnipeg, MB, Canada P1389 Prognostic Scoring System for Incurable Metastatic Colorectal Carcinoma – A Tool to Guide Palliative Resection Tuesday Monitor #3, located in Hall C Neoplastic Disease W. Tan, S. Dorajoo, S. Koo, W. Tan, M. Chew, H. Wee, C. Yap, Singapore *All ePoster presenters are listed first unless otherwise noted. 138 P1390 Combination of Metabolic Equivalents and ASA Score in Elderly Patients: A Useful Predictor of Postoperative Complication Tuesday Monitor #3, located in Hall C Neoplastic Disease H. Ito, Y. Miyakura, M. Morimoto, M. Koizumi, K. Koinuma, H. Horie, A. Lefor, N. Sata, Y. Yasuda, Shimotsuke City, Japan P1397 The Pull-Through Procedure as First Choice Treatment in High-Risk Patients with Low Rectal Cancer Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease F. Bianco, S. De Franciscis, A. Belli, V. Ragone, G. Romano, Naples, Italy P1391 Early Results of the Two Minimal Invasive Approaches for Rectal Tumors Compared with Each Other Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease S. Demirbas, I. Gecim, H. Celasin, N. Ersoz, T. Ozer, Kavaklidere, Turkey; Ankara, Turkey P1398 Laparoscopic Colorectal Resection with Transanal Extraction: Phase II trial Sunday Monitor #3, located in Hall C Neoplastic Disease J. Rodriguez-Garcia, S. Moral, R. Fresnedo, C. Alvarez-Laso, G. Carreno, Oviedo, Spain; Gijon, Spain P1399 P1392 Colon Cancer with Unresectable Synchronous Metastases: AAAP Scoring System for Predicting Outcome after Primary Tumor Resection Tuesday Monitor #3, located in Hall C Neoplastic Disease Z. Li, J. Gu, Beijing, China High Levels of PDGFAA in Tumor Drainage Blood and HER2 in Peripheral Venous Blood are Predictors for Colorectal Cancer Liver Metastasis Tuesday Monitor #5, located in Hall C Neoplastic Disease H. Pan, Y. Peng, J. Gu, Beijing, China P1400 P1393 Adherence to Surveillance Guidelines after Resection of Stage II Colon Cancer: Experience of a Tertiary Care Institution Monday Monitor #9, located outside Room 304 Neoplastic Disease K. Dugan, S. Maithel, C. Staley, C. Moreno, J. Srinivasan, V. Shaffer, C. Staley, P. Sullivan, Atlanta, GA Does Omental Pedicle Flap Reduce Anastomotic Leak and Septic Complications after Rectal Cancer Surgery? Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease V. Ozben, E. Aytac, X. Liu, G. Ozuner, Cleveland, OH P1401 P1394 HIV Positivity and Anal Cancer Outcomes: A Single-Center Experience Sunday Monitor #6, located in Hall D Neoplastic Disease N. Wieghard, K. Kelley, T. Mitin, D. Herzig, K. Lu, C. Thomas Jr., V. Tsikitis, Portland, OR Transanal Endoscopic Microsurgery Resection of Rectal Neuroendocrine Tumors: A Single Center Canadian Experience Tuesday Monitor #9, located outside Room 304 Neoplastic Disease C. Jonker, A. Karimuddin, T. Phang, M. Raval, C. Brown, Vancouver, BC, Canada P1395 Survival Time and Trognostic Factors for Colorectal Cancer Patients with Liver Metastases: A Single Hosptial Experience Tuesday Monitor #6, located in Hall D Neoplastic Disease Q. Liu, C. Fu, Shanghai, China P1402 P1396 Comparision between Emergency Surgery and Endoscopic Colon Stenting in the Treatment of Obstructive Left Colon Cancer Tuesday Monitor #3, located in Hall C Neoplastic Disease J. Barreiro, I. Garcia Bear, C. Ildefonso Cienfuegos, L. Garcia Florez, P. Fernandez Muniz, Aviles, Spain Impact of Laparoscopic Surgery on the Time to Initiation of Adjuvant Chemotherapy for Colon Cancer Monday Monitor #9, located outside Room 304 Neoplastic Disease Y. Jung, E. Park, J. Kang, S. Baik, S. Sohn, I. Kim, K. Lee, Seoul, Korea P1403 How Significant is a Variant of Unknown Significance? Monday Monitor #9, located outside Room 304 Neoplastic Disease D. Shaw, C. Ternent, J. Beaty, G. Blatchford, N. Bertelson, J. Bikhchandani, A. Thorson, M. Shashidharan, Omaha, NE *All ePoster presenters are listed first unless otherwise noted. 139 EPOSTERS ePoster Presentations ePoster Presentations P1404 Transanal Endoscopic Microsurgery for Early Rectal Cancer: A Single Center Experience Tuesday Monitor #9, located outside Room 304 Neoplastic Disease C. O’Neill, J. Platz, J. Moore, P. Callas, P. Cataldo, Burlington, MA P1405 Patient-Reported Roles, Preferences, and Expectations Regarding Treatment of Stage I Rectal Cancer Monday Monitor #8, Outside Ballroom B Neoplastic Disease C. Ellis, M. Charlton, K. Stitzenberg, Chapel Hill, NC; Iowa City, IA P1406 Short-term Outcome of Tumor-specific Extralevator Abdominoperineal Excision (TSELAPE) for Rectal Cancer Sunday Monitor #3, located in Hall C Neoplastic Disease J. Han, Z. Wang, G. Wei, Y. Yang, Z. Gao, Beijing, China P1407 P1408 P1409 Prediction of Lateral Pelvic Lymph Node Metastasis by MRI in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy Monday Monitor #4, located in Hall C Neoplastic Disease T. Akiyoshi, M. Ueno, Y. Fukunaga, S. Nagayama, Y. Fujimoto, T. Konishi, T. Yamaguchi, Tokyo, Japan Laparoscopic Translevator Approach to Abdominoperineal resection APR) for Rectal Adenocarcinoma: Feasibility and Short-Term Oncologic Outcomes Monday, Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease V. Palter, S. MacLellan, S. Ashamalla, Toronto, ON, Canada Laparoscopic versus Hybrid Natural Orifice Transluminal Endoscopic Surgery (hNOTES) for Rectal Cancer after Neoadjuvant Chemoradiation: A Matched Case-controlled Study Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease C. Chen, S. Yang, Taipei, Taiwan P1410 Management of Locally Advanced Perianal Extra-Mammary Paget’s Disease Sunday Monitor #6, located in Hall D Neoplastic Disease O. Lo, M. Razali Ibrahim, G. Li, W. Law, Hong Kong P1411 Postoperative Pelvic Sepsis Rates following Complete Pathologic Response to Neoadjuvant Therapy in Rectal Cancer Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease D. Mihalicz, M. Brar, I. Datta, A. MacLean, W. Buie, S. Schmocker, E. Kennedy, J. Heine, Calgary, AB, Canada; Toronto, ON, Canada P1412 Laparoscopic-Assisted Extralevator Abdominoperineal Excision using a Parastomal Prophylactic Mesh and a Biological Mesh for Pelvic Floor Reconstruction Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease S. Avital, B. Banjamin, R. Ghinea, I. White, D. Kidron, B. Shpitz, Tel-Aviv, Israel; Kfar Saba, Israel P1413 Adherence to the American Society of Colon and Rectal Surgeon’s Practice Parameters in the Management of Rectal Cancer, How are We Doing? Monday Monitor #8, Outside Ballroom B Neoplastic Disease K. Khanduja, R. Singh, J. Madhavan, A. Padhmanabhan, C. Taylor, M. Lindsey, B. Kerner, T. Colbert, Columbus, OH P1414 Which Operative Technique Offers the Optimal Lymph Node Harvest for Patients Undergoing Right Colectomy? Monday Monitor #5, located in Hall C Neoplastic Disease M. Honaker, S. Scouten, J. Sacksner, M. Ziegler, T. Riggs, H. Wasvary, Royal Oak,MI P1415 Tumor Regression and Tolerability of Neoadjuvant High-Dose-Rate Endorectal Brachytherapy in Rectal Cancer: A Retrospective Cohort Study Tuesday Monitor #5, located in Hall C Neoplastic Disease F. Rouleau Fournier, A. Martin, S. Drolet, R. Gregoire, A. Bouchard, P. Bouchard, C. Lavoie, Quebec, QC, Canada *All ePoster presenters are listed first unless otherwise noted. 140 P1416 Complications following Low Anterior Resection for Rectal Carcinoma with and without Diverting Ileostomy Tuesday Monitor #4, located in Hall C Neoplastic Disease S. Maroney, C. Chavez De Paz, M. Duldulao, M. Reeves, K. Kazanjian, N. Solomon, Loma Linda, CA; Los Angeles, CA P1424 Long-Term Results Including Local Recurrence for Laparoscopic Resection of Stage2/ 3 R ectal Cancer Tuesday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease R. Kuwahara, S. Yamaguchi, K. Hara, H. Kondo, J. Tashiro, T. Ishii, Hidaka, Japan P1417 Anastomotic Site Recurrence after Colorectal Cancer Surgery: A Rare Entity with Poor Prognosis Monday Monitor #9, located outside Room 304 Neoplastic Disease V. Ozben, M. Valente, M. Costedio, F. Remzi, E. Gorgun, Cleveland, OH P1425 P1418 Clinicolpathological Risk Factors and Survival Outcome for 222 Bone Metastasis of Colorectal Cancer: A Retrospective Study Tuesday Monitor #6, located in Hall D Neoplastic Disease F. Liu, J. Zhao, Y. Xu, Shanghai, China How Accurately Does CRP Predict Anastomotic Leak after Laparoscopic Colorectal Surgery? Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease P. Waterland, J. Ng*, V. Decaro, K. Goonetilleke, M. Zilvetti, D. Nicol, S. Lake, S. Pandey, Worcester, United Kingdom P1426 Risk Factors for Developing Peritoneal Dissemination in Laparoscopic Colorectal Cancer Surgery Monday Monitor #3, located in Hall C Neoplastic Disease S. Yang, J. Jiang, J. Lin, S. Chang, Taipei, Taiwan P1427 Is Serum C-Reactive Protein a Reliable Predictor of Anastomotic Leak in the First Week after Anterior Resection for Rectal Cancer? Monday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease I. S. Reynolds, F. Reilly, A. Deasy, M. H. Majeed, J. P. Burke, J. Deasy, D. A. McNamara, Dublin, Ireland P1419 Comparison of Early and Late Surgery following Colonic Stenting for Obstructive Colorectal Cancer Tuesday Monitor #3, located in Hall C Neoplastic Disease W. Jeong, S. Bae, S. Baek, Daegu, Korea P1421 Prognostic Comparison between Mucinous and Nonmucinous Adenocarcinoma in Colorectal Cancer Tuesday Monitor #6, located in Hall D Neoplastic Disease J. Huh, W. Lee, Y. Park, Y. Cho, S. Yun, H. Kim, H. Chun, Seoul, Korea P1422 Laparoscopic Resection for Clinically Suspected T4 Colorectal Cancer Tuesday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease J. Huh, H. Kim, Y. Park, Y. Cho, S. Yun, W. Lee, H. Chun, Seoul, Korea P1423 Long-term Oncologic Outcomes of Obstructive Colorectal Cancer Patients who Performed Single-stage Resection with Immediate Anastomosis: A Case-Matched Study Tuesday Monitor #7, located in Hall C Foyer (by registration) Neoplastic Disease S. Kim, S. Jung, J. Kim, Daegu, Korea *All ePoster presenters are listed first unless otherwise noted. 141 EPOSTERS ePoster Presentations Featured Lecturers and Faculty Cary B. Aarons, MD, FACS H. Randolph Bailey, MD, FACS Joshua I. S. Bleier, MD Asst. Professor of Surgery, Hospital of the University of Pennsylvania, Div. of Colon & Rectal Surgery, Philadelphia, PA Professor of Surgery, University of Texas Medical School, Houston; Clinical Professor of Surgery, Baylor College of Medicine, Houston and Weil/Cornell (Methodist), Houston, TX Assoc. Professor of Surgery; Chief of Colorectal Surgery, Pennsylvania Hospital; Program Director, Colorectal Surgery Fellowship, University of Pennsylvania, Philadelphia, PA Amir Bastawrous, MD, MBA Liliana Bordeianou, MD, MPH, FACS, FASCRS Maher A. Abbas, MD, FACS, FASCRS Chief, Digestive Disease Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates; Professor of Surgery, Cleveland Clinic Lerner College of Medicine, Cleveland, OH Armen Aboulian, MD Kaiser Permanente Medical Center, Woodland Hills, CA; University of California, Los Angeles, CA Karim Alavi, MD, MPH, FACS, FASCRS Program Director, Colon and Rectal Surgery Fellowship Program, University of Massachusetts Medical School, Worcester, MA John C. Alverdy, MD, FACS Sarah and Harold Lincoln Thompson Professor and Executive Vice Chair, Dept. of Surgery, University of Chicago, Chicago, Illinois Bonnie Alvey, ACNS-BC WOCN Enterostomal Therapy Dept., Wound & Ostomy Clinical Specialist, Ochsner Clinic, New Orleans, LA Medical Director, Swedish Colon and Rectal Clinic; Program Director, Swedish Colon and Rectal Surgery Training Program, Swedish Medical Center, Swedish Cancer Institute, Seattle, WA Director, MGH Colorectal Surgery Program; Co-Director, MGH Pelvic Floor Disorders Center; Asst. Professor of Surgery, Harvard Medical School; Massachusetts General Hospital, Boston MA Nancy Baxter, MD, PhD Assoc. Professor of Surgery, St. Michael’s Hospital, Toronto, ON, Canada Jennifer S. Beaty, MD, FACS, FASCRS Program Director Colon and Rectal Surgery, Asst. Professor of Surgery, Creighton University School of Medicine; Asst. Professor of Surgery, University of Nebraska College of Medicine, Omaha, NE W. Donald Buie, MD Assoc. Professor of Surgery and Oncology; Chief, Div. of General Surgery, Foothills Hospital; Program Director, Colorectal Surgery Program, Dept. of Surgery, University of Calgary, Calgary, AB, Canada Marcus Burnstein, MD Assoc. Professor, Dept. of Surgery, University of Toronto; St. Michael’s Hospital, Toronto, ON, Canada David E. Beck, MD, FACS, FASCRS John Byrn, MD Professor and Chairman Emeritus, Dept. of Colon and Rectal Surgery, Ochsner Clinic Foundation; Professor of Surgery, University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA Clinical Asst. Professor; Chief, Section of Colorectal Surgery, Div. of Gastrointestinal, Minimally-invasive and Bariatric Surgery, Dept. of Surgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa Sandra J. Beck, MD, FASCRS Jamie Cannon, MD, FACS Assoc. Professor of Surgery; Chief, Section of Colon and Rectal Surgery, University of Kentucky, Lexington, KY Asst. Professor of Surgery, Div. of Gastrointestinal Surgery, University of Alabama at Birmingham, Birmingham, AL Wayne Ambroze, MD Program Director, Colon and Rectal Surgery, Northside Hospital, Atlanta, GA Robin Anderson, BSN, RN Strategic Services Associate, Performance Services, Enhanced Recovery Program Coordinator, Duke University Health System, Durham, NC Mariana Berho, MD Mark Arnold, MD Mitchell Bernstein, MD, FACS, FASCRS Joseph C. Carmichael, MD Assoc. Professor of Surgery; Director, Div. of Colon & Rectal Surgery, NYU Langone Medical Center, New York, NY Asst. Professor; Colon and Rectal Surgery Residency, Program Director, Dept. of Surgery, University of California, Irvine, Orange, CA J. Michael Berry-Lawhorn, MD Peter Cataldo, MD Clinical Professor of Medicine, Div. of Hematology Oncology; Assoc. Director HPV-Related Clinical Studies, University of California San Francisco, San Francisco, CA Samuel B. and Michelle D. Labow Professor of Colon and Rectal Surgery at the University of Vermont Medical Center, Burlington, VT Ohio State University Medical Center, Dept. of Surgery, Columbus, OH Glenn T. Ault, MD, MSEd Assoc. Professor & Residency Program Director, Div. of Colorectal Surgery; Vice-Chair/Chief of Surgery (LAC+USC), Dept. of Surgery; Vice Dean, Keck School of Medicine of USC, Los Angeles, CA Heidi Bahna, MD, FACS Asst. Professor of Clinical Surgery; Assoc. Director, Colon and Rectal Residency Program Miller School of Medicine, University of Miami, Miami, FL Cleveland Clinic Staff Physician, Cleveland Clinic Florida, Hollywood, FL Richard Billingham, MD Clinical Professor, Dept. of Surgery, University of Washington, Seattle, WA Teresa L. Carman, MD Director, Vascular Medicine, University Hospitals Case Medical Center, Cleveland, OH Bradley J. Champagne, MD, FACS, FASCRS Assoc. Professor of Surgery, Case Western Reserve University, Div. of Colorectal Surgery, University Hospitals, Case Medical Center; Program Director, Colorectal Residency, Cleveland, OH George J. Chang, MD, MS Assoc. Professor, Depts. of Surgical Oncology and Health Services Research; Chief, Colon and Rectal Surgery; Assoc. Medical Director, Colorectal Center; Director of Clinical Operations, Minimally Invasive and New Technologies in Oncologic Surgery Program, The University of Texas, MD Anderson Cancer Center, Houston, TX James M. Church, MD Victor W. Fazio Chair in Colorectal Surgery; Director, Sanford R. Weiss, MD Center for Hereditary Colorectal Neoplasia; Dept. of Colorectal Surgery, Digestive Diseases Institute, Cleveland Clinic, Cleveland, OH Robert R. Cima, MD, MA, FACS, FASCRS Professor of Surgery, Mayo Clinic College of Medicine; Consultant, Div. of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN Robert K. Cleary, MD, FACS, FASCRS Program Director, Colon and Rectal Surgery Residency, St. Joseph Mercy Health System, Ann Arbor, MI Jeffrey L. Cohen, MD, FACS, FASCRS, CPE Vice President, Specialty Services, Hartford HealthCare Medical Group; Clinical Professor of Surgery, University of Connecticut, Farmington, CT; Chief of Colorectal Surgery, Hartford Hospital, Hartford, CT Jeffrey S. Cohen, MD Chief, Div. of Colon and Rectal Surgery, Wellstar Kennestone Regional Medical Center, Marietta, GA; Director, Robotic Surgery Epicenter, Northside Hospital, Cherokee; Atlanta Colon and Rectal Surgery, Atlanta, GA Kyle G. Cologne, MD Thomas E. Cataldo, MD, FACS, FASCRS Beth Israel-Deaconess Medical Center; Instructor in Surgery, Harvard Medical School, Boston, MA 142 Asst. Professor of Clinical Surgery, Div. of Colorectal Surgery, University of Southern California Keck School of Medicine, Los Angeles, CA Featured Lecturers and Faculty Molly M. Cone, MD John C. Eggenberger, MD Fergal Fleming, MD Timothy Geiger, MD Asst. Professor of Surgery, Colon and Rectal Surgery, Vanderbilt University Medical Center, Nashville, TN Staff Surgeon, St. Joseph Mercy Hospital, Ann Arbor, MI; Program Director of the General Surgery Residency and Vice-chair of the Dept. of Surgery, St. Joseph Mercy Hospital, Ann Arbor, MI; Clinical Asst. Professor, Dept. of Surgery, University of Toledo; Clinical Asst. Professor, College of Osteopathic Medicine, Michigan State University Asst. Professor of Surgery and Oncology; Div. of Colorectal Surgery; Director, Surgical Health Outcomes and Research Enterprise (SHORE), University of Rochester Medical Center, Rochester, NY Asst. Professor of Colon and Rectal Surgery, Vanderbilt University, Nashville, TN Certified Wound, Ostomy, Continence Nurse; Beth Israel Deaconess Medical Center, Boston, MA Meaghen Costedio, MD Cleveland Clinic, Cleveland, OH Chris Cunningham, MB ChB, MD, BSc (Hons), FRCSEd Consultant Colorectal Surgeon, Honorary Senior Lecturer, Oxford University Hospitals NHS Trust, Churchill Hospital, Oxford, United Kingdom Michael I. D’Angelica, MD Enid A. Haupt Chair in Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; Attending Surgeon, Memorial Sloan Kettering Cancer Center, New York, NY; Assoc. Professor of Surgery, Cornell University/Weill Medical College, New York, NY André D’Hoore, MD, PhD Assoc. Professor of Surgery; Chair, Dept. of Abdominal Surgery, University Hospital Leuven, Leuven, Belgium Bradley R. Davis, MD Assoc. Professor of Surgery, Div. of Colon and Rectal Surgery; Director, Residency Program in General Surgery; Director, Div. of Surgical Education, University of Cincinnati; Cincinnati, OH Conor P. Delaney, MD, PhD The Jeffrey L. Ponsky Professor of Surgical Education; Chief, Div. of Colorectal Surgery; Vice-Chair, Dept. of Surgery; Director, CWRU Center for Skills and Simulation; Surgical Director, Digestive Health Institute, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH Alex E. Elobu, MD, MMed, FCSECSA David W. Dietz, MD Vice-Chairman and Staff Surgeon, Dept. of Colorectal Surgery, Digestive Diseases Institute, Cleveland Clinic, Cleveland, OH Seeger Professor and Chairman of Surgery, Baylor University Medical Center; Professor of Surgery, Texas A&M Health Sciences, Dallas, TX Phillip Fleshner, MD Colorectal Surgery Unit, Mulago National Referral Hospital, Makerere University College of Health Sciences, Kampala, Uganda Cedars-Sinai Medical Center, Los Angeles, CA Cathy Eng, MD, FACP Professor, Div. of General Surgery; Adjunct Professor, Depts. of Public Health and Pharmacy; Assoc. Chair for Research, Dept. of Surgery; Medical Director, Surgical Outcomes Research Center (SORCE), Seattle, WA Professor, Dept. of Gastrointestinal Medical Oncology; Director, Dept. of Gastrointestinal Medical Oncology, Network Clinical Research; Assoc. Medical Director, Colorectal Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX Todd Francone, MD, MPH Dept. of Colon and Rectal Surgery, Lahey Hospital and Medical Center, Burlington, MA; Asst. Professor of Surgery, Tufts Medical Center, Boston, MA David Etzioni, MD Assoc. Professor, Mayo Clinic College of Medicine; Chair, Div. of Colon and Rectal Surgery, Mayo Clinic Arizona, Phoenix, AZ Charles M. Friel, MD Daniel L. Feingold, MD, FACS, FASCRS Assoc. Professor of Surgery; Chief, Section of Colon and Rectal Surgery; Surgical Director of the Digestive Health Center, University of Virginia, Charlottesville, VA The Stanley Edelman, MD – Stephen Jarislowsky Assoc. Professor of Surgery, Columbia University, New York, NY Robert D. Fry, MD Alessandro Fichera, MD, FACS, FASCRS Emilie & Roland deHellebranth Professor of Surgery; Chief, Div. of Colon and Rectal Surgery, UPHS, Philadelphia, PA Professor and Chief, Section Gastrointestinal Surgery, Div. of General Surgery, Dept. of Surgery, University of Washington Medical Center, Seattle, WA Julio Garcia-Aguilar, MD, PhD Robert L. Fine, MD, FACP, FAAHPM Clinical Director, Office of Clinical Ethics and Palliative Care, Baylor Scott and White Health, Dallas, TX; Clinical Assoc. Professor of Internal Medicine and Medical Humanities, Texas A&M College of Medicine Charles O. Finne, MD Clinical Professor of Surgery, Div. of Colon and Rectal Surgery, University of Minnesota, Minneapolis, MN Clinical Professor of Surgery, Div. of Colon and Rectal Surgery, Dept. of Surgery, University of Minnesota, Minneapolis, MN Stephen E. Goldstone, MD, FACS David R. Flum, MD, MPH Sekhar Dharmarajan, MD Washington University School of Medicine, St. Louis, MO James Fleshman, MD Stanley M. Goldberg, MD, FACS, HonFRACS (Aust), HonFRCS (Eng), HonAFC (Fr), HonFRCPS (Glasg), HonFRSM (Eng), HonFPCS (Phil), HonFRCS (Edin), Honoris Causa (Lleida), HonSAS (Spain), HonJSS (Japan) Chief, Colorectal Service, Stuart H.Q. Quan Chair in Colorectal Surgery, Dept. of Surgery, Memorial SloanKettering Cancer Center, New York, NY Kelly A. Garrett, MD, FACS, FASCRS Asst. Professor of Surgery, Weill Cornell Medical College – NY Presbyterian Hospital, Dept. of General Surgery, Div. of Colon and Rectal Surgery, New York, NY Susan Gearhart, MD Assoc. Professor of Colorectal Surgery, Johns Hopkins Hospital, Baltimore, MD 143 Asst. Clinical Professor of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY I. Emre Gorgun, MD, FACS, FASCRS Staff Surgeon, Quality Improvement Officer, Dept. of Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH Wilhelm Graf, MD, PhD Professor of Gastrointestinal Surgery, Institution of Surgical Sciences, Uppsala University; Dept. of Surgery, Akademiska Sjukhuset, Uppsala, Sweden John Griffin, MD Program Director, Colon and Rectal Surgery Residency Program, St. Mark's Healthcare Foundation Colon and Rectal Surgery Program; Central Utah Clinic, Salt Lake City, UT José G. Guillem, MD, MPH Attending Surgeon, Memorial Sloan Kettering Cancer Center; Professor of Surgery, Weill Medical College of Cornell University, New York, NY Brooke Gurland, MD Asst. Clinical Professor of Surgery, Lerner College of Medicine, Dept. of Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH Eric M. Haas, MD President, Colorectal Surgical Associates; Program Director, Minimally Invasive Colon & Rectal Surgery Fellowship, University of Texas Medical School Houston, Houston, TX F A C U LT Y A. Murray Corliss, RN, BSN, CWOCN Featured Lecturers and Faculty Jason F. Hall, MD, MPH, FACS Torbjörn Holm, MD, PhD Lahey Hospital and Medical Center, Dept. of Colon and Rectal Surgery, Burlington, MA; Program Director, Residency in Colon and Rectal Surgery, Lahey Hospital and Medical Center; Asst. Professor of Surgery, Tufts University School of Medicine, Boston, MA Section for Lower Abdominal Surgery Center of Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden; Professor of Surgery, Dept. of Molecular Medicine and Surgery, Karolinska Institutet Amy Halverson, MD Assoc. Professor, Northwestern University, Feinberg School of Medicine, Chicago, IL Andreas M. Kaiser, MD, FACS, FASCRS Professor of Clinical Surgery, USC Div. of Colorectal Surgery, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA Matthew F. Kalady, MD Stefan D. Holubar, MD, MS Asst. Professor of Surgery, Div. of Colon and Rectal Surgery, DartmouthHitchcock Medical Center, Lebanon, NH; Geisel School of Medicine at Dartmouth; The Dartmouth Institute for Health Policy & Clinical Practice Heather Hampel, MS, LGC Assoc. Director, Div. of Human Genetics; Assoc. Director, Biospecimen Research; Professor, Internal Medicine; Licensed Genetic Counselor; The Ohio State University Comprehensive Cancer Center, Columbus, OH Karin Hardiman, MD, PhD Asst. Professor of Surgery, Div. of Colorectal Surgery, University of Michigan, Ann Arbor, MI Alan E. Harzman, MD Asst. Professor of Surgery, The Ohio State University, Columbus, OH Assoc. Professor of Surgery, Cleveland Clinic Lerner College of Medicine; Krause-Lieberman Chair in Colorectal Surgery, Dept. of Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH Brian R. Kann, MD, FACS, FASCRS M. Benjamin Hopkins, MD Duke Colorectal Surgery at Raleigh, Raleigh, NC Staff Surgeon, Dept. of Colon and Rectal Surgery, Ochsner Medical Center, New Orleans, LA Jon S. Hourigan, MD, FACS, FASCRS Sergey V. Kantsevoy, MD, PhD Assoc. Professor of Surgery, Colon and Rectal Surgery, University of Kentucky, Lexington, KY Professor of Medicine, University of Maryland School of Medicine; Director of Therapeutic Endoscopy, Institute for Digestive Health and Liver Disease at Mercy Medical Center, Baltimore, MD Traci L. Hedrick, MD, FACS Asst. Professor of Surgery, Section Colon and Rectal Surgery, University of Virginia, Charlottesville, VA Alexander Heriot, MD, MBA, FRACS, FRCS Director of Surgery, Peter MacCallum Cancer Center, Melbourne, VIC, Australia; Clinical Professor, University of Melbourne Daniel O. Herzig, MD Assoc. Professor of Surgery, Digestive Health Center and Knight Cancer Institute, Oregon Health & Science University, Portland, OR Tracy Hull, MD Professor of Surgery, Holder of the Shafran Family Charitable Trust Endowed Chair, Dept. of Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH Vice Chair, Dept. of Colon and Rectal Surgery, Ochsner Clinic, New Orleans, LA; Clinical Professor of Surgery, LSU School of Medicine, New Orleans, LA Rebecca Hoedema, MD, MS Spectrum Health Medical Group, Ferguson Clinic, Center for Digestive Diseases, Grand Rapids, MI Anjali S. Kumar, MD, MPH Colon and Rectal Surgery, MedStar Washington Hospital Center; Asst. Professor of Surgery, Georgetown University School of Medicine, Washington, DC Alex Jenny Ky, MD, FACS, FASCRS Assoc. Professor of Surgery, Dept. of Surgery, Mount Sinai School of Medicine, New York, NY; Medical Director, Mount Sinai Downtown office Mayo Clinic College of Medicine, Div. of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN Gregory D. Kennedy, MD, PhD Asst. Professor of Surgery, Ohio State University Wexner Medical Center, Columbus, OH Assoc. Professor of Surgery; Vice Chair of Quality, Dept. of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI Neil Hyman MD, FACS Hermann Kessler, MD, PhD, FACS Chief, Section of Colon and Rectal Surgery, Professor of Surgery, University of Chicago Medicine, Chicago, IL; Co-Director, Center for Digestive Diseases, University of Chicago Medicine, Chicago, IL Section Head, Minimally Invasive Surgery, Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH Donald Kim, MD Naomi Jay, RN, NP, PhD Asst. Clinical Professor, School of Nursing UCSF; Assoc. Director, HPVRelated Clinical Studies, UCSF Anal Neoplasia Clinic, Mount Zion Hospital, San Francisco, CA Professor of Surgery, University of Leeds and Leeds Teaching Hospitals, NHS Trust, Leeds, United Kingdom Spectrum Health Medical Group, Grand Rapids, MI Jin C. Kim, MD Professor, Div. of Colorectal Surgery, Dept. of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea Jorge Lagares-Garcia, MD, FACS, FASCRS Chief, Div. of Colon and Rectal Surgery; Director, Robotic Colorectal Epicenter, Roper Hospital, Charleston Colorectal Surgery, Charleston, SC Sean Langenfeld, MD Asst. Professor of Surgery; Assoc. Program Director, General Surgery Residency, University of Nebraska Medical Center, Omaha, NE Sergio W. Larach, MD Florida Hospital Orlando; Asst. Professor of Surgery, University of Central Florida College of Medicine, Orlando, FL; Asst. Professor, Florida State University, Tallahassee, FL David W. Larson, MD, MBA, FACS, FASCRS Professor of Surgery, Chair of Colorectal Surgery, Consultant, Dept. of Surgery, Mayo Clinic, Rochester, MN Sanghyun Kim, MD Sang W. Lee, MD Mount Sinai School of Medicine, New York, NY Cindy Kin, MD Assoc. Professor of Surgery; Vice Chief, Colon and Rectal Surgery, NY Presbyterian Hospital, Weill-Cornell Medical College, New York, NY Asst. Professor of Surgery, Stanford University, Stanford, CA Paul-Antoine Lehur, MD, PhD Eric K. Johnson, MD, FACS, FASCRS Assoc. Professor of Surgery, Uniformed Services University of the Health Sciences, Madigan Army Medical Center, Fort Lewis, WA Chief, Gastrointestinal Surgery Dept., Institute of Digestive and Metabolic Diseases, Hospital Clinic de Barcelona; Professor of Surgery, Universitat de Barcelona; Director, Institute of Surgery, Hospital Quiron; President, Barcelona International Medical Academy (BIMA), Barcelona, Spain Scott R. Kelley, MD, FACS Syed Husain, MD David Jayne, MB BCh MD FRCS Terry C. Hicks, MD Assoc. Professor of Surgery, University of Washington, Dept. of Surgery, Seattle, WA Antonio M. Lacy, MD, PhD Imran Hassan, MD Clinical Assoc. Professor, University of Iowa, Iowa City, IA Mukta Krane, MD Natalie Kirilcuk, MD Asst. Professor of Surgery, Stanford Hospital and Clinics, Stanford, CA 144 Professor of Digestive Surgery, University Hospital of Nantes, Nantes, France Featured Lecturers and Faculty Ann C. Lowry, MD, FASCRS Slawomir Marecik, MD, FACS, FASCRS James T. McCormick, DO, FACS, FASCRS Colorectal Surgery Attending, Advocate Lutheran General Hospital, Park Ridge, IL; Assoc. Professor of Clinical Surgery, University of Illinois at Chicago College of Medicine, Chicago, IL Program Director, General Surgery, Allegheny Health Network; Chief, Div. of Colon and Rectal Surgery, Forbes Hospital; Assoc. Professor of Surgery, Temple University School of Medicine, Pittsburgh, PA Allison B. McCoy, PhD Kirk Ludwig, MD David A. Margolin, MD, FACS, FASCRS The Vernon O. Underwood Professor, Professor of Surgery; Chief, Div. of Colorectal Surgery, Dept. of Surgery, Medical College of Wisconsin, Milwaukee, WI Professor and Director, Colon and Rectal Surgical Research, The Ochsner Clinic Foundation, New Orleans, LA; The University of Queensland School of Medicine, Ochsner Clinical School Asst. Professor, Dept. of Biostatistics and Bioinformatics, Tulane University School of Public Health and Tropical Medicine; Center for Health Research, Ochsner Health System, New Orleans, LA Helen MacRae, MD Jeffrey M. Marks, MD, FACS, FASGE Michael F. McGee, MD, FACS Professor of Surgery, University of Toronto, Toronto, ON, Canada Professor of Surgery; Director, Surgical Endoscopy; Program Director, Case Surgery, University Hospitals Case Medical Center, Cleveland, OH Asst. Professor of Surgery, Colorectal Surgery, Div. of Gastrointestinal and Oncologic Surgery, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL Clinical Professor of Surgery, Div. of Colon and Rectal Surgery, University of Minnesota, Minneapolis, MN Martin Luchtefeld, MD Chief, Div. of Colon and Rectal Surgery, Spectrum Health Medical Group, Grand Rapids, MI James Merlino, MD Consultant Staff, Dept. of Colorectal Surgery, Cleveland Clinic; President and Chief Medical Officer, Strategic Consulting Div., Press Ganey Associates, Inc., Chicago, IL Craig Messick, MD Asst. Professor of Surgery, Dept. of Surgical Oncology, Section of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center, Houston, TX; University of Texas MD Anderson Cancer Center, Regional Care Center, Sugar Land, TX John Migaly, MD Professor of Surgery; Medical Director, William C. Bernstein, MD Familial Cancer Registry; Stanley M. Goldberg, MD Chair and Chief, Div. of Colon and Rectal Surgery, Dept. of Surgery, University of Minnesota, Minneapolis, MN John H. Marks, MD Chief of Colorectal Surgery, Main Line Health Systems; Director of Minimally Invasive Colorectal Surgery and Rectal Cancer Management Fellowship, Lankenau Medical Center; Professor, Lankenau Institute of Medical Research, Wynnewood, PA Najjia N. Mahmoud, MD Assoc. Professor of Surgery; Chief, Div. of Colon and Rectal Surgery, University of Pennsylvania Health System, Philadelphia, PA David J. Maron, MD, MBA Vice Chairman, Dept. of Colorectal Surgery; Director, Colon and Rectal Surgery Residency Program, Cleveland Clinic Florida, Weston, FL Tony Wing Chung Mak, MD Asst. Professor, Div. of Colorectal Surgery, Chinese University of Hong Kong, Hong Kong Joseph Martz, MD Chief, Div. of Colon and Rectal Surgery, Mount Sinai Beth Israel Medical Center, New York, NY Ronnie Mathew, MD, MBBS Asst. Professor of Surgery, Rutgers – Robert Wood Johnson Medical School, New Brunswick, NJ Consultant in General and Colorectal Surgery, University Hospitals Leicester NHS Trust, Leicester, United Kingdom Mark L. Manwaring, MD Klaus E. Matzel, MD, Hon FASCRS, EBSQColoproct. Peter W. Marcello, MD, FACS, FASCRS Chairman, Dept. of Colon and Rectal Surgery, Lahey Hospital and Medical Center, Burlington, MA Jorge Marcet, MD Professor of Surgery; Chief, Section of Colon and Rectal Surgery; Director, Colon and Rectal Surgery Residency, Tampa General Hospital, University of South Florida, Tampa, FL Head, Section of Coloproctology, Dept. of Surgery, University Erlangen; Professor of Surgery, Friedrich Alexander University, Erlangen/ Nurnberg, Erlangen, Germany Justin A. Maykel, MD Chief, Div. of Colorectal Surgery; Assoc. Professor of Surgery, UMass Memorial Medical Center, University of Massachusetts Medical School, Worcester, MA Chief, Colorectal Surgery; Director, Minimally Invasive Surgery Center, Kaiser Permanente LA Medical Center, The Teaching and Tertiary Referral Center for Southern California Permanente Medical Group, Los Angeles, CA Chief, Colon and Rectal Surgery; Jerome J. DeCosse Professor of Surgery; Executive Director, Center for Advanced Digestive Care (CADC); Executive Director, Minimally Invasive New Technologies (MINT); Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY John R. T. Monson, MD Robin S. McLeod, MD Professor of Surgery and Health Policy Management and Evaluation, University of Toronto, Mount Sinai Hospital, Toronto, ON, Canada M. Shane McNevin, MD Nell Maloney Patel, MD, FACS, FACRS Colorectal Surgery, Asst. Professor of Surgery, East Carolina University, Greenville, NC Jeffrey W. Milsom, MD Elisabeth (Lisa) C. McLemore, MD, FACS, FASCRS Surgical Specialists of Spokane; Director, Providence Continence Center, Spokane, WA Armando Melani, MD Assoc. Professor of Minimally Invasive Surgery, Section of Colon and Rectal Surgery; Scientific Director of the IRCAD Latin American; Ribeirão Preto School of Medicine, University of São Paulo, Barretos, São Paulo, Brasil Anders Mellgren, MD, PhD, FACS, FASCRS Professor, Chief Colon & Rectal Surgery, Dept. of Surgery, University of Illinois at Chicago, Chicago, IL Genevieve Melton-Meaux, MA, MD, FACS, FASCRS Assoc. Professor of Surgery and Informatics, University of Minnesota; Chief Health Information Officer, Fairview Health Services, and University of Minnesota Physicians, Minneapolis, MN 145 Professor of Surgery and Oncology; Chief, Div. of Colorectal Surgery and Vice-Chairman of Surgery; ViceChairman of Quality and Outcomes; Director, Surgical Health Outcomes and Research Enterprise (SHORE), University of Rochester Medical Center, Rochester, NY Arden M. Morris, MD, MPH Assoc. Professor of Surgery; Chief, Div. of Colorectal Surgery, University of Michigan, Ann Arbor, MI Sthela Murad-Regadas, MD, PhD, FASCRS Assoc. Professor of Surgery, Federal University of Ceara Medical School; Coordinator of Section of Anorectal Physiology and Pelvic Floor, Clinical Hospital and Sao Carlos Hospital, Forteleza, CE, Brazil Jamie Murphy, BChir, PhD, FRCS NIHR Lecturer in Surgery, University of London, London, United Kingdom M. Margarita Murphy, MD, FASCRS Medical Director, Colorectal Endosurgery Institute of the Carolinas, Roper Mt. Pleasant Hospital, East Cooper Regional Medical Center, Mount Pleasant, SC F A C U LT Y Robert D. Madoff, MD, FACS, FASCRS, FRCSEd (hon) Program Director, General Surgery Residency; Assoc. Professor, Colon and Rectal Surgery, Div. of Advanced GI and Oncologic Surgery, Duke University Medical Center, Durham, NC Featured Lecturers and Faculty Matthew G. Mutch, MD Bruce A. Orkin, MD Hiram C. Polk, Jr., MD Assoc. Professor of Surgery, Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, MO Professor of Surgery; Vice Chair for Academic Affairs, Dept. of General Surgery; Chief, Section of Colon and Rectal Surgery, Rush University Medical Center, Chicago, IL Ben A. Reid, Sr. Professor of Surgery, Emeritus; Former Chair, Dept. of Surgery, School of Medicine, University of Louisville, Louisville, KY Deborah Nagle, MD Chief, Div. of Colon and Rectal Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA Darren Pollock, MD Joel Palefsky, MD, CM, FRCP(C) Infectious Disease Specialist, Professor of Medicine and Laboratory Medicine, University of California, San Francisco, San Francisco, CA Govind Nandakumar, MD Asst. Professor, Dept. of Surgery, Div. of Colorectal Surgery, NYPH/Weill Cornell Medical Center, New York, NY Ian M. Paquette, MD Asst. Professor of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH Johan Nordenstam, MD, PhD University of Illinois at Chicago, Chicago, IL Eduardo Parra-Davila, MD, FACS, FASCRS Professor of Surgery, Chairman, Dept. of Colorectal Surgery, Rupert B. Turnbull, Jr., MD Endowed Chair in Colorectal Surgery, Digestive Disease Institute; Director, Center for International Medical Education, Cleveland Clinic, Cleveland, OH Harry Reynolds, Jr., MD Vitaliy Poylin, MD Jevon Puckett, MBBS Assoc. Professor of Surgery, Case Western Reserve University; Director Colon and Rectal Cancer Surgery, University Hospitals Case Medical Center, Div. of Colorectal Surgery, Cleveland, OH Dept. of Surgery, The University of Auckland, Auckland, New Zealand Craig Rezac, MD, FACS, FASCRS Div. of Colon and Rectal Surgery, Beth Israel Deaconess Medical Center, Boston, MA Heidi Nelson, MD Fred C. Andersen Professor of Surgery; Chair, Dept. of Surgery; Mayo Clinic, Rochester, MN Staff Colon and Rectal Surgeon, Swedish Cancer Institute, Swedish Medical Center, Seattle, Washington Feza H. Remzi, MD, FACS, FASCRS, FTSS (Hon) Director for Minimally Invasive & Colorectal Surgery; Director of Hernia and Abdominal Wall Reconstruction, Florida Hospital Celebration, Celebration, FL Janice Rafferty, MD John H. Pemberton, MD Sonia Ramamoorthy, MD, FACS, FASCRS Professor of Surgery; Chief, Div. of Colon and Rectal Surgery, University of Cincinnati College of Medicine, Cincinnati, OH Assoc. Professor of Surgery, Rutgers Medical School; Section Chief, Colon and Rectal Surgery; Chief of Robotic Surgery, RWJUH Div. of General Surgery, New Brunswick, NJ Rocco Ricciardi, MD, MPH Juan J. Nogueras, MD, MBA, FACS, FASCRS Clinical Professor of Surgery, Florida International University; Affiliate Professor of Clinical Biomedical Science, Florida Atlantic University, Weston, FL Professor of Surgery, Mayo Clinic College of Medicine; Consultant, Div. of Colon & Rectal Surgery, Mayo Clinic College of Medicine, Rochester, MN Rodrigo Oliva Perez, MD, PhD Assoc. Professor of Surgery; Chief, Section of Colon and Rectal Surgery, Rebecca and John Moores Cancer Center, UC San Diego Medical Center, La Jolla, CA Asst. Professor of Surgery; Director, Div. of Colon and Rectal Surgery, George Washington University, Washington, DC University of São Paulo School of Medicine, Colorectal Surgery Div.; Angelita & Joaquim Gama Institute Colorectal Surgery Div.; Ludwig Institute for Cancer Research – São Paulo Branch, Brazil David O’Brien, MD W. Brian Perry, MD The Oregon Clinic PC, Portland, OR Chief of Surgery, Audie L. Murphy VA Medical Center, San Antonio, TX Chief of Surgery at Memorial Hermann Northeast Hospital; Staff surgeon, Houston Methodist Willowbrook Hospital, St. Luke's Hospital at the Vintage, Houston Northwest Medical Center and Cypress-Fairbanks Medical Center, Humble, TX P. Ronan O’Connell, MD, FRCSI, FRCS (Glas), FRCS (Edin) Walter R. Peters, Jr., MD, MBA Elizabeth Raskin, MD Head, Section of Surgery and Surgical Specialties, University College Dublin; Consultant Surgeon, St Vincent’s University Hospital, Dublin, Ireland President, Columbia Surgical Associates; Clinical Assoc. Professor of Surgery, University of Missouri, Columbia, MO Colon and Rectal Surgery Associates, St. Paul, MN Frank G. Opelka, MD, FACS Alessio Pigazzi, MD, PhD Medical Director, Quality and Health Policy, The American College of Surgeons; Professor of Surgery and Executive Vice President, Louisiana State University, New Orleans, LA Assoc. Professor of Clinical Surgery; Chief, Div. of Colon and Rectal Surgery, University of California, Irvine, Orange, CA Vincent J. Obias, MD Assoc. Professor of Clinical Surgery; Chief, Section of Colon and Rectal Surgery, Adjunct Assoc. Professor of Clinical Surgery, Tulane School of Medicine/Dept. of Surgery, New Orleans, LA Thomas E. Read, MD, FACS, FASCRS Senior Staff Surgeon, Dept. of Colon and Rectal Surgery, Lahey Hospital and Medical Center, Burlington, MA; Professor of Surgery, Tufts University School of Medicine, Boston, MA University of Chicago, Dept. of Medicine, Section of Hematology/ Oncology, Chicago, IL David E. Rivadeneira, MD, MBA, FACS, FASCRS Vice Chair, Surgical Strategic Initiatives for North Shore-LIJ Health System; Director, Surgical Services and Colorectal Surgery at Huntington Hospital; Professor of Surgery, Hofstra University School of Medicine, Woodbury, NY Bruce Robb, MD Assoc. Professor of Surgery, Section Chief, Colon and Rectal Surgery, Indiana University School of Medicine, Indianapolis, IN Patricia L. Roberts, MD, FACS, FASCRS Senior Staff Surgeon, Dept. of Colon and Rectal Surgery; Chair, Div. of Surgery, Lahey Hospital and Medical Center, Burlington, MA; Professor of Surgery, Tufts University School of Medicine, Boston, MA Lester Rosen, MD Craig Reickert, MD Blase Polite, MD, MPP Guy R. Orangio, MD Tal Raphaeli, MD, FACS Chief Scientific Officer, Lahey Hospital and Medical Center, Burlington, MA Senior Staff Surgeon, Div. of Colon and Rectal Surgery; Program Director, Residency in Colon and Rectal Surgery; Director of the Center for Simulation, Education and Research, Henry Ford Hospital; Asst. Professor of Surgery, Wayne State University, Detroit, MI 146 Staff Colon and Rectal Surgeon, Cleveland Clinic Florida, West Palm Beach; Affiliate Professor of Clinical Biomedical Science, Charles Schmidt College of Medicine at Florida Atlantic University; Clinical Professor of Surgery, Florida International University, Herbert Wertheim College of Medicine Featured Lecturers and Faculty Michael J. Rosen, MD, FACS Giulio A. Santoro, MD, PhD David Shibata, MD, FACS, FASCRS Scott A. Strong, MD Professor of Surgery, Medical Director, Comprehensive Hernia Center, Cleveland Clinic, Cleveland, OH Consultant Colorectal Surgeon, Cleveland Clinic Abu Dhabi, United Arab Emirates Howard Ross, MD, FACS, FASCRS David Schoetz, Jr., MD Professor and Chief, Div. of Colon and Rectal Surgery, Temple University School of Medicine, Philadelphia, PA Tufts School of Medicine Academic Dean at Lahey Hospital and Medical Center; Chief Education Officer, Lahey Hospital and Medical Center, Burlington, MA; Designated Institutional Official, Graduate Medical Education; Chairman Emeritus, Dept. of Colon and Rectal Surgery; Professor of Surgery, Tufts University School of Medicine, Boston, MA Senior Member, Professor of Surgery and Oncology; Vice-Chair, Dept. of Gastrointestinal Oncology; Chief, Section of Colorectal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL Staff Physician, Holder of the Thomas C. and Sandra S. Sullivan Family Endowed Chair, Dept. of Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH Steven W. Siegel, MD Patricia Sylla, MD Director of Metro Urology’s Center for Continence Care, Woodbury, MN Asst. Professor of Surgery, Mount Sinai Hospital, Div. of Colon and Rectal Surgery, New York, NY Asst. Professor of Surgery, University Colon and Rectal Surgery; Assoc. Program Director, General Surgery Residency, Dept. of Surgery, University of Tennessee Medical Center, Knoxville, TN Rudolph B. Rustin, MD, FACS, FASCRS Human Resources for Health Program, Huye, Rwanda, University of Virginia Dept. of Surgery Michael J. Snyder, MD James Picker Professor and Chairman, Dept. of Radiology, Columbia University Medical Center; Radiologist-in-Chief, New York Presbyterian Hospital, Columbia, New York, NY Clinical Assoc. Professor of Surgery, The University of Texas Health Science Center at Houston, Houston, TX Anthony J. Senagore, MD, MS, MBA Professor, Div. of Colorectal Surgery, University Hospitals/Parma Medical Center, Parma, OH Timothy S. Sadiq, MD Asst. Professor, Dept. of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC Peter Sagar, BSc, MD, FRCS Consultant Surgeon, Clinical Assoc. Professor, St. James’s University Hospital, Leeds, United Kingdom Stephen M. Sentovich, MD, MBA Chief, Section of Colon and Rectal Surgery; Clinical Professor of Surgery, City of Hope National Medical Center, Los Angeles, CA Virginia O. Shaffer, MD Asst. Professor of Surgery, Emory University, Atlanta, GA Jaime E. Sanchez, MD, MSPH Asst. Professor of Surgery , Div. of Colon & Rectal Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL Nishit Shah, MB ChB Dana R. Sands, MD, FACS, FASCRS Skandan Shanmugan, MD Staff Surgeon, Cleveland Clinic Florida; Director, Colorectal Physiology Center, Cleveland Clinic Florida, Weston, FL; Affiliate Assoc. Professor of Surgery, Florida Atlantic University; Clinical Assoc. Professor of Surgery, Florida International University; Voluntary Asst. Professor of Surgery, University of Miami Asst. Professor of Surgery, Div. of Colon and Rectal Surgery, University of Pennsylvania, Pennsylvania Hospital, Philadelphia, PA Cesar A. Santiago, MD, FACS, FASCRS Medical Director, Advanced Center for Robotic Surgery, St. Joseph Hospital, Tampa, FL Asst. Professor, Section of Colon and Rectal Surgery, Rush University Medical Center, Chicago, IL Lawrence H. Schwartz, MD Theodore Saclarides, MD Professor of Surgery and Director of the Div. of Colon and Rectal Surgery, Loyola University, Maywood, IL Marc Singer, MD Dept. of Surgery, Warren Alpert Medical School of Brown University, Providence, RI Yury Shelygin, MD, PhD Profesor of Surgery; Director, State Scientific Center of Coloproctology, Moscow, Russia; Associated Professor, Russian Medical Academy of Postgraduate Education, Moscow, Russia Eric J. Szilagy, MD, FACS, FASCRS Asst. Professor of Surgery, Wayne State University School of Medicine, Detroit, MI; Service Chief, Colon and Rectal Surgery, Henry Ford West Bloomfield Hospital, West Bloomfield, MI Larissa Temple, MD, FACS, MSc Michael J. Stamos, MD The John E. Connolly Professor and Chair, Dept. of Surgery, University of California, Irvine, Orange, CA Assoc. Attending Surgeon, Memorial Sloan Kettering Cancer Center; Assoc. Professor of Surgery, Weill Cornell Medical Center, New York, NY Scott R. Steele, MD, FACS, FASCRS Charles Ternent, MD Chief, Colon & Rectal Surgery, Madigan Army Medical Center, Fort Lewis, WA; Clinical Assoc. Professor of Surgery, University of Washington, Seattle, WA Assoc. Clinical Professor, Dept. of Surgery, Section of Colon and Rectal Surgery, Creighton University School of Medicine; Adjunct Assoc. Professor of Clinical Surgery, Dept. of General Surgery, University of Nebraska College of Medicine, Omaha, NE Randolph Steinhagen, MD Chief, Div. of Colon and Rectal Surgery, Mount Sinai Hospital; Program Director, Colon and Rectal Surgery Fellowship Program, Mount Sinai Hospital, New York, NY Julie Thacker, MD Duke University School of Medicine, Durham, NC Robert H. Thiele, MD Andrew RL Stevenson, MB BS, FRACS Study Chair – AlaCaRT (Australasian Laparoscopic Cancer Rectum Trial); Assoc. Professor, University of Queensland; Director, Colorectal Surgery, Royal Brisbane Hospital; Australian Colorectal Endosurgery, Chermside, QLD, Australia Asst. Professor, Depts. of Anesthesiology and Biomedical Engineering Divs. of Cardiac, Thoracic, and Critical Care Anesthesiology Director; Technology in Anesthesia & Critical Care Group Co-Director; UVA Enhanced Recovery after Surgery (ERAS) Program University of Virginia School of Medicine, Charlottesville, VA David B. Stewart., Sr., MD, FACS, FASCRS Christopher C. Thompson, MD, MHES Assoc. Professor of Surgery, Dept. of Surgery/Div. of Colorectal Surgery, Pennsylvania State University, Hershey Medical Center, Hershey, PA Director of Developmental Endoscopy, Div. of Gastroenterology, Brigham and Women’s Hospital, Boston, MA; Asst. Professor, Harvard Medical School Lisa Strate, MD, MPH Amy J. Thorsen, MD Assoc. Professor of Medicine, Dept. of Medicine, University of Washington School of Medicine, Div. of Gastroenterology, Seattle, WA Clinical Asst. Professor of Surgery, Div. of Colon and Rectal Surgery, University of Minnesota, Minneapolis, MN 147 F A C U LT Y Andrew J. Russ, MD Featured Lecturers and Faculty Kiran K. Turaga, MD, MPH Martin R. Weiser, MD Charles B. Whitlow, MD Asst. Professor, Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI Stuart HQ Quan Chair, Colorectal Surgery; Attending Surgeon, Memorial Sloan Kettering Cancer Center; Professor of Surgery, Cornell Weill Medical College, New York, NY Residency Program Director, Colon and Rectal Surgery, Ochsner Clinic, New Orleans, LA Konstantin Umanskiy, MD, FACS Asst. Professor, Surgery; Program Director, Colon and Rectal Surgery Residency Program; Assoc. Program Director, General Surgery Residency Program, The University of Chicago, Chicago, IL Elizabeth Wick, MD Assoc. Professor of Surgery, Johns Hopkins University, Baltimore, MD Mark Lane Welton, MD, MHCM Harry A. Oberhelman Professor; Chief, Colon and Rectal Surgery, Stanford University School of Medicine; Vice Chief of Staff, Stanford Hospital and Clinics, Stanford, CA Paul E. Wise, MD Assoc. Professor of Surgery, Section of Colon and Rectal Surgery; General Surgery Program Director, Washington University in St. Louis School of Medicine, St. Louis, MO Brian T. Valerian, MD, FACS, FASCRS Assoc. Professor of Surgery, Albany Medical College, Albany, NY Steven D. Wexner, MD, PhD(Hon), FACS, FRCS, FRCS(Ed) Jon Vogel, MD Director, Digestive Disease Center; Chair, Dept. of Colorectal Surgery; Cleveland Clinic Florida, Weston, FL; Affiliate Professor Florida Atlantic University College of Medicine; Clinical Professor Florida International University College of Medicine Assoc. Professor of Surgery, University of Colorado, Aurora, CO Richard L. Whelan, MD H. David Vargas, MD, FACS, FASCRS Staff Surgeon, Dept. of Colon and Rectal Surgery, Ochsner Clinic Foundation, New Orleans, LA Sarah A. Vogler, MD, MBA Clinical Asst. Professor of Surgery, Div. Colon and Rectal Surgery, University of Minnesota, Minneapolis, MN Theodoros Voloyiannis, MD, FACS, FASCRS Colon & Rectal Surgery, Memorial Hermann Medical Group, Memorial Hermann Hospital Southeast; Clinical Asst. Professor in Surgery, University of Texas Houston, Health Sciences Center, Houston, TX James Yoo, MD Asst. Professor, Tufts University School of Medicine; Chief, Div. of Colon and Rectal Surgery, Tufts Medical Center; Co-Director, Tufts Colorectal Cancer Program, Boston, MA Yi-Qian Nancy You, MD, MHSc Professor of Surgery; Chief, Colon and Rectal Surgery; Chief, Surgical Oncology, St. Luke’s Roosevelt Hospital, New York, NY Assoc. Professor, Section of Colorectal Surgery, Dept. of Surgical Oncology; Medical Director, Familial High-risk Gastrointestinal Cancer Clinic, University of Texas MD Anderson Cancer Center, Houston, TX Mark H. Whiteford, MD, FACS, FASCRS Massarat Zutshi, MD Gastrointestinal & Minimally Invasive Surgery Div., The Oregon Clinic, PC; Director, Colon and Rectal Surgery, Providence Cancer Center; Affiliate Professor of Surgery, Oregon Health & Science University, Portland, OR Assoc. Professor of Surgery; Staff surgeon, Cleveland Clinic, Dept. of Colorectal Surgery; Joint Appointment Dept. of Biomedical Engineering, Lerner Research Institute, Cleveland, OH 148 Disclosures Disclosure Policy and Disclosures As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American Society of Colon and Rectal Surgeons (ASCRS) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ASCRS. All identified conflicts of interest have been resolved. H. Randolph Bailey, MD Consultant: Ethicon, Inc. Louis Barfield, MD Consultant: Cook Medical; Speaker: Cook Medical Amir Bastawrous, MD Honorarium: Intuitive Surgical, Salix Pharmaceuticals; Speaker: Salix Pharmaceuticals; Teacher: Intuitive Surgical David Beck, MD Consultant: Pacira; Honorarium: Mallinckrodt Pharm, Pacira; Speaker: Pacira Mariana Berho, MD Consultant: Mediri Joshua Bleier, MD Consultant: Medtronic; Honorarium: Medtronic, Cook; Speaker: Medtronic, Cook; Teacher: Medtronic, Cook Liliana Bordeianou, MD Royalty: Up to Date; Kinetic Concepts Incorporated (KCI); Research Support: Kinetic Concepts Incorporated (KCI) Jamie Cannon, MD Honorarium: Intuitive Surgical; Speaker: Intuitive Surgical; Teacher: Intuitive Surgical Joseph Carmichael, MD Honorarium: Salix Pharmaceuticals, Ethicon Endosurgery; Speaker: Salix Pharmaceuticals; Teacher: Ethicon Endosurgery; Educational Grant: Ethicon Endosurgery James Church, MD Honorarium: Exact Sciences; Speaker: Exact Sciences Robert Cleary, MD Honorarium: Intuitive; Speaker: Intuitive Jeffrey S. Cohen, MD Honorarium: Intuitive; Speaker: Intuitive; Teacher: Intuitive Philip Cole, MD Consultant: Christus North La. Margot Damaser, MD Research Grant: Lily Pharmaceuticals, Beech Tree Labs, Acorda Labs Bradley Davis, MD Consultant: Ethicon Endo; Honorarium: Ethicon Endo Sandra de Montbrun, MD Research Grants: 1)2013 SSAT Career Development Award for Clinical/Outcomes/ Education Research (primary Investigator), The Society for Surgery of the Alimentary Tract. Conor Delaney, MD Consultant/Research Trial Development: Edwards Lifesciences; Honorarium: Covidien; Speaker: Covidien; Royalty/Licenced Patent: Ethicon; Intellectual Property Rights: Socrates Analytics; Ownership Interest (ie stocks)/Inventor and Founder: Socrates Analytics; Royalty/Licensed Simulator: Simbionix Cathy Eng, MD Consultant: Bayer, Genentech; Research Grant: Daiichi and Keryx Virgilio George, MD Consultant: Cook Medical, Ethicon EndoSurgery, Inc, LifeCell Corporation; Honorarium: Lifecell Corporation; Research Grant: Cook, W. L. Gore & Associates, Inc, Helsinn Company, ACOSOG, Covidien, Durect, Corp, Durect, Corp, LifeCell, Inc Stephen Goldstone, MD Consultant/Advisory Committee: Merck and Co., Conmed Inc., Covidien; Honorarium: Merck and Co.; Research Grant: Merck and Co., Covidien; Speaker: Merck and Co.; Investigator: Merck and Co. Brooke Gurland, MD Honorarium: Salix, Medtronic; Speaker: Salix; Education: Medronic Heather Hampel, MD Honorarium: Quest Diagnostics, Invitae Laboratories; Research Grant: Myriad Genetic Laboratories, Inc.; Speaker: Quest Diagnostics, Invitae Laboratories Alan Herline, MD Consultant: Third Dimension Technologies, Pathfinder Therapeutics, Inc. (founder); Royalty: Pathfinder Therapeutics, Inc.; Ownership Interest: Pathfinder Therapeutics, Inc. Terry Hicks, MD Honorarium: Pennsylvana Society of CRS, Greater Baltimore Hospital; Royalty: Improved Outcomes in Colon and Rectal Surgery book published Michael Hopkins, MD Consulting: American Medical Systems Sandy Fang, MD Research Grant: Cigarette Restitution Fund Grant Steven Hunt, MD Honorarium: Cook Medical George Chang, MD Research Grant: Agendia; Consultant: Johnson & Johnson Ethicon Todd Francone, MD Consultant: Olympus; Honorarium: Covidien, Olympus; Teacher: Covidien, Olympus Gerald Isenberg, MD Research Grant: Ventrus Biosciences anal fissure study Hueylan Chern, MD Research Grant: WGEA, intramural Kelly Garrett, MD Honorarium: Olympus; Teacher: Olympus Eric Johnson, MD Honorarium: Cook Medical, Cubist; Teacher: Cook Medical; Speaker: Cubist *Will be discussing off-label products. 149 DISCLOSURES Bonnie Alvey, RN Advisory Board: Coloplast; Honorarium: Coloplast; Per Diem: Calmoseptine; Independent Contractor: Calmoseptine Disclosures Andreas Kaiser, MD Honorarium: GI Health Foundation; Speaker: GI Health Foundation; Royalty: McGraw Hill Publisher, Up to date; Author: McGraw Hill Publisher, Up to date Matthew Kalady, MD Consultant: Precision Therapeutics; Honorarium: Precision Therapeutics; Speaker: Precision Therapeutics Sergey Kantsevoy, MD Consultant: Boston Scientific Corporation, Olympus America; Honorarium: Boston Scientific Corporation, Olympus America; Ownership Interest (ie stocks)/co-founder and shareholder: Apollo Endosurgery Inc Joshua Katz, MD Consultant: Speakers Bureau Cubist Pharmaceuticals; Medical Review Committee, LifeCell Corporation stoma reinforcement trial 2010-2012; Expert Witness Malpractice Consultant list available on request; Royalty: Life Cell Corporation, Cubist Pharmaceuticals; Ownership Interest: Stocks held by mutual funds in which I have invested Karamjit Koko Khanduja, MD Consultant: President, Colon and Rectal Surgery Inc.; Program Director, Mount Carmel Health System, Colorectal Surgery Fellowship; Colorectal Advisor, Mount Carmel Health System, Columbus, Ohio; President, Green St. Surgery Center. Columbus, Ohio Walter Koltun, MD Consultant: Dr Reddy's Laboratories; Research Grant: Philadelphia Health Care Trust, Pennsylvania DOH Tobacco CURE grant Mary Kwaan, MD Research Grant: U54 NIMHD Kim Lu, MD Consultant: Former: Glaxo-Smith-Kline/Cubist Vincent Lucente, MD Consultant: American Medical Systems, Kimberly Clark, Astellas, Coloplast, Medtronic Honorarium: American Medical Systems, Allergen, Bard, Kimberly Clark, Astellas, Coloplast, Medtronic; Speaker: American Medical Systems, Allergen, Coloplast; Research Grants: American Medical Systems, Kimberly Clark, Coloplast; Expert Witness: Bard Genevieve Melton-Meaux, MD Salary: St. Jude Medical (spouse is employee), Matonich Persson, NIH, AHRQ; Consultant: Matonich Persson; Research Grants: NIH, AHRQ Robert Madoff, MD Consultant/Advisory Committee: LifeBond Ltd., Torax Medical Inc.; Consultant: Tsumura USA James Merlino, MD Ownership interest (ie stocks): Emmi Solutions (Board member) Najjia Mahmoud, MD Research Grant: 3M, Inc. John Migaly, MD Consultant: CareFusion Peter Marcello, MD Consultant: Applied Medical, Covidien, Olympus; Honorarium: Applied Medical Covidien, Olympus; Teacher: Covidien Jeffrey Milsom, MD Research Grant: Olympus Corp.; Teacher: Olympus Corp. Jorge Marcet, MD Honorarium: Covidien, Applied Medical, Merck, Pacira; Teacher: Covidien, Applied Medical, Pacira; Speaker: Merck John Marks, MD Consultant: Covidien, Intuitive, Stryker, Wolf, Cubist; Speaker: Cubist Jeffrey Marks, MD Advisory Committee: Apollo Endosurgery; Consultant: GI Supply, US Endoscopy, Merck, Olympus; Honorarium: GI Supply, US Endoscopy, Merck, Apollo Endosurgery, Olympus Jorge Lagares-Garcia, MD Honorarium: Intuitive Surgical; Teacher: Intuitive Surgical Sean Langenfeld, MD Honorarium: Sanofi; Speaker: Sanofi Catherine Matthews, MD Consultant: Pelvalon Sergio Larach, MD Consultant: Applied Medical; Ownership interest (ie stocks): Applied Medical Klaus Matzel, MD Advisory Committee: Medtronic, Oceana; Consultant: Medtronic, Oceana; Honorarium: Medtronic, Covidien, Oceana, Uroplasty; Speaker: Medtronic, Covidien, Uroplasty; Teacher: Medtronic, Covidien Michael Leitman, MD Research Grant: New York State Department of Health, AHRQ Anne Lin, MD Research Grant: Center for Health Quality Initiatives Grant, UCLA, PI, Center for Health Quality Intiatives Grant, UCLA, Co-PI, Reducing Perioperative Complications after Colorectal Surgery Anders Mellgren, MD Advisory Committee: American Medical Systems, Medtronic; Consultant: American Medical Systems, Medtronic; Honorarium: American Medical Systems, Medtronic, Salix; Speaker: Medtronic, Salix Martin Luchtefeld, MD Ownership interest (ie stocks): Pacira, Amgen, Stryker, Baxter, Actavis Joseph Martz, MD Honorarium: Novadaq, Intuitive Surgical, Cubist; Speaker: Novadaq, Cubist; Teacher: Intuitive Surgical Paul Lehur, MD Consultant: Torax Medical Inc.; Honorarium: Torax Medical Inc.; Speaker: Torax Medical Inc.; Teacher: Torax Medical Inc. Armando Franchini Melani, MD Consultant/Advisory Committee: Covidien, Ethicon Medical Brazil; Speaker: Covidien; Teacher: Covidien, Ethicon Medical Brazil James McCormick, MD Honorarium: McCormick; Speaking: McCormick; Teaching: McCormick Elisabeth McLemore, MD Consultant: Covidien; Honorarium: Applied Medical, Covidien, Ethicon EndoSurgery, Novadaq, Genomic Health; Speaking: Genomic Health; Teaching: Applied Medical, Ethicon EndoSurgery, Novadaq; Research: Novatract Surgerical; Ownership interest (ie stocks): Cubist *Will be discussing off-label products. 150 Roberta Muldoon, MD Research Grant: PI for Randomized, Control Trial with Duke Clinical Research Institute M. Margarita Murphy, MD Honorarium: Medtronic; Teacher: Medtronic Deborah Nagle, MD Consultant: Cohera, Intuitive, ConMed; Honorarium: Intuitive; Speaker: Intuitive; Teacher: Intuitive Govind Nandakumar, MD Honorarium: Olympus; Teacher: Olympus Heidi Nelson, MD Royalty: Titan; American College of Surgeons Oncology Group – Co-Chair. NIH, Role of the Microflora Mikio Nihira, MD Consultant: American Medical Systems; Honorarium: American Medical Systems; Research Grant: American Medical Systems, Ethicon, Coloplast, Salix, Cook, Proaccess Vincent Obias, MD Consultant: THD America; Honorarium: Intuitive Surgical; Teacher: Intuitive Surgical; Research: THD America; Honorarium: Intuitive Surgical; Speaker: Intuitive Surgical; Teacher: Intuitive Surgical Joel Palefsky, MD Consultant: Research Grants: Merck & Co., Hologic, Qiagen; Research Grants: Merck & Co., Hologic; Research: Merck & Co., Hologic; Board Member: Merck & Co.; Stock shareholder: Aura Bioscience Disclosures Eduardo Parra-Davila, MD Consultant: Ethicon, Intuitive, BARD/DAVOL; Honorarium: Ethicon, Intuitive, BARD/DAVOL; Speaker: Ethicon, Intuitive, BARD/DAVOL; Research Study: BARD/DAVOL; Research: BARD/DAVOL Walter Peters, Jr., MD Honorarium: Ethicon EndoSurgery; Speaker: Ethicon EndoSurgery; Teacher: Ethicon EndoSurgery Alessio Pigazzi, MD Consultant: Xodus, Novadaq, Intuitive; Honorarium: Intuitive Surgical Inc., Covidien, Ethicon, Cook, Novadaq; Teacher: Intuitive Surgical Inc., Covidien, Ethicon, Cook; Educational Grants: Ethicon, Cook, Covidien, Cubist; Royalty: Xodus Janice Rafferty, MD Consultant: Aptalis; Honorarium: Lifecell, Aptalis, IFlow, Novadaq; Speaker: Lifecell, IFlow, Novadaq Elizabeth Raskin, MD Consultant: Intuitive Surgical Inc.; Honorarium: Intuitive Surgical Inc.; Speaker: Intuitive Surgical Inc.; Teacher: Intuitive Surgical Inc. Harry Reynolds, MD Honorarium: Covidien; Teacher: Covidien Holly Richter, MD Consultant: Pelvalon Timothy Ridolfi, MD Research Grant: We Care Research Award for Medical Innovation David Rivadeneira, MD Honorarium: Sanofi, TEI Bioscience, Pacira, Salix, Genomic Health; Speaker: Sanofi, TEI Bioscience, Pacira, Salix, Genomic Health; Teacher: Spring Publishing; Research: Salix; Royalty: Up to Date, Springer Publishing; Review Panel: Up to Date Patricia Roberts, MD Ownership interest (ie stocks): Merck Michael Rosen, MD Honorarium: Bard, W. L. Gore; Speaker: Bard; Research: W. L. Gore Howard Ross, MD Consultant: Intuitive Surgical; Honorarium: Intuitive Surgical Theodore Saclarides, MD Honorarium: Richard Wolf; Teacher: Richard Wolf Jaime Sanchez, MD Advisory Board: IrriMax; Consultant: Salix Pharmaceuticals; Honorarium: Covidien, Applied Medical, IrriMax, Salix Pharmaceuticals; Speaker: Salix Pharmaceuticals; Teacher: Covidien, Applied Medical, Salix Pharmaceuticals Dana Sands, MD Honorarium: Pacira; Teacher: Pacira Kiran Turaga, MD Consultant: Ethicon, CARIS Steven Schechter, MD Consultant: Speaker for Cubist Pharmacia and Salix Pharmaceutical; Honorarium: Cubist speaker, Salix; Research Grant: Ethicon, Inc Kelly Tyler, MD Consultant: Legal review - Brown Paradis and Scott Hartford CT 2008-2014/Concluded David Schoetz, Jr., MD Salary: American Board of Colon and Rectal Surgery (management position/Executive Director), Elsevier (Editor-in-chief, Seminars in Colon and Rectal Surgery); Honorarium: Elsevier Steven Siegel, MD Advisory Committee: Medtronic, QIG, Allergen, Uroplast; Consultant: Medtronic, Allergen, Honorarium: Medronic, Allergen; Speaker: Medtronic, Allergen, Uroplast; Teacher: Medtronic, Allergen; Research: Medtronic, Allergen; Review Panel: Medtronic; Equity Interest: QIG Marc Singer, MD Consulting: Olympus; Honorarium: Pacira; Speaker: Parira Bradford Sklow, MD Research Grant: Was involved in multi-center clinical trial funded by W.L. Gore Michael Snyder, MD Honorarium: Salix Pharmaceuticals, THD America, Pacira Pharmaceuticals; Speaker: Salix Pharmaceuticals, THD America, Pacira Pharmaceuticals Michael Stamos, MD Consultant: Ethicon, Novadaq, Boston Scientific, Olympus, Edwards Life Science, Neomend/Bard; Honorarium: Ethicon, Novadaq, Boston Scientific, Olympus, Neomend/Bard; Speaker: Ethicon, Novadaq, Boston Scientific, Olympus, Neomend/Bard; Teacher: Ethicon, Olympus; Research: Novadaq; Royalty: Elsevier; Review Panel: Elsevier; Author: Elsevier Scott Steele, MD Honorarium: Ethicon Endosurgery, Sanofi Genzyme; Speaker: Ethicon Endosurgery, Sanofi Genzyme; Teacher: Ethicon Endosurgery, Sanofi Genzyme H. David Vargas, MD Consultant: Ethicon Endosurgery Inc, consultant, speaker Applied Medical, consultant Madhulika Varma, MD* Consultant: Pelvalon Sarah Vogler, MD Honorarium: Medtronics; Teacher: Medtronics Theodoros Voloyiannis, MD Honorarium: Applied Medical Inc.; Teacher: Applied Medical Inc. Eric Weiss, MD Consultant: Pacira, Baxter, Bovie, Olympus; Speaker: Pacira Steven Wexner, MD Advisory Committee: Medtronic, CareFusion, Edwards Lifesciences; Consultant: Medtronic, Mederi Therapeutics, Karl Storz Endoscopy, Medtronic, Novadaq, GIView, NovoGI; Honorarium: Mediri Therapeutics, Incontinence Devices, Johnson and Johnsonn Medical Precision Therapeutics, Pacira, CareFusion, Edwards Lifesciences; Teacher: Mederi Therapeutics, Precision Therapeutics, Pacira, Medtronic; Intellectual Property Rights: Karl Storz Endoscopy, Covidien, NovoGI; Intellectual Property License: Covidien, Karl Storz Endoscopy; Royalty: Covidien, Karl Storz Endoscopy; Ownership Interest (ie stocks): NovoGI Paul Wise, MD Research Grant: Cancer Prevention Pharmaceuticals; Research: Cancer Prevention Pharmaceuticals Massarat Zutshi, MD* Consultant: AMS; Honorarium: Salix, AMS; Speaker: Salix; Research Grant: Cook Medical, AMS Lisa Strate, MD Consultant: GSK; Honorarium: American College of Gastroenterology, Oak Ridge Associated Universities; Speaker: American College of Gastroenterology; Research: GSK; Royalty: Up To Date; Author: Up To Date; Review Panel: Oak Ridge Associated Universities DISCLOSURES Ian Paquette, MD Advisory Committee: Medtronic; Consultant: Medtronic; Honorarium: Medtronic; Teacher: Medtronic Julie Thacker, MD Consultant: Premier, Edwards Lifesciences, Cheetah Medical; Speaker: Cheetah Medical Amy Thorsen, MD Salary: Medtronic, Salix Pharmaceuticals, Tsumura; Honorarium: Medtronic, Salix Pharmaceuticals; Teacher: Medtronic; Research: Salix Pharmaceuticals, Tsumura *Will be discussing off-label products. 151 Disclosures The following have no relevant financial relationships to disclose: Cary Aarons, MD A. Corliss, MD Kerry Hammond, MD Maher Abbas, MD Meagan Costedio, MD Mark Hanna, MD Armen Aboulian, MD Jonathan Cowley, MD Karin Hardiman, MD Jennifer Agnew, MD Alejandro Cracco, MD Melike Harfouche, MD Karim Alavi, MD Benjamin Crawshaw, MD Alan Harzman, MD Ahmed Al-Khamis, MD Jay Crockett, MD Imran Hassan, MD Suraj Alva, MD Chris Cunningham, MD Lisa Haubert, MD John Alverdy, MD Michael D'Angelica, MD Elizabeth He, MD Wayne Ambroze, MD Sekhar Dharmarajan, MD Traci Hedrick, MD Robin Anderson, RN Andre D'Hoore, MD Alexander Heriot, MD Mark Arnold, MD David Dietz, MD Daniel Herzig, MD Amir Aryaie, MD Gary Dunn, MD Afshin Heydari, MD Susan Asuncion, RN John Eggenberger, MD Caitlin Hicks, MD Glenn Ault, MD Alex Elobu, MD Rebecca Hoedema, MD Jennifer Ayscue, MD David Etzioni, MD Torbjörn Holm, MD Heidi Bahna, MD Jeffrey Farma, MD Stefan Holubar, MD Matthew Bailey, MD Daniel Feingold, MD Jon Hourigan, MD Badma Bashankaev, MD Melissa Felinski, DO Tracy Hull, MD Nancy Baxter, MD Alessandro Fichera, MD Syed Husain, MD Jennifer Beaty, MD Robert Fine, MD Grace Hwang, MD Sandra Beck, MD Emily Finlayson, MD Neil Hyman, MD Irina Bernescu, MD Charles Finne, MD James Iannuzzi, MD Mitchell Bernstein, MD Fergal Fleming, MD Atif Iqbal, MD J. Berry-Lawhorn, MD James Fleshman, Jr., MD Jennifer Irani, MD Fabiana Bettoni, MD Phillip Fleshner, MD Mehraneh Jafari, MD Richard Billingham, MD Dave Flum, MD Naomi Jay, MD Elisa Birnbaum, MD Joseph Frenkel, MD David Jayne, MD Sarah Boostrom, MD Charles Friel, MD Arjun Jeganathan, MD Shayna Brathwaite, MD Robert Fry, MD Barry Jenkins, MD Marc Brozovich, MD Ashley Gabiou, RN Christine Jensen, MD Nicolas Buchs, MD Aakash Gajjar, MD Huw Jones, MD W. Buie, MD Julio Garcia-Aguilar, MD Brian Kann, MD Marcus Burnstein, MD John Garry, MD Kevork Kazanjian, MD John Byrn, MD Susan Gearhart, MD Scott Kelley, MD Teresa Carman, MD Timothy Geiger, MD Gregory Kennedy, MD, PhD Peter Cataldo, MD Amandeep Ghuman, MD Hermann Kessler, MD Thomas Cataldo, MD Stanley Goldberg, MD Donald Kim, MD Gentry Caton, MD Lori Gordon, MD HyungJin Kim, MD Varun Chakravorty, MD I. Emre Gorgun, MD Jin Kim, MD Bradley Champagne, MD Wilhelm Graf, MD Sanghyun Kim, MD Christin Choi, MD John Griffin, MD Cindy Kin, MD Heidi Chua, MD Jose Guillem, MD Pokala Ravi Kiran, MD Robert Cima, MD Brian Gulack, MD Natalie Kirilcuk, MD Jeffrey L. Cohen, MD Michael Guzman, MD David Kleiman, MD Jessica Cohan, MD Eric Haas, MD Kevin Kniery, MD Dorin Colibaseanu, MD Angelita Habr-Gama, MD Ira Kodner, MD Kyle Cologne, MD Glenn Hall, MD Sarah Koller, MD Molly Cone, MD Jason Hall, MD Toru Kono, MD Tara Connelly, MD Amy Halverson, MD Mukta Krane, MD *Will be discussing off-label products. 152 Anjali Kumar, MD Paul O’Mahoney, MD Josef Shehebar, MD Alex Ky, MD Frank Opelka, MD Paul Shellito, MD Antonio Lacy, MD Guy Orangio, MD Yury Shelygin, MD David Larson, MD Bruce Orkin, MD Marc Sher, MD Sang Lee, MD Gokham Ozuner, MD Matthew Sherman, MD Ira Leeds, MD Sushil Pandey, MD David Shibata, MD Daniel Leonard, MD Harry Papaconstantinou, MD Kinga Skowron, MD L. Li, MD Jitesh Patel, MD Ricardo Sordo-Mejia, MD Charles Littlejohn, MD Sunil Patel, MD Randolph Steinhagen, MD Wendy Liu, MD John Pemberton, MD Andrew Stevenson, MD Ann Lowry, MD Rodrigo Perez, MD David Stewart, Sr., MD Kirk Ludwig, MD W. Brian Perry, MD Luca Stocchi, MD Allan Mabardy, MD Francisco Pinheiro Regadas, MD Scott Strong, MD Helen MacRae, MD Madeleine Poirier, MD Gokulakkrishna Subhas, MD Mari Madsen, MD Blase Polite, MD Patrick Sullivan, MD Krishnaraj Mahendraraj, MD Hiram Polk, Jr., MD Li Sun, MD* Tony Mak, MD Darren Pollock, MD Zhifel Sun, MD Nell Maloney Patel, MD Vitaliy Poylin, MD Patricia Sylla, MD Mark Manwaring, MD Jevon Puckett, MD Eric Szilagy, MD Slawomir Marecik, MD Jan Rakinic, MD Sanda Tan, MD David Margolin, MD Sonia Ramamoorthy, MD Larissa Temple, MD David Maron, MD Jose Ramirez, MD Charles Ternent, MD Marianne Masse, MD Tal Raphaeli, MD Robert Thiele, MD Ronnie Mathew, MD Jennifer Rea, MD Alan Thorson, MD Justin Maykel, MD Thomas Read, MD Melissa Times, MD Ryan McColl, MD Craig Reickert, MD Ester Trinos, NP Allison McCoy, MD Feza Remzi, MD Judith Trudel, MD Michael McGee, MD Craig Rezac, MD Konstantin Umanskiy, MD Robin McLeod, MD Rocco Ricciardi, MD Brian Valerian, MD Michael McNevin, MD Bruce Robb, MD Alessio Vinci, MD Bryant Megna, MD Mary Roen, RN Jon Vogel, MD George Melich, MD Lester Rosen, MD Mercy Wagner, MD Craig Messick, MD Andrew Russ, MD Avery Walker, MD Peter Miller, MD Andrew Russell, MD Zhenjun Wang, MD Jeffrey Mino, MD Rudolph Rustin, MD Martin Weiser, MD Nitin Mishra, MD Timothy Sadiq, MD Mark Welton, MD Jason Mizell, MD Bashar Safar, MD Richard Whelan, MD Husein Moloo, MD Peter Sagar, MD Mark Whiteford, MD John Monson, MD Chitra Sambasivan, MD Charles Whitlow, MD Arden Morris, MD Cesar Santiago, MD Elizabeth Wick, MD Melanie Morris, MD Guilio Santoro, MD Kirsten Wilkins, MD David Mukkar Krishnamurty, MD Tereza Sardinha, MD Lawrence Yee, MD Sthela Murad-Regadas, MD David Schneider, MD James Yoo, MD Jamie Murphy, MD Caleb Schroeder, MD Y. Nancy You, MD Matthew Mutch, MD Lawrence Schwartz, MD D. Mark Zebley, MD Caio Nahas, MD Anthony Senagore, MD R. Scott Nelson, MD Stephen Sentovich, MD Juan Nogueras, MD Xavier Serra-Aracil, MD Johan Nordenstam, MD Virginia Shaffer, MD David O'Brien, MD Nishit Shah, MD P. Ronan O'Connell, MD Skandan Shanmugan, MD *Will be discussing off-label products. 153 DISCLOSURES Disclosures Program Participants Aarons, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106 Abbas, M. . . . . . . . . . . . . . . . . . . . . . . . .49, 65, 70, 103 Aboulian, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55 Agnew, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85 Alavi, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52 Al-Khamis, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70 Alverdy, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57 Alvey, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78 Ambroze, W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69 Anderson, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105 Arnold, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61 Aryaie, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97 Ault, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50 Ayscue, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62 Bahna, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102 Bailey, H . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72 Bailey, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70 Bashankaev, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103 Bastawrous, A. . . . . . . . . . . . . . . . . . . . . . . . .39, 41, 66 Baxter, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54 Beaty, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93 Beck, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78, 105 Beck, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78 Berho, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43 Bernescu, I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103 Bernstein, M. . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45 Berry-Lawhorn, J. . . . . . . . . . . . . . . . . . . . .36, 37, 38 Bettoni, F. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .90 Billingham, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . .72, 95 Bleier, J. . . . . . . . . . . . . . . . . . . . .18, 34, 35, 43, 44, 45 Bordeianou, L. . . . . . . . .34, 43, 44, 45, 51, 58, 102 Brathwaite, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100 Brozovich, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88 Buchs, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62 Buie, W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51, 65 Burnstein, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50 Byrn, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46 Cannon, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46 Carman, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57 Carmichael, J. . . . . . . . . . . . . .40, 41, 78, 83, 89, 102 Cataldo, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35 Cataldo, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79 Chakravorty, V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70 Champange, B. . . . . . . . . . . . . . . . . . . . . . . . . . . .69, 94 Chang, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47, 82 Choi, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84 Church, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59 Cima, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54 Cleary, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47, 66 Cohan, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84, 88 Cohen, J. L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53 Cohen, J. S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47 Cologne, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .92 Cone, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59 Connelly, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89 Corliss, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .83 Costedio, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55 Cowley, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73 Cracco, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73 Crawshaw, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85 Cunningham, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .56 D'Angelica, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99 Davis, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51 Delaney, C. . . . . . . . . . . . . . . . . . . .51, 61, 92, 95, 105 Dharmarajan, S. . . . . . . . . . . . . . . . . . . . . . . . . . .80, 97 D'Hoore, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43 Dietz, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .80 Eggenberger, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57 Elobu, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .76 Eng, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99 Etzioni, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55, 78 Feingold, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48 Felinski, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84 Fichera, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96, 99 Fine, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75 Finne, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .35 Finlayson, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89 Fleming, F. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82, 89 Fleshman, Jr., J. . . . . . . . . . . . . . . . . . . . . . .64, 69, 78 Fleshner, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78, 94 Flum, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106 Francone, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52, 94 Friel, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61 Garcia-Aguilar, J. . . . . . . . . . . . . . . . . . .66, 82, 95, 99 Garrett, K. . . . . . . . . . . . . . . . . . . . .43, 44, 45, 55, 78 Gearhart, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61 Geiger, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .80, 106 Ghuman, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103 Goldberg, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65 Goldstone, S. . . . . . . . . . . . . . . . . . . . . . . . . .36, 37, 38 Gorgun, I. . . . . . . . . . . . . . . . . . . . . . . . . . . . .47, 48, 77 Graf, W. . . . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 89 Griffin, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41 Guillem, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67 Gulack, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62 Gurland, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65 Guzman, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97 Haas, E. . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 77, 105 Habr-Gama, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62 Hall, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .98, 103 Hall, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . .56, 60, 89, 93 Halverson, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73, 78 Hampel, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59 Hanna, M. . . . . . . . . . . . . . . . . . . . . . . . . . . .70, 85, 100 Hardiman, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55 Harfouche, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100 Harzman, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .39, 41 Hassan, I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .39, 41, 88 Haubert, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84 He, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84 Hedrick, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 70 Heriot, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82 154 Herzig, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41 Heydari, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73 Hicks, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60, 68, 75 Hicks, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73 Hoedema, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52 Holm, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67 Holubar, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54 Hopkins, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93 Hourigan, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78 Hull, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50, 58 Husain, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79 Hwang, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70, 84 Hyman, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . .83, 88, 94 Iannuzzi, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97 Jafari, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100 Jay, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .36, 37, 38 Jayne, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66 Jeganathan, A. . . . . . . . . . . . . . . . . . . . . . . . . . . .89, 98 Johnson, E. . . . . . . . . . . . . . . . . . . . .39, 40, 41, 77, 95 Jones, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62 Kaiser, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43 Kalady, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59, 65 Kann, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79 Kantsevoy, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48 Kennedy, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52 Kelley, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66 Kessler, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55, 96 Kim, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93 Kim, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88 Kim, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66 Kim, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55 Kin, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52 Kirilcuk, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87 Kleiman, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103 Kniery, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100 Kodner, I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75 Koller, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85 Kono, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88 Krane, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89, 100 Kumar, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51 Ky, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .58 Lacy, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .63, 67 Lagares-Garcia, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . .47 Langenfeld, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . .51, 93 Larach, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 67 Larson, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47 Lee, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .51 Leeds, I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84 Lehur, P. . . . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 71 Leonard, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .63 Li, L.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89 Liu, W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70 Lowry, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72, 81, 95 Luchtefeld, M. . . . . . . . . . . . . . . . . . . . . . . . .68, 78, 92 Ludwig, K. . . . . . . . . . . . . . . . . . . . . . . . .57, 61, 78, 99 Mabardy, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88 MacRae, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64 Madoff, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65, 67 Mahendraraj, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84 Mahmoud, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50 Maloney Patel, N. . . . . . . . . . . . . . . . . . . . . . . . . .39, 41 Mak, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88 Manwaring, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57 Marcello, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48, 96 Marcet, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .35 Marecik, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41, 67 Margolin, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60 Marks, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49 Marks, J. H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47 Maron, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53, 56 Martz, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46 Masse, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84 Mathew, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103 Matzel, K. . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 58 Maykel, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .52, 80 McColl, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62 McCormick, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93 McCoy, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54 McGee, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57 McLemore, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35 McLeod, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61 McNevin, S. . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 50 Megna, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89 Melani, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55 Melich, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100 Mellgren, A. . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 58 Melton-Meaux, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . .54 Merlino, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53, 57 Messaris, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89 Messick, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59 Migaly, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87 Miller, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97 Milsom, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49 Mino, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100 Mizell, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73, 74 Monson, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82 Morris, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54 Morris, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62 Mukkai Krishnamurty, D. . . . . . . . . . . . . . . . . . . . . .97 Muldoon, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60 Murad-Regadas, S. . . . . . . . . . . . . . . . .43, 44, 45, 73 Murphy, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55 Murphy, M. . . . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45 Mutch, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55, 80 Nagle, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47, 54 Nahas, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62 Nandakumar, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49 Nelson, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57 Nogueras, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65 Nordenstam, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43 Obias, V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46, 77, 79 O’Brien, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53 O'Connell, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18, 79 O'Mahoney, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100 Opelka, F. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53, 92 Orangio, G. . . . . . . . . . . . . . . . . . . . . . . . . . . .53, 65, 92 Orkin, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .35 Palefsky, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37, 38 Paquette, I. . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 58 Parra-Davila, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47 Patel, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103 Pemberton, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .61 Perez, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 90, 95 Perry, W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53, 95 Peters, Jr., W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95 Pigazzi, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .56, 67 Polite, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96 Polk, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75 Pollock, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41 Poylin, V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79 Prosst, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77 Puckett, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70 Rafferty, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87 Ramamoorthy, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . .77 Ramirez, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103 Raphaeli, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40, 41 Raskin, E. . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 46, 79 Rea, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .70 Read, T. . . . . . . . . . . . . . . . . . . . . . . . . . . .65, 67, 76, 86 Reickert, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95 Remzi, F. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88 Reynolds, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57 Rezac, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66 Ricciardi, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65, 87 Rivadeneira, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48 Robb, B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87 Roberts, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .86, 106 Rosen, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .72 Rosen, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .83 Ross, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66 Russ, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69 Rustin, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57 Saclarides, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35 Sadiq, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59 Sagar, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82 Sanchez, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35 Sands, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 102 Santiago, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46 Santoro, G. . . . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45 Schneider, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103 Schoetz, Jr., D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .86, 94 Schroeder, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .97 Schwartz, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96 Senogore, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68 Sentovich, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53, 65 Shaffer, V. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102 Shah, N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79 Shanmugan, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34 155 Shellito, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60 Shelygin, Y. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99 Shibata, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96 Siegel, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45 Singer, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . .39, 41, 80 Skowron, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .88 Snyder, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93 Sordo-Mejia, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84 Stamos, M. . . . . . . . . . . . . . . . . .61, 65, 68, 69, 72, 92 Steele, S. . . . . . . . . . . . . . . . . . . . . . .34, 35, 51, 56, 64 Steinhagen, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78 Stevenson, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67 Stewart, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .80, 89 Strate, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .81 Strong, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95, 106 Subhas, G. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89 Sun, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89 Sun, Z. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62 Sylla, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 67 Szilagy, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95, 97 Temple, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54, 87 Ternent, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65 Thacker, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54, 105 Thiele, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .105 Thorsen, A. . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45, 52 Times, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .89 Turaga, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99 Tyler, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60 Umanskiy, K. . . . . . . . . . . . . . . . . . . . . .40, 45, 89, 100 Valerian, B. . . . . . . . . . . . . . . . . . . . . . . .34, 35, 84, 100 Vargas, H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60 Varma, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73 Vinci, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84 Vogel, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55 Vogler, S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .43, 44, 45 Voloyiannis, T. . . . . . . . . . . . . . . . . . . . . . . . . . . . .34, 35 Wagner, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84 Walker, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .84 Wang, Z. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .74 Weiser, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .96 Weiss, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103 Welton, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .87, 88 Wexner, S. . . . . . . . . . . . . . . . . .44, 45, 60, 61, 63, 72 Whelan, R. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .48, 64 Whiteford, M. . . . . . . . . . . . . . . . . . . . . . . . . .34, 35, 55 Whitlow, C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64, 93 Wick, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54, 105 Wilhelm, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .77 Wise, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59 Yoo, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106 You, Y. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .55, 82 Zutshi, M. . . . . . . . . . . . . . . . . .43, 44, 45, 58, 73, 102 P R O G R A M P A R T I C I PA N T S Program Participants Product Theaters These are commercial presentations conducted by exhibiting companies in a specially constructed theater on the exhibit floor. This year the Product Theater will be Exhibit Halls C & D where the following sessions will be presented each day during the lunch breaks. Product Theaters are non-CME forums organized by industry and designed to enhance your learning experience. Monday, June 1 12:35 – 1:30 pm Supported by Intuitive Surgical, Inc. Lunch and Learn: Three Cases That Could Have Kept Me Up at Night Presented by: Benyamine Mizrahi, MD Craig Rezac, MD How did I deal with low set rectal tumors, acute inflammatory bowel disease & difficult patient presentations? Presenters will show three videos of their cases that required skill and the help of new technology in order to achieve the desired outcome. Also, visit Intuitive Surgical, Inc. at Booth #401 - Tuesday, June 2 12:20 – 1:30 pm Supported by ConvaTec, Inc. Risk Mitigation of Infection Following Colorectal Surgery Presented by: Mark A. Singer, MD Joseph R. Cali, MD Bidhan Das, MD The presentation will cover advances in surgical techniques and post-operative wound protocols to reduce the risk of infections following colorectal surgery. Also, visit ConvaTec, Inc. at Booth #142 156 NOT FOR CREDIT Exhibits The American Society of Colon & Rectal Surgeons (ASCRS) established as part of its Annual Scientific Meeting, an Exhibit Hall to facilitate the sharing and dissemination of information regarding industry products and services. The exhibition is made available for information purposes. The participation of any exhibitor in the Exhibit Hall does not constitute an endorsement or representation of any kind regarding the qualifications, quality, expertise, capabilities, skill, message, value or competence of the exhibitor or of the exhibitor’s products or services. All information contained in the exhibits is provided by the individual exhibitors and has not been independently reviewed or verified by the Society. The ASCRS does not endorse exhibit hall products or services. By attending the ASCRS Annual Scientific Meeting, you acknowledge and accept that ASCRS has assumed no duty to review, investigate or otherwise approve and has not reviewed, investigated or otherwise approved the qualifications, quality, expertise, capabilities, skill, message, nature, value or competence of the exhibitor or of any product or service marketed by attendees and exhibitors. ASCRS specifically disclaims any liability for any damage to person or property arising out of your attendance at the Exhibit Hall and/or arising out of any exhibitor product or service. You further waive any and all claims, demands, actions or causes of action of any kind you may have directly or indirectly against ASCRS of any of its directors, officers, employees, agents and other representatives resulting from, arising out of, or in any way related to your attendance at the Exhibit Hall and/or your use or reliance on any exhibitor product or service. ASCRS Product/Service Endorsement Policy It is the policy of the American Society of Colon & Rectal Surgeons not to endorse commercial products or services. 157 EXHIBITS Exhibition Hall and Exhibitor Disclaimer Exhibits Exhibits are located in Exhibit Halls C&D (2nd Floor) and will be open the following hours: Sunday: 3:00 – 5:00 pm Monday: 9:00 am – 4:30 pm Tuesday: 9:00 am – 2:00 pm 11Health & Technologies, LLC Booth 136 Kinetic Business Centre Borehamwood, Herts WD6 4PJ UK Phone: 44 7866 621 956 Website: www.11health.com Contact Email: [email protected] 11health was founded by Michael Seres after becoming the 11th patient in the UK to undergo an intestinal transplant in Oxford. The company has developed the first ever sensor device for Ostomy care known as The Ostom-i Alert sensor. This is a discrete innovative device that alerts patients as to how full their ostomy/stoma bags are so that they can decide if and when to empty them. The device clips on to any ostomy pouch sending Bluetooth alerts to an app on your mobile device telling you that your pouch is filling up. You can set individual alerts as to when you wish to be notified. The device also captures guidance information about volume of output over a time period and allows you to email that information. In addition this data is stored safely on our website allowing you to access it at any given time. ACell, Inc. Booth 126 6640 Eli Whitney Dr Columbia, MD 21046 Phone: (800) 826-2926 Fax: (410) 715-4511 Website: www.acell.com Contact Name: Customer Service Contact Email: [email protected] ACell’s patented ECM devices address important clinical needs, while providing safe, effective, economical and therapeutic outcomes to the wound care and surgical communities. These devices, trademarked as MatriStem®, are comprised of naturally-occurring porcine urinary bladder matrix (UBM). The products are non-cross linked, completely resorbable, acellular, and feature naturallyoccurring collagens and an epithelial basement membrane surface that is not available in synthetic materials. MatriStem completely incorporates into the surrounding tissue during the healing process and leaves new tissue where scar tissue formation is normally expected. The result is constructively remodeled, site-specific tissue for a variety of medical procedures. Agency for Medical Innovations (AMI) Booth 134 25 Washington Ave Natick, MA 01760 Phone: (508) 655-1200 Fax: (508) 655-0012 Website: www.amisurgical.com Contact Name: Andrew Bendheim Contact Email: [email protected] AMI (Agency for Medical Innovations) is an Austrian based device manufacturer developing innovative products and treatment methods in numerous areas including coloproctology. AMI’s HAL/RAR and Trilogy devices are leading technologies for Doppler guided treatment of hemorrhoid disease. They offer safe minimally invasive treatment to patients who want less pain and faster recovery. AMI’s comfort drain is a knotless seton for anal fistulas, which helps patients avoid the irritation of a knot. Ambry Genetics Booth 522 15 Argonaut Aliso Viejo, CA 92656 Phone: (949) 900-5500 Fax: (949) 900-5501 Website: www.ambrygen.com Contact Email: [email protected] American College of Surgeons Booth 531 633 N St Clair St Chicago, IL 60611 Phone: (312) 202-5263 Fax: (312) 202-5029 Website: www.surgicalpatienteducation.org The ACS Ostomy Home Skills Kit supports patients with education and simulation materials to learn and practice the skills needed for optimal postoperative recovery. The kit supports the entire surgical team with quality, comprehensive education. The standardized interactive program has been developed by the American College of Surgeons (ACS) in collaboration with the American Society of Colon and Rectal Surgeons (ASCRS), American Urological Association (AUA), Certified Enterostomal Therapy Nurses (CETN), Wound, Ostomy and Continence Nurses Society (WOCN), and the United Ostomy Associations of America (UOAA). 158 Exhibits PLATINUM PARTNER Booth 206 1 Spring Knoll Court Lutherville, MD 21093 Phone: (410) 302-2021 Fax: (410) 293-1739 Contact Name: Francesca Grasso Contact Email: [email protected] Applied Medical Booth 411 22872 AvenidaEmpresa Rancho Santa Margarita, CA 92688 Phone: 949-713-8687 Website: www.appliedmedical.com Contact Name: Lauren Mariorenzi Contact Email: [email protected] American Distributors of Colon and Rectal Supplies ADCRS, LLC offers a whole line of high quality disposable devices for hospital and office based proctology procedures as hemorrhoids elastic banding ligation, anoscopy, proctoscopy, infrared coagulation, trans-anal excision of rectal polyps, fistulotomy and more. ADCRS LLC is the only authorized importer and distributor of SAPI MED products for the USA. The SAPI MED line includes Self Light anoscopes, proctoscopes, anal and rectal retractors, disposable hemorrhoidal banding ligators and the innovative patients accessible cryo-thermic anal and stomaldilators. Applied Medical is committed to advancing minimally invasive colorectal surgery by offering sophisticated training, clinical solutions and breakthrough technologies, including the GelPOINT® Path transanal access platform, Alexis® wound protector/retractors and Voyant® Intelligent Energy System. Applied’s minimally invasive procedural workshops, clinical symposia, and Simsei® laparoscopic trainer enable surgeons to enhance their skills and their patient outcomes. To register for a workshop, visit www.appliedmedical.com. SILVER PARTNER Bard Davol American Medical Systems, Inc. Booth 130 10700 Bren Rd W Minnetonka, MN 55343 Phone: (952) 930-6463 Website: www.americanmedicalsystems.com Contact Name: Lisa Dahlstrom Contact Email: [email protected] American Medical Systems (AMS), headquartered in Minnetonka, Minn., is a diversified supplier of medical devices and procedures to treat benign prostatic hyperplasia (BPH), urinary incontinence, fecal incontinence, sexual dysfunction, and other pelvic disorders in men and women. AMS continues to develop new therapies to restore bodily functions enabling people to regain control of their lives. These therapies provide new options for patients, providers and payers, and are often inspired by the urologists, gynecologists and urogynecologists who choose AMS as their solutions partner. Booth 208 100 Crossing Blvd Warwick, RI 02886 Phone: (800) 556-6756 Website: www.davol.com Contact Email: [email protected] Bard Davol offers a variety of innovative soft tissue reconstruction products including aresorbable synthetic mesh and the first antimicrobial-coated biologic graft for hernia repair. For more information, visit www.davol.com. Bellevue Pharmacy Booth 132 212 Millwell Drive Maryland Heights, MO 63043 Phone: (800) 728-0288 Fax: (800) 458-9182 Website: www.bellevuerx.com Bellevue Pharmacy is the leader in individualized medicine. We are a state-of-the-art pharmacy headquartered in St. Louis, Missouri. Our team of experienced pharmacists offers more than 200 years of combined experience in compounded medication to bring our physicians and their patients the highest level of service, quality, and care. 159 EXHIBITS American Distributors of Colon & Rectal Supplies, LLC Exhibits biolitec biomedical technology, GmbH Booth 135 BRONZE PARTNER Otto-Schott Str 15 Jena, 07445 Germany Phone: 49 228 9796 768 BK Ultrasound As a global pioneer in laser technique, biolitec introduced the first medical 1470 nm diode laser in 2006 to improve the outcome of soft tissue laser use. Since then biolitec has developed different minimally invasive treatment modalities in proctology like for hemorrhoids (HeLP and LHP) and Fistulas (FiLaC). FiLaC ensures highest patient comfort and sphincter protection during anal fistulas therapy. Using the 360° ring light energy distribution to homogeneously illuminate the fistulas tract and the intersphinkteric space it traces back the origin of the disease. Birchwood Laboratories, Inc. BK Ultrasound systems are the leading choice for colorectal procedures. Offering premium performance in a small, lightweight system, our Flex Focus system is designed to help you clearly visualize the anal canal and rectum on a high resolution 19” monitor. Our easy-to-use anorectal transducer provides complete 360 degrees imaging and encapsulated automatic 3D, enabling you to image all layers of the rectal wall, see the extent of fistula tracts, visualize rectal tumors and assess anal sphincter tears. Our dedicated solution helps you plan preoperative treatment and postoperative detection with increased diagnostic confidence. Booth 222 7900 Fuller Road Eden Prairie, MN 55344 Phone: (952) 937-7900 Fax: (952) 937-7979 Website: www.birchlabs.com Birchwood Laboratories LLC is a privately held medical manufacturer committed to providing healthcare professionals and their patients quality products for wound care and prevention, incontinence and associated skin conditions,personal care and the exam room. FDA registered for the manufacture of both drugs and medical devices, Birchwood lines include AER Witch Hazel, B-Sure Incontinence Care, Scopettes Large-Tip Applicators and LiquiCell wound care products. Founded in 1948 as Fuller Pharmaceutical Company, Birchwood has a long-standing tradition of providing quality products and service to the Acute Care, Long-Term Care and Retail markets. Today Birchwood Laboratories LLC manages both the production and distribution of its products from the company headquarters in Eden Prairie, MN. Booth 209 8 Centennial Drive Peabody, MA 01960 Phone: (978) 326-1300 Fax: (978) 326-1399 Website: www.bkultrasound.com Contact Email: [email protected] Braintree Laboratories, Inc. Booth 425 PO Box 850929 Braintree, MA 02184 Phone: (781) 348-0732 Fax: (781) 843-7932 Website: www.braintreelabs.com Braintree Laboratories is a privately held phannaceutical company founded in 1982 in Braintree, Massachusetts. Braintree Labs currently has four bowel preparations available in the US market. The product line is diverse and consists of the following products: GoLYTELY®, NuL YTELY®, SUPREp® Bowel Prep Kit and Suclear®. Braintree Laboratories is a fully integrated specialty phannaceutical company maintaining its own manufacturing, warehousing operations facilities, sales and marketing divisions and a pioneering research and development team. Visit us at www.braintreelabs.com. 160 Exhibits Booth 202 6655 N MacArthur Blvd, 3rd Floor Irving, TX 75039 Phone: (612) 695-6080 Website: www.carislifesciences.com Contact Name: Cindy Fleshman Contact Email: [email protected] Caris Life Sciences® is a leading biosciences company focused on fulfilling the promise of precision medicine through quality and innovation. Caris Molecular Intelligence®, provides oncologists with the most potentially clinically actionable treatment options available to personalize cancer care today. Using a variety of advanced profiling technologies to assess relevant biological changes in each patient’s tumor, CarisMolecular Intelligence connects biomarker data generated from a tumor with biomarker-drug associations supported by evidence in the relevant clinical literature. CONMED Booth 431 525 French Rd Utica, NY 13502 Phone: (315) 624-3170 Fax: (315) 797-4528 Website: www.conmed.com Contact Name: Alan Fink Contact Email: [email protected] The Hyfrecator® is the most compact of Conmed’s Advanced Energy generators. Since its introduction in 1937, the Hyfrecator® has become a world leader in office-based electrosurgery. The Hyfrecator® 2000 is used by physicians to achieve two main outcomes: the destruction of all types of cutaneous lesions and to precisely control bleeding. BRONZE PARTNER ConvaTec Cine-Med, Inc Booth 216 127 Main St N Woodbury, CT 06798 Phone: (203) 263-0006 Fax: (203) 263-4839 Website: www.cine-med.com Cleveland Clinic Departments of Colorectal Surgery Booth 538 9500 Euclid Ave Cleveland, OH 44195 Phone: (216) 445-3832 Fax: (216) 445-1079 Website: www.ccf.org Contact Name: Kathrina Allen Contact Email: [email protected] Colon Cancer Alliance Booth 204 1025 Vermont Ave NW, Ste 1066 Washington, DC 20005 Phone: (202) 628-0123 x132 Website: www.ccalliance.org Contact Name: Ervin Pinckney Contact Email: [email protected] Coloplast Booth 312 1601 W River Rd Minneapolis, MN 55411-3431 Phone: (800) 788-0293 Website: www.coloplast.us Contact Name: Hailey Wachlarowicz Contact Email: [email protected] Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes ostomy care, urology and continence care, and wound and skin care. Booth 142 1160 Route 22 Bridgewater, NJ 08807 Phone: (800) 422-8811 Website: www.convatec.com Contact Name: Patrick Gillespie Contact Email: [email protected] Cook Medical Booth 527 PO Box 489 Bloomington, IN 47402 Phone: (800) 468-1379/(812) 339-2235 Fax: (812) 339-3704 Website: www.cookmedical.com Together with surgeons, Cook Medical leads workshops on advanced procedures and develops next-generation devices. In 1963, Cook Medical’s founder, Bill Cook, worked with a surgeon to launch the field of minimally invasive medicine. Now we continue his vision worldwide, through educational programs like Cook Vista and through technology like Biodesign and Zenapro. Our goal is to deliver devices that give the best outcomes to surgeons, hospitals, and —most importantly—patients. Learn more about us at www.cookmedical.com. CooperSurgical, Inc. Booth 523 75 Corporate Dr Trumbull, CT 06611 Phone: (203) 601-5200 Fax: (203) 601-4741 Website: www.coopersurgical.com Contact Email: [email protected] CooperSurgical will be featuring our highly recognized and clinically successful products including the Lone Star SelfRetaining Retractor System and our Carter-Thomason Port Site Closure System for use in both open and laparoscopic colon and rectal procedures. Visit us at booth #523 161 EXHIBITS Caris Life Sciences Exhibits Curaseal, Inc. GOLD PARTNER Covidien Booth 301 5920 Longbow Drive Boulder, CO 80303 Phone: (303) 581-6997 Fax: (303) 581-6898 Website: www.covidien.com/surgical/ Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Please visit www. covidien.com/surgical/ CRC Press/Taylor & Francis Group Booth 104 6000 Broken Sound Parkway NW Ste 300 Boca Raton, FL 33487 Phone: (561) 998-2507 Fax: (561) 998-2559 Website: www.crcpress.com Contact Name: Charmaine Lowe Contact Email: [email protected] CRC Press – Taylor & Francis Group is a global publisher of world-class references, handbooks, journals, and textbooks for the medical, scientific and technical communities including academics, professionals, and students. Our award-winning CRCnetBASE has our eBook collections. For a complete catalog of our colorectal publications including bestselling and forthcoming titles, or to sign up for our email list to receive exclusive offers, visit www.crcpress.com today or contact us at 1-800-634-7064, or +44 (0) 1235400 524. CS Surgical, Inc. Booth 314 662 Whitney Dr Slidell, LA 70461 Phone: (985) 781-8292 Fax: (985) 781-8244 Website: www.cssurgical.com Contact Name: Craig Simpson Contact Email: [email protected] CS Surgical is your leading supplier of surgical instruments for the Colon & Rectal surgeon. Our exhibit will feature the new FERGUSON PLASTIC RETRACTORS, the industry’s widest variety of deep pelvic retractors, the newest Cima– St. Mark’s retractor for Hand Assisted Laparoscopic Deep Pelvic Surgery, our table mounted retractor system, hemorrhoidalligators, latex and non-latex bands for the ligator, suction ligators, anoscopes, rectal retractors, intestinal clamps, scissors, needle holders, probes and directors, and Welch Allyn products. Booth 537 2231 Calle de Luna Santa Clara, CA 95054 Phone: (408) 565-8787 Fax: (408) 986-8643 Website: www.curaseal.com Contact Email: [email protected] Based in Santa Clara, CA Curaseal, Inc. is improving patient quality of life through combining tissue engineering and minimally invasive techniques to deliver next generation benchmark devices, creating better surgical outcomes. Introducing a CE cleared implantable device for treatment of anorectal fistulas, the Curaseal AF™, Curaseal’s next generation benchmark fistula repair technology, combining internal ostium sealing, tissue engineering and device fixation in minimally invasive techniques. Featuring an Engineered Seal, simple procedure (mucosal flap/internal stitching or stapling not required), treatment of high and low fistulas, Curaseal AF delivery catheter, Curaseal AF collagen matrices and integrated secure anchoring. www.curaseal.com Deltex Medical Booth 722 330 E. Coffee Street Greenville, SC 29601 Phone: (884) 527-5913 Fax: (864) 527-5914 Website: www.deltexmedical.com Contact Name: Melissa Till Contact Email: [email protected] Deltex Medical’s EDM+ is a fluid management and cardiac output monitoring system which measures both flow and pressure directly. EDM+ helps anesthetists guide individualized fluid management during Surgery. It is highly responsive in tracking changes in Stroke Volume and Cardiac Output during intervention and is widely used in Enhanced Recovery Programs (ERP). The benefits of ERP show improved outcomes and shorter hospital stays in surgical specialties, including: Colorectal, endocrine, gynaecological, urological, vascular and orthopaedic surgeries. It is rewarding working with leading institutions across the country to adopt individualized fluid management as the initial or part of a bigger enhanced recovery program. 162 Exhibits Entera Health, Inc. Edwards Lifesciences Booth 712 1 Edwards Way Irvine, CA 92614 Phone: (949) 250-2500 Website: www.edwards.com/esr Contact Name: Carol Fields Contact Email: [email protected] ERBE USA, Inc. Enhanced Surgical Recovery Resource Center – an initiative by Edwards Lifesciences. You can reduce post-surgical complications such as AKI, anastomotic leaks, and pneumonia in your moderate to high-risk patients. Take action now to reduce variability and standardize care with hemodynamic optimization through PGDT. Evaluate the clinical evidence of how you can reduce LOS, complications and associated costs, and inform patient transitions from OR to ICU. Start here or visit Edwards.com/ESR. Electro Surgical Instrument Company Booth 622 Booth 223 2225 Northwest Parkway Marietta, GA 30067 Phone: (770) 955-4400 Fax: (770) 955-2577 Website: www.erbe-usa.com Contact Name: Howard Justan Contact Email: [email protected] ERBE USA offers the next generation ESU with Power Dosing Technology and APC™ workstation, VIO®/APC™ 2, with multiple possibilities for open, laparoscopic and endoscopic procedures featuring ENDO CUT® and proprietary PRECISE™, PULSED™ and FORCED™ APC – Argon enhanced tissue effects. In addition, ERBE brings you ERBEJET® 2 Hydrodissection Technology. 37 Centennial St Rochester, NY 14611 Phone: (585) 235-1430 Fax: (585) 235-1438 Website: www.electrosurgicalinstrument.com PLATINUM PARTNER Ethicon Electro Surgical Instrument Company (ESI) offers a wide array of fiberoptic lighted instruments for the colon and rectal surgeon including anoscopes, specula and deep pelvic retractors. We offerrepair service on ESI manufactured instruments as well as instruments of other manufacturers. Elsevier, Inc. Booth 718 2000 Regency Parkway, Suite 255 Cary, NC 27518 Phone: (515) 963-7569 Website: www.enterahealth.com Contact Name: Tom Heck Ethicon US LLC , a Johnson & Johnson company, commercializes a broad range of innovative surgical products, solutions and technologies used to treat some of today’s most prevalent medical issues, such as: colorectal and thoracic conditions, women’s health conditions, hernias, cancer and obesity. Learn more at www.ethicon.com, or follow us on Twitter @Ethicon. Booth 108 1600 JFK Blvd, Ste 1800 Philadelphia, PA 19103 Phone: (215) 239-3722 Fax: (215) 239-3494 Website: www.elsevierhealth.com Contact Name: Kim Pollock Contact Email: [email protected] ELSEVIER is a leading publisher of health science publications, advancing medicine by delivering superior reference information and decision support tools to doctors, nurses, health practitioners and students. With an extensive media spectrum — print, online and handheld, we are able to supply the information you need in the most convenient format. Booth 601 4545 Creek Rd Cincinnati, OH 45242 Phone: 877-ETHICON 384-4266 Website: www.ethicon.com Ferring Pharmaceuticals, Inc. Booth 530 100 Interpace Pkwy Parsippany, NJ 07054 Phone: (973) 796-1600 Fax: (973) 796-1660 Website: www.ferringusa.com Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of gastroenterology, reproductive health, obstetrics, osteoarthritis and urology. To view all of our US offerings, please visit www.ferringusa.com. 163 EXHIBITS SILVER PARTNER Exhibits General Surgery News Booth 137 Halo Medical Technologies, LLC Booth 106 545 W 45th St, 8th Flr New York, NY 10036 Phone: (212) 957-5300 Fax: (212) 957-7230 Website: www.generalsurgerynews.com Contact Name: Diane Lodse Contact Email: [email protected] 1805 Foulk Road Wilmington, DE 19810 Phone: (302) 475-2300 Fax: (302) 475-2301 Website: www.halomedtech.com Contact Name: Jennifer Kinney Contact Email: [email protected] General Surgery News is a monthly newspaper designed to keep general surgeons abreast of the latest developments in the field online, in print, and around the world. The publication features extensive meeting coverage, analysis of journal articles, educational reviews, and information on new drugs and products. Endoanal, Transrectal, and Transperineal Ultrasound. Optional Anorectal Manometry. The Catalyst – affordable, intelligent ultrasound for diagnosing fecal incontinence, staging rectal cancer, and investigating other pelvic floor disorders. Portable and all-in-one cart models.Optimized imaging and proprietary software designed specifically for CRS requirements. True video recording, complete postprocessing capabilities, and EMR-automated reports. Uniquely-configured USB probes are interchangeable during exam, for one comprehensive report. Also available as combined ultrasound/ARM system with Medspira software, on one hardware platform (see separate description under Medspira, booth #428). Entire ultrasound system costs less than half of leading competitive system. Visit us at Booth #106. GI Supply Booth 200 200 Grandview Ave Camp Hill, PA 17011 Phone: (440) 669-9031 Fax: (717) 761-0216 Website: www.gi-supply.com Contact Name: Lisa Szpak Contact Email: [email protected] GI Supply is a medical manufacturer of specialty, endoscopic assist and diagnostic products. Signature products include: Spot® – the first and only FDA cleared non-India ink endoscopic tattoo; Taewoong Through-TheScope (TTS) Stent – the only Esophageal TTS Stentavailable in the US; Polar Wand® –cryotherapy system which ablates tissue throughout the GI tract; RenovaRP™, an automatic paracentesis pump for fast, safe removal of ascites –without glass vacuum bottles; HpFast™ and HpOne™, accurate, easyto-use rapid urease tests for the presumptive identification of H. pylori gastritis. Biteblocs™ – available in a wide range of sizes and styles, designed for specific needs of patients and endoscopic procedures. GMed Booth 211 2125 N Commerce Pkwy Weston, FL 33326 Phone: (954) 659-9310 Fax: (954) 659-9326 Website: www.gmed.com gMed provides the gastroenterology industry with a fully integrated platform consisting of an Electronic Health Record, Endoscopy Report Writer, Practice Management solution, Patient Portal, a Data Analytics tool and Revenue Cycle Management. Fully scalable through the cloud or using an on-site server, gMed’s products are all Meaningful Use Certified and ICD-10 compliant. To find the right gGastro solution for your practice visit www.gmed.com or call 888.577.8801. Halyard Health Booth 422 43 Discovery Suite 100 Irvine, CA 92618 Phone: (949) 293-9298 Website: www.halyardhealth.com Contact Name: Trina Grazier Contact Email: [email protected] Halyard Health is a medical technology company focused on preventing infection, eliminating pain and speeding recovery. Come to our booth to learn about the ON-Q* Pain Relief System which reduces narcotic usage and provides better pain relief than narcotics alone in post-surgical patients. For more information, visit www.halyardhealth.com. Hawaiian Moon 321 S. Missouri Ave Clearwater, FL 33756 Phone: (888) 256-3276 Website: www.aloecream.biz Contact Email: [email protected] 164 Booth 423 Exhibits Booth 225 SILVER PARTNER 2516 Jane St Pittsburgh, PA 15203 Phone: (412) 559-1813 Website: www.helomics.com KARL STORZ Endoscopy-America, Inc. Helomics™ Corporation, a privately-held personalized healthcare company. We are dedicated to improving patient outcomes through personalized comprehensive tumor profiles that help to inform effective treatment selection. We utilize a proprietary set of laboratory platforms leveraging both live and fixed cellular analysis allowing physicians to characterize their patient’s malignant tumors on a personalized basis. Our novel molecular and cellular markers along with our bioinformatics services can inform medical practice with specific biological processes of each individual’s cancer. Hitachi ALOKA Medical Konsyl Pharmaceuticals, Inc. Hitachi Aloka Medical’s commitment to ultrasound for surgeons offers a wide range of consoles and specifically designed transducers to meet the needs of every surgeon. Recognized for our superior image quality, system reliability and use of cutting edge technology, we remain the standard in the field of ultrasound for surgeons. PLATINUM PARTNER Booth 401 1020 Kifer Rd Sunnyvale, CA 94086 Phone: (510) 882-6948 Website: www.intuitivesurgical.com Intuitive Surgical is the global leader in minimally invasive, robotic-assisted surgery. Its da Vinci® System – with a 3D-HD vision system and EndoWrist® instrumentation – enables surgeons to offer a minimally invasive approach for a range of complex procedures. With more than 2,500 Systems installed in hospitals around the world, the da Vinci System is enabling surgeons to redefine the standard-of-care in a range of specialties: urology, gynecology, head and neck, general surgery, cardiac and thoracic surgery. Irrisept KARL STORZ offers a range of state-of-the-art products for surgical procedures, including colorectal procedures. Among the technology solutions we offer are KOH macro needle holders that can be dismantled and re-assembled for separate cleaning and sterilization, and our 3-mm Mini laparoscopy Instrument Set that offers an ideal alternative to single-site procedures. Booth 430 10 Fairfield Blvd Wallingford, CT 06492 Phone: (203) 269-5088/(800) 872-5652 Fax: (203) 269-6075 Website: www.hitachi-aloka.com Contact Email: [email protected] Intuitive Surgical, Inc. Booth 619 2151 E Grand Ave El Segundo, CA 90245-2838 Phone: (800) 421-0837 Website: www.karlstorz.com Contact Name: Julia Benoit Contact Email: [email protected] Booth 318 8050 Industrial Park Rd Easton, MD 21601 Phone: (410) 822-5192 Fax: (410) 822-5264 Website: www.konsyl.com Contact Name: Kim Vaccari Contact Email: [email protected] LABORIE Booth 133 400 Ave D, Ste. 10 Williston, VT 05495-7828 Phone: (800) 522-6743 Fax: (802) 878-1122 Website: www.laborie.com Contact Name: Craig Middleton Contact Email: [email protected] LABORIE, the leader in Pelvic Floor Diagnostics and Rehabilitation, is your source for Complete Colorectal Assessment, including Anorectal Manometry – to analyze pressure and function of the rectum and anal sphincter; Electro diagnostics - to evaluate patients with suspected pathologies with neurological involvement; Pelvic Floor Rehabilitation - for a conservative treatment option; and Transrectal Ultrasound - a portable and easy-to-use probe for anal canal visualization. We offer a full range of solutions for all budgets, clinical and research needs. Welcome to our MEDIWATCH CUSTOMERS - Learn how we are here to support you! Booth 139 1665 Lakes Pkwy, Ste 102 Lawrenceville, GA 30043 Phone: (770) 807-3355 Fax: (866) 788-1079 Website: www.irrisept.com Contact Email: [email protected] 165 EXHIBITS Helomics Exhibits Lexion Medical Booth 322 Mederi Therapeutics, Inc. Booth 214 545 Atwater Circle St. Paul, MN 55103 Phone: (651) 635-0000 Fax: (651) 636-1671 Website: www.lexionmedical.com Contact Email: [email protected] 800 Connecticut Ave Norwalk, CT 06854 Phone: (203) 930-9980 Website: www.secca-therapy.com Contact Name: Sheila Doyle Contact Email: [email protected] LEXION Medical is a world leader in the design and manufacturing of advanced technologies for gas conditioning in minimally invasive surgical procedures. Our goal is to provide innovative technologies that help patients return to their normal, productive lives faster. Appropriately conditioning the gas before it enters the body and when it leaves the patient can dramatically help patients, surgeons, and make operating rooms more efficient with improved clinical outcomes. Mederi Therapeutics manufactures innovative non-ablative radiofrequency (RF) therapies for GI disorders. Secca for bowel incontinence fills the void between failed conservative therapies and invasive and expensive alternatives, like surgery or implants. Secca uses controlled delivery of RF energy to the muscle of the IAS. Recent studies show the underlying mechanism of Secca is a regeneration of muscle tissue, including a growth in muscle fibers and an improvement in collagen. This allows restored sphincter function and explains how Secca provides relief for patients with fecal incontinence. Secca therapy is minimally invasive, outpatient, and is available in more than 35 countries. LifeCell Booth 224 95 Corporate Drive Bridgewater, NJ 08807 Phone: (908) 9471667 Website: www.acelity.com Contact Name: Shawn Kennedy Contact Email: [email protected] Medical Measurement Systems (MMS) LifeCell Corporation, an Acelity Company, develops and markets innovative products for reconstructive, cosmetic and general surgery. Core LifeCell™ products include: AlloDerm® Regenerative Tissue Matrix and Strattice™ Reconstructive Tissue Matrix for breast reconstruction, revision and abdominal wall repair surgery; and REVOLVE™ System for high-volume fat processing. GOLD PARTNER Mallinckrodt Pharmaceuticals Booth 329 12481 High Bluff Drive Ste 200 San Diego, CA 92130 Phone: (858) 436-1464 Fax: (858) 436-1401 Website: www.mallinckrodt.com Contact Name: Joe Robitaille Contact Email: [email protected] Mallinckrodt is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Mallinckrodt is an industry leader in intravenous analgesia for acute pain management. Visit www.mallinckrodt.com to learn more. Booth 716 53 Washington Street, Suite 400 Dover, NH 03820 Phone: (800) 236-9310 Fax: (603) 750-3155 Website: www.mmsusa.net Contact Name: Rebecca Schmitt Contact Email: [email protected] MMS offers GERD diagnostic and GI Motility products. Our Ohmega Ambulatory Impedance-pH recorder is an easy to use, small and lightweight recorder that combines impedance and pH recording offering complete reflux measurement. MMS supplies a broad range of impedance and pH catheters. Our Solar GI HRM/HRIM/HRAM systems have revolutionary QuickView software with the automatic classification per the latest edition of the Chicago classification. HRM analysis becomes easier, quicker and better. The 3D Esophageal Pressure Topography and 360 degrees tube view for LES and HRAM provide even more information. MMS HRM can be performed with solid state or single-use/multi-use water perfused catheters. Medspira, LLC Booth 428 2718 Summer St NE Minneapolis, MN 55413 Phone: (800) 345-4502 Fax: (612) 789-2708 Website: www.medspira.com Contact Name: Judy Carter Contact Email: [email protected] Medspira partners with leading medical institutions to develop and market medical devices that provide cost effective diagnosis and treatment for a variety of medical conditions. Medspira’s mcompass is a portable solution to navigating precision anorectal manometry, and now we are happy to be able to include biofeedback pelvic floor retraining (pending FDA approval). The mcompass is a mobile, portable, and affordable device designed to help patients suffering from fecal incontinence and chronic constipation. 166 Exhibits Microline Surgical, Inc. Medtronic Booth 311 710 Medtronic Parkway Minneapolis, MN 55432 Phone: (763) 514-4000 Fax: (763) 514-4879 Website: www.medtronic.com At Medtronic, we’re committed to Innovating for life by pushing the boundaries of medical technology and changing the way the world treats chronic disease. Our medical technologies help make it possible for millions of people to resume everyday activities, return to work, and live better, longer. Products include the InterStim® System, providing Sacral Neuromodulation for Bowel Control and Bladder Control. Memorial Healthcare System Booth 140 4320 Sheridan Street Hollywood, FL 33021 Phone: (954) 265-0902 Fax: (954) 989-7959 Website: www.memorialphysician.com/mhs.net Contact Name: Ken Bolis Contact Email: [email protected] Microline Surgical utilizes a reposable platform to deliver high-quality laparoscopic instruments to healthcare facilities worldwide. Our reusable, ergonomically designed hand pieces are paired with single-use tips to configure hybrid disposable/re-usable devices offering precision and cost-effectiveness. neoSurgical, Inc. Booth 138 275 Grove St., Suite 2-400 Newton, MA 02466 Phone: (617) 663-4999 Email: [email protected] Website: www.neosurgical.com Novadaq Booth 213 5090 Explorer Drive Mississauga, ON L4W 4T9 Canada Phone: (800) 230-3352 Fax: (800) 888-2419 Website: www.novadaq.com Contact Email: [email protected] BRONZE PARTNER Merck & Company Booth 613 50 Dunham Road Beverly, MA 01915 Phone: (978) 922-9810 Fax: (978) 922-9209 Website: www.microlinesurgical.com Booth 317 600 Corporate Drive Lebanon Township, NJ 08833 Phone: (908) 236-1125 Fax: (908) 236-4717 Website: www.merck.com Today's Merck is working to help the world be well. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. Merck. Be Well. For more information, visit www.merck.com. Never before in the history of worldwide healthcare, has there been such a need to achieve and demonstrate the highest quality of care and outcomes, at a lower cost. NOVADAQ’s global mission is to empower medical professionals and hospitals by providing clinically-relevant, innovative fluorescence imaging solutions to enhance the lives of patients and their surgeons, while reducing healthcare costs. As pioneers, NOVADAQ developed SPY fluorescence imaging technology to provide surgeons and medical practitioners with real-time visualization of blood flow or perfusion, leading to improved outcomes and reduced costs without exposing the patient to harmful ionizing radiation or contrast dye toxicity. 167 EXHIBITS PLATINUM PARTNER Exhibits NovaTract Surgical, Inc. Booth 426 170 Fort Path Road, Suite 13 Madison, CT 06433 Phone: (203) 533-9710 Website: www.novatract.com Contact Email: [email protected] NovaTract Surgical, Inc. offers multiple minimally invasive retraction options for conventional, reduced-port and robotic procedures. Both the NovaTract™ Laparoscopic Dynamic Retractor and the NovaGrasp™ Laparoscopic Tethered Grasper are single-use, 5mm devices, offering improved tissue manipulation, an exclusive tension adjusting system, and the ability to easily modify the angle of retraction as needed. Not requiring a dedicated port, the NovaTract™ family of products helps facilitate improved visualization during complex laparoscopic and robotic procedures. OBP Medical Booth 620 360 Merrimack St, Bldg 9 Lawrence, MA 01843 Phone: (978) 291-6853 Fax: (866) 636-2718 Website: www.obpmedical.com Contact Name: Matthew Traub Contact Email: [email protected] OBP Medical is the leading global developer of single-use, self-contained, illuminating medical devices. Our single-use lights are the brightest on the market, allowing for optimal visualization during procedures. Our innovative products are used in physician offices, surgery centers and more than 2,000 hospitals throughout the U.S., as well as healthcare facilities worldwide. SILVER PARTNER Olympus America Inc. Booth 513 3500 Corporate Pkwy Center Valley, PA 18034 Phone: (484) 896-5000 Fax: (484) 896-7133 Olympus is advancing minimally invasive surgical solutions designed to help Surgeons improve clinical outcomes through our innovative world’s only technologies: ENDOEYE FLEX 3D, the only articulating HD 3D video laparoscope; THUNDERBEAT, the only integration of both advanced bipolar and ultrasonic energies delivered simultaneously from a single, multifunctional instrument for laparoscopic and open procedures. Our commitment to clinical support, professional education, flexible service and financing packages, and knowledgeable local account management make Olympus the partner of choice. Through innovative diagnostic and therapeutic solutions, Olympus is transforming the future of minimally invasive surgery. Visit our Booth to discover where innovation can take you. Otto Trading, Inc. Booth 220 1921 Carnegie Ave Suite C Santa Ana, CA 92705 Phone: (714) 540-5595 Fax: (949) 660-8073 Website: www.irestmassager.com Contact Name: AdemKutlug Contact Email: [email protected] Ovesco Endoscopy USA, Inc. Booth 100 455 Los Gatos Blvd., Suite 101 Los Gatos, CA 95032 Phone: (408) 884-8976 Fax: (408) 608-2077 Website: www.ovesco.com Contact Name: Geoffrey Yates Contact Email: [email protected] Ovesco Endoscopy USA is a medical device company operating in the fields of flexible endoscopy and endoluminal surgery. The company develops, manufactures and markets innovative products for the treatment of gastrointestinal disease. Innovative endoscopic clipping systems are Ovesco’s hallmark. The OTSC – Over-The-Scope Clip is Ovesco’s product platform for the treatment of gastrointestinal hemorrhage and for endoscopic digestive organ wall closure. Please visit our website www.ovesco.com for more information. Pacira Pharmaceuticals, Inc. Booth 212 5 Sylvan Way Parsippany, NJ 07054 Phone: (973) 254-3575 Fax: (973) 267-0060 Website: www.pacira.com Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development of products that meet the needs of acute care practitioners and their patients. Its lead product, EXPAREL® (bupivacaine liposome injectable suspension), was launched in 2012. EXPAREL utilizes the Pacira proprietary delivery technology DepoFoam®. For more information, visit http://www.pacira.com. Plasma Surgical 1129 North Meadow Parkway, Suite 100 Roswell, GA 30076 Phone: (678) 892-6730 Website: www.plasmasurgical.com Contact Email: [email protected] 168 Booth 218 Exhibits Booth 623 336 W Passaic St Rochelle Park, NJ 07662 Phone: (201) 845-3990 Fax: (201) 845-3993 Website: www.irc2100.com Contact Name: Andrew Gould Infrared Coagulation has long been the leading treatment for early and mid-stage hemorrhoids. Now, it is also utilized to treat AIN. The IRC2100™ is easy to use, safe, and well tolerated. Its clinical effectiveness has been proven for thirty years. Please visit us for more information as to how infrared coagulation can benefit your practice. ResiCal, Inc. Booth 120 PO Box 489 Orchard Park, NY 14127 Phone: (716) 472-0021 Fax: (716) 662-5871 Website: www.resical.com Contact Name: Brooks Cole Contact Email: [email protected] ResiCalInc provides patient samples for Calmol 4 ® Hemorrhoidal Suppositories. Calmol 4 is non-prescription and available by special order at any pharmacy counter. Active ingredients are Cocoa Butter and Zinc Oxide which lubricate and heal hemorrhoids, fissures, inflamed tissues and other anorectal disorders. Calmol 4 contains no topical steroids, no anesthetics, no vaso constrictors or other active ingredients that can be absorbed internally or can interact with other internal medications. Calmol 4 contain no package warnings for high blood pressure, diabetes, heart, prostate or thyroid disease. Calmol 4 Patient samples and clinical information may be requested at www.Calmol4.com SILVER PARTNER Richard Wolf Medical Instruments Corp. Booth 308 353 Corporate Woods Pkwy Vernon Hills, IL 60061 Phone: (800) 323-WOLF (9653) Fax: (847) 913-6846 Website: www.richardwolfusa.com Contact Name: Evan Mix Contact Email: [email protected] We are a global business with headquarters in Germany and over a century of tradition and expertise in the field of endoscopy. We develop, manufacture and market specific system solutions for minimally invasive human medicine. Sandhill Scientific Booth 528 9150 Commerce Center Circle, #500 Highlands Ranch, CO 80129 Phone: (303) 470-7020 Fax: (303) 470-2975 Website: www.sandhillsci.com Contact Name: Stuart Wildhorn Contact Email: [email protected] Sandhill Scientific continues to be a recognized global leader in G.I. Diagnostics. The broad capabilities of our new insight Ultima Manometry Platform include multiple configurations of High Resolution Anorectal Manometry(HRAM) using either directional or circumferential sensors, as well as linear and radial air charged configurations. The BioVIEW Acquisition and Analysis software program features SyncVIEW, a multidimensional wireframe representation of the anal canal. And our industry leading Sandhill University provides the most comprehensive training and education options to meet the clinical needs of users around the world. Sanofi Biosurgery Booth 323 55 Cambridge Parkway Cambridge, MA 02142 Phone: (908) 268-1229 Website: www.sanofi.com Sanofi Biosurgery takes a diversified approach to medicine. As part of the Patient Centered Solutions group, we address patients’ unmet medical needs by providing best-in-class products for symptomatic relief and regenerative care. These include a wide range of innovative devices and biologics across a variety of indications, include: • Osteoarthritis pain relief • Adhesion prevention following surgery • Temporary endovascular occlusion of blood vessels • Cartilage repair • Treatment of severe burns Sanofi Biosurgery provides unique, differentiated, and innovative products for large and growing populations, resulting in sustainable growth opportunities. Sebela Pharmaceuticals, Inc. Booth 316 645 Hembree Pkwy Ste I Roswell, GA 30076 Phone: (678) 736-5204 Fax: (678) 736-5201 Website: www.sebelapharma.com Contact Name: Autumn Akin Contact Email: [email protected] Sebela Pharmaceuticals Inc. is a gastroenterology focused company located in Roswell, GA. Sebela’s product portfolio includes Analpram HC Cream, Analpram Lotion and Analpram Advanced Kit. 169 EXHIBITS Redfield Corporation Exhibits Shire Booth 219 550 Hills Drive, 3rd Floor Bedminster, NJ 07921 Phone: (908) 375-7596 Website: www.shire.com Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. Please visit www.shire.com Sigma Tau Pharmaceuticals Booth 521 9841 Washingtonian Blvd, Ste 500 Gaithersburg, MD 20878 Phone: (301) 670-2185 Website: www.sigmatau.com Contact Name: Mary Oenean Contact Email: [email protected] Booth 429 7248 S Tucson Way Centennial, CO 80112 Phone: (303) 790-9411 Fax: (303) 792-2606 Website: www.sontecinstruments.com Contact Name: Dennis Scanlan Contact Email: [email protected] Booth 122 333 Quarry Rd Milford, CT 06460 Phone: (203) 799-2400 Fax: (203) 799-2401 Website: www.surgiquest.com SurgiQuest, Inc. is the maker of The AirSeal® System, the world’s first and only integrated access system for Minimally Invasive Surgery that provides stable pneumo, continuous smoke evacuation, and valve-free cavity access to enhance surgeon capabilities, improve anesthesia parameters, protect OR staff, and reduce OR time in both robotic and laparoscopic surgery. TEI Biosciences, Inc. Sigma-Tau Pharmaceuticals, Inc. manufactures and distributes refrigerated VSL#3, a potent probiotic medical food. VSL#3 is for the dietary management of an ileal pouch, ulcerative colitis or irritable bowel syndrome. VSL#3 is one of the most clinically evaluated probiotics available, with over 140 published citations listed. The five formulations of VSL#3 in the USA deliver from 112. 5 to 900 billion bacteria per serving making VSL#3 one of the most potent probiotics available.VSL#3 Double Strength (DS) is only available with a prescription due to its potency. Sontec Instruments, Inc. SurgiQuest, Inc. Booth 617 1000 Winter St, Suite 4900 Waltham, MA 02451 Phone: (866) 524-0022 Fax: (888) 623-2259 Website: www.teibio.com Contact Name: Customer Service Contact Email: [email protected] TEI Biosciences is a Boston-based, leading biomedical company, applying its expertise inregenerative medicine to develop and commercialize novel biologicdevices for a broad spectrum of soft tissue repair, reinforcement, and reconstruction applications. THD America Booth 627 9 Tech Circle, Suite 103 Natick, MA 01760 Phone: (866) 375-9442 Fax: (813) 626-0303 Website: www.thdamerica.com Contact Email: [email protected] The Medicines Company Booth 524 Sontec offers a comprehensive selection of exceptional hand held surgical instruments, headlights and loupes available to the discriminating surgeon. There is no substitute for quality, expertise and individualized service. Sontec’s vast array awaits your consideration at our booth. 8 Sylvan Way Parsippany, NJ 07054 Phone: (973) 290-6000 Fax: (973) 656-9898 Website: www.themedicinescompany.com Contact Name: Siobhan Macre Contact Email: [email protected] Stryker The Medicines Company’s Purpose is to save lives, alleviate suffering, and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide in its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland. Booth 436 77 Great Valley Parkway Malvern, PA 19355 Phone: (610) 407-5209 Fax: (215) 253-5006 Website: www.stryker.com Contact Name: Stephen Chou Contact Email: [email protected] Stryker is the dedicated to providing cutting edge medical solutions in a variety of surgical specialties. This year we are proud to exhibit Vitagel, our revolutionary Surgical Hemostat formulated with Microfibrillar Collagen. 170 Exhibits Booth 210 43 New Scotland Ave, MC 28 Albany, NY 12208 Phone: (518) 262-5079 Fax: (518) 262-5528 Website: www.oley.org Contact Email: [email protected] The Oley Foundation, the home nutrition support community’s Help along the way, provides medical information and peer support to enhance the lives of home tube-fed and IV-fed adults and children through newsletters, an online community forum, annual and regional conferences, regional volunteers, advocacy, a video library, and more. Founded in 1983 by a patient and clinician, the foundation serves 14,000+ people worldwide. All services, including membership are free of charge. Medical information is peer reviewed. Enjoy a visit to www.oley.com and be sure to stop by booth #210. The Prometheus Group Booth 626 1 Washington St, Ste 303 Dover, NH 03820 Phone: (603) 749-0733 Fax: (603) 749-0511 Website: www.theprogrp.com Contact Name: Richard Poore Contact Email: [email protected] Torax Medical, Inc. United Ostomy Association of America, Inc Booth 217 PO Box 512 Northfield, MN 55057 Phone: (800) 826-0826 Fax: (507) 645-5168 Website: www.ostomy.org Contact Email: [email protected] The United Ostomy Associations of America, Inc. (UOAA) is dedicated to advocating for the intestinal/urinary diversion community and to providing information and service to, and for, its affiliated support groups and their members. UOAA has 350 Affiliated Support Groups in the United States which are organized for the benefit of people who have or will have intestinal or urinary diversions, and their caregivers. UOAA works toward a society where people with ostomies and intestinal or urinary diversions are universally accepted and supported socially, economically, medically, and psychologically. All are welcome at our National Conference in St. Louis September 1-6, 2015. Wolters Kluwer Health Booth 144 Two Commerce Square Philadelphia, PA 19103 Phone: (612) 259-8114 Fax: (612) 677-3059 Contact Name: Joey-Rose Jester Contact Email: [email protected] Booth 102 4188 Lexington Ave North Shoreview, MN 55126 Phone: (651) 361-8900 Fax: (651) 361-8910 Website: www.toraxmedical.com Contact Name: Maggie Wallner Contact Email: [email protected] Torax® Medical, Inc. is a privately held medical device company headquartered in St. Paul, Minnesota that develops and markets products designed to treat sphincter disorders utilizing its technology platform, Magnetic Sphincter Augmentation (MSA). The FENIX® Continence Restoration System is comprised of interlinked titanium beads with magnetic cores. The magnetic attraction between the beads augments the anal sphincter muscles in patients with severe fecal incontinence. The device is implanted via a perineal incision. The FENIX device is CE marked and is not available for sale in the United States. For more information, please visit www.toraxmedical.com. Wolters Kluwer Health is a global provider of information, business intelligence and point-of-care solutions for the healthcare industry. We are the proud publisher of Diseases of the Colon & Rectum, the world’s leading publication in colorectal surgery and the Official Journal of the American Society of Colon and Rectal Surgeons (ASCRS). Additional brands include Lippincott Williams & Wilkins, Lippincott Nursing Solutions and Ovid online. We proudly offer specialized publications and software for physicians, nurses, students and clinicians. Please visit our booth to browse our comprehensive product line. Xodus Medical, Inc. Booth 326 702 Prominence Dr New Kensington, PA 15068 Phone: (724) 337-5500 Fax: (724) 337-0555 Website: www.xodusmedical.com Xodus Medical is featuring its Pink Pad® Patient Positioning System, the clinically-preferred product for increasing patient safety in steep Trendelenburg, preventing patient slippage in colorectal procedures. The Pink Pad places no pressure on the neck, shoulders or arms; safeguarding against nerve damage; while protecting the skin from breakdown and pressure ulcers. The single-use design eliminates potential cross-contamination, standardizes preparation, reduces setup time and saves money. It is now also available in a longer version, The Pink Pad® XL, providing a better fit for taller patients. See our new One-Step face and arm protectors and full line of surgical safety products. 171 EXHIBITS The Oley Foundation, Inc. ePoster Theater 172 ePoster Station #2 ePoster Station #4 154 #3 #5 Merck Executive Suite ePoster Station ePoster Station ePosters Wolters Kluwer Health 144 #1 ePoster Station 142 140 Memorial 138 139 Irrisept & Tech 136 137 General Surgery News System neoSurgical, 11Health ConvaTec Healthcare Inc. Product Theater AMI 134 132 #7 ePoster Station 130 Bellevue American Pharmacy Medical 133 biolitec Laborie 135 637 613 Microline Surgical 617 TEI Biosciences 619 Karl Storz Endoscopy 120 CCF 437 423 Hawaiian Moon 425 Braintree Labs 429 Sontec 431 CONMED ENTRANCE 401 Stryker 108 F&B 323 Sanofi 329 Mallinckrodt Pharmaceuticals 337 106 104 CRC Press/ Taylor & Francis Xodus Medical Ovesco Endoscopy USA, Inc 100 227 209 BK Ultrasound/ BK Medical 211 gMed 213 Novadaq Tech 217 United Ostomy 219 Shire 223 ERBE USA 225 Helomics F&B 102 308 Richard Wolf Medical 312 Coloplast 314 CS Surgical 316 Sebela 318 Konsyl Pharmaceuticals 322 Lexion Medical 326 Torax Medical 301 Covidien 311 Medtronic 317 Merck & Company 422 Halyard Health 426 NovaTract Surgical 428 Medspira 430 Hitachi Aloka Medical 436 Halo Elsevier, Medical Inc Tech 411 Applied Medical Lounge 522 Ambry Genetics 524 The Medicines Company 528 Sandhill Scientific 530 Ferring Pharmaceuticals 537 Curaseal Intuitive Surgical 513 Olympus 521 Sigma-Tau Pharmaceuticals 523 Cooper Surgical 527 Cook Medical 531 American College of Surgeons 538 F&B OBP Medical 620 ResiCal Inc 601 Ethicon 712 Edwards Lifesciences 716 Medical Measurement Systems 718 Entera Health, Inc 622 Electro Surgical Instrument 623 Deltex Medical 722 626 The Prometheus Group 630 627 Redfield Corp THD USA F&B 736 ACell, Inc SurgiQuest 126 122 #6 ePoster Station LifeCell A KCI 200 GI Supply 202 Caris Life Sciences 204 Colon Cancer Alliance 206 American Dist of Colon & Rectal Supplies 208 Bard Davol 210 The Oley Foundation 212 Pacira Pharmaceuticals 214 Mederi Therapeutics 216 Cine-Med 218 Plasma Surgical 220 Otto Trading 222 Birchwood Lab 224 Exhibit Hall Map W M 173 200 Up 202 Speaker Ready Room 201 207 W M M W 204 Boylston Hallway 203 208 Registration MAPS Product Theater ePosters General Session Online CME HALL C South Lobby AUDITORIUM M W Level 2 205 209 W M ENTRANCE Exhibits HALL D 206 210 On-Going Video Room Hynes Convention Center #8 ePoster Station 174 #9 ePoster Station Level 3 Hynes Convention Center Sheraton Boston Hotel Second Floor, Plaza Level ENTRY D REPUBLIC FOYER A REPUBLIC BALLROOM B REPUBLIC CORRID. C BACK BAY BALLROOM EAST IND. FOYER WEST EAST GRAND BALLROOM INDP. BLLRM B A LIBERTY BALLROOM A B C GRAND BALLROOM PREFUNCTION CONSTITUTION BALLROOM A B 175 MAPS WEST Sheraton Boston Hotel Third Floor C COMMONWEALTH BOARDROOM H B G A F E KENT D JEFFERSON HAMPTON FAIRFAX GARDNER CONF. EXETER CLARENDON DALTON BERKELEY 176 BEACON COMPLEX A-H Ethicon is committted to enabling your success s in colorectal surgery. Ethicon’s innovations work with your preferred surgical approach, to meet the unique challenges of minimally invasive colo orectal surgery. Whether your case calls for a laparoscopic, robot-assisted or open approach, Ethicon has a full range of solutions designe ed to satisfy the needs of your technique choice. ECHELON FLEX™ GST System HARMONIC ACE®+7 Shears with Advanced Hemostasis Endo Endo doscco opic pic Cur C ved Cu Intralumin uminal um miinal nal St n Stapler Staple pler Come see us at Bo ooth 601 to learn more about Ethicon's off fferings in colorecctal surgery. © 2015 Ethicon, Inc. All rights reserved. 028376-150122